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Resumen 
 La nanociencia y la nanotecnología tratan principalmente con la síntesis, 
caracterización, exploración y explotación de materiales nanoestructurados. Estos 
materiales se caracterizan por tener al menos una de sus dimensiones en el rango 
nanométrico (1 nm = 10-9 m). Los nanomateriales constituyen un puente entre las 
moléculas y los sistemas macroscópicos. Las propiedades físicas y químicas de los 
nanomateriales pueden diferir considerablemente de la de los átomos/moléculas simples 
o de los materiales macroscópicos de la misma composición. La particularidad de sus 
características nos conduce a la obtención de nuevos dispositivos y a su aplicación en la 
mejora de tecnologías ya existentes o en el desarrollo de unas nuevas.  
 La nanociencia y la nanotecnología han crecido explosivamente en las últimas 
dos décadas debido a la creciente disponibilidad de nuevos métodos de síntesis de 
nanomateriales así como de herramientas para su caracterización y manipulación. De 
igual manera, el nivel de entendimiento y conocimiento de las propiedades eléctricas, 
ópticas y magnéticas de las nanoestructuras de materiales semiconductores, metales y 
poliméricos ha avanzado significativamente.  
 Las herramientas de caracterización tales como las miscroscopías electrónicas, 
cristalografía,  espectroscopía, entre otras, han permitido seguir y controlar el tamaño, la 
forma y la estructura de los nanomateriales. Sin embargo, la nanociencia y 
nanotecnología aún cuentan con un enorme campo de investigación y 
perfeccionamiento en lo que concierne al diseño, síntesis, caracterización y aplicación 
de sistemas nanométricos. 
 Una de las áreas de la nanotecnología que aún se encuentra en una etapa de 
desarrollo inicial es la nanomedicina.  Ésta nueva rama de la nanotecnología involucra 
su aplicación al cuidado de la salud humana y se encuentra actualmente en una etapa de 
crecimiento. El uso de la nanotecnología ha permitido crear nuevos sistemas que 
revolucionarán la forma en que se diagnostica y se trata un gran número de 
enfermedades. Entre los nuevos nanomateriales que se han utilizado para estos fines 
podemos encontrar nanopartículas y nanocápsulas poliméricas, liposomas, micelas, 
nanopartículas magnéticas, nanopartículas semiconductoras (quantum dots), 
nanopartículas metálicas de diferentes geometrías, nanotubos de carbono, grafeno, 
nanodiamantes,  dendrímeros, nanoestructuras basadas en biomoléculas (ácidos 
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nucléicos, proteínas, cápsides víricas), por mencionar algunos. Estas nanoestructuras 
ofrecen propiedades diferentes, y podríamos decir mejoradas con respecto a la forma 
macroscópica del material que las compone debido a su tamaño nanométrico.  
 Por ejemplo, nanopartículas poliméricas y liposomas se han venido utilizando en 
el tratamiento de enfermedades para transportar fármacos y liberarlos de manera 
controlada específicamente en el sitio del tumor. Nanopartículas magnéticas 
modificadas se han utilizado como agentes de contraste en imagen por resonancia 
magnética con excelentes resultados. De igual forma, también se han utilizado 
nanopartículas de oro como agentes fototerapéuticos, un nuevo tipo de terapia contra el 
cáncer en la cual las células malignas son destruidas gracias a la capacidad de las 
nanopartículas de oro de absorber energía lumínica y convertirla en calor. 
  Algunos ejemplos de nanotransportadores que han sido aprobados para su 
aplicación médica son:  
• Doxil, liposomas cargados con doxorubicina, que fue el primer sistema basado 
en liposomas que recibió la aprobación de la Agenica del Medicamente 
americana (FDA en sus siglas en inglés). 
• Abraxane, conjugados de albúmina y paclitaxel de 130 nm de tamaño, también 
aprobado por la FDA como tratamiento de segunda línea contra el cáncer de 
mama.  
• Combidex (ferumoxtran-10), agente de contraste basado en nanopartículas de 
óxido de hierro, que está siendo utilizado para la diferenciación de ganglios 
linfáticos cancerosos y normales. 
• DaunoXome, liposomas cargados con el agente quimioterapéutico 
daunorubicina. 
• Ambisome, liposomas cargados con el antifúngicida amfotericina. 
• Genexol-PM, partículas poliméricas formadas por el copolímero PEG-PLGA 
cargaas con el fármaco anticancerígeno paclitaxel. 
• DE-310, complejo de dextrano y camptotecina para el tratamiento de tumores de 
pulmón, colon y mama. 
Por otra parte, las formas tradicionales de suministrar fármacos en muchas 
ocasiones no son las más eficientes, pudiendo llegar a ser bastante agresivas con los 
pacientes, prolongadas y costosas. El uso de nanomateriales en el área médica permitirá 
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reducir las dosis, los tiempos y los costes de los tratamientos. De igual forma, la 
incorporación de nuevas formas de contraste para imagen y diagnóstico permitirá 
realizar una evaluación en tiempo real de la eficiencia del régimen de tratamiento que se 
ha elegido, facilitando de esta forma modificar y ajustar las dosis de acuerdo a la 
respuesta de cada paciente (medicina personalizada), así como la detección temprana de 
enfermedades.  
 La combinación de agentes terapéuticos y diagnósticos en un solo sistema da 
origen a un nuevo concepto, la llamada teragnóstica. Un sistema teranóstico es capaz de 
tratar la enfermedad al mismo tiempo que sirve como agente de diagnóstico y de 
visualización de la misma.  
 Además de la combinación de las dos funcionalidades, terapia y diagnosis, 
también es deseable la incorporación de múltiples elementos que permitan abordar la 
enfermedad desde varios ángulos, de tal forma que las debilidades que presenta un 
agente terapéutico/diagnóstico sean subsanadas con las fortalezas de otro y viceversa (la 
denominada multiterapia o terapia multimodal).  
 La principal característica que deben cumplir estos nuevos sistemas 
teragnósticos es su capacidad de dirigirse y acumularse específicamente en el lugar 
donde se espera que realicen su función y, así, evitar un diagnóstico errado o daños a 
tejidos sanos. Por ejemplo, la doxorubicina, uno de los fármacos más utilizados en el 
tratamiento de varios tipos de cáncer, puede causar mielodepresión y cardiotoxicidad 
además de potenciar la toxicidad de otros agentes anticancerígenos. Su vía de 
administración es estrictamente intravenosa, puesto que toda extravasación puede 
producir necrosis del tejido circundante y se requieren altas dosis para lograr 
concentraciones en el organismo que sean terapéuticamente efectivas. Por lo tanto, es 
deseable un sistema capaz de transportar el fármaco por el torrente sanguíneo de forma 
protegida, que disminuya su contacto con cualquier otro órgano o tejido sano,  que se 
dirija al sitio del tumor, que nos indique su localización y distribución, y que sea 
activable remotamente para liberar su carga y ejercer su actividad terapéutica. 
 Un sistema teragnóstico dirigible supondría un avance enorme en el tratamiento 
de enfermedades como el cáncer y, sin lugar a dudas ,la nanotecnología ofrece múltiples 
herramientas para hacer realidad estas ideas. 
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 Por todo ello, el objetivo de esta Tesis Doctoral ha sido diseñar, sintetizar, 
caracterizar y probar la eficiencia de nuevos sistemas nanoteragnósticos 
multifuncionales capaces de efectuar eficientemente el tratamiento, diagnóstico y 
visualización de células tumorales Para ello, se han sintetizado una serie de 
nanoplataformas que combinan múltiples terapias y varios métodos de visualización y 
diagnóstico.  
 Por un lado, se han incorporado la doxorubicina (DOXO) como agente 
quimioterapéutico, el verde-indocianina (ICG, indocyanine green) como 
fotosensibilizador para terapia fotodinámica (photodynamic therapy, PDT) y 
nanoestructuras de oro, que combinan las propiedades ópticas de las nanocorazas 
(nanoshells) y de las nanostrellas de oro, como agentes para terapia fototérmica 
(photothermal therapy, PTT) y transportadores del principio activo quimiterapétutico. 
Por otra parte, se han incorporado nanopartículas superparamágneticas de óxido de 
hierro (SPIONs - Superparamagnetic Iron Oxide Nanoparticles) como agentes de 
visualización por resonancia magnética y, además, se ha tomado ventaja de la 
posibilidad de guiar las nanoplataformas mediante la aplicación de un campo magnético 
externo. La DOXO y la ICG además de agentes terapéuticos son moléculas 
fluorescentes, por lo que es posible utilizarlas como agentes de contraste ópticos, 
especialmente la ICG cuyas longitudes de onda de excitación y emisión (780 y 820 nm, 
respectivamente) caen dentro del rango de la llamada “ventana biológica” del espectro 
electromagnético, la región en la cual la absorción del agua y de la hemoglobina, 
principal cromóforo de la sangre, presentan su máxima transmitancia. Ambas, DOXO e 
ICG, han sido utilizadas como agentes de contraste in vitro, y la ICG también se ha 
probado in vivo en modelos animales. De igual forma, las estructuras de oro obtenidas 
permitirían utilizar nuestras nanoplataformas como agentes de contraste en técnicas de 
visualización in vitro e in vivo como la tomografía computerizada o en imágenes 
fotoacústicas. En este trabajo se tomó ventaja para una visualización directa de las 
plataformas de la alta dispersión de luz y densidad que presentan las nanoestructuras 
metálicas empleadas para visualizar su internalización celular por medio de microscopía 
confocal láser y microscopía de transmisión electrónica.  
 Otro aspecto importante fue la incorporación de una molécula guía, el ácido 
fólico (FA), en nuestro caso con la finalidad de dotar a las nanoplataformas con 
especificidad hacia las células cancerosas. Un gran número de células tumorales 
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sobreexpresan ciertos receptores de moléculas específicas, como lo son los receptores 
de ciertos factores de crecimiento, péptidos y del ácido fólico. Las razones por las que 
se ha utilizado el ácido fólico son  debido a su estabilidad, la relativa facilidad con la 
que se puede conjugar a otras moléculas y su bajo coste. 
 Por otra parte, otro objetivo del presente trabajo fue la de desarrollar rutas 
sintéticas que permitieran la escalabilidad de los sistemas obtenidos. Al final de este 
trabajo fue posible producir las nanoplataformas a la escala de decenas de  miligramos 
y, además, fue posible liofilizarlas para su conservación. Este es un aspecto importante 
en vistas a su posible producción a mayor escala, en la que se sigue trabajando. 
  Después de su producción estas nanoplataformas fueron caracterizadas por 
diversas técnicas experimentales. Se determinaron sus propiedades fisicoquímicas más 
importantes, sus propiedades ópticas y magnéticas, su capacidad y eficiencia de 
incorporación y liberación de fármaco, SPIONs, ICG y ácido fólico, además de su 
estabilidad a corto plazo. De igual forma, se realizaron estudios de liberación 
fotoactivada por medio de iluminación con luz láser, se comprobó la efectiva 
internalización celular de las nanoplataformas y la eficiencia de moléculas guías para 
mejorar esta inclusión, su eficiencia terapéutica, el efecto sinergético de la aplicación 
simultánea de varias formas de terapia, y se realizaron estudios preliminares de 
biodistribución in vivo. 
 Así, esta tesis se divide en siete capítulos. En el capítulo I se da una introducción 
general a algunos de los conceptos, términos y fundamentos más importantes de la 
nanotecnología, dando una breve descripción de los nanomateriales de mayor 
aplicación, que clasificamos en tres grupos: inorgánicos, orgánicos/poliméricos y 
biológicos. De cada grupo se dan algunos ejemplos, se explican brevemente sus 
propiedades más importantes y se dan ejemplos de aplicaciones. En general, se ha 
puesto mayor atención en aquellos materiales que tienen mayor aplicación en el área 
biomédica. Posteriormenten se describen más detalladamente las nanoestructuras de 
oro, las nanopartículas superparamagnéticas de óxido de hierro y las nanopartículas 
poliméricas de ácido poliláctico-co-ácido glicólico (PLGA). En cada una de estas 
secciones se ofrece una descripción de las propiedades especiales que poseen y de las 
técnicas más comunes para la síntesis/producción de cada tipo de nanopartícula. En la 
parte final del capítulo se introducen conceptos importantes en nanomedicina, como la 
biofuncionalización, el direccionamiento pasivo y activo o los materiales terágnosticos. 
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 En el capítulo II se da una breve descripción de los materiales especiales que se 
han utilizado para la síntesis de las nanoplataformas multifuncionales. También se 
describen las técnicas experimentales de caracterización que se han empleado, entre 
otras, la dispersión de luz dinámica (DLS), potencial zeta, microscopías electrónicas de 
barrido y de trasmisión (SEM y TEM, respectivamente), espectroscopías de UV-visible 
y de fluorescencia, magnetometría, imagen por resonancia magnética (MRI), 
microscopía de fluorescencia, microscopía confocal o la difracción de rayos X. 
 En el capítulo III trata se realiza la síntesis de nanoplataformas multifuncionales 
basadas en nanopartículas de PLGA cargadas con DOXO y SPIONs, y funcionalizadas 
con chitosano, un polisacárido biocompatible que debido a su gran número de cargas 
positivas se utilizó como medio para adsorber moléculas de ICG en la superficie de la 
nanoplataforma mediante interacción electrostática. Se observó que la estabilidad de la 
ICG es favorecida al encontrarse conjugada a la nanoplataforma. En este capítulo se 
presenta un estudio detallado de los efectos de los diferentes parámetros de síntesis, 
como son la composición de las fases orgánica y acuosa, los volúmenes de las mismas o 
las cantidades iniciales de DOXO y SPIONs en el tamaño, potencial zeta, y la capacidad 
(%DL, drug loading) y eficiencia de carga (%EE, entrapment efficiency) de la 
estructura interna de la nanoplataforma. También se determinaron los perfiles de 
liberación de DOXO y de ICG a pH neutro y ácido. Por otro lado, se determinó la 
capacidad como agente de contraste de imagen magnética del nanodispositivo mediante 
la realización de pruebas de visualización por MRI en células HeLa en “phantoms” de 
agar. Además, se comprobó con éxito la posibilidad que presentan las nanoplataformas 
de ser movilizadas y guiadas mediante un campo magnético externo gracias a la 
presencia de SPIONs en su estructura. Por otro lado, se demostró mediante ensayos in 
vitro que las nanoplataforma diseñadas para ejercer simultáneamente acciones quimi y 
foto-terapéuticas presentan una citotoxicidad muy mejorada respecto a aquellas 
diseñadas para ejercer una única acción de tratamiento. Finalmente, se realizaron 
estudios in vivo preliminares para determinar la localización y biodistribución de estas 
plataformas en un modelo animal de ratón en el que se indujo un tumor de mama. Los 
resultados obtenidos mostraron una eficiente acumulación en la zona del tumor, en el 
bazo y en el hígado, eliminándose en estos dos últimos casos a las pocas horas. 
Sorprendentemente, también se observó una cierta acumulación en la zona del cerebro 
lo que sugiere que las nanoplataformas lograron pasar la barrera hematoencefálica, 
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abriendo nuevas posibilidades para su aplicación en el tratamiento y visualización de 
enfermedades cerebrales como Alzheimer.  
 El capítulo IV trata específicamente de la síntesis de nanocorazas de oro 
utilizando las nanopartículas de PLGA como núcleo en un proceso de crecimiento por 
semillas (seeded-growth method) en ausencia de tensioactivos (surfactant-less). En este 
caso, se ha utilizado un método de crecimiento usando pequeñas nanopartículas de oro 
como semillas conjugadas a la superficie de las nanopartículas de PLGA previamente 
modificadas con chitosano para, posteriormente, realizar el crecimiento de la coraza 
usando una disolución de crecimiento compuesta por HAuCl4/K2CO3 y ácido ascórbico 
(AA) como agente reductor, a concentraciones superiores a la estequiométrica. Las 
estructuras que se obtuvieron presentaron una topografía ramificada, típica de las 
llamadas “nanoestrellas” y que se asemeja a la estructura de algunos virus. El estudio 
demostró que es posible regular el tamaño (desde 150 a 240 nm) y el grado de 
ramificación de las nanoestructuras simplemente modificando las relaciones de los tres 
reactivos: disolución de crecimiento, precursor de NP-seed y AA, así como la forma en 
que se adiciona el AA, ya sea en una sola adición o en múltiples adiciones seguidas, 
obteniéndose de esta última manera nanoestructuras de tamaños menores (~100 nm). 
Finalmente, se realizó un estudio de viabilidad celular en el rango de concentraciones 
2·108-2·1011 NP/mL, obteniéndose valores por encima del 90% para todo el rango. 
También se presentan imágenes de microscopía diferencial de contraste de interferencia, 
demostrando la eficiente internalización de la nanoplataforma híbrida en células. 
 En el capítulo V se presenta la síntesis de nanoplataformas híbridas de PLGA y 
oro, como las preparadas en el capítulo anterior, pero que ya incorporan el fármaco 
(DOXO) y las nanopartículas magnéticas (SPIONs) en su núcleo polimérico. Además, 
estas nanoplataformas fueron funcionalizadas con ácido fólico (FA) previamente 
conjugado a un poli(etilenglicol) (PEG) hetero-bifuncionalizado que consta de un grupo 
tiol en uno de sus extremos y un grupo amino en el otro. La conjugación del FA al SH-
PEG-NH2 se realizó mediante química de carbodiimida; posteriormente el SH-PEG-FA 
obtenido se conjugó a la estructura de oro mediante el enlace de grupo tiol a la 
superficie de oro de la nanoplataforma. El tamaño de estas nanoplataformas fue de 
alrededor de 180 nm con un grado de ramificación bajo. Se realizaron estudios de 
liberación controlada mediante iluminación con láser con longitud de onda en el 
infrarrojo cercano, en la llamada “ventana biológica”. Se demuestró la capacidad  que 
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presentan nuestros sistemas para liberar de manera controlada la carga que llevan en su 
núcleo después de ser iluminadas mediante un pulso corto de 1 segundo de duración 
(superficie irradiada 6 μm2) con un láser de 820 nm de longitud de onda acoplado a un 
microscopio óptico. De esta forma, se obtuvieron imágenes de microsopía confocal de 
células HeLa (previamente incubadas con nanoplataformas) antes y después de iluminar 
a diferentes potencias del láser, en la cuales se observa la liberación de la carga solo 
después haber irradiado la célula que contiene las nanoplataformas. Con esta 
configuración del láser se obtuvieron también imágenes de TEM antes y después de 
irradiar las nanoplataformas con el fin de observar el efecto de la irradiación en su 
estructura y, de esta forma, correlacionar los patrones de liberación de fármaco con los 
cambios estructurales de los nanosistemas a diferentes potencias del láser. Debido a la 
alteración estructural de las nanoplataformas bajo irradiación láser pulsante, se empleó 
otro tipo de configuración para realizar ensayos de liberación. En este caso, se empleó 
un láser de iluminación continua a 808 nm, con una superficie irradiada de 0.13 cm2 y 
tiempos de iluminación en el rango de los 5-10 minutos. Así, se comprobó que la 
liberación de DOXO se ve estimulada por la acción lumínica de la irradiación, aunque 
de forma más suave que en el caso del láser pulsante debido a la menor acumulación de 
energía de un tiempo corto de exposición. Las plataformas, asimismo, también 
presentaron una potencial aplicación como agentes de contraste para visualización de 
imágenes por resonancia magnética. Finalmente, se realizaron pruebas de citotoxicidad 
in vitro que demostraron la acción sinergística de la aplicación simultánea de las 
terapias quimio- y fototérmica gracias a la multifuncionalidad terapéutica de las 
plataformas diseñadas y a la eficacia en la combinación de los sistemas de 
direccionamiento específicos basados en la presencia de una molécula gúia (FA) en la 
estructura de la plataforma y el guiado magnético. 
 En el capítulo VI, se presenta la preparación de un sistema basado al producido 
en el capítulo V pero funcionalizado con un complejo de albúmina de suero humano 
(HSA), ICG y FA. Este complejo se obtuvo mediante la conjugación no-covalente de 
ICG con la HSA por simple incubación. Posteriormente, se conjugó el FA al complejo 
HSA-ICG mediante química de cabodiimida. Una vez obtenido el complejo HSA-ICG-
FA, este se adsorbió sobre la superficie de las nanoplataformas híbridas de 
PLGA/DOXO con coraza de oro. Este tipo de nanoplataformas presentó un tamaño 
alrededor de los 100 nm. La incorporación de ICG en la superficie de la nanoplataforma 
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originó la posibilidad de aplicar tres tipos de terapia diferentes combinados en un solo 
sistema, pues la ICG puede actuar como fotosensibilizador en terapia fotodinámica 
(PDT). Esta terapia se basa en la generación de oxígeno singlete, altamente citotóxico, 
capaz de reaccionar con la membrana plasmática de las células cancerígenas y, por lo 
tanto, destruirlas. Por otra parte, también se observó una mejora en la estabilidad de la 
ICG conjugada a la nanoplataforma que en estado libre, principal limitación de esta 
molécula para su amplia aplicación en la práctica clínica. Mediante la incorporación de 
los tres tipos de terapia (PDT, quimio y fototerapia), aunados a la capacidad del FA 
como molécula guía, en una nanoplataforma única se obtuvieron efectos citotóxicos 
superiores a aquellos originados con un solo tipo de terapia o en ausencia de molécula 
guía. Estos resultados se reprodujeron en diferentes líneas celulares. De igual forma, se 
probó también la capacidad de esta nanoplataforma como agente de contraste 
fluorescente in vitro e in vivo en un modelo animal. Los resultados obtenidos de las 
pruebas de biodistribución in vivo mostraron una eficiente acumulación en la zona del 
tumor y en el bazo. 
 En el capítulo VII presentamos la síntesis de nanoplataformas multiterapéuticas 
basadas en nanoestrellas de oro (NS). Estas NS fueron funcionalizadas con DOXO por 
medio de un enlace escindible (puente disulfuro) que permite su liberación bajo la 
acción de enzimas reductoras. La nanoplataforma también fue funcionalizada con ácido 
fólico (FA) para asegurar la liberación específica del fármaco de la nanoplataforma y 
aumentar la eficiencia de internalización en células HeLa. Al modificar sintéticamente 
el plasmón de resonancia superficial, la presente nanoplataforma también fue capaz de 
actuar como agente fototerapéutico. De esta forma, se combinaron dos tipos de terapia 
en un solo sistema. También fue posible visualizar la internalización celular de las 
nanoplataformas gracias a la autofluorescencia de la DOXO. Se observó una mejora en 
la internalización cuando la nanoplataforma presentaba en su estructura la molécula 
guía, presentando una menor viabilidad celular en células HeLa gracias a una mejor 
eficiencia citotóxica de las terapias fototérmica y química combinadas.  
 En resumen, se ha logrado sintetizar diferentes nanoplataformas 
multifuncionales teranósticas aplicables en el tratamiento, diagnóstico y visualización 
de cáncer. Los procesos que se utilizaron para su preparación han sido de bajo consumo 
de energía y con materiales, en su mayoría, biocompatibles. Los resultados obtenidos de 
su caracterización fisicoquímica y de la evaluación de su desempeño in vitro e in vivo 
Resumen 
 
 
xxiv 
 
sugieren que estas nanoplataformas podrían ser utilizadas como tratamientos 
anticancerígenos con resultados más efectivos, permitiendo disminuir las dosis y los 
tiempos de tratamiento, y realizar terapias combinadas de forma simultánea y 
localizada. 
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Summary 
Nanoscience and nanotechnology deal mainly with the synthesis, 
characterization, exploration and exploitation of nanostructured materials. These 
materials are characterized by having at least one of its dimensions in the nanometre 
range (1 nm = 10-9 m). Nanomaterials are a bridge between the molecules and the 
macroscopic systems. The physical and chemical properties of nanomaterials may differ 
considerably from that of the atoms/molecules or simple macroscopic materials of the 
same composition. The particularity of their features leads us to the development of new 
devices and their application in the improvement of existing technologies or in the 
development of new ones. 
 Nanoscience and nanotechnology have grown explosively in the last two 
decades due to the increasing availability of new methods for the synthesis of 
nanomaterials as well as tools for their characterization and manipulation. Similarly, the 
level of understanding of the electrical, optical and magnetic propeties of 
semiconductor, metals and polymer nanostructures has advanced significantly in last 
years. 
 Also, characterization tools such as the electronic miscroscopies, 
crystallography, spectroscopy, among others, have allowed us to follow and control the 
size, shape, and structure of nanomaterials. However, nanoscience and nanotechnology 
still have a huge field of research and development to be done with regard to the design, 
synthesis, characterization and application of nanoscale systems. 
One of the fields of nanotechnology that is still in an initial development stage is 
nanomedicine. This new area of nanotechnology is just the application of 
nanotechnology concepts and techniques to the biomedical field and it is currently in a 
great growing phase. The use of nanotechnology has enabled us to create new systems 
that may revolutionize the way in which a large number of diseases can be diagnosed 
and treated. Among the new nanomaterials that have been use for these purposes, we 
can find polymeric nanoparticles and nanocapsules, liposomes, micelles, magnetic 
nanoparticles, semiconductor nanoparticles (quantum dots), metal nanoparticles of 
different shapes, carbon nanotubes, grapheme, nanodiamonds, dendrimers, biomolecule-
based nanostructures (nucleic acids, proteins, viral capsides) just to mention a few. 
These nanostructures offer different properties and we could even say improved 
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characteristics respect to the macroscopic-composing bulk material due to its nanometer 
size.  
 For example, polymeric nanoparticles and liposomes have been used in drug 
delivery treatments of several diseases. They can be controlled to transport drugs and 
release them specifically at the tumor site. Modified magnetic nanoparticles have been 
used as contrast agents in resonance magnetic imaging with excellent results. Also, gold 
nanoparticles have been applied as phototherapeutic agents, a new type of therapy 
against cancer in which malignant cells are destroyed by the ability of gold 
nanoparticles to absorb light and convert it into heat.  
Some examples of nanocarriers that have been approved for medical applications in 
clinical practice are: 
• Doxil, doxorubicin-loaded liposomes, which was the first liposomal system 
approved by the Federal Drug Administation (FDA) of USA. 
• Abraxane, paclitaxel-loaded albumin nanoparticles of 130 nm in size, also 
approved by the FDA as a second-line treatment against breast cancer.  
• Combidex (ferumoxtran-10), contrast agent based on iron oxide nanoparticles, 
which is being used for differentiation of lymphatic cancerous and healthy 
nodes.  
• DanoXome, liposomes loaded with the chemotherapeutic agent daunorubicin. 
• Ambisome, amphotericin-loaded liposomes for antifungal treatment. 
• Genexol-PM, polymeric particles made by the block copolymer PEG-PLGA and 
loaded with the chemotherapeutic drug paclitaxel. 
• DE-310, a camptothecin-dextran complex for treatment of lung, colon and breast 
tumors.  
On the other hand, in general the traditional forms of drug administration are not the 
most efficient many times, which can be quite aggressive with the patients, lengthy and 
costly. The use of nanomaterials in the medical area would reduce the dose, frequency 
and economical costs of disease treatments. Similarly, the incorporation of new forms 
of contrast agents for imaging and diagnosis should not only allow to perform a real-
time monitoring about the treatment´s efficiency chosen facilitating. in this way, to 
change and adjust the therapeutic dose according to the response of each patient 
(personalized medicine), but also the early detection of diseases.  
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Then, the combination of therapeutic and diagnostic agents in one system creates a 
new concept called theranostics; hence, a theranostic system can treat the disease and, 
at the same time, work as a diagnostic and imaging agent.   
 In addition to the combination of these two features, therapy and diagnosis, it is 
also desiderable the incorporation of other elements in theranostic nanosystems which 
enable to address the disease from multiple angles, so that the weaknesses of one 
therapeutic or diagnostic agent can be remedied with the strengths of another and vice 
versa (the so-called multimodal treatment or therapy). 
The main feature that must be complied with these new theranostic systems is 
their ability to target and accumulate specifically in the site where it is expected to carry 
out their function and, thus, avoid misdiagnosis or damage to healthy tissues. For 
example, doxorubicin, one of the most widely used drugs in the treatment of several 
types of cancer, can cause myelosupression and cardiotoxicity besides enhancing the 
toxicity of other anti-cancer agents. Its administration route is strictly parenteral since 
any extravasation can produce necrosis of the surrounding tissue and require high doses 
to achieve concentrations in the body that are therapeutically effective. Therefore, it is 
desirable to have a system capable of i) transporting and protecting a drug in the 
bloodstream; ii) diminishing interactions with any other organ or healthy tissue, iii) 
specifically targeting the tumor site; iv) indicating its localization and biodistribution; 
and finally v) being remotely activated to release its payload and exercise its therapeutic 
activity. 
 Hence, a targeted teranostic system would be a great advance in diseases 
treatments such as in cancer and, with no doubts, nanotechnology offers several tools to 
make these ideas completely real.  
 The main goal of this PhD thesis has been to design, synthesize, characterize and 
test the efficiency of new multifunctional nanotheranostics systems capable of imaging, 
diagnosing and treating cancer tumor cells. To accomplish this aim, we have 
synthesized a series of nanoplatforms that combine multiple therapies and several 
visualization and diagnosis methods.  
 On one hand, we have incorporated doxorubicin (DOXO) as a chemotherapeutic 
agent, indocyanine green (ICG) as a photosensitizer for photodynamic therapy (PDT) 
and gold nanostructures that combine the optical properties of nanoshells and gold 
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nanostars for photothermal therapy (PTT), and also serve as carriers for the 
chemotherapeutic agent. On the other hand, we have incorporated superparamagnetic 
iron oxide nanoparticles (SPIONs) as magnetic resonance imaging (MRI) contrast 
agents, taking also advantage of the possibility of magnetic guiding of the 
nanoplatforms by applying an external magnetic field. Besides their therapeutic 
functions, DOXO and ICG are also fluorescent molecules, being possible to use them as 
fluorescent optical contrast agents, in particular ICG, whose excitation and emission 
wavelengths (780 and 820 nm, respectively) lye within the range of the so-called 
“biological window” of the electromagnetic spectrum, the region in which the light 
absorption of water and hemoglobin (the main cromophore in blood) is minimal. Both 
DOXO and ICG have been used as contrast agents in vitro, and ICG has also been 
tested in in vivo animal models. In the same way, the obtained gold structures would 
allow our nanoplatforms to be used as contrast agents in other optical imaging 
techniques in vitro and in vivo such computed tomography or photoacoustic imaging.  
In this work, we took advantage of the high light dispersion and density shown by 
nanoshells to visualize its cellular internalization by confocal laser microscopy and 
TEM microscopy.  
 Another important factor has been the incorporation of a targeting molecule, 
folic acid (FA), with the objective of providing the platforms specificity towards cancer 
cells. A large number of tumor cells overexpress certain receptors of specific molecules, 
such as growth factors receptors, peptides and folic acid. We have used folic acid due to 
its stability, its relatively ease to be conjugated with other molecules and its low cost.  
 On the other hand, other objetive of the present has been to develop new 
synthetic procedures to be able to scale the produced nanoplatforms. At the end of this 
works tens of milligrams were able to be obtained in simple and easy steps, and stored 
after lyophilization for extended preservation. This latter aspect is key in order to extend 
production to the gram-scale, which I am working on.  
 After their obtention, these nanoplatforms were characterized through different 
experimental techniques. We determined their main physicochemical properties, their 
optical and magnetic properties, their capacity and efficiency to incorporate and release 
DOXO, SPIONS, ICG and folic acid and, finally, their short-term stability. Likewise, 
we performed detailed studies on photo-triggered laser cargo released,  nanoplatform´s 
cellular uptake and internalization, multiple tests on the therapeutic effectiveness of the 
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synthesized nanoconstructs, the synergistic cytotoxic effect created upon the 
simultaneous application of different types of therapy, the positive effects of targeting 
ligands on cellular internalization, and preliminary in vivo nanoplatform biodistribution 
studies.  
 This thesis is divided into seven chapters. Chapter I is an introduction to some of 
the main concepts, terms and fundamentals of nanotechnology. It briefly describes the 
most common and applied nanomaterials, which we classify into three groups: 
inorganic, organic/polymeric and biological ones. We give examples for each group and 
explain their main properties and applications. Mostly, we have focused our attention on 
those materials that have greatest applications in biomedicine. Later, we detail the 
description of gold nanostructures, superparamagnetic iron oxide nanoparticles and 
polymeric poly(lactic-co-glycolic acid) (PLGA) nanoparticles. In each of these sections 
we describe their special properties and the most common techniques used for their 
synthesis/production. At the end of the chapter, we introduce some important concepts 
in nanomedicine such as which is biofunctionalization, passive and active targeting or 
theranostics materials.  
 Chapter II is a brief description of the special materials we have used for the 
synthesis of multifunctional nanoplatforms. We also illustrate the experimental 
characterization techniques we have employed throughout the work such as dynamic 
light scattering (DLS), zeta potential, scanning electronic microscopy (SEM), 
transmission electronic microscopy (TEM), UV-visible and fluorescence 
spectroscopies, magnetometry, magnetic resonance imaging (MRI), fluorescence 
microscopy, confocal laser scanning microscopy or X-ray diffraction amongst others.   
 In chapter III, we explain the synthesis of multifunctional nanoplatforms based 
on DOXO and SPIONs-loaded PLGA NPs which are subsequently functionalized with 
chitosan, a biocompatible polysaccharide used as a medium to adsorb ICG molecules on 
the nanoplatform surface by electrostatic interaction due to its large number of positive 
charges. It was observed that the stability of ICG dye was improved while conjugated to 
the nanoplatform. Here, a detailed study on the influence of the different synthetic 
parameters such as the aqueous and organic phase volumes or the initial DOXO and 
SPIONs feeding ratios on the size, potential zeta, and drug loading (% DL) and 
entrapment efficiency (%EE) of the nanoplatform cores. We have also determined the 
release profiles of DOXO and ICG at neutral and acidic pH. On the other hand, the 
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ability of these nanoplatforms as MRI contrast agents was performed in vitro using Hela 
cells phantoms. Moreover, the ability of nanoplatforms to be guided by an external 
magnetic field was verified under application of an external magnetic field. In vitro 
studies demonstrated that these nanoplatforms specially designed to simultaneously act 
as chemo and photo-therapeutic agents possess an enhanced cytotoxicity regarding 
those designed for single therapeutic activity. Finally, preliminary in vivo studies in a 
breast tumor-bearing mice model were performed in order to analyze the localization 
and biodistribution of the present nanoplatforms. The results showed that these 
nanoconstructs efficiently accumulate in/close to the tumor site, in the spleen and liver, 
being cleared from the two latter after a few hours. Surprisingly, the present 
nanoplatforms were also retained in the brain area overcoming the blood brain barrier, 
which opens up new possibilities to use these nanosystems for visualization and 
treatment of brain diseases such as Alzheimer´s. 
 In chapter IV we deal with the synthesis of gold nanoshells using PLGA 
nanoparticles as cores through a seeded-growth surfactant-less method. In this case, we 
have used a growth method using small gold nanoparticles as seeds conjugated to the 
surface of chitosan-modified PLGA nanoparticles to allow the growth of the shell using 
a growth solution consisting only of HAuCl4/K2CO3 and ascorbic acid (AA) as reducing 
agent at concentrations above the stoichiometric one. The as-obtained structures a 
branched morphology, typically of the so-called “nanostars”, and resemble the structure 
of some viruses. This study demonstrated that it is possible to fit the size (from 150 to 
240 mn) and the degree of branching of the nanostructures by simply changing the 
relations among the three reagents: the growth solution, the NP-seed precursor and AA 
reducing agent, and how AA is added, either in a single or in multiple additions; in this 
manner, smaller nanostructures (less than 100nm) are obtained. To conclude, we 
conducted a cell viability study of the as-obtained nanostructures in the concentration 
range 2·108-2·1011 NP/mL, obtaining viability values above 90% in all cases. We also 
demonstrate by differential interference contrast (DIC) microscopy the efficient cell 
uptake and internalization of the hybrid nanoplatforms.  
 In Chapter V we report the synthesis of hybrid nanoplatforms oconstutited of 
PLGA and gold nanoshells, as those elaborated in a previous chapter, but incorporating 
a chemotherapeutic drug (DOXO) and magnetic nanoparticles (SPIONs) in their 
polymeric nuclei. Furthermore, these nanoplatforms were functionalized with folic acid 
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(FA), previously conjugated to a hetero bifunctional thiol-amino poly (ethylene glycol) 
(PEG). The conjugation between the FA and the SH-PEG-NH2 was made by 
carbodiimide chemistry and, later, the SH-PEG-FA obtained was conjugated to the gold 
structure by binding the thiol group with the gold surface of the nanoplatform. The size 
of these nanoplatforms was around 180 nm with a low degree of branching. We 
performed near infrared (NIR) laser–triggered controlled release studies in the so-called 
“biological window”. In this chapter we demonstrate the ability of our systems to 
release their cargo in a photocontrolled manner after being illuminated by a short laser 
light pulse of 1 s and with a spot size of 6 μm2 using a 820 nm laser (within the 
“biological window”) coupled to a microscope. As a result, we obtained confocal 
images of HeLa cells (previously incubated with nanoplatforms) where it was possible 
to observed how the nanoplatform cargo is released to the cell only when applying the 
external light stimulus.  We also obtained TEM images before and after irradiating the 
nanoplatforms with this laser configuration to observe the effect of laser illumination on 
their structure and correlate drug release patterns with their structural changes at 
different laser powers. Provided that structural changes of the platforms were observed 
under pulsed light irradiation, we also used other type of laser configuration to perform 
additional release experiments. Hence, we used continuous wave laser illumination at 
808 nm, with a spot size of 0.13 cm2 for 5-10 minutes. We checked that DOXO release 
was also triggered by this light irradiation but smoother (if compared with pulsed 
irradiation) due to the lower energy light density accumulated. Moreover, nanoplatforms 
were also tested as MRI imaging contrast agents. Finally, in vitro cytotoxicity tests 
proved the cytotoxic synergism upon combined application of chemo- and photothermal 
therapies provided by these nanoconstructs, and the successful specific targeting of 
these when functionalized with folic acid ligand and magnetic guidance.  
 In chapter VI a modification of platforms developed in chapter V was 
performed. In this case, the platforms are additionally functionalized with a complex of 
human serum albumin (HSA), ICG and FA. This complex was obtained through non-
convalent conjugation of ICG to HSA by simple incubation. Later on, FA was 
covalently conjugated to the HSA-ICG complex by carbodiimide chemistry. Once 
obtained the HSA-ICG-FA complex, this was adsorbed onto the surface of the 
PLGA/DOXO hybrid nanoplatforms with a gold shell. This type of nanoplatforms 
presented a size around 100 nm. The incorporation of ICG on the nanoplatform surface 
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allowed simultaneously applying three different types of therapies with one unique 
system. In this way, ICG dye acts as a photosensitizer for photodynamic therapy (PDT). 
This therapy consists in the generation of highly cytotoxic singlet oxygen capable of 
reacting with the cytoplasmatic membrane of cancerous cells and destroying them. We 
also observed an improvement in the ICG stability when conjugated to the nanoplatform 
if compared with that of free dye, which is the main drawback fro the widespread use of 
this molecule in the clinical practice. Upon incorporation of these three types of therapy 
(PDT, chemo and phothermal therapies) and the ability of FA as targeting ligand in a 
single nanoplatform, we obtained enhanced cytotoxic effects than single therapy-based 
platforms, or in the absence of the targeting molecule. These data were reproduced 
when using different cancer cell lines. We also tested the ability of these nanoplatforms 
as fluorescent contrast agents in vitro and in vivo. The experimental data obtained in the 
biodistribution tests in vivo showed an efficient accumulation in the tumor and in the 
spleen.  
 In chapter VII, we present the development of another novel multimodal therapy 
platform based on gold nanostars (Au NS) as core particles. These NS are 
functionalized with the chemotherapeutic drug DOXO, which is conjugated to the NS 
surface by means of a cleavable heterofunctional crosslinker (sulfo-LC-SPDP) to allow 
its relase under breakage of a disulfide bond under the action of reducing enzymes. To 
ensure a specific delivery of the chemotherapeutic drug, the nanoplatoform is 
additionally functionalized with FA as targeting ligand and cellular uptake adjuvant. By 
synthetically modifying the plasmon band of Au NS to the near infrared (NIR) region of 
the electromagnetic spectrum, the present nanoplatform are able to simultaneously 
combine the capability of phototothermal therapy (PTT), through the conversion of 
absorbed light energy into localized heat, and chemotherapy, enabling their monitoring 
by means of optical fluorescence imaging thanks to DOXO autofluorescence. The 
cellular uptake was observed to be enhanced when the targeting ligand was bound to the 
nanoplatform. In addition, the therapeutic efficiency of the nanoplatform tested in HeLa 
cells demonstrated the larger cytotoxicity efficiency of the combined chemo and 
photothermal therapies if compared to individual ones, as observed in the other 
nanoplatforms studied throughout the present PhD thesis. 
 In summary, we have successfully synthesized different multifunctional 
theranostic nanoplatforms that can be applied in cancer treatment, diagnosis and 
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imaging. The processes used to prepare them have involved low energy consumption 
and most of the materials were biocompatible. The results obtained from their 
physicochemical characterization and performance in vitro and in vivo suggest that 
these nanoplatforms could be used in as anticancer treatments with more effective 
results, allowing lower doses, treatment times, and combined therapies applied locally 
and simultaneously. 
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CHAPTER I – INTRODUCTION  
 
1.1 Nanoscience and nanotechnology 
Nanoscience and nanotechnology are relatively new areas of knowledge that 
study the synthesis, characterization and applications of nanostructured materials, which 
are characterized by having at least one of their dimensions in the nanometric range (1 
nm = 10-9 m). Nanomaterials are considered to be the transition between atomic and 
macroscopic systems. Their physical and chemical properties can considerably differ 
from those of the atoms/molecules or bulk materials of the same composition [1]. There 
are two main approaches for the production of new nanomaterials:  top-down and 
bottom-up methodologies [2] (Figure 1.1). 
 
1.1.1 The top-down approach 
The top-down approach relies on the concept that nanostructured materials can 
be obtained from macroscopic materials by extracting the excess of material by 
physical, chemical and mechanical means. Amongst the different top-down 
methodologies we can mention, for example, photolithography, which is used to obtain 
micro- and nanometer sized patterns of semiconductor materials using a positive or 
negative patterned mask, a photoresist and UV light; electron beam lithography (EBL), 
which consists of a scanning electron microscope (SEM) in which the beam can be 
turned on and off by a computer and directed to draw a prearranged pattern over the 
surface of a resist-coated substrate; molecular beam epitaxy, which is based on the 
epitaxial growth of atomic layers on a single crystal substrate; focused ion beam milling, 
which is essentially identical to EBL but instead of electrons, ions are used to eject 
atoms from the sample substrate and generate micro- and nanometric patterns and 
structures [3]. 
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The covalent force acts when two atoms bind to form a molecule, with a bonding energy 
of ca. 200 – 800 kJ/mol (~100kBT) [3]. A metallic bond acts in the same manner than a 
covalent one but it takes place between metals that possess a “sea of electrons”. These 
both are short range forces. Each atom or molecule involved in one of these bonds lost 
their identity after the bonding. In this sense, they are known as “chemical forces” that 
produce “chemical bonds”. The electronic density of each atom or molecule is modified 
completely. On the other hand, hydrogen bonds and van der Waals forces are usually 
weak (a bond is called “weak” when it is in the order of kBT at room temperature so the 
bond rapidly breaks and reforms as a result of thermal fluctuations [2]) and act at longer 
range distances; the result of these forces doesn’t change the identity of atoms or 
molecules involved. In contrast to chemical forces, these are known as “physical forces” 
that generate “physical bonds”. In general, in self-assembly processes weaker forces of 
longer range of action than chemical ones become more important.  
The typical example of a self-assembly is the formation of micelles from 
amphiphilic molecules in aqueous medium. When amphiphilic molecules, with both 
hydrophilic and hydrophobic moieties, are dissolved in an aqueous medium they will 
spontaneously assembly in such a way that the hydrophobic parts avoid contact with 
water molecules, and the hydrophilic ones are exposed to water, leading to the 
formation of micelles. The driving force for the self-assembly of these structures is the 
hydrophobic interaction. Another example of self-assembly is provided by nature with 
the specific assembly of DNA strands with their complementary ones by hydrogen 
bonding. The nature of DNA molecules also leads to the formation of higher order 
structures driven by the combination of electrostatic, hydrophobic and hydrogen bond 
forces. Another example is the layer-by-layer assembly technique, which consists in the 
alternating deposition of oppositely charged poly-ions onto a substrate. After the 
deposition of the first layer, a second one of opposite charge is assembled and so on 
until the desired thickness is achieved. The substrate can be removed by chemical or 
thermal decomposition. This method is based on the coulombic (electrostatic) 
interaction between opposite charges and has been used, for example, to produce 
polymeric nanocapsules [4, 5]. pH and ionic strength of the medium where the assembly 
process is being done are crucial parameters, as the charge of polyelectrolytes are 
determined by these factors. In conclusion, if appropriate conditions and elements are 
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chosen, nanostructures with almost any shape, size and physicochemical characteristics 
can be constructed by employing the tool provided by nanoscience and nanotechnology.  
 
1.2 Nanomaterials 
Nanomaterials are defined by the European Commission as: A natural, 
incidental or manufactured material containing particles, in an unbound state or as an 
aggregate or as an agglomerate, and where for 50 % or more of the particles in the 
number size distribution, one or more external dimensions is in the size range 1 – 100 
nm [6]. Nowadays a large number of nanomaterials can be produced and the number of 
synthetic processes for their obtention has been exponentially growing during last years 
[1, 7-9] , and the range of their potential application seems to be far from limits. 
Accordingly to their composition, we can classify nanomaterials in three main groups: 
inorganic, organic/polymeric and biological ones [10]. In next sections, we will give a 
brief description of those most important with a special focus on those intended for 
biomedical applications. 
 
1.2.1 Inorganic nanomaterials 
Inorganic nanomaterials are fabricated from metals, semiconductor and rare 
earth elements in their neutral valence state and/or with their oxides, chalcogenides, 
pnictides, alloys and their combinations [9]. The unique properties of inorganic 
nanomaterials arise from the different behavior of electrons confined in a nanometered 
region [1]. Most used and studied inorganic nanomaterials are noble metal [11], iron 
oxide [12], semiconductor and silica nanoparticles (NPs) [13], mesoporous materials 
[14], semiconductor and oxide nanosheets [15] and nanowires [16], etc. In this section, 
we will focus on gold and iron oxide nanoparticles because they are primary elements in 
biomedical nanoplatforms as those synthesized and applied in the present work. We 
describe also semiconductor nanoparticles, known as quantum dots [17], because they 
are a representative example of how nanometered size affects the physical, chemical, 
electronic and optical properties of nanomaterials and, although not studied here, also 
display remarkable properties for biomedical applications.  
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1.2.1.1 Metallic nanoparticles 
Metallic nanoparticles are synthesized mainly from noble metals as Au, Ag, Pt 
and Pd and can have different shapes, from spheres, rods, shells, stars, etc. Their optical 
response depends closely on their size, shape, composition and surrounding medium 
[18]. They present a localized surface plasmon resonance (LSPR) which makes them 
very attractive as contrast agents [19], biosensors [20], fluorescence enhancers [21], 
SERS substrates [22] or photothermal therapy agents [23], amongst others. The LSPR 
peak in the visible and near infrared region (NIR) of the electromagnetic spectrum can 
be tuned just by varying their geometry, size and/or composition. Their surface 
chemistry allows easy conjugation of molecules, for example hydrophilic polymers, 
which improve their stability and/or biodistribution [24], or specific groups/ligands for 
example, to specifically target certain molecules, cells or tissues [23, 25, 26]. Despite 
their great potential applicability in biomedical applications thanks to their exciting 
optical properties and excellent stability and inertness, they also display very promising 
uses as catalysts, and as building blocks in electronic and energy storage and 
transformation devices [8]. 
 
1.2.1.2 Magnetic nanoparticles 
They are synthesized mainly by thermal decomposition or coprecipitation of 
Fe+3 and Fe+2 salts to generate Fe3O4 and γ-Fe2O3 magnetic nanoparticles. Their size 
spans from few to tenths of nanometers and they can be stabilized with biocompatible 
polymers [27]. They can be manipulated by external magnetic fields and have been 
found used in biomedical applications as imaging contrast agents for magnetic 
resonance imaging (MRI) and/or stimuli responsive drug/protein delivery vehicles, as 
hyperthermia agents or energy storage devices [28].  
 
1.2.1.3 Quantum dots 
Quantum dots (QDs) are nanocrystals of semiconducting materials with sizes 
ranging from 2 to 120 nm. They consist of a number of atoms ranging from a few 
hundreds to a few thousands, with their crystalline structure being the same as the bulk 
materials they form. When synthesized in solution they form colloidal NPs stabilized by 
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amphiphilic organic molecules. Their shape can be spherical, cubic, rod or tetrapod 
[29]. They present novel properties due to the space confinement of charge carriers 
(electrons and holes) within the physical dimensions of the nanocrystals in opposition to 
the free diffusion of charge carriers in the bulk material. One of the most studied and 
understood confinement effects is the broadening of the band gap as the size of the 
nanocrystals is decreased. This effect manifests as a blue shift of the first absorption 
peak and the photoluminescence maximum, together with the appearance of higher 
discrete energy states in the valence and conduction bands. Varying the combination of 
the components (binary: CdSe and CdS; tertiary: ZnCdSe and CdSeTe) is possible to 
broaden the accessible wavelengths in the optical spectrum. As the metallic 
nanoparticles, quantum dots have been found application in optics, electronics, light 
emitting diodes, photovoltaic devices and, recently, there has been an increasing interest 
in their potential biomedical applications as cell markers and contrast agents due to their 
outstanding photostability, much better than common organic fluorophores [17, 29].  
 
1.2.2 Organic/Polymeric nanomaterials 
In this category we find two important groups, carbon based nanomaterials such 
as carbon nanotubes [30], fullerenes [31] and nanodiamonds [32], and 
polymeric/surfactant based nanomaterials [33, 34]. Fullerenes are carbon hollow 
clusters, being C60 the most thoroughly studied. Fullerenes have been applied as 
artificial photosynthetic systems to transform light into chemical energy in the 
fabrication of plastic solar cells in combination with polymers, and as therapeutic 
products of several diseases [35].  
Carbon nanotubes were discovered in 1991 as a minor byproduct of fullerenes 
synthesis. Carbon nanotubes are perfect hollow cylinders and can be single walled 
(SWNT) or multiwall tubes (MWNT). Carbon nanotubes present outstanding physical 
properties derived from their single tube structure, preferred orientation, network 
connectivity, carbon-carbon bonds etc. The most significant properties of carbon 
nanotubes are their outstanding mechanical strength, high thermal and electrical 
conductivity and special optical properties such as absorption in the NIR region, 
photoluminescence and special Raman spectroscopy [36]. Potential applications of 
carbon nanotubes are numerous and are currently being incorporated into hundreds of 
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different applications from textiles, construction materials for vehicles as a due to their 
mechanical strength,  and medicine [30, 31].  
Nanodiamonds are diamond-based materials at the nanoscale, including pure 
phase diamond films, diamond particles and their structural assemblies. There is a 
special class of nanodiamond material called “ultrananocrystalline” diamonds, with a 
size in the order of a few nanometers; their applications include polishing, engine oil 
additives, dry lubricants, and as chemotherapeutic delivery devices [37].  
Polymeric/surfactant nanomaterials have found numerous applications in 
biomedical areas as therapeutics and diagnostics carriers. They can be produced from 
natural or biocompatible synthetic surfactants and block copolymers by exploiting the 
self-assembling properties of these special molecules, thus, they can be used as 
biocompatible carriers for toxic or dangerous drugs in order to prevent unspecific action 
and damage of healthy cells and tissues [38] and as delivery agents for labile or 
sensitive substances such as fluorescent dyes [39], proteins [40] or DNA [41]. 
Micellization is the typical self-assembly process of surfactant molecules. Starting from 
the simplest spherical micelles, as the solutions conditions (concentration, pH, 
temperature, ionic strength, etc) are changed, it is possible to induce the self-assembly 
of these primary spherical micelles into more complex structures such as vesicles, 
cylinders, worm-like micelles, lamellar structures consisting of surfactant bi-layers, and 
bicontinuous structures with surfactant molecules assembled into connected films [2, 
42]. This behavior is sometimes also observed with amphiphilic block copolymers  [42]. 
Polymeric/surfactant nanomaterials can also be used as substrates and/or templates to 
build more complex nanoplatforms, as those synthesized for this research. In this 
section, we mention three examples: micelles, polymeric nanoparticles and liposomes, 
since we consider them some of the most representative examples of this group of 
nanomaterials 
 
1.2.2.1 Micelles 
They are self-assembled aggregates usually composed of surfactant or 
amphiphilic copolymers. They are formed by a lyophobic part surrounded by a lyophilic 
one that stabilizes the supramolecular structure in the solvent. The concentration at 
which appears the first aggregate/micelle is known as the critical micellar concentration 
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(CMC). Usually micelles have spherical geometries, although depending on the 
conditions they can also have rod-like and worm-like shapes [43]; vesicles or 
mesophases with cubic, hexagonal and lamellar structure can be also formed depending 
on solution conditions. Micelles are capable to solubilize lyophobic substances [44] but 
present an important  disadvantage, which is their inherent instability at long periods of 
time due to their dynamic nature. 
 
1.2.2.2 Polymeric nanoparticles 
Polymeric NPs possess sizes ranging from 10 – 1000 nm. They are produced 
from non-degradable (polystyrene) or biodegradable polymers such as the poly (lactic 
acid) (PLA), poly (lactic-co-glicolic acid) (PLGA), polycaprolactones, chitosan, gelatin, 
sodium alginate, etc. They are mainly used for targeted delivery and release of drugs 
[45], although they are capable to transport other cargo molecules such as nucleic acids 
[41], proteins [46], peptides [33] and even inorganic nanoparticles of smaller size, such 
as magnetic nanoparticles [47]. Their geometry is usually spherical, even though they 
have been produced with ovoid or prism geometries, for example, through 
photolithography techniques. They are generally produced by emulsion-evaporation, 
emulsion-diffusion, or nanoprecipitation techniques [48], but lately nanofluidic NP 
assembly methodologies are gaining great interest due to the large monodisperse nature 
of the resulting NPs and the easy scalability of the Np production process [49]. The 
polymeric NP structure is a monolithic matrix with the cargo-substance (if present) 
solubilized and uniformly distributed within the NP core. The cargo is released mainly 
by diffusion and erosion processes of the polymeric matrix [50], although different 
stimuli responsive (pH, temperature, light, sound…) cargo delivery NP systems have 
been developed in recent years [51-53]. Polymeric NPs are very stable and many of 
them biocompatible, being eliminated basically by metabolic or enzymatic excretion 
pathways [54].  
 
1.2.2.3 Liposomes 
They are biocompatible and biodegradable structures produced form natural and 
synthetic lipids. They consist of an aqueous core surrounded by single or multiple 
lipidic bilayers; they are biologically inert, and very slightly immunogenic with a very 
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low intrinsic toxicity. They are capable to transport drugs with different lipophilicities: 
highly lipophilic cargos accumulate almost completely in the lipidic bilayer and poorly 
lipophilic ones localized in the aqueous compartment; drugs with middle characteristics 
can be localized in both regions. Unilamellar liposomes have sizes ranging 50 – 250 nm 
and multilamellar ones up to 1 – 5 µm. The former are used for transport hydrophilic 
drugs as they posses big aqueous compartments, and the latter ones for the transport of 
lipophilic drugs. However, this type of particles posses several disadvantages such as 
poor entrapment efficiencies and low solution stabilities [55]. 
 
1.2.3 Biological nanomaterials 
Living systems can produce nanostructured materials e.g. in the 
biomineralization process, where calcium carbonate, calcium phosphate particles and 
microstructures in the nanometer size range are produced [56]. Nature has been an 
inspiration to produce materials with outstanding properties, e.g. gecko-inspired 
adhesives [57] or urchin-like nanoparticles [58]. A different approach is to manipulate 
biological materials to produce nanomaterials. Biomolecules, such as nucleic acids or 
proteins, have been used as building blocks to obtain materials with complex structures 
taking advantage of their self-assembly abilities [59]. Viral capsides, protein-based 
nanostructures, have been used as gene delivery vectors as well as drug and contrast 
agents carriers [60, 61]. In this section, we will mention two types of nanomaterials 
produced using biomolecules as building blocks, DNA complexes and protein based 
nanoparticles. We consider both of them good examples of clever manipulation of 
materials provided by nature in order to obtain biocompatible and biostable 
nanostructures. We will also give a brief description of virus capsides in order to 
highlight the importance of bio-shape in efficient drug delivery.     
 
1.2.3.1 DNA complexes  
Nucleic acids are polyanions that can adopt diverse structures, and their 
conformation can respond to different external stimuli such as pH, temperature or ionic 
strength [62]. DNA is easy to synthesize (by polymerase chain reaction, PCR), 
functionalize and manipulate. It has been used to form complexes with cationic 
surfactants, lipids, peptides and cationic polymers (the latter known as “polyplexes”) 
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[63]. These complexes can be used as vectors to introduce nucleic acids, plasmid DNA, 
antisense oligonucleotides or siRNA (small interfering RNA) to living cells for 
therapeutic purposes, for example, to fight against hereditary diseases, multigenetic 
disorders or cancer [63-65]. 
 
1.2.3.2 Protein-based structures  
Physicochemical properties of proteins make them very attractive for the 
construction of nanomaterials [59] by exploiting their structural complexity and the 
great number of functionalities they bear. For example, amyloid fibrils made from 
proteins are excellent candidates for the construction of nanobiomaterials such as 
nanowires, nanolayers, gels, scaffolds, templates and liquid crystals, using the bottom-
up approach as a result of their outstanding physicochemical properties (rigidity, 
stability against heat and destabilizing agents, resistance against proteases, amongst 
others), structural compatibility, nanometric dimensions and efficient self-assembling in 
well defined ultrastructures [66]. Nanoparticles are another example of protein based 
structures. Albumin based nanoparticles bound to paclitaxel (Abraxane), an anticancer 
drug, already approved by FDA for the treatment of metastatic breast cancer. These 
nanostructures take advantage of the natural properties of albumin to reversibly bind 
paclitaxel, transport it across endothelial cells and concentrate it in areas of tumor [67]. 
 
1.2.3.3 Viral capsides 
Viral capsides are nanosized protein shells whose main functions are to protect, 
transport and deliver their genome inside a host cell [68]. They are typically built from 
several copies of one or a few different proteins often clustered into multimers called 
capsomers or five (pentamers) or six (hexamers) proteins. Viral capsides can adopt 
several shapes from roughly spherical with icosahedral symmetry to rod-like and prolate 
shapes. These nanostructures are promising candidates in nanoscience and 
nanotechnology applications, they have been successfully applied in gene therapy [69], 
encapsulation and attachment of specific materials (e.g. drugs [60], quantum dots [61]) 
and as biotemplates for the fabrication of nano-wires [70].  
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1.3 Gold Nanoparticles 
The use of metal colloids, mainly of noble metals, dates back from more than 
1000 years ago as, for example, Lycurgus cup, which contains Au and Ag particles of 
50 -70 nm distributed in the glass. When the cup is illuminated from outside a green 
color is observed whilst when illuminated from the inside it has a red color. Michael 
Faraday, in 1857, was the first to describe that optical properties of colloidal gold are 
different from those of the bulk material, and was the first in evaluating the preparation 
and outstanding properties of gold nanoparticles [71].  
 
1.3.1 Optical properties of gold Nanoparticles. 
The optical properties of gold nanoparticles (Au NPs) depend on their size and 
shape, as well as on the medium they are dispersed. Intense brilliant colors of colloidal 
metallic NPs are an evident example of their interesting optical properties that arise 
from their special interaction with light. In the presence of an oscillating 
electromagnetic field, such as light, free electrons from a metallic nanoparticle have a 
coherent collective oscillation respect to the metal. This process is known as the 
localized surface plasmon resonance (LSPR) [18] (Figure 1.2). This electronic 
oscillation can be visualized in a simple way as one photon confined in the reduced 
space of the NP forming an intense electric field around the nanoparticle. The LSPR is 
manifested with a strong extinction whose maximum wavelength is placed exactly at the 
resonance frequency. Some of the absorbed photons will be dispersed in all directions at 
the same frequency in a process known as scattering. Other part of the absorbed 
photons will be converted into phonons or vibrations of the metal lattice, this process is 
called absorption [11]. The absorption and scattering contributions to the total 
extinction cross section depends strongly on the dimensions of the Au NPs. Another 
unique property of these is the possibility to adjust the LSPR by changing the size, 
shape, composition and the surroundings of the nanoparticle. In the case of spherical Au 
NPs, they have a red color with an absorption peak localized at ca. 530 nm, while 
triangular and branched nanoparticles have a blue color with an absorption peak that can 
be tuned from 600 to 1000 nm [72]. 
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are obtained. However, this method is limited in controlling NP size, shape and further 
functionalization. The bottom-up methodology is based on the assembly of Au atoms by 
chemical or biological reduction. The chemical reduction involves two steps: the 
nucleation and the subsequent NP growth. When both steps are completed in the same 
process this is called a in situ synthetic procedure, otherwise it is referred to a seed-
growth method [71].  
In 1857, Faraday reported the formation of deep red gold solution upon 
reduction of chloroaurate (AuCl4-) with white phosphorous in a two-phase CS2-water 
mixture. Since then, many different synthetic wet chemical routes have been developed 
to date to obtain Au NPs with well-defined sizes and shapes. In 1951, Turkevich [73] 
synthesized 20 nm Au NPs by reduction of HAuCl4 with trisodium citrate. In 1971, 
Frens [74] refined the method to control the size of the resulting NPs. Schmid [75] in 
1981 reported the synthesis of clusters of Au55 and phosphine and the notion of quantum 
dots. In 1993, Mulvaney and Giersig [76] were the first to synthesize thiolate capped 
NPs by substituting the citrate for a thiol compound. In 1994, the Brust-Schiffrin´s [77] 
method was developed, also using thiolated stabilizer to control NP size and stability 
but in a biphasic reaction, obtaining smaller NPs. 
 
1.3.2.1 In situ synthesis 
This method consists in the reduction of a gold salt solution, for example 
HAuCl4, with a reducing agent and then being stabilized by a ligand with affinity to 
gold. In some cases, the reducing agent can also act as the stabilizer.  Some of the 
reducing agents that have been used include ascorbic acid, sodium citrate, sodium 
borohydride, alcohols, hydrogen, hydroxylamine, formaldehyde, ozone, carbon 
monoxide, hydrazine, etc [71]. The reduction process can also be done 
electrochemically, photochemically and sonochemically [71]. During reduction, capping 
agents such as surfactants, polymers ions or organic acids are used to confine the NP 
size in the nanometer range, to direct the growth and/or to stabilize the nanoparticles. 
Stabilization can be accomplished, for example, by electrostatic repulsion and/or steric 
hindrance [71].  
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1.3.2.1.1 Turkevich method 
The Turkevich´s method, published in 1951, is one of the first reported methods 
for spherical gold nanoparticles production based on a single phase water-based 
reduction of gold salt by citrate ions. In the standard method, th e  reduction of a 
boiling gold hydrochlorate solution by tri-sodium citrate added quickly under 
vigorous stirring takes place. After a few minutes, a wine-red AuNPs colloid 
is formed with sizes ca. 20 nm. In this method, the citrate acts as both reducing 
agent and stabilizer [78]. 
In 1970, Frens made some changes to the Turkevich’s method to obtain 
nanoparticles with sizes from 15 to 150 nm by varying the citrate: Au ratio, although 
obtained NPs larger than 20 nm were always polydisperse [74]. In later years, many 
groups have examined in detail this method in order to elucidate the mechanism of 
nanoparticle formation. For example, it was determined  that higher concentrations of 
citrate ions stabilize more rapidly the NPs, leading to smaller sizes, while lower 
concentrations give larger NPs and even lead to aggregation. It has also been elucidated 
that the “true” stabilizing molecule is the dicarboxy acetone, the oxidized product of 
citrate. Variations of the reaction pH and temperature also allow extra control over the 
NPs size. NPs of 5 nm were obtained by Puntes’ group [79] using D2O instead of water. 
Also, changing the order of addition (Au solution to citrate) leads to 10 nm NPs. In 
conclusion, the final characteristics of spherical NPs obtained by Turkevich’s method 
can be controlled by manipulating the kinetic and thermodynamic reaction parameters 
e.g. the relative reactant concentrations, temperature, pH… 
 
1.3.2.1.2 Brust-Schiffrin’s method 
The Brust-Schiffrin’s method, published in 1994, is used for the synthesis of 
thiolate protected nanoparticles. This synthesis uses a biphasic (an aqueous and organic 
phase solution) and tetraoctylammonium bromide (TOAB) as a phase-transfer agent to 
reduce the [AuCl4]- anion with NaBH4 in the presence of alkanethiols [77]. The pros of 
this synthesis are that it is carried out at ambient conditions, the high stability of the 
resulting NPs, the absence of NP aggregation after isolation and redispersion, small NP 
sizes with narrow distributions, and ease of functionalization and ligand modification.  
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The particle size can be controlled between 2 and 5 nm by adjusting the 
temperature, reduction rate and thiol to Au ratio. Larger S:Au ratios give smaller NPs 
due to the growth inhibition by the sulfur containing agents. Fast addition of NaBH4 and 
low temperature conditions also produce NPs with narrower size distributions. This 
method has been also modified, for example, by changing the solvent to methanol, 
where both the HAuCl4 and p-mercaptophenol are soluble, avoiding the phase-transfer 
of TOAB impurities. Any thiol that is soluble in the same solvent (methanol, ethanol or 
water) than HAuCl4 can be used to obtain NPs in single phase reactions. The reducing 
agent used in Brust-Schiffrin method is stronger than the citrate used in Turkevich’s 
method, therefore, the reaction rate is faster and much smaller NP sizes are obtained.   
 
1.3.2.2 Seed-growth methods 
The seed-mediated growth is another approach to produce well defined 
nanoparticles. This method is used to prepare nanoparticles with different morphologies 
and aspect ratios (Figure 1.3). In a typical seed-mediated growth synthesis, a precursor 
solution of small and highly stable nanoparticles between 3 – 5 nm is prepared. These 
nanoparticles, called seeds, act as nucleation sites to generate larger nanoparticles in the 
presence of a gold salt growth solution, and a capping/directing agent (e.g. CTAB, 
sodium citrate trihydrate, polymers). A mild reducing agent (ascorbic acid, 
formaldehyde) is used to reduce Au+3 to Au0 only in the presence of Au seeds as 
catalysts; thus, the newly reduced Au0 can only assemble on the seeds and no new 
particle nucleation occurs in solution. The growing process is slow due to the mildness 
of the reducing agents, and subsequent growing steps can be done.  
This method has also been used to obtain non-spherical particles such as, for 
example, nanorods, branched nanoparticles, or gold nanoshells. These nanoparticles, 
with a non-spherical shape, are quite interesting because they present a surface plasmon 
resonance located at different wavelengths depending on their size and aspect ratio. In 
contrast to spherical nanoparticles whose surface plasmon resonance peak is positioned 
around 520 nm and is barely modified with size changes (approximately only 20 nm for 
sizes ranging from 5 nm to 100 nm), non-spherical nanoparticles have a plasmon peak 
(or multiple plasmon peaks in some cases) that can be readily tuned from the visible to 
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Then, the seeds are added to a solution containing a HAuCl4 growth solution, CTAB 
and freshly prepared ascorbic acid. This method generated Au NRs with aspect ratios 
(longitudinal axis/transversal axis) from 4 – 20. Later, Mulvaney’s and Liz-Marzán’s 
[85] groups made modifications in the solution temperature and CTAB concentration to 
obtain better yields of nanorods and less secondary nucleation of NPs with spherical 
shapes. The synthesis was much improved when AgNO3 is introduced in the growth 
solution [86]. The role of Ag ions in the directional growth of AuNRs was explained by 
Liu and Guyot-Sionnet [87] in terms of the underpotential deposition of metallic silver 
on the different crystal facets of gold, leading to symmetry breaking and rod formation. 
Nikoobakht and El Sayed [88] improved the method using CTAB-capped seeds instead 
of citrate-capped seeds, and using AgNO3 in the growth solution they obtained up to 99 
% yield of nanorods with aspect ratios ranging from 1.5 – 5 and generating only traces 
of spherical NPs.  
Au NPs have an extinction cross-section composed by an absorptive component 
and a scattering component. Among Au NPs, Au NRs have a very large absorption 
cross-section, and provided that they possess a longitudinal LPSR band that can be 
finely tuned in the NIR region, these characteristics makes them a promising 
photothermal therapy agent. A pitfall for biomedical use of Au NRs is the relative 
toxicity they can present as a consequence of using CTAB as the capping agent. To 
solve this issue, they have been functionalized with silica, iron oxide or polymeric 
coatings such as polyethylene glycol, PEG, or bioactive molecules [24, 89-92]. 
Figure 1.4: UV-vis spectra and TEM images of AuNRs with and different aspect ratios. The 
first peak at 520 nm in the UV-Vis spectra corresponds to the transverse plasmon band and the 
second peak at 900-1200 nm corresponds to the longitudinal plasmon one (images used with 
permission from [88]. Copyright® 2003, American Chemical Society). 
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1.3.2.2.3 Au nanoshells (Au NShs) 
Au nanoshells (Au NShs) (Figure 1.5a) are another type of metal nanostructures 
which have highly tunable plasmon resonances in the NIR region of the electromagnetic 
spectrum (700-1200 nm), known as the “biological window” due to the high light 
penetration in human tissues and low energy absorption by water and hemoglobin 
present in human body. This fact makes them quite interesting for biomedical 
applications since they can be used simultaneously as therapeutic and diagnostic 
devices. Halas and coworkers [93] formed such core-shell structures for first time by a 
seeded metallization of colloidal silica spheres. The silica particles are functionalized 
with a monolayer of aminopropyltriethoxysilane molecules (APTES), which is 
subsequently used to bind small colloidal Au seeds by electrostatic attraction. Silica-
seed nanoparticles are mixed with a plating solution of HAuCl4 and K2CO3 growing 
solution, and, subsequently, a reducing agent is added to reduce Au+3 ions to Au0. The 
seeds act as nucleation sites, and after a few minutes the mixture takes a bluish-greenish 
color indicating the shell formation. The thickness of the final Au shell can be 
controlled by adjusting the ratios of seed-decorated SiO2 NPs, reductant and plating 
solutions. The plasmon resonance frequency is tuned by adjusting the relative sizes of 
the core and shell dimensions.  
Figure 1.5. a) UV-Vis spectrum and b) TEM image of Au NShs. The broadening of the 
plasmon band can be attributed to NP polydispersity and to the nature of the dielectric function 
of gold shell. 
The UV-Vis spectrum of Au NShs presents a broad single peak due to the nature 
of the synthesis, which generates not uniform sizes. As a result, the plasmon resonance 
peak becomes a weighted average of the contributions of the resonance peaks of 
a) b)
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individual nanoshells (Figure 1.5b); a second contribution arises from the nature of the 
dielectric function of gold shell, which is modified by electron scattering at the gold 
interface [94].  
1.3.2.2.4 Au nanostars 
Another interesting group of Au NPs are Au nanostars (Figure 1.6), which are 
branched structures with star, flower or sea-urchin shapes. These structures are quite 
interesting due to their special response toward optical illumination. Like AuNSh and 
Au NRs, Au nanostars present a LSPR tunable in the NIR region providing them with 
potential biomedical applications as therapeutic and diagnosis devices. The position and 
energy of the LSPR band can be tuned by modification of their total size as well as the 
number, size and aperture angle of tips.  
Figure 1.6: a) UV-Vis spectrum and b) TEM image of Au nanostars. 
An interesting feature of anisotropic Au NPs, in general is the generation of very 
high electromagnetic fields at the nanoparticles’ surface. Electromagnetic enhancements 
due to LSPR are considered the main effects behind of surface enhanced Raman 
scattering (SERS). SERS spectroscopy is one of the most powerful analytical techniques 
for identification of molecular species [95]. Coupling of plasmons, for example, at the 
gap between nanospheres dimers, are known as “hot spots” due to the high 
electromagnetic field enhancements, reaching at these sites, the single molecule 
detection limit. Au NPs can therefore be regarded as nanoamplifiers and, since the 
discovery of this effect, SERS spectroscopy has been studied intensively [96]. In 
particular, Au nanostars present “hot spots” localized at the tips with extraordinary field 
enhancements, with calculated enhancement factors up to 108, much larger than those of 
a) b)
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sphere dimers. It has also been observed experimentally that Au nanostars display 
stronger SERS activity than spheres and rods, and similar to sphere dimers [95]. The 
advantage of Au nanostars is the possibility to observe in solution single molecules 
adsorbed on the tips with no need for the formation of hot spots within nanoparticle 
aggregates, which makes Au nanostars prospects for Raman imaging applications [95, 
97].  
Synthetic methods for obtention of Au nanostars can be classified in seeded-
growth and one-pot methods. In seeded-growth methods preformed seeds act as 
nucleation sites on which additional material can be deposited for subsequent growth, 
usually leading to monodisperse particles with different sizes. One of the most popular 
methods was inspired by the seeded growth process employed in the synthesis of Au 
NRs. In this method, a chloroauric acid (HAuCl4) solution is reduced with ascorbic acid 
at room temperature in the presence of one or more cationic surfactants (typically 
CTAB). Many reported methods based on this approach suggest that the use of capping 
agents, (i.e. surfactants or polymers), which seem to display preferential adsorption on 
certain crystalline facets of the metal seed surface, is the responsible of the anisotropic 
growth process through the alteration of the growth rates along specific crystallographic 
directions [98]. The nature of the reducing agent has also significant influence in the 
final Au nanostars. For example, poly-crystalline branched Au NPs with sizes ranging 
47-185 nm were produced using hydroxylamine sulfate as reducing agent [99]. A 
successful protocol used N,N dimethylformamide (DMF) as reducing agent and 
poly(vinylpyrrolidone) as protecting polymer with 100% production of nanoparticles 
with multiple sharp spikes at room temperature [100]. Au nanostars suitable for 
biological systems were obtained using gelatin as capping ligand, silver 4 nm seeds and 
a growth solution containing K2CO3, which was claimed to provide optimal conditions 
for the kinetic control reduction by ascorbic acid [101]. In these nanoparticles, gelatin 
molecules tend to bind onto the 100 planes of the initial seeds, giving rise to a slow 
growth in the <100> direction and, thus, promoting anisotropic growth in the <111> 
direction.  
In non-seeded methods, nuclei evolve in situ to form nanocrystals seeds and 
subsequently bigger spiky particles through the direct addition of metal atoms. 
Controlling the formation of nuclei at these one-pot synthetic conditions is complicated 
and usually leads to wider distributions of particle sizes and shapes. Ascorbic acid  has 
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been used as reducing agent to obtain multiple-twinned crystals with preferential growth 
on the <111> facets [102]. HEPES, which performed both as reducing and stabilizing 
agent, was used to obtain branched nanocrystals with high yield (> 90%) in a “green” 
chemical synthesis [103]. In a different approach, high yields of polydisperse branched 
gold nanoparticles with one, two or three single crystalline tips were obtained using 
hydrogen peroxide (H2O2) and sodium citrate as reducing agents, in combination with 
bis(p-sulfonatophenyl) phenylphosphinedihydrate dipotassium as stabilizer [104]. 
Multi-branched urchin-like Au NPs were also obtained using thiolated capping 
molecules, with significant improvements in terms of solubility and stability in organic 
solvents [58]. 
 
1.3.3 Biomedical applications of Au NPs 
Thanks to their especial optical properties and their inertness and low toxicity 
[105], Au NPs have found many applications in the biomedical area. Despite they have 
been used since ancient Romans for example, in glass staining, it is just recently they 
have received a significant attention in biology and medicine research and praxis. The 
conjugation of biomolecules to NPs surface has opened a wide range of applications. 
The first applications of Au NPs bioconjugates were as biosensors. Au NPs dispersions 
suffer a visible color change when they aggregate. For example, this property was used 
by Mirkin et al. [20] to detect oligonucleotides. Au NPs were functionalized with single 
strands of DNA. When the complementary strands coupled to the functionalized NPs, a 
change in color from ruby red to blue occurred due to NP aggregation. On the other 
hand, the SPR of Au NPs is very sensitive to the dielectric constant of the surrounding 
medium, especially in the proximity of the surface as already commented previously. 
When the nanoparticles are functionalized with certain ligands (e.g. antibodies) they 
show a shift in their SPR peak when the ligand counterpart is attached. The SPR shift is 
closely correlated to the concentration of counter-ligand allowing its quantification if a 
sort of calibration curve is created. The nanoparticles can be functionalized to observe 
only the attachment of the desired target molecules, and the binding can be observed as 
a color change of the NPs dispersion or a shift in the SPR wavelength.  
Au NPs can be also used as contrast agents in biological systems thanks to their 
enhanced scattering cross section, which increases with the AuNP size. An example of 
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this application was demonstrated by El Sayed et al. [25], who used anti-EGFR 
conjugated Au NPs to distinguish between cancerous and normal tissue. The scattering 
of Au NPs was observed by a simple optical microscope, with a 600 % greater binding 
ratio to cancerous cells than to normal ones, enabling the detection of cancerous cells by 
a dark field microscope.  
Another application of Au NPs is as drug carriers and delivery systems. 
Therapeutic biomolecules have been delivered to cells using Au NPs. Solid Au NPs 
only have one possible way to transport cargos, this is by attachment on their surface. 
Although it has certain advantages when compared to “free” drug treatments, a major 
pitfall is that the payload is exposed to the environment. This could lead to drug loss 
before the carrier reaches the target tissue/cells. At this respect, hollow structures 
present a notorious advantage over solid NPs. Nanoshells have the ability of carrying 
the payload in the core, protecting it from losses, enzymatic attack and premature 
clearance from the body.  
The use of Au NPs as photothermal therapy agents has also been exploited. This 
therapy consists in the accumulation in the tumor cells/tissues of light-absorbing NPs 
and subsequent illumination of the tumor region with a NIR laser of low power. 
Optimal wavelengths are in the range of 800 – 1000 nm because of the previously 
mentioned “biological window”, the region of the electromagnetic spectrum where 
water and tissue light absorption is minimal. El Sayed et al. [23] demonstrated the 
effective tumor destruction after 514 nm-laser visible illumination of citrate stabilized 
40 nm Au NPs functionalized with anti-EGFR. Caruso’s group [106] used AuNPs in a 
different approach. They incorporated Au NPs in layer-by-layer-assembled 
microcapsules. The Au NPs, entrapped in the layers of polyelectrolytes served as 
triggering agents for cargo release after irradiation with NIR laser due to localized 
temperature increases and subsequent capsule disruption.  
 
1.3.3.1 Au NShs in biomedical applications 
Au NShs present a surface plasmon resonance, a phenomena occurring on 
metallic nanoparticles in which the valence electron cloud oscillates collectively upon 
excitation with light at the same frequency of the surface plasmon. The surface plasmon 
resonance position wavelength of gold nanoshells can be tuned from the visible to the 
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near-infrared region of the electromagnetic spectrum by varying their dimensions and 
the shell thickness [93, 107].  Au NShs can be strong photoabsorbers and scatters 
depending on their dimensions: smaller and thinner nanoshells will be better absorbers 
and larger and thicker will be better scatters. Au NShs have absorbing cross-sections 
several orders of magnitude higher than those of the commonly used fluorescent dyes 
such as indocyanine green (commonly used in cancer photothermal cancer therapy that 
presents photobleaching and short plasma half-life) or rhodamine 6G. Absorbing and 
scattering cross-sections of gold nanoshells are comparable and even higher than those 
of solid Au nanospheres and Au NRs. 
The total extinction cross-section of Au NSh is composed by two components, 
an absorption cross-section and a scattering cross-section. Absorption cross-section is 
not as large as the Au NRs, but if the size is tuned correctly, Au NSh with acceptable 
absorption and scattering properties can be synthesized.  According to El Sayed et al. 
[18], nanoshells with a core radius of 60 nm and a total radius of 70 nm will have both 
acceptable scattering and absorbing cross-sections with optical resonances lying in the 
NIR region, where transmissivity of biological tissue is the highest [108] and away from 
oxyhemoglobin’s visible absorption at 500-600 nm [109]. Nanoparticle with these 
characteristics would  have both abilities, as phototherapeutic agents and as imaging 
agents for dark field microscopy [110], photoacoustic imaging [111], confocal scanning 
optical microscopy [25], light scattering microscopy [112] and optical coherence 
tomography, [112]. Also, for biomedical applications Au NShs possess the interesting 
property of enabling double-carrying capacity: they can transport payloads in the inner 
core and attached on their surface, and can release the cargo in a controlled manner by 
light stimuli, for example. In this way, Au NShs have been tested in canine in vivo 
models for brain tumor ablation [113], and in vitro in different cells lines combined with 
chemotherapeutics agents, showing very promising results [114, 115].  
 
1.3.3.2 Au nanostars in biomedical applications 
Like Au NShs, Au nanostars possess a LSPR tunable in the NIR region of the 
electromagnetic spectrum. This characteristic makes Au nanostars very valuable for 
biomedical applications. Optical response of Au nanostars is also dependent on their 
size and shape. Sizes of Au nanostars are generally smaller as compared to Au 
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nanoshells. The position of Au nanostars LSPR can be controlled by modification of 
their whole size but in it has also been observed by many researchers that tuning the 
LSPR position can be achieved by the modification of the branching degree, the 
distance between tips/branches and sharpness of the tips/branches [116-118]. In this 
way it is possible to obtain Au nanostars with LSPR located at different NIR 
wavelengths with minimal changes in total size, therefore and study the effect of light 
absorption without changing significantly the dimensions of the nanostructure.   
Generally, Au nanostars are smaller than AuNShs, so higher cellular uptake 
efficiencies are expected (see section 1.6.1.1). Au nanostars can be surface 
functionalized easily and it is possible to conjugate drugs [119], targeting ligands [119] 
and photosensitizers [120] to their surface. Their optical response to NIR light 
illumination makes them also good contrast agents and photothermal therapy agents. 
Like Au NShs. Au nanostars can be used as multifunctional nanoplatforms as they are 
able to combine multiple imaging and multiple therapeutic strategies in a single device. 
Nevertheless, an important disadvantage of Au nanostars is the single carrying 
capability on their surface, unlike Au NShs which can carry loads in their dielectric 
core.  
 
1.3.3.3 Photothermal therapy  
Traditional methods against cancer, chemotherapy and radiotherapy are 
unspecific and must be applied for long periods of time and with high and toxic doses of 
anticancer therapeutics or high energy X rays. This involved important side effects upon 
treatment such as structural and functional morbidity, skin redness, cosmetic defects 
(deformations), vomiting, hair loss, and many other without the guarantee of the tumor 
being fully eradicated. Another type of therapies are non-surgical ablation methods. 
Tumor ablation refers to the complete destruction of the tumor by direct application of 
chemical or thermal energy while sparing nearby vital and healthy structures [121]. 
These methods, also known as hyperthermia, consist in the moderate heating of the 
tissue, up to 42 – 47 ºC, for tens of minutes to induce cell membrane damage and 
protein denaturation. Radiofrequency, microwaves and ultrasound are some of the 
heating sources used in hyperthermia [122-124]. The difference with traditional surgery 
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is that these therapies can be applied in a minimal or non-invasive manner. 
Nevertheless, the accuracy and efficacy of these methods are yet to be improved.  
Photothermal therapy is a method that uses light absorbing elements, such as 
dyes, for achieving thermal damage to tumors. When photothermal agents absorb light, 
electrons make transitions from the ground state to the excited state. The electronic 
excitation energy subsequently relaxes through non, for example, radioactive decay 
channels. This results in the increase in the kinetic energy leading to overheating of the 
local environment around the light absorbing species. The heat produced can be 
employed for local cell or tissue destruction. The photoabsorbing agents can be natural 
chromophores in the tissue or externally added dye molecules such as indocyanine 
green, naphthalocyanines and porphyrins coordinated with transition metals [125]. An 
innovative approach to accomplish this goal is the use of nanoparticles that are able to 
focus the energy on the desired spot or zone. Au NPs seem to be the ideal materials to 
this purpose thanks to their optical properties (intense LSPR-enhanced absorption), size, 
functionalizability with targeting ligands, stability and non-toxicity. The photothermal 
properties of Au NPs have been studied by Link and El-Sayed [96], who have shown 
that the photoexcitation of metal nanostructures results in the formation of a heated 
electron gas that subsequently cools rapidly within one picosecond by exchanging 
energy with the nanoparticle lattice. This is followed by phonon-phonon interactions 
where the nanoparticle lattice cools rapidly by exchanging energy with the surrounding 
medium on the timescale of 100 picoseconds. This fast energy dissipation and 
conversion can be readily used for the heating of the local environment by using light 
radiation with a frequency strongly overlapping with the NP’s SPR absorption band 
[125]. 
As a consequence of their unique optical properties, Au nanoshells have been 
used as cancer photothermal therapy agents. The ability to increase temperature of the 
surrounding medium after NIR laser illumination makes them effective photothermal 
agents for cancer cell killing. Functionalization of nanoshells with polyethylene glycol 
(PEG) have been demonstrated to enhance their colloidal stability [126] and to improve 
their residence times in the bloodstream, providing an effective means to reduce 
macrophage phagocytosis and increasing chances of nanoshells to reach the tumor site.  
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1.3.3.4 Photodynamic therapy 
Photodynamic therapy (PDT), also known as photochemotherapy, involves cell 
destruction caused by means of toxic singlet oxygen (the metastable excited state of 
triplet molecular oxygen, in which all electrons are paired) and/or free radicals that are 
produced from a sequence of photochemical and photobiological processes [125]. These 
processes are initiated by the reaction of a photosensitizer with tissue oxygen upon 
exposure to a specific wavelength of light in the visible or near-infrared (NIR) region 
following the process: 
Sens + hv Î 1Sens* 
1Sens* Î  1Sens* 
3Sens* + 3O2 Î 2O1 + Sens 
2O1 + substrate ÎOxidation 
where Sens is the sensitizer; 1Sens* is the excited singlet state of sensitizer; 3Sens* is 
the excited triplet state of the sensitizer; 3O2 is ground state triplet oxygen; and 2O1 is 
excited singlet state of oxygen [127].  
PDT is already approved by the U.S. government to treat solid tumors (lung, 
esophagus, bladder and cervix), age related macular degeneration, actinic keratosis, and 
is under trials for brain, ocular melanoma, ovarian, prostate, renal cell, pancreas, bone, 
head and neck cancers, papilloma, rheumatoid arthritis, cosmesis, psoriasis, endometrial 
ablation, localized infection (bacterial and fungal)  and prophylaxis of arterial 
restenosis, with highly positive results [109]. The major disadvantages of PDT are its 
limited light penetration in tissues; dependency on the oxygen concentration in the 
tumor (numerous tumors present hypoxia [128, 129]), short blood half-life and limited 
target specificity of photosensitizers.  
However, PDT also present several important advantages such as the possibility 
to be applied several times without apparent induction of cell resistance (unlike 
radiation therapy, DNA is not targeted so there is no opportunity for treatment-induced 
mutation or selection) or exceeding tissue tolerance (since there is preservation of the 
collagen [130] and, hence, of the tissue architecture). The principal requirements for 
efficient PDT are that the light source matches the activation wavelength of the 
photosensitizer. In particular, the two main chromophores in the organism are water and 
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hemoglobin. The absorption coefficient of hemoglobin changes upon binding to oxygen 
(oxy-hemoglobin) (Figure 1.7); hence, the minimum absorption of tissue is between 700 
and 1000 nm, so the use of photosensitizers with maximum absorption in this range of 
wavelengths are the optimal for PDT.  
Figure 1.7: Absorption coefficient of oxy-hemoglobin and water as a function of wavelength. 
1.4 Superparamagnetic iron oxide nanoparticles (SPIONs) 
When the size is reduced to nanoscale, as with metallic and semiconducting 
nanoparticles, metal oxide nanoparticles start to show different properties to those of the 
bulk material. At this size scale, the thermal fluctuations are sufficient to induce a 
rotation on the direction of the nanometric nanoparticle magnetization. This 
phenomenon is called superparamagnetism. Superparamagnetic nanoparticles, 
especially iron oxide, have been used as magnetic resonance imaging contrast agents for 
disease diagnosis and, also, as hyperthermia agents. In this section a brief introduction 
to the subject will be given. 
1.4.1 Introduction to magnetic parameters 
All materials interact with a magnetic field, and this interaction can be either 
attractive toward a magnetic pole (ferro- and paramagnetism) or repulsive 
(diamagnetism). The application of a magnetic field (H) results in magnetization (M) of 
a sample, which can be measured by, for example, a superconductive quantum 
interference device (SQUID), one of the most popular and sensitive methods of 
investigating magnetic properties. When a ferromagnetic material is magnetized by an 
increasing applied field and, subsequently, the field is decreased, the magnetization does 
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domains are separated from each other by a domain wall known as the Bloch wall. The 
length of the Bloch wall depends on the material, for example for Fe is approximately 
14 nm and for γ-Fe2O3 is approximately 170 nm, thus, magnetic nanoparticles normally 
consist of a single domain [8]. 
The main property of magnetic nanoparticles is that they show 
superparamagnetism at ambient temperature. Under a magnetic field with zero 
magnitude, there is an energetic barrier ΔE that must be overcome in order to turn the 
magnetization of a single-domain particle. This energetic barrier, ΔE = KV, is 
proportional to the particle volume (K is the magnetic anisotropy constant). As the size 
of the particle decreases, ΔE may become comparable to the thermal energy (kBT, where 
kB is the Boltzmann’s constant). In this case, the energy barrier can no longer pin the 
direction of magnetization to the time scale of observation, and rotation of the 
magnetization direction occurs due to thermal fluctuations. Such a particle is said to be 
superparamagnetic. The coercivity of a superparamagnetic particle is zero (Hc = 0), 
because thermal fluctuations prevent the existence of a stable magnetization. Cooling of 
a superparamagnetic particle reduces the energy of thermal fluctuations and, at a certain 
temperature, the free movement of magnetization becomes blocked by anisotropy. The 
temperature of the transition from the superparamagnetic to the ferromagnetic state is 
called the blocking temperature (TB). The blocking temperature is related to the particle 
volume and the anisotropy constant. The latter can be calculated as K = 25kBTB/V. For 
Fe3O4 and γ-Fe2O3 NPs the size limit at which superparamagnetism occurs is around 20-
30 nm [8].  
 
1.4.3 Magnetic Resonance Imaging (MRI) 
Magnetic resonance imaging (MRI) is a real time technique that allows the non-
invasive visualization of cellular functions and tissues in living organisms. It is 
frequently used to diagnose diseases such as cancer, neurodegenerative diseases, as well 
to provide biological function information in preclinical stages. Recently, 
nanotechnology has led to the development of new types of contrast agents based on 
superparamagnetic NPs. MRI is nowadays one of the most powerful diagnosis 
techniques employed by medical science and it has become the favorite tool for 
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MRI contrast agents work by shortening the T1 or T2 relaxation times of protons 
located nearby. Reduction of the T1 relaxation time results in a hypersignal and, 
consequently, gives rise to a positive contrast, while reduced T2 relaxation time reduces 
both T2 and T2* (describing the decay of the transverse magnetization taking into 
account the inhomogeneity of local static magnetic fields) signals, leading to a negative 
contrast. 
ଵ
்ଶכ ൌ
ଵ
்ଶ ൅  ߛܤ௦      (Eq 1.2) 
where the term γBS represents the relaxation by the field inhomogeneity and is referred 
to susceptibility effect. Typically, elements with unpaired electron spins such as 
gadolinium, manganese, and iron can effectively reduce the T1 relaxation time [12, 131]. 
 
1.4.4 Synthesis of SPIONs 
The synthetic routes for SPIONs can be classified in two categories: physical 
methods such as mechanical grinding and biomineralization, and chemical methods 
such as coprecipitation, microemulsion, hydrothermal, sol-gel, electrochemical, polyol, 
flame assisted, sonochemical, thermal decomposition synthesis, etc. [12] Chemical 
methods offers certain advantages over the physical methods when the nanoparticles are 
intended to be used as MRI contrast agents because of important parameters such as 
particle size, size distribution, crystallinity degree and phase purity can be readily 
controlled. These parameters are the most critical for achieving a good MRI contrasting 
performance [132]. 
In turn, accordingly to chemical principles, solution-based methods can be 
classified into two categories: the hydrolytic routes and non-hydrolytic routes. In the 
first category, we find coprecipitation method, microemulsion, hydrothermal synthesis, 
electrochemical method, sol-gel synthesis and sonochemical method. These routes rely 
on the hydrolysis of ferrous and ferric ions, while the thermal-decomposition method, 
the main non-hydrolytic method, relies on the pyrolysis of iron-organic compounds. 
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1.4.4.1 Co-precipitation method 
The co-precipitation method is the most important and used hydrolytic method 
for the production of iron-oxide based MRI contrast agents. The first synthetic routes 
for the production of magnetite are based on the co-precipitation of Fe(II)/Fe(III) in 
aqueous medium, and the reduction of Fe(III) salts with KNO3 at 90 °C under alkaline 
conditions [133]. Based on these first works, further synthetic routes for the production 
of magnetite and maghemite were developed. Magnetite has higher magnetization than 
maghemite and is more used for MRI, although the latter is more chemical stable under 
ambient conditions [12]. 
In order to control the size of magnetic nanoparticles, it is necessary to use 
capping agents to inhibit their growth. There exist two approaches when polymers 
(either biopolymers or synthetic polymers) are used as stabilizers and size controlling 
agents: by coating the particles after precipitation or adding the polymer directly during 
the synthesis. Elmore in 1936 [134] and Cox in 1965 [135] used dextrane to obtain 
stable ferromagnetic colloids following the first and second approaches, respectively. 
Based on the foundations of these pioneering works, many of the MRI contrast agents 
used nowadays were developed. Massart [136] pioneering work´s demonstrated that 
colloidal stable magnetic nanoparticles can be synthesized under alkaline conditions in 
the absence of organic capping agents. He studied the effect on size, polydispersity and 
yield of the base type (ammonia, CH3NH2 or NaOH), cations (N(CH3)4+, CH3NH3+, 
NH4+, Na+, Li+, K+) and Fe(II)/Fe(III) ratios. Massart’s work served as a founding base 
for the development of synthetic routes of aqueous magnetic fluids making 
coprecipitation method one of the most recurred. 
For example, magnetite (Figure 1.10) is an amphoteric solid and presents an 
isoelectric pH (pHPZC) of 6-8 as determined by potentiometric titration [137, 138] . 
Below pHPZC, protonation of the particle surface leads to the formation of Fe–OH2+ 
moieties, while deprotonation occurring above the isoelectric point gives rise to Fe–O- 
surface moieties which affect the electrostatic attachment of polymers on the magnetic 
iron oxide particle surfaces [137]. Apart from the electrostatic interaction, ligand 
exchange (surface complexation), hydrophobic interactions, entropic effects, hydrogen 
bonding, and cation bridging were also reported to be responsible for the adsorption of 
stabilizing agents on the surface of iron oxides. Carboxylic acid moieties and hydroxyl 
groups of organic acids have a strong affinity for the iron oxide surface [12]. Dextran is 
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the most commonly used biopolymer in commercialized MRI contrast agents [12]. 
Oleic acid has been also used to synthesize hydrophobic magnetite NPs with narrow 
size distributions and high stability [139]. 
 
Figure 1.10: Magnetite (Fe3O4) stabilized with dextrane. Size is ca. 10 nm. 
 
1.4.5 SPIONs as MRI contrast agents 
In contrast to T1 probes, superparamagnetic nanoparticles such as maghemite (γ-
Fe2O3) and magnetite (Fe3O4) nanocrystals can produce predominantly spin–spin 
relaxation effects due to the induced local field inhomogeneities, consequently resulting 
in shorter T1 and T2 relaxation times. Magnetic iron oxide nanoparticles are 
predominately used as T2 contrast agents, producing negative enhancement effects on T2 
and T2* weighted images, as commented previously. Iron oxide nanoparticles have 
revolutionize disease detection methods due to their remarkable interactions with blood 
proteins, mononuclear phagocytic cells, macrophage in tissues, cancer cells, biological 
barriers, etc. As a matter of fact, all these interactions are determined not only by the 
particle size but also by the particle physicochemical surface characteristics, leading to 
different fates for various types of iron oxide contrast agents; hence, different diagnostic 
methodologies are being developed. Therefore, the magnetic susceptibility, 
hydrodynamic size, size distribution, and surface physiochemical properties of the 
particle contrast agents are the most important parameters regarding their potential 
biomedical applications [12].  
The contrast enhancing efficacy of T2 contrast agents is characterized by their 
relaxivity coefficient (r2), which is related to T2 through the equation [12]: 
ଵ
்ଶ ൌ
ଵ
்ଶ° ൅ ܥݎଶ     (Eq 1.3) 
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where C is the contrast agent concentration and T2° is the relaxation rate of pure water. 
Iron oxide nanoparticles are classified in two categories; SPIONs, with 
hydrodynamic radius larger than 40 nm and USPIONs (ultra small) with sizes below 40 
nm. The former are quickly taken up by the reticuloendothelial system (RES) and 
eventually accumulate in the liver or spleen; therefore, they have been widely used for 
lesion detection and tumors in the liver. It has been proved that pegylation of Fe3O4 
enables nanoparticles to escape the RES system opening new possibilities of 
functionalization with numerous targeting molecules (proteins, aptamers, peptides) for 
an active cancer detection and treatment [12]. On the other hand, USPIONs present 
longer blood circulation times and tend to accumulate in lymph nodes producing 
hypointense signals. Unlike normal lymph nodes, metastatic nodes lack macrophages, 
they appear isointense in comparison to the pre-contrast stage. Therefore, USPIONs are 
potentially useful to detect lymph node metastases. Taking advantage of their long 
blood circulation time, USPIONs conjugated to Herceptin molecules have been used to 
detect breast tumor and to detect human colon carcinoma after labeling with monoclonal 
antibody [140].   
 
1.5 PLGA nanoparticles  
Entrapment of hydrophilic and hydrophobic drugs and bioactive molecules 
(proteins, DNA, siRNA, etc.) in biodegradable polymer nanoparticles present great 
advantages over the direct administration of therapeutic agents. Biodegradable polymer 
nanoparticles increases the solubility, biodisponibility and retention time of drugs, 
making possible to lower doses and diminish secondary adverse side effects in patients. 
Entrapping drugs in polymeric nanoparticles avoids probable drug degradation in 
biological media, and allows a controlled and sustained release. By modifying the 
nanoparticle surface with suitable molecules, targeted delivery to a specific site of 
action can be achieved, reducing the interaction of drugs with healthy tissues [141]. 
Some of the most used biodegradable polymers for nanoparticle preparation and 
subsequent drug loading and delivery are the family of aliphatic polyesters such as 
poly(lactic-co-glycolic acid) (PLGA), poly(lactic acid) (PLA), poly(glycolic acid) 
(PGA); poly-ε-caprolactone, poly (alkyl cyanoakrylates), chitosan and gelatin [48, 54].  
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PLGA is a polymer formed by a block of poly(lactic acid) and another of 
poly(glycolic acid) (Figure 1.11). PLGA has been widely used for the preparation of 
nanoparticles provided that it is easily hydrolyzed into their two forming monomers, 
lactic acid and glycolic acid, which are degraded and eliminated without difficulty by 
the organism [48, 54].  
 
Figure 1.11: PLGA chemical formula. Monomers product of hydrolysis PGA and PLA are 
metabolized by human body. 
 
1.5.1 Synthesis of PLGA-based drug delivery systems 
Besides controlled release, PLGA NPs are capable to protect the therapeutic 
cargo from possible attacks during the track through blood stream before reaching its 
site of action. Many researchers have obtained biodegradable PLGA polymer 
nanoparticles through multiple techniques. Although with different variation on 
processing parameters, almost all of them are based on the same principles of emulsion, 
coacervation or conventional polymer processing techniques adapted to obtain nano- 
and micrometric materials. PLGA nanoparticles have been used to carry hydrophilic and 
hydrophobic drugs, fluorophores, magnetic nanoparticles, quantum dots and 
biomolecules [48, 142-145].  
Some techniques for the production of PLGA nanoparticles are based on the 
emulsion of an organic solution of the polymer and the load in to an aqueous phase 
containing an emulsifier or stabilizer. Once the emulsion is formed, the organic solvent 
is evaporated or extracted, either by agitation at ambient conditions or at low pressure 
conditions. Higher temperatures can be used to accelerate evaporation although 
temperatures above the Tg of the used PLGA are not recommended. Finally, the 
dispersion is purified/washed to eliminate the excess emulsifiers and lyophilized for 
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conservation. The double emulsion (explained with detail later) technique consists of an 
aqueous solution emulsion containing a hydrophilic substance into an organic solution 
containing the polymer and further processing as previously described [48]. 
 
1.5.2 Emulsions 
Emulsions are liquid-liquid dispersions thermodynamically unstable of 
immiscible or partially miscible substances. Natural evolution of an emulsion leads to a 
complete phase separation. This evolution can be retarded using additives (surfactants 
or fine solids). Emulsions are more stable if the size distribution of the dispersed drops 
is narrow. High viscosity of the dispersant phase also favors the emulsion, retarding 
rupture processes such as coalescence and creaming. The thermodynamic instability of 
an emulsion is intimately related to its history and, in particular, to the preparation 
process. Emulsions can be classified in single and double emulsions.  Single ones are, at 
the same time, classified in oil-in-water (o/w) and water-in-oil (w/o), and double ones in 
water-in-oil-in-water (w/o/w) and oil-in-water-in-oil (o/w/o). 
During emulsification, small drops in the micro and nanometric order are formed 
by breaking one of the phases after an energy supply. Under drop braking conditions, an 
enhanced coalescence rate can be expected. From a dynamic point of view, the 
emulsion formed (by agitation or shearing) will be that in which the coalescence rate is 
the lowest. Emulsion-based methods follow the main steps represented in the following 
scheme: 
 
Figure 1.12: Basic steps for emulsion-based techniques to produce PLGA nanoparticles. 
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1.5.2.1 Single emulsion method (o/w) 
In the single emulsion (or emulsion-evaporation) process the PLGA is dissolved 
in a volatile organic solvent (e.g. dichloromethane), together with the cargo molecules. 
The organic phase is added to the aqueous phase containing a stabilizer (e.g. poly (vinyl 
alcohol), Pluronic F127…) and sonicated or homogenized to produce an emulsion. 
Once the emulsion is formed it is necessary to remove the organic solvent by 
evaporation to obtain stable solid spheres. The next step consists of the NP purification, 
also known as washing. It is important to consider that the excess of surfactant that is 
not protecting the emulsion droplets can form micelles in the continuous phase, and 
with some organic phase solubilized inside, which can decrease the entrapment 
efficiency; hence, it is important to eliminate this excess. Finally, the product is 
lyophilized to avoid payload leakages and stored.  
This process has been used to encapsulate hydrophobic substances such as 
drugs, fluorescent dyes, and nanocrystals, among others, with the only requirement that 
the solubility of the cargo must be greater in the organic phase than in the aqueous one, 
in this way, cargos stay inside the PLGA/solvent droplets during the processing phase. 
 
1.5.2.2 Double emulsion method (w/o/w) 
The double emulsion process is used to encapsulate hydrophilic substances such 
as hydrosoluble drugs, proteins, peptides, etc. in polymeric nanoparticles. It consists of 
two emulsion processes. In the first step, the hydrophilic substance is dissolved in a 
small volume of water or buffer containing a stabilizer (e.g. a protein or a polymer, for 
example). This first emulsion is identified as phase W1; on the other hand, PLGA chains 
are dissolved in an organic solvent, known as phase O. Then, phase W1 is emulsified in 
the phase O with the aid of a homogenizer or a sonicating tip. At this point of the 
process small droplets of aqueous phase have been formed inside the organic phase. 
Subsequently, the phase O is added to a second aqueous phase, W2, containing a 
stabilizer (e. g. poly (vinyl alcohol), Pluronic F127…) and is again emulsified with a 
homogenizer or sonicating tip. This further process is similar to that of the single 
emulsion method [48]. This methodology enables the incorporation of two compounds 
with a different solubility profile in one highly stable system. The polar or hydrophilic 
substance can be entrapped in the first emulsion step, and the second compound would 
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be incorporated in the organic phase together with the PLGA. Generally, the 
nanoparticle sizes obtained by the double emulsion method are larger than those 
obtained with the single emulsion one [48]. 
 
1.5.2.3 Nanoprecipitation 
This technique presents numerous advantages regarding the former ones, in that 
it is a straightforward technique, fast and easy to perform. The nanoparticle formation is 
instantaneous and the entire procedure is carried out in only one step. Briefly, it requires 
two solvents that are miscible. Ideally, both the polymer and the drug must be dissolved 
in the first one (the solvent), but not in the second system (the non-solvent).  
Nanoprecipitation occurs by a rapid desolvation of the polymer when the 
polymer solution is added to the non-solvent solution. Indeed, as soon as the polymer-
containing solvent has diffused into the dispersing medium, the polymer precipitates, 
involving immediate drug entrapment. The rapid nanoparticle formation is governed by 
the so-called Marangoni effect, which originates from interfacial turbulences that take 
place at the interface of the solvent and the non-solvent and result from complex and 
accumulated phenomena such as flow, diffusion and surface tension changes.  
Nanoprecipitation often enables the production of small nanoparticles (100–300 
nm) with narrow unimodal distribution and a wide range of preformed polymers can be 
used, such as poly(d,l-lactic-coglycolic acids), cellulose derivatives or 
poly(caprolactones) [146]. This method does not require extended shearing/stirring 
rates, sonication or very high temperatures, and is characterized by the absence of oily-
aqueous interfaces, conditions that might damage, for example a protein structure. 
Moreover, surfactants are not always needed and unacceptable toxic organic solvents 
are generally excluded from this procedure.  
However, the original nanoprecipitation method suffers from some drawbacks. 
This technique is mostly suitable for cargo compounds having a hydrophobic nature 
such as indomethacin, which is soluble in ethanol or acetone, but displays very limited 
solubility in water. Consequently, reduced or even zero drug leakage toward the outer 
medium led to nanoparticles with entrapment efficiency values reaching 100% [49, 146, 
147]. 
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1.6 Surface functionalization and bioconjugation of 
nanoparticles 
As previously mentioned, the synthesis of NPs involves stabilizing molecules 
which prevent aggregation and, in many cases, also control the growth in terms of final 
size and geometrical shape. Stabilization of NPs can be due to electrostatic repulsion, 
steric exclusion or hydration layer on the NP surface. The nature of the stabilizing 
molecules will determine the physicochemical surface properties of the nanoparticle. 
For example, hydrophobic NPs can be transferred to hydrophilic or aqueous solvents if 
the initial hydrophobic stabilizing agent is exchanged by hydrophilic ligand molecules.  
Surface stabilizing agents can be additionally modified with molecules of 
different nature; for example, hydrophobic nanoparticles stabilized with 
mercaptocarboxylic acid can be modified by molecules covalently bound to the terminal 
carboxylic acids. Another way to change NPs properties is by adding a molecular layer 
that adsorbs on the original ligand molecules and changes the surface properties 
accordingly [148]. No matter the chemical nature of NPs, their surface can be modified 
to change hydrophobicity, surface charge or attach functional groups at the NP surface 
in order to increase stability, enhance interaction with specific surfaces or molecules, or 
target NPs to specific sites of interest.  
 
1.6.1 Influence of NPs physicochemical properties on biodistribution 
and cellular uptake. 
The surface physicochemical properties of NPs play an important role on their 
biological performance as surface is the region of NPs that interacts with the 
surroundings. When strange elements enter the organism, the mononuclear phagocyte 
system (MPS), also known as reticulendothelial system (RES), is activated. This is the 
mechanism by which the human body fights against external elements such as bacteria, 
fungi or viruses. First, the foreign material is identified by opsonines, followed by 
phagocytosis by macrophages. Opsonines are proteins that help the RES to identify 
strange materials [149]. Most of nanoparticles are recognized by RES within minutes 
after intravenous injection. The main factors that determine RES uptake are the size, 
shape, surface charge [150]. Most of nanoparticles used in biomedical applications have 
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sizes and hydrophobic surfaces that make them very susceptible to activate the RES, 
preventing them to reach the desired site of action. After reaching the tumor, organ or 
tissue of interest, NPs must be efficiently internalized by cells, a process also affected 
by NPs surface properties. Herein, we briefly comment some aspects on the effects of 
size, shape and surface charge of NPs on biodistribution and cellular uptake.  
 
1.6.1.1 Effect of NPs size 
Size is a key factor in determining the biodistribution and cellular uptake and 
therefore the efficacy of nanoparticles. The first barriers that nanoparticles must 
overcome before reaching the target site are the liver, spleen and the kidneys. NPs with 
sizes < 10 nm are filtrated and eliminated by kidneys while NPs with sizes > 200 nm are 
eliminated by phagocytic uptake clearance and hepatic filtration [151]. An in vivo 
biodistribution study with polystyrene NPs with sizes ranging 50-500 nm have 
demonstrated  that larger NPs accumulate with higher levels in the liver [152]. It was 
also shown that size substantially affects protein adsorption, showing a direct 
correlation between size and degree of adsorption. After 2 h of incubation in serum 
protein, 100 nm pegylated poly(cyanoacrylate-co-n-hexadecyl) cyanoacrylate NPs had 
6% of protein adsorption while for 171 and 234 nm NPs was 23 and 34% respectively 
[153]. Sonavane et al. [154] studied the biodistribution in mice after intravenous 
administration of citrate-capped Au NPs of 15, 50, 100 and 200 nm. Their results 
showed a size dependent biodistribution with higher accumulation of smaller NPs in 
tissues, mainly accumulated in liver, followed by lung, spleen and kidney; interestingly, 
15 and 50 nm NPs were able to trespass the blood brain barrier. Similar results were 
obtained by De Jong et al. [155] for AuNPs of 10, 50, 100 and 250 nm injected 
intravenously to rats, showing a size dependent distribution with the most widespread 
distribution of the smallest NPs in blood, heart, liver, lungs, spleen, kidneys, thymus, 
reproductive organs and a very low but detectable concentration of gold in the brain for 
10 nm NPs. Chithrani et al. [156] studied the size dependency of cellular uptake of 
citrate-capped AuNPs with sizes ranging from 14 to 100 nm; their results indicate a 
maximum cellular uptake of 50 nm NPs. De Santos et al. [157] studied the effect of size 
on cellular uptake of carboxyl terminated poly(styrene) NPs with sizes ranging from 40 
nm-2000 nm in five different cell lines. Although all NPs, even the larger ones, entered 
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all kinds of cells, the cell uptake rate was highly size dependent with a dramatic uptake 
decrease as the size of NPs increased.  
 
1.6.1.2 Effect of NPs shape 
Chithrani et al. [156] also reported the shape effect by comparing cellular uptake 
of Au NRs and spherical Au NPs. Their results showed that the uptake of Au NRs is 
lower than their spherical counterparts. For example, cells took up to more 500 and 
375% 74 and 14 nm spherical Au NPs than 74·14 nm Au NRs, respectively. Cellular 
uptake of citrate-capped Au NRs with lower aspect ratio (1:3) was greater than higher 
aspect ratio (1:5). Gratton et al. [158] reported the cellular uptake of cationic PEG 
hydrogel nanoparticles fabricated by a top-down lithographic method. Their results 
differ from Chithrani’s for cylindrical nanoparticles with similar volumes but different 
aspect ratios, 200 · 200 nm and 150 · 450 nm, the higher aspect ratio were internalized 
in HeLa cells ~ 4 times faster than lower aspect ratio ones. Interestingly, cylindrical NPs 
of 100 nm of diameter and aspect ratio of 3 showed lesser internalization that 150 nm-
NPs with the same aspect ratio. This result is also different from Chithrani’s and could 
be explained by the different surface charge of NPs. 
 
1.6.1.3 Effect of NPs surface charge 
Surface charge is undoubtedly an important factor in the biodistribution and 
cellular uptake of NPs. Cell membrane is formed by a lipid bilayer with a negative 
surface charge due to the phosphate head groups of phospholipid molecules. Therefore, 
positively charged NPs will be taken up more efficiently than neutral and negatively 
charged NPs. Positively charged NPs are also expected to have higher nonspecific 
internalization rate and shorter blood circulation half-times [151]. Nevertheless, there is 
evidence of uptake of negatively charged NPs despite the unfavorable interactions of 
NPs with the negatively charged cell membrane [159, 160]. The internalization of 
negatively charged NPs is believed to occur through nonspecific binding and clustering 
of the NPs on cationic sites on the plasma membrane (that are relatively scarcer than 
negatively charged domains) [159]. For example, Hirn et al. [161] have studied the 
biodistribution of Au NPs 24 h after intravenous administration in mice for aminated or 
carboxylated 2.8 nm Au NPs. After 24 h both types of NPs were accumulated mostly in 
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the liver, with an 81% of negative NPs and 72% of positive NPs. In contrast, positively 
charged NPs were accumulated in a greater extent in the spleen, heart, kidneys and 
remaining organs, and a higher amount of negative NPs in urine was detected. Balogh et 
al. [162] reported that positive Au/poly(amidoamine) (PAMAM) nanocomposites 
showed a greater accumulation in kidneys while negative and non-charged were 
accumulated preferentially in the liver. He et al. [163] reported the in vitro cellular 
uptake by murine macrophages and non-phagocytic cells and the  biodistribution in 
tumor bearing mice of chitosan NPs with zeta potentials ranging from -40 mV to +35 
mV. Their results indicated that NPs bearing higher positive or negative charges were 
more attractive to macrophages; non-phagocytic cellular uptake was charge dependent 
with greater internalization of less negative NPs. Biodistribution results indicated that 
NPs with slight negative charge were more efficiently accumulated in tumor, probably 
due to the longer blood circulation time than highly negative and positive NPs.  
 
1.6.2 Pegylation 
Different methods have been used to increase nanoparticles biostability and 
blood circulation half-life by several orders of magnitude. Polyeters, poloxamers 
(Pluronics), poloxamines and chitosan have been tested to decrease the opsonines 
attachment to nanoparticles surface [144]. The most used polymer for functionalization 
of nanoparticles is poly(ethylene glycol) (PEG), an ethylene oxide polymer, with 
hydrophilic and biocompatible characteristics. Owing to its simple structure and 
chemical stability is the prototype of an inert, biocompatible polymer [148]. Pegylation 
(functionalization of NP’s surface with PEG) provides the nanoaparticles with steric 
stability and a hydrophilic coating that minimizes macrophage recognition. Nowadays, 
is possible to find PEG with numerous molecular weights and multiple combinations of 
terminal end functional groups, e.g. thiols (-SH), amines (-NH2), carboxylic acids (-
COOH), N-hydroxisuccinimides (NHS), maleimides, etc (Figure 1.13).   
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Gref et al. [165] studied the effect of PEG chain length in preventing protein 
adsorption on the surface of NPs. Their results showed that an optimal molecular mass 
(Mw) range exists (between 2 and 5 kDa) in order to reduce plasma protein adsorption. 
The amount of protein adsorbed on 5kDa PLA-PEG was substantially reduced (~80%) 
compared to the amount of non-pegylated PLA NPs. NP size is altered by the PEG 
shell, that can be in the order of a few to tenths of nanometers, while the shell thickness 
is of same magnitude as the hydrodynamic diameter of a free PEG molecule in a 
random coil configuration [166].  
The circulation half-time (t1/2) describes the blood pool residence and is the 
period over which the concentration of circulating nanoparticles remains above 50% of 
the injected dose, and it is equivalent to drug’s half-life. The required circulation half-
time depends on the intended application but, in general, it must be long enough to let 
nanoparticles get the desired site before elimination by the RES system.  Many studies 
have demonstrated that pegylation of nanoparticles surface with different compositions 
(SPIONs, quantum dots, gold NPs, polymeric NPs) [24, 40, 126, 151, 167-174] 
minimizes non-specific adsorption of proteins through its hydrophilicity and steric 
repulsion reducing opsonization and complement activation, as well as reduction in 
uptake by the liver and increases the circulation half-time.  
 
1.6.2.1 Pegylation of polymeric nanoparticles 
Polymeric nanoparticles can be pegylated by two main approaches: adsorption 
on preformed polymeric nanoparticles of PEG homopolymers or PEG-containing block 
copolymers, e.g. Pluronics composed of poly(propylene oxide) (PPO) hydrophobic 
blocks and poly(ethylene oxide) PEO hydrophilic blocks; or the synthesis of 
copolymers with a PEG block and the hydrophobic biodegradable moiety eg. PLGA, 
poly(caprolactone), poly(cyanoacrylate) to generate the polymeric NP.  
 
1.6.2.2 Pegylation of inorganic nanoparticles 
In order to pegylate metallic and semiconductor nanoparticles, a thiol terminated 
PEG (SH-PEG) is the most used approach. Thiol-containing molecules can interact with 
metal ions and metal surfaces to form dative Au-S bonds (47 kcal/mol) [175]. Dative 
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the active species and form thioester linkages, although these are not as stable as the 
bond formed with an amine [177].  
 
 
Figure 1.16: Reaction between EDC and a carboxylated molecule or particle (1) to form the 
amide bond (peptide bond) with the aminated ligand (2) (image taken from [178]). 
 
 
Figure 1.17: Reaction of EDC and sulfo-NHS with a carboxylated molecule (1) to produce the 
semi-stable active intermediate. The aminated molecule (2) attacks this intermediate to form the 
amide bond (image taken from [178]). 
 
EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride) is the 
most popular carbodiimide used for conjugating biological substances bearing 
carboxylates and amines. Its application in particle and surface conjugation procedures 
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along with NHS (N-hydroxysuccinimide) and sulfo-NHS (N-hydroxysulfosuccinimide) 
is nearly universal, and this fact makes it the most common bioconjugation reagent in 
use today. EDC is water soluble, which allows for its direct addition to a reaction 
without prior organic solvent dissolution. Both the reagent itself and the isourea formed 
as by-product of the crosslinking reaction are water soluble, and may be removed easily 
by dialysis or gel filtration. The advantage of adding sulfo-NHS to EDC reactions is to 
increase the solubility and stability of the active intermediate, which ultimately reacts 
with the attacking amine (Fig. 17). Carbodiimide chemistry is a simple way to 
biofunctionalize NPs with biomolecules with interesting properties such as nucleic 
acids, proteins, peptides or antibodies [177].  
 
1.6.3 Passive adsorption of proteins 
Another way to biofunctionalize NPs is through passive adsorption of proteins 
which tend to adsorb onto NPs due to electrostatic attraction if both parts are oppositely 
charged, by van der Waals forces, hydrogen bridges, gold-thiol bonds (from cysteine 
residues) or by hydrophobic interactions, e.g. when the pH is near the protein or NPs 
isoelectric point so that the electrostatic repulsion is reduced. After adsorption, protein 
can be irreversibly immobilized by those forces, or a combination of them [148]. After 
intimate contact of protein and the NPs surfaces the protein can suffer conformational 
changes, which may lead to complete denaturation of the first protein layer adsorbed on 
NPs. The subsequent protein molecules are adsorbed onto the first layer through 
protein-protein interactions, which finally results in an external layer of protein with 
more of a native activity and conformation. If done in a controlled manner, protein 
passive adsorption could provide NPs with colloidal stability and provide the possibility 
to travel undetected by RES largely extending blood circulation times [148, 179]. 
 
1.6.4 Passive targeting: the EPR effect 
There are two mechanisms for nanoparticle targeting to cancerous tissues: 
passive and active targeting. These mechanisms are responsible of increased efficiencies 
and reduction of adverse side effects with nanoparticle-based therapies in contrast to the 
direct administration of free chemotherapeutics. Passive targeting is based on the 
enhanced permeation and retention (EPR) effect that cancerous tissues displayed due to 
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their abnormal physiology compared to healthy ones. Many of the drugs used nowadays 
against cancer do not discriminate between healthy tissues and cancerous tissues: they 
reach and exert their function by a free diffusion-dependent equilibrium in both normal 
and tumor tissues without distinction. 
Maeda and co-workers, who coined the EPR concept, were the first researchers 
to devised a nano-sized targeted anticancer drug to tumor tissues by using the EPR 
effect [180]. Characteristics of the EPR effect include extensive angiogenesis and, 
hence, enhanced vascular density, extensive extravasation (vascular permeability) and 
impaired lymphatic drainage/recovery system of the tumors. The vascular permeability 
is induced by factors such as: bradykinin, a peptide that causes blood vessels to dilate, 
nitric oxide (NO), vascular permeability factor (VPF) and vascular endothelial growth 
factor (VEGF), prostaglandins, collagenase (matrix metalloproteinase MMP) and 
peroxynitrite (ONOO-). 
The enhanced production of these permeability mediators augments the 
permeability of tumor tissues in comparison to normal ones, thereby also contributing to 
the EPR effect. Solid and rapidly growing tumors suffer from an inadequate supply of 
nutrients and oxygen. Accordingly, they possess an extensive angiogenesis, resulting in 
a high vascular density. The formation of tumor blood vessels proceeds in a chaotic 
manner and, hence, a defective architecture of the vascular endothelium with large gaps 
in endothelium cell–cell junctions takes place, leading to hyperpermeability. The EPR 
effect provides an opportunity for more selective targeting of NPs. Size and surface of 
the nanoparticle carrier play a very crucial role with respect to uptake by the tumor. 
Particles of size < 200 nm with hydrophilic surfaces tend to exhibit an improved EPR 
effect, which has been attributed to the increased residence time of the carrier in blood 
[145]. 
Most normal drugs have a plasma half-life of 20 min. The minimum time 
necessary to exert the EPR effect is 6 h. To take advantage of the EPR effect, it is 
critical for the nanocarriers to evade immune vigilance and circulate for a prolonged 
period. Therefore, the targeting efficacy of nanocarriers is achieved as long as they 
remain in the bloodstream where the vessel structure is normal, but would extravasate 
through the leaky vasculature at the tumor site. Upon arrival at the target sites, the 
nanocarriers release the drug in the vicinity of the tumor cells. The absence of lymphatic 
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drainage from the tumors contributes to retention of the nanocarriers, ultimately leading 
to the accumulation of high concentrations of drug [181]. 
On the other hand, the kidneys are capable of filtering particles smaller than 10 
nm and the liver can capture particles larger than 100 nm. Therefore, the ideal 
nanocarrier size is somewhere between 10 and 100 nm. Clearance organs (such as 
kidneys) can filter nanocarriers not only based on their size, but also by their surface 
charge. Ideally, the nanocarriers should not be positively charged but either neutral or 
negatively charged because the luminal surface in the endothelium possesses highly 
negative surface charges; thus, positively charged nanocarriers would be adsorbed and 
decrease their in vivo half-life [145].  
 
1.6.5 Active targeting 
The alternative mechanism, active targeting, is based on the biofunctionalization 
of nanoparticles with targeting ligands that have an enhanced affinity to cancer cells as a 
consequence of the overexpression of receptors of these targeting ligands on the cell 
membrane. These targeting moieties act as “keys” to open “cell doors” that allow their 
specific accumulation and enhanced internalization inside cells [182] into cancerous 
cells without entering into the healthy cells. On the following section we will mention 
some of the most important targeting ligands that have been used for cancer diagnosis, 
imaging and therapy.  
 
1.6.5.1 Antibodies 
Antibodies are immunoglobulin proteins produced by B-cells. They have the 
function of recognizing foreign materials circulating in the bloodstream. Toxins and 
pathogenic bacteria have surfaces that present antigens. The antigen is recognized by 
antibodies which form an antigen-antibody complex. This complex, then, attracts the 
attention of other components of the immune system, such as macrophages, which have 
antibody receptors on their surfaces, facilitating destruction of pathogens (Figure 1.18). 
Antibody functions also include neutralization and blocking of pathogens and toxins, 
activation of the complement system, response to parasites, allergic responses and 
mucosal protection [183].  
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Figure 1.18: Phagocytosis of an antibody-bound virus by a macrophage (taken from [62]). 
 
Growth factors are polypeptides that stimulate cell proliferation by binding to 
their specific high-affinity cell membrane receptors, activating tyrosine kinase, 
signaling cell division [184]. In all types of cancer, the normal regulation of cell 
division has become dysfunctional due to defects in one or more genes. For example, 
genes encoding proteins that normally send intermittent signals for cell division become 
oncogenes, producing constitutively active signaling proteins; or genes encoding 
proteins that normally restrain cell division (tumor suppressor genes) mutate to produce 
proteins that lack this breaking function. In many tumors, both kinds of mutation have 
occurred [62]. Mutations are also believed to be responsible of another characteristic of 
tumor cells, the overexpression of certain growth factor receptors. The molecular 
mechanisms of overexpression are not fully understood but some studies indicate that 
are correlated to aneuploidy, an abnormal number of chromosomes that occurs during 
cell division when the chromosomes do not separate properly between the two cells 
[185], and overexpression of certain genes such as human papilloma virus 16 E6  [186]. 
For example, EGFR is overexpressed in cervical and pancreatic cancers [186]; KIT (a 
member of the tyrosine kinase family of growth factor receptors), PDGFR (platelet 
derived growth factor receptor); HER2 GFR (human epidermal growth factor receptor 
2) are overexpressed in breast cancers [187]; and KGFR (keratinocyte growth factor 
receptor) is overexpressed in colorectal cancer [188]. Other growth factor receptors 
frequently overexpressed in cancer cells are human epidermal growth factor receptors 3 
and 4 (HER3 and HER4), vascular endothelial growth factor receptor (VEGFR), basic 
fibroblast growth factor receptor (BFGFR), transforming growth factor β (TGFR-β), 
amongst others [184]. 
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Monoclonal antibodies (mAbs) are produced in vitro using hybridomas, a fusion 
of B cells and tumoral cells. mAbs can besynthesized with a great selectivity for their 
receptors. mAbs are designed to bind to extracellular portions of growth factor receptor 
competing with growth factors for receptor binding, blocking autocrine and paracrine 
growth factor loops, and induce receptor dimerization and downregulation, as in the 
case of antiEGFR mAbs [187]. Another example is anti-HER2 mAb, which can reduce 
tumor cell proliferation and sensitize them to chemotherapeutic agents [189]. Numerous 
monoclonal antibodies have been approved by the FDA for clinical use to treat tumors 
and can be conjugated to nanoparticles. Table 1.1 gives a brief list of mAbs approved 
for human therapy and some of their applications. Nanoparticles of different nature have 
been functionalized with antibodies for therapeutic and diagnosis applications [23, 190-
193] resulting in improved efficiencies and specificity (Figure 1.19). 
 
Table 1.1: Antibodies approved by FDA for cancer therapy [183]. 
Antibody Brand 
name 
Target Cancer type 
Bevacizumab Avastin Vascular endothelial 
growth factor (VEGF) 
Colorectal, non-small 
cell lung, breast,  
Trastuxumab Herceptin HER2 receptor Breast 
Tositumomab Bexxar CD20 Lymphoma 
Rituximab Rituxan CD20 Lymphoma 
Nofetumomab Verluma Glycoprotein 40 kD Several tumors 
Gemtuzumab  Mylotarg CD33 Myeloid leukaemia 
Ibritumomab Zevalin CD20 Non-Hodgkin 
lymphoma 
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and these positively charged residues have been identified as key determinants of 
cellular uptake as they mediate the initial interactions of the peptide with the negatively 
charged cell surface [200]. Peptides with domains rich in positive residues (e.g. 
polyarginine and polylysisne) have found great utility as mediators of NP cellular 
uptake [201]. One example is the 86 aminoacid Tat protein from HIV-1 virus. Tat HIV-
1 peptide has been conjugated to gold nanoparticles resulting in rapid intracellular 
uptake and particle localization to the nucleus [202].  
Cell-targeting peptides (CTP) are composed of a few aminoacids (from 3 to 10) 
and show high cell specificity and strong affinity for a given targeted cell line upon 
interactions with a receptor that is exclusively overexpressed by these cells. The most 
studied CTP is RGD peptide, which targets the ανβ-3 integrin receptor and plays a role 
in angiogenesis of solid tumors, cell migration, invasion and also metastatic activity 
[199, 203]. Polymeric NPs [204], Au NPs [205], SPIONS [206] have been 
functionalized with RGD peptide to target cancer cells with imaging and therapeutic 
purposes. Another example is CTX, a peptide derived from the venom of the giant 
Israeli scorpion which targets the protein matrix metalloproteinase-2 overexpressed on 
the cell surface of cancers such as malignant glioma, medulloblastoma, prostate cancer, 
intestinal cancer, and sarcoma [207]. CTX-activated iron oxide NPs have demonstrated 
an improved pharmacokinetics and biodistribution, and also show excellent targeting of 
cancer cells both in vitro and in vivo [208]. 
 
1.6.5.4 Folic acid 
Folic acid, also known as vitamin B9, is a molecule which plays a fundamental 
role in nucleotide and DNA synthesis and is essential for rapidly proliferating cells and 
tissues, which includes advanced stages of cancer. In many cells, the intracellular 
acquisition of folates is mediated through folate receptors alpha, beta and gamma 
(FOLR1-3), which bind to folates with a very high affinity (Kd ~ 100 pM). In particular, 
folate receptors alpha or FOL1, and many of the folate-cycle related genes are highly 
expressed in rapidly proliferating cells. FOLR1 and FOLR3 are considerably 
overexpressed in a subset of cancers of the breast, pleural mesothelioma, 
endometrium/uterine, and particularly the ovary, while folate receptor beta or FOLR2 is 
a promising target in myeloid leukemia [209].  Different NPs have been functionalized 
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with folic acid in order to specifically target cancerous cells with enhanced 
internalization rates and larger amounts. For example, iron oxide NPs coated with a 
monolayer of PEG activated with folic acid show cancer cell specific uptake in human 
adenocarcinoma cells, process which can be monitored by using MRI [210]. Mansoori 
et al. [211] have reported the synthesis of two folate conjugated Au NPs and the 
analysis of folate receptor tissue distribution and particle endocytosis in cells with both 
high and low folate receptor expression (HeLa and MCF-7, respectively).  
 
1.7 Theranostic nanomaterials 
 
1.7.1 Nanomedicine: objectives and challenges 
Nanotechnology offers a tremendous potential in applications such as 
biomedical diagnosis and therapy giving rise to a new field named Nanomedicine which 
nowadays constitutes one of the priority areas in most of the developed countries. For 
example, the National Institute of Health of USA  created a budget of 1443M$ for the 
period 2006-2011 to encourage and develop projects in this research field. 
The main applications of nanomaterials in the biomedical field can be split in 
imaging diagnosis and therapeutics. A majority of the imaging and therapeutic 
compounds widely used in clinical practice are composed of small molecules as, for 
example, the gadolinium complexes employed as T1 imaging contrasts in nuclear 
magnetic resonance imaging (MRI), or the anticancer drugs used in oncology.  The 
main drawbacks of this kind of small-sized molecules are their too short blood 
circulating times, lack of enough image resolution for an early detection of diseases like 
cancer, unspecific biodistribution, non-controlled release, unavailability to overcome 
biological barriers, cytotoxity... 
To solve some of these problems, nanotechnology enabled the design and 
obtention of the so-called drug delivery vehicles, also known as nanoplatforms or 
nanovectors, nanoparticles capable of carrying and delivering one or more bioactive 
molecules [182, 212].  Amongst the most well-known representatives of this type of 
nanomaterials in clinical use, for example for cancer treatment, we can find liposomes 
(for example, DOXIL™, liposomes loaded with the anticancer drug doxorubicin 
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approved in 1995 for the treatment of Kaposi´s sarcoma) [213]; albumin nanoparticles 
(as ABRAXANE™, approved in 2005 for the treatment of methastatic breast cancer) 
[67]; or polymer nanoparticles (as GENEXOL-PM, a formulation of polymeric micelles 
loaded with the anticancer drug paclitaxel and free of Cremophor-El, which is in phase 
II trial for treating pancreatic tumours in USA) [214]. However, the generation of 
nanovectors based on nanoparticles in the market nowadays, around a couple of dozens, 
are non-targeting passive systems whose biodistribution along the human body cannot 
be traced [215]. The localization of these systems is only directed by their size (in 
particular, by the enhanced retention and permeation effect, EPR, which leads to the 
nanovehicle to be localized in areas with uncontrolled increases of vascularity, as 
ocurred in solid tumours [216], and is not related with a specific recognition by the 
targeted cell or tissue. 
Moreover, a shared characteristic of all commercialized nanoplatforms is that 
they are designed for only one specific application (either diagnosis or therapy), and a 
vast majority of them are only developed to look for an improvement in the drug dosage 
process or pharmaceutical efficacy of previously approved drug compounds for clinical 
use. In addition, most of the studies performed in research labs are also still only 
focused on the obtention of monofunctional nanoparticle systems which improve the 
properties of the commercialized products for their applications in therapeutics, 
diagnosis, as biomarkers, biosensors...[34, 217, 218], as commented before, or which 
allow the incorporation of additional functionalities as the molecular recognition of the 
target-tissue and/or the controlled release of drugs. The best examples among the former  
type of systems are liposomes and nanoparticles functionalized with antibodies [219], 
aptamers and small peptides [198, 202, 220] which bind to over-expressed specific 
markers in the misfunctional area. Amongst the nanovectors in the second category we 
can find pH-responsive [34] or enzimatycally-activated [221] polymers, as well those 
systems which are active when an external stimulus is applied: For example, Au NSh’s 
[170], Au NRs [222] and carbon nanotubes [223], which are activated by infrared light 
generating a local heat release used for photothermal therapy, superparamagnetic iron 
oxide nanoparticles (SPION) guided by magnetic fields which can be employed as 
imaging contrast agents in MRI [217] and magnetic hyperthermia [224]; or 
semiconductor quantum dots (QDs), which can emit fluorescent light of different 
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wavelengths, and with a suitable functionalization can bind to tumor cells to obtain clear 
images of these cells in vivo [218].  
 
1.7.2 Theranosis: therapeutics + diagnosis 
However, there is no a response to other of the most important challenges in 
clinical practice: the independent performance of diagnosis and therapeutical phases in 
the treatment of diseases like cancer, which involves a time delay which may lead to a 
worsening of the disease and the subsequent risk for the patient´s health. Thus, 
Nanomedicine is called to solve the lack of a system based on nanoparticles which 
would be able to simultaneously posess the capability of acting as a diagnosis element 
and of exhibiting a therapeutical action. This is the subject of theragnosis (theragnosis = 
therapeutics + diagnosis). The suitable combinations of different nanostructured 
materials should give rise to the development of these multifunctional nanomedical 
platforms (theragnostic platforms) and their commercialization. To achieve this goal, it 
is necessary to assemble the different components of the nanoplatform, to analyze their 
properties and to check if they fulfill all necessary requirements about biostability and 
biocompatibility.  
In this regard, first attempts to create theragnostic nanoplatforms at lab scale can 
be found in the studies of Kopelman et al. [225], who synthesize polyacrylamide 
nanoparticles loaded with photosensible molecules and magnetic contrast agents for 
their simultaneous use in MRI detection and photodynamic therapy (PDT) treatment of 
brain cancer in rats. Viese et al. [226] covered SPIONs with polyethylene glycol (PEG) 
and conjugated the nanoparticles with an antibiotic (chlortoxin) and the chromophore 
fluorescein, thus obtaining a system capable of marking and eliminating gliome 
cancerous cells. Cheon et al. developed SPIONs functionalized with antibodies to 
improve  the nanoparticle targeting [132]. They also attached radionuclide to SPIONS 
for the simultaneous obtention of images by MRI and positon emission tomography 
(PET) [227]. Kim et al. [228] and Sukhorukov et al. [4] developed polymeric 
nanocapsules through the layer by layer technique (LbL). These capsules posses 
fluorescent groups and paramagnetic complexes to enable their detection through MRI 
and fluorescence imaging; or they are simultaneously loaded with a drug and metallic 
nanoparticles with photothermal activity for a combined therapeutical action against 
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cancer cells, respectively. Hyeon et al [229, 230] Haam et al. [142, 190] and 
Salgueiriño-Maceira et al. [231] synthesized multifunctional nanoparticles (silicon 
oxide-based or polymer-based) able to be used as contrast agents in MRI and/or 
fluorescence imaging, with the possibility of achieving a combined therapeutical action 
through the pharmacological activity of an anticancer drug (doxorubicin, for example)  
and the phothermal capability of a gold layer deposited on the nanoplatform surface. 
Also, porous silicon oxide nanoparticles have been used very recently as nanovectors 
for the combined action of the loaded anticancer drug paclitaxel and attached small-
interfering RNA (si-RNA) constructs on different cell lines [232]. On the other hand, 
docetaxel-loaded polymeric nanoparticles functionalized with fluorescent aptamers 
which recognize the extracellular domain of the prosthatic membrane antigen (PSMA) 
were used by Langer´s group to localize and kill prosthatic cancerous cells in animal 
models [198, 233]. 
 
1.7.3 Unsolved handicaps of theranosis 
Nevertheless, in sipte of the evident progresses achieved, all these systems 
display different inconvinients such as: 
a) The necessity of obtaining previously special molecules through laborious 
synthetic routes to achieve the desired properties of the construct, which 
implies larger manufacture costs, formation of by-products, biocompatibility 
issues... 
b) Cytotoxicity of some of the constituent elements of these platforms, as 
ocurred, for example with QDs. 
c) Reduced contrast imaging resolution in MRI for an early detection of very 
small tumours. 
d) Reduced efficacy in vitro and in vivo of the nanoplatforms with 
photothermal capabilities due to the quality of the metal nanoparticles/shells 
obtained (inhomogeneities, roughness), and the deformation experienced by 
these nanomaterials after a short exposure to radiation. 
e) Reduced efficacy in vivo of those platforms which employed photodynamic 
therapy. 
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f) Unavailability of systematic studies which enable  an optimization of the 
platform design. 
Unefficient platform sizes and shapes: Recent theoretical and experimental 
modelizations applied to analyze the nanoparticle behavior in the blood current 
demonstrated that spherical nanovectors with sizes around ~ 100 nm (most of the 
commercial available nanovectors nowadays) display the worst lateral movement 
through the blood vessel walls, that is, they have a complete unsuitability to find the 
conjugated antigen at the target-endotelium, and also the worst penetration through 
blood vessels which would difficult their accumulation, for example, in solid tumours.  
 
1.7.4 PLGA/Au theranostic nanoplatforms as a solution 
For the previously mentioned reasons, in this research we have synthesized a 
theragnostic multifunctional nanoplatform injectable via parenteral and which can be 
simultaneously used in cancer diagnosis and therapy by combining: 
a) diagnosis capacity through optical (fluorescence) and magnetic (MRI) imaging. 
b) therapeutical capacity through the combination of chemical, photothermal and 
photodynamic therapy. < 
with which we try to overcome, at least in part, the weakness of the different systems 
studied up to now. This nanoplatform was constructed with biocompatible and 
biodegradable materials (PLGA, F127, chitosan) through a method composed of easy 
and scalable steps. In this way, all elements are enclosed (or supported) in a polymeric 
nanoparticle with such characteristics. At the same time, this polymeric nanovector 
ensures long circulating times and controlled drug release in human body. Nanovectors 
of different architecture were tested in order to define the best structure with optimal 
properties. Moreover, to allow specific recognition in tumor sites, this ensembles were 
functionalized with specific molecules which easily bind to over-expressed membrane 
receptors in cancerous cells. To achieve this goal, the nanoplatform was composed of: 
1. Iron oxide superparamagnetic nanoparticles (SPIONs) with high enhanced R2 
relaxitivity, which makes them excellent candidates as MRI contrats agents. In 
addition, the presence of these NPs as part of the nanodevice can be also 
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exploited as a guiding mechanism for the whole nanodevice under the 
presence of suitable applied external magnetic fields. 
2. Biocompatible FDA-approved fluorochrome indocyanine green (ICG), with 
absorption and emission at the near infrared (NIR) biological window, for 
fluorescence optical imaging, as photosensitizer for photodynamic therapy and 
as photothermal agent. 
3. A potent chemotherapeutic agent: doxorubicin. 
4. Gold nanoshells (AuNShs) with near infrared (NIR) absorption capacity to 
enable the use of the device as a photothermal agent too, and which would 
complement both chemotherapeutic effects.  
5. Spherical nanoparticles formed by biodegradable, biocompatible and FDA-
approved polymer, PLGA, which encapsulates (or holds) part or all of the 
previous components, and also regulates the nanovector size, its circulating 
time and drug delivery release profile.   
6. Attached guiding molecules, folic acid and anti-HER2 monoclonal antibody 
Herceptin, for an efficient site-directed targeting of the nanoplatform to 
receptors overexpressed on abnormal cell membranes. 
 
Important issues such as size and shape control, polydispersity, solubilization 
capacity, drug delivery release rate and efficacy as MRI and optical contrast agent were 
fitted when developing these nanodevices.The therapeutical efficacy of the nanodevice 
takes place through several mechanisms as: 
a) Targeted controlled release of the antitumoral drug due to the presence of the 
guiding molecules on the nanovector surface and the additional guiding 
effect provided by SPIONs upon application of suitable external magnetic 
fields. 
b) Drug release assisted by both diffusion through the nanovector walls and by 
the exposition to NIR. The latter involves a local heating in the areas where 
the nanovectors, surrounded by ICG/chitosan or gold shell, are localized 
giving rise to a fracture of the nanovector and subsequent release. 
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c) This local temperature increase through optical excitation might also help in 
killing tumoral cells (phothermal effect), and could be combined with the 
chemotherapeutic effect of the drug compound and the magnetothermal 
effect created by application of external magnetic fields (in the same way as 
the photothermal effect).  
 
These multifunctional nanoparticles have the additional advantage that the 
therapeutic efficacy might be evaluated in situ and would enable to define their 
mechanism of action much more precisely. Furthermore, the design of these systems 
would also serve for a) achieving the needed action specificity to decrease the 
affectation of healthy cells and tissues and thus, diminishing the toxic side effects; b) 
reducing of the necessary dose levels to reach the desired therapeutically response; c) 
combining chemo, photothermal and/or photodynamic therapies to increase malign cell 
mortality; d) increasing the blood circulating time by avoiding recognition by RES 
through protection offered by polymeric nanomatrixes, which would also help to 
decrease the needed drug concentration in dosages; e) decreasing the time needed for a 
correct diagnosis  and treatment; f) diminishing the associated economical cost to 
diagnosis and therapy upon integration of all functionalities an unique system. Finally 
these theranostic nanoplatforms would also allow their easy modification to offer new 
funtionalities through: a) conjugation  of, for example, DNA or siRNA for gene therapy; 
b) conjugation of radionuclide for their use in computerized tomography, etc. 
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CHAPTER II – Materials and Characterization 
Techniques 
 
2.1 Materials 
 
2.1.1 Doxorubicin 
Doxorubicin (DOXO) is a drug used against a great number of cancers. It is a 
DNA intercalating molecule. The action mechanism of DOXO is complex and it is not 
completely clarified, although it is believed that acts by intercalation of the plane 
cromophore group of anthracycline between to base pairs of DNA. It is known that 
when it intercalates, inhibits biosynthesis of macromolecules as it hinders the 
progression of the enzyme topoisomerase II, which uncoils DNA during transcription. 
Topoisomerases I and II are enzymes that modify topological state of DNA. DOXO 
poisons these enzymes, stabilizing a DNA –topoisomerase II complex, an intermediate 
called the cleavable complex in a reaction where the topoisomerase remains covalently 
attached to a single strand (I) or both strands (II) of the double helix, avoiding liberation 
of the double helix and stopping in this way the replication process. Other suggested 
mechanisms of DOXO cytotoxicity include free radical formation, lipid peroxidation, 
and direct membrane effects. DOXO binding to cell membranes ultimately results in 
production of active oxygen species, especially hydroxyl radicals generated in DOXO 
enzymatic reduction catalyzed by iron and/or copper ions; this results in a decline of 
mitochondrial oxidative phosphorylation. The attack of reactive oxygen species on the 
myocytes has been implicated as the main cause of a severe DOXO cardiotoxicity. 
DOXO is used against certain leukemias, Hodgkin lymphoma, bladder, breast, stomach, 
lung, ovarian and thyroids cancer, soft tissue sarcoma, multiple myeloma, amongst 
others. DOXO is also administered in a liposome encapsulated form called Doxil. Some 
of the secondary effects are nausea, vomit, arrhythmia, neutropenia, complete alopecia 
[1].  
DOXO is a photoactive molecule with absorption maxima at 484 nm and 
emission maxima at 594 nm. pKa of the amine in the 3’ position varies from 7,2 to 8,6 
Chapter II: Materials and chara
 
depending on the concentr
phenol group at position 11
and has a positive charge. O
neutral DOXO fraction is
Commercially available DO
30 g/L. The most favorable
is the neutral form, therefo
chloride by reaction with t
with dichloromethane. Des
due the presence of the glyc
Figure 2.1: Hydrophilic and 
done by reacting it with three 
 
2.1.2 PLGA  
PLGA is a polyest
blocks (Figure 2.2). It is b
and toxicity. Synthesis of 
glycolic acid ring and linke
Poly (lactic acid) ca
active, and the racemic for
the structure regularity whi
due to the lack of methyl
crystalline while those cont
cterization techniques 
82 
ation, ionic strength and measurement meth
’ is 9,5. At low pH = 4 – 6, amino sugar moi
ver pH = 6 DOXO has a neutral charge. Abo
 reduced due to the deprotonation of its
XO is in its hydrochloride salt form with w
 form of DOXO for encapsulation in polyme
re is necessary to hydrophobize it eliminati
riethylamine (Figure 2.1) and extracting hy
pite its hydrophobicity DOXO has certain 
olic group. 
hydrophobic forms of doxorubicin. Hydrophobi
molar equivalents of triethylamine. 
er composed by poly(lactic acid) and pol
iodegradable and biocompatible with low 
PLGA is obtained by the rupture of lacti
d via ester bonds.  
n present two isomeric forms, L-poly(lactic
m D,L-poly(lactic acid). The former is sem
le the latter is amorphous. Poly (glycolic ac
 group. PLGA copolymers with dextro fo
aining the D,L-PLA form are amorphous [2]
 
od. pKa of the 
ety is protonated 
ve pH = 7,5 the 
 phenol group. 
ater solubility of 
ric nanoparticles 
ng the hydrogen 
drophobic form 
water solubility 
 
zation of DOX is 
y(glycolic acid) 
immunogenicity 
c acid ring and 
 acid), optically 
i-crystalline due 
id) is crystalline 
rm of PLA are 
. 
  
Figure 2.2: Lactic acid and gl
 
Molar ratio and seq
the physicochemical prope
with less than 85 % of g
poly(L-lactic acid) are cry
ratio as lactic is more hydr
used ratio is 50:50. In aque
are eliminated by metabolic
Degradation and r
controlled by modifying the
PLGA with more PLA con
and will degrade more slow
the proportion of PLA as w
way to modify release kine
CH3O (metoxi) group or 
driven by two mechanism
surface and volume erosio
shoe two steps, a first bur
PLGA nanoparticles can 
residence time or with targe
About the environ
entrapped drug experiments
the amorphous content of 
nanoparticle is above Tg 
from 42 – 60° C depending
European Medicines Ag
Administration (FDA) for p
Chapter II: Materials and characte
83 
ycolic acid are the monomers of PLGA polymer
uence arrangement of lactic acid al glycolic
rties of PLGA copolymer. Poly(D,L-lactic a
lycolic acid are amorphous while poly(gly
stalline. Solvation of PLGA depends on th
ophobic than glycolic. For nanoparticle fabr
ous medium PLGA is degraded by hydrolysi
 route or in combination with kidney excreti
elease of substances from PLGA nanop
 molecular weight and the PLA:PGA ratio o
tent will be more hydrophobic, therefore ab
ly. Glass transition temperature (Tg) of PLG
ell as the molecular weight of copolymer de
tics is by changing the terminal group of PLG
with a COO- (carboxi) group. Release of 
s: diffusion of cargo through the polymeric
n of polymeric matrix. Generally, release 
st release followed by a slow prolonged rel
be tailored with hydrophilic polymers to
ting molecules conjugated to carboxyl group
ment in the nanoparticle matrix during d
 a considerable drop in pH. Hydrolisis of PL
copolymer increases. If the temperature arou
of copolymer degradation accelerates. Tg o
 on the amorphous content.  PLGA has been 
ency (EMA) and the United States F
harmacological formulations porpoises [3].  
rization techniques 
 
. 
 acid determine 
cid) and PLGA 
colic acid) and 
e lactic:glycolic 
ication the most 
s. Both products 
on [3].  
articles can be 
f the copolymer. 
sorbs less water 
A decreases as 
crease. Another 
A, either with a 
cargo is mainly 
 matrix and by 
kinetics profiles 
ease. Surface of 
 increase their 
s of PLA [3]. 
egradation, the 
GA increases as 
nd the polymer 
f PLGA ranges 
approved by the 
ood and Drug 
Chapter II: Materials and chara
 
2.1.3 Indocyanine gree
ICG is a water solu
with attractive features of lo
– 900 nm, which is known 
of tissues and water.  
Figure 2.3: ICG molecule. 
 
ICG has been w
measurements, blood volu
analysis, choroidal angiogr
enzymes and proteins. It i
(joining of tissues using alb
and photodynamic therap
concentration dependent du
and self-quenching, and al
solvents such as water, p
emission strength and ICG
strength in plasma or bloo
which the emission strength
0,05 mg/ml (~64,5 μM) in
rapid clearance by the li
fluorescence quantum yiel
PLGA NPs [8] and in li
photothermal therapies with
 
 
cterization techniques 
84 
n (ICG) 
ble fluorescent tricarbocyanine dye approv
w toxicity a high absorbance in the wavelen
as the biological window because of the min
 
idely applied in medical diagnosis for 
me determinations, liver function studies, 
aphy, object localization in tissue and fluor
s also applied in tissue welding with near 
umin as solder [4]), in photosclerosis of ven
y studies. Absorption and emission beha
e to the formation of dimmers and higher nu
so changes in its optical properties are obse
lasma, serum albumin [5, 6]. A relationsh
 concentration and observed a maximum va
d solvent has been reported [7]. The ICG 
 reaches a maximum is 0,1 mg/ml (~129 μM
 blood .  Major pitfalls of ICG are its poo
ver, insufficient stability in aqueous solu
ds. ICG has been also encapsulated with
pid-polymeric NPs [9] in order to combi
in a single system. 
 
ed by US FDA 
gth range of 600 
imal absorption 
cardiac output 
pharmacokinetic 
escence probing 
IR light sealing 
ous varicosities 
vior of ICG is 
mber oligomers  
rved in different 
ip between the 
lue of emission 
concentration at 
) in plasma and 
r photostability, 
tions and poor 
 doxorubicin in 
ne chemo- and 
Chapter II: Materials and characterization techniques 
 
85 
 
2.1.3.1 Indocyanine green (ICG) as photosensitizer  
Photophryn is the prototypical photosensitizer. It is a combination of many 
different porphyrin molecules derived from blood. Photophryn presents several 
absorption peaks being the longest at 630 nm, where hemoglobin absorption is still 
large. A new generation of photosensitizers has emerged with better properties and, 
amongst them, it is indocyanine green (ICG), a FDA approved fluorescent dye with 
maximum absorption peak at 783 nm and emission at 820 nm. ICG has been used 
mainly as a contrast agent and for cardiac output diagnosis. Recently, ICG has been 
used as photothermal therapeutic agent and PDT photosensitizer due to its very low 
toxicity, optimal absorption wavelength peak and its photoluminescence which allows 
monitoring its biodistribution [5-7]. The photothermal effect originates from internal 
conversion (heat) of absorbed photons instead of being emitted as fluorescence. In order 
to improve its biodistribution, specific targeting ability and optical properties, ICG has 
been incorporated to different nanocarriers such as polymeric NPs, liposomes, micelles, 
Au NPs, etc [8-13]. The organic nanocarriers (polymeric, liposome, micelle) enhance 
the targeting efficiency of ICG either by passive targeting or active targeting, and 
protect the molecule from degradation [8, 10]. Au NPs can act as transporters by 
attaching the ICG molecule to their surface along with a targeting ligand for specific 
accumulation in tumor [13]. An important fact is that both Au nanoshells and Au NRs 
can act as fluorescence enhancers [14], making it possible to track the NP-ICG 
conjugate by fluorescence imaging. A new class of PDT nanoparticle is the use of 
quantum dots-photosensitizer conjugates, where the QD serves as the primary light 
absorber and then, through FRET, activates the photosensitizer [15], The potential 
advantage of this approach is that the NP can be selected to have a very high photon 
cross-section at an optimal wavelength for the specific application, while the 
photosensitizer can be selected in the basis of, for example, its highly singlet oxygen 
yield. 
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2.2. Characterization techniques 
 
2.2.1 Dynamic light scattering 
When light impinges on matter, the electric field of the light induces an 
oscillating polarization of the electrons in the molecules. The molecules they serve as 
secondary sources of light and subsequently radiate (scatter) light. The frequency shifts, 
the angular distribution, the polarization, and the intensity of the scattered light are 
determined by the size, shape and molecular interactions in the scattering material. Thus 
form the light-scattering characteristics of a given system it should be possible with the 
aid of electrodynamics and the theory of time-dependent statistical mechanism, to 
obtain information about the structure and molecular dynamics of the scattering medium 
[16].  
For molecules or particles equal or larger than λ/20, being λ the wavelength of 
the incident radiation, several of these oscillating dipoles are created simultaneously 
within one given particle. As a consequence, some of the emitted light waves possess a 
significant phase difference. Accordingly, interference of the scattered light emitted 
from such individual particles leads to a non-isotropic angular dependence of the 
scattered light intensity. The interference pattern of intra-particular scattered light, also 
called the particle form factor, is characteristic of the geometry of the scattering particle. 
Hence, this provides a quantitative means for the structural characterization of particles 
in very dilute solutions by light scattering. On the other hand, for particles smaller than 
λ/20, regarded as point-dipole oscillators, only a negligible phase difference exists 
between light emitted from various scattering centres within a given particle; in this 
case, the detected scattered intensity will be independent of the scattering angle, and it 
only will depend on the particle mass, which is proportional to the total number of 
scattering centers one particle contains. [17]. 
So far, we have considered light scattering as a purely elastic process where the 
emitted light has exactly the same wavelength as the incident light. Particles in solution, 
however, usually show a random motion (Brownian motion) caused by thermal density 
fluctuations of the solvent. This theory known as fluctuation theory of light scattering 
was developed by Smoluchowski [16] in 1908 and Einstein [16] in 1910. As a 
consequence of temporal changes in inter-particle positions and the corresponding 
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temporal concentration fluctuations, both the interference pattern and the resulting 
scattered intensity detected at a given scattering angle also change with time, reflecting 
the Brownian motion of the scattering particles [17]. This phenomenon provides the 
basis of dynamic light scattering, an experimental procedure which yields a quantitative 
measure for the mobility of scattering particles in solution, characterized by their self-
diffusion coefficients. Most modern particle size analyzers used to determine the size of 
particles in solution are based on this principle [16-18]. General standard light scattering 
setups consist of the following components: 
1. The incident light source, typically a laser source. This provides coherent and 
monochromatic light with intensity between some few miliwatts (mW) and 
several watts (W). In practice, the light intensity needed for a successful 
scattering experiment depends on the sensitivity of the optical detector and on 
the scattering power of the sample itself, as determined by its size, 
concentration, and refractive index increment. As shown in Figure 23, typically, 
the primary laser beam is guided and focused onto the sample by optical mirrors 
and lenses. The laser beam diameter within the sample is well below 1 mm, 
which defines the scattering volume.  
2. The light scattering cell, in most cases a cylindrical quartz glass cuvette of 
outer diameter between 10 and 30 mm, embedded within an index matching and 
thermostating bath. Using an index matching bath around the cylindrical light 
scattering cuvette is important to suppress unwanted diffraction effects of the 
incident and the scattered light at the sample-air interfaces.  
3. The detector, either a photo-multiplier tube or a very sensitive avalanche 
photo diode (APD) and its associated optics (pinhole or optical fiber) mounted 
on the arm of a goniometer. The detector optics determines the horizontal and 
vertical dimensions of the scattering volume, whereas its depth is defined by the 
incident laser beam width. Band pass filters with high transmission at the 
incident laser light wavelength are often used in front of the detector to suppress 
undesired contributions of stray light or fluorescence from the sample.  
4. The electronic hardware components associated with the detector used for 
signal processing. The scattered intensity I (q,t), which is monitored by the 
optical detector, is typically digitalized and stored in a computer. These raw data 
have to be further processed: In the case of static light scattering, particle form 
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factor models can be used to fit the experimental data; in a dynamic light 
scattering experiment, the raw data have to be converted into the time intensity 
correlation function g2 (q, τ). This is done during the measurement using a very 
fast hardware correlator as, for example, the ALV 5000 from ALV, Langen, 
Germany. 
Light scattered by a set of mesoscopic particles produces a random interference 
pattern on a screen. This pattern, generally possess the form of irregularly spaced and 
sized bright spots called speckles. The scattered light intensity pattern remains 
unchanged as long as the particles do not change their position. Particle motion 
naturally leads to a temporal evolution of the scattered speckle field since one 
interference pattern is continuously replaced by another. In a single speckle spot, this 
evolution is observed as strong temporal intensity fluctuations, with a certain well-
defined temporal correlation. The intensity fluctuations are inherently related to the 
scatter dynamic and, therefore, the temporal correlation function depends on the 
particles shift. Thus, the measurable correlation properties of light can be linked to the 
dynamical properties of particles which, in turn, can provide information about their 
flow velocity and direction, particle size, density of moving scatters, etc.  
In dynamic light scattering, also known as photon correlation spectroscopy 
(PCS) or quasi-elastic light scattering (QELS), the diffusive motions of particles in 
solution gives rise to fluctuations in the scattered light intensity on the microsecond 
timescale. This technique is one of the most popular methods used to determine the 
particles size by measuring the temporal fluctuations of the scattered light intensity. 
Roughly, this is made by focusing a monochromatic light beam, such a laser, on a 
solution with particles in Brownian motion; this causes a Doppler shift when the light 
“hits” the moving particle, changing the light wavelength. This change is related to the 
size particle [19, 20]. 
In the scope of DLS, temporal fluctuations are usually analyzed by means of the 
intensity autocorrelation function (ACF). In the time domain, the correlation function 
usually decays with time (Figure 2.4), and faster dynamics leads to faster decorrelation 
of the scattered intensity trace. It can be shown that for a random process the intensity 
ACF is the Fourier transform of the power spectrum and, therefore, DLS measurements 
can be equally well-performed in the spectral domain. In fact, DLS experiments were 
initially discussed in terms of the broadening of the spectrum peak of monochromatic 
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light due to Doppler shifts experienced by propagating light waves scattered by moving 
particles [21].  
 
Figure 2.4: Illustration of autocorrelation function (Image taken from [21]). 
 
To detect the intensity fluctuation with time, a DLS system requires an 
autocorrelator on top of a regular SLS system, as shown in Figure 2.5. 
 
 
Figure 2.5: Sketch of a dynamic light scattering system. The pulse amplifier discriminator 
converts the analogic signal of the photodetector, I(t), in a digitalized signal, which is further 
processed by the autocorrelator into the autocorrelation function. 
 
As commented above, Figure 2.6a illustrates how the intensity (I) varies with 
time (t). I(t) fluctuates around its mean value, <I>. It may appear completely random 
and, therefore, meaningless, but it is not. Motions of particles (i.e. polymer molecules) 
and solvent molecules contribute to the change of I(t) with time. This apparently noisy 
signal carries the information about particles motions. 
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Figure 2.6: (a) Light scattering intensity I(t) fluctuates around its mean value ۃܫۄ. (b) 
Autocorrelation function ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ is obtained as the long-time average of ܫሺݐሻܫሺݐ ൅ ߬ሻ for 
various delay times τ. The aurocorrelation function decays from ۃܫଶۄ to ۃܫۄଶ over time. The 
amplitude of the decaying component is ۃ∆ܫଶۄ. 
 
The autocorrelator calculates the product average of two scattering intensities 
I(t) and I(t+τ) measured at two different times separated by τ, the delay time. The 
average product ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ is a function of τ and is called the correlation function of 
I(t), or the intensity-intensity correlation function. The correlator converts I(t) into 
ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ. Hence, the intensity-intensity correlation function is the average of 
ܫሺݐሻܫሺݐ ൅ ߬ሻ over a long period T. Hence, assuming that the long time average is equal 
to the ensemble average, we can write [16]:  
 
ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ ൌ lim்՜ஶ ଵ் ׬ ܫሺݐሻܫሺݐ ൅ ߬ሻ݀ݐ
்
଴    (Eq 2.1) 
 
Note that, if the system is at equilibrium, the ensemble average does not change 
with time and, therefore, ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ ൌ ۃܫሺݐ0ሻܫሺ߬ሻۄ. The autocorrelation function of 
I(t) (Figure 2.6a) is shown in Figure 2.6b. When τ = 0, ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ ൌ ۃܫଶۄ. With 
increasing τ, ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ decays to an asymptotic level (baseline), ۃܫۄଶ. 
 
Because the scattering intensity I(t) fluctuates around a mean value ۃܫۄ, it is 
convenient to separate its fluctuating component, ∆ܫሺݐሻ, as ܫሺݐሻ ൌ ۃܫۄ ൅ ∆ܫሺݐሻ. By 
definition, ۃ∆ܫሺݐሻۄ ൌ 0. Then, the correlation function can be rewritten as: 
 
ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ ൌ ۃܫۄଶ ൅ ۃ∆ܫሺݐሻ∆ܫሺݐ ൅ ߬ሻۄ   (Eq 2.2) 
 
Chapter II: Materials and characterization techniques 
 
91 
 
The autocorrelation of ∆ܫሺݐሻis zero upon increases of τ. When ߬ ՜ ∞, 
ۃ∆ܫሺݐሻ∆ܫሺݐ ൅ ߬ሻۄ ൌ ۃ∆ܫሺݐሻۄۃ∆ܫሺݐ ൅ ߬ሻۄ ൌ 0. The decaying componet in ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ 
is ۃ∆ܫሺݐሻ∆ܫሺݐ ൅ ߬ሻۄ. The initial height of the decaying component is ∆ܫଶ ൌ ۃܫଶۄ െ ۃܫۄଶ. 
Division of ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ by ۃܫۄଶ leads to the intensity autocorrelation function as: 
 
ۃܫሺݐሻܫሺݐ ൅ ߬ሻۄ ۃܫۄଶ ൌ 1 ൅⁄ ۃ∆ܫሺݐሻ∆ܫሺݐ ൅ ߬ሻۄ ۃܫۄଶ ൌ 1 ൅ ௖݂݃ଶሺ߬ሻ⁄ (Eq 2.3) 
 
where ௖݂ ؠ ۃ∆ܫଶۄ ۃܫۄଶ⁄  (the coherent factor), and the second factor is the baseline-
subtracted, normalized intensity autocorrelation function: 
 
݃ଶሺ߬ሻ ؠ ۃ∆ܫሺݐሻ∆ܫሺݐ ൅ ߬ሻۄ ۃ∆ܫۄଶ⁄     (Eq 2.4) 
 
The coherent factor depends on the coherence of the light reaching the 
photodetector. The measured intensity correlation function is related to the field 
correlation function by the Siegert relation: 
 
݃ଵሺ߬ሻ ൌ 1 ൅ ܾ|݃ଶሺ߬ሻ|ଶ     (Eq 2.5) 
 
where ݃ଵሺ߬ሻ is: 
 
݃ଵሺ߬ሻ ൌ |ܧכሺݐሻܧሺݐ ൅ ߬ሻ| ۃ|ܧሺݐሻ|ଶۄ⁄     (Eq 2.6) 
 
where ܧכሺݐሻ is the electric field conjugate function. For monodisperse spherical 
particles: 
 
݃ଵሺݐሻ ൌ ݁ݔ݌ሺെΓ߬ሻ     (Eq 2.7) 
 
where Γ is the characteristic delay rate, which is related to the translational diffusion 
coefficient, D, of a solute by means of the expression: 
 
Γ ൌ ݍଶܦ      (Eq 2.8) 
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The diffusion coefficient is frequently used to determine the hydrodynamic 
radius, RH, of the constituent particles by using the Stokes-Einstein equation [22]:  
 
ܦ ൌ ௄ಳ்଺గఎோಹ      (Eq 2.9) 
 
where KB is the Boltzmann constant, T the absolute temperature and η the liquid 
viscosity. The hydrodynamic radius obtained by DLS represents an ideal hard sphere 
that diffuses with the same speed as the particle under examination. Actually, particles 
are solvated and the radius calculated from the particle diffusion corresponds to the size 
of the dynamic solvated particle. 
 
2.2.2 Zeta potential 
When a charge is present on the surface of a particle, the distribution of ions in 
the surrounding interfacial region is affected, resulting in an increased concentration of 
counter ions (ions with opposite charge) in the proximity of the particle’s surface. In 
this way an electrical double layer exists around each particle.  
The liquid layer surrounding the particle is divided in two regions: one inner 
region known as Stern layer where the ions are strongly attached to the surface; and a 
second external diffuse region where the ions are less firmly attached. Within the 
diffuse layer there is a certain type of boundary where the particle and the ions form a 
stable entity. When the particle moves, for example by gravity, the ions inside this 
boundary travel together with the particle, buy any other ion beyond this boundary does 
not move with the particle. This boundary is called the surface of hydrodynamic shear 
or slipping plane (Figure2.7). The potential existing in this boundary is known as the 
zeta potential [23]. The magnitude of the zeta potential gives an indication of the 
colloidal system potential stability. A colloidal system is when one of the three states of 
matter: gas, liquid and solid, are finely dispersed in one of the others. For this technique 
we are interested in the two states of: a solid dispersed in a liquid, and a liquid dispersed 
in a liquid, i.e. an emulsion [23]. 
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Figure 2.7: The surface of hydrodynamic shear or slipping plane is the distance from the 
surface at which ions become bound (essentially immobile), beyond this boundary ions do not 
travel with the particle when the particle moves (image taken from [23]). 
 
If all the particles in suspension have a large negative or positive zeta potential 
then they will tend to repel each other and there is no tendency to flocculate. However, 
if the particles have low zeta potential values then there is no force to prevent the 
particles coming together and flocculating. The general dividing line between stable and 
unstable suspensions is generally taken at either +30 mV or -30 mV. Particles with zeta 
potentials more positive than +30 mV or more negative than -30 mV are normally 
considered stable [23]. 
The most important factor affecting the zeta potential is pH (Figure2.8). A zeta 
potential value on its own without a quoted pH is virtually meaningless. At acid pH zeta 
potential will be positive and at alkaline pH it will be negative. The point at which the 
sign of zeta potential switches is known as the isoelectric point, at this point the 
colloidal system is less stable [23].  
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Figure 2.8: Zeta potential as a function of pH. The point of zero zeta potential is known as the 
isoelectric point (image taken from [23]). 
 
When an electric filed is applied trough an electrolyte, the charged particles 
suspended on it are attracted to oppositely charged electrode. The viscous forces will 
oppose to this movement and when the equilibrium between both forces is reached the 
particles move with a constant velocity, known as electrophoretic mobility [23]. 
The velocity of particles depends of the following parameters:  
• Force of the electric field 
• Dielectric constant. 
• Viscosity of the medium. 
• Zeta potential of particles. 
The zeta potential of the particle can be calculated if the electrophoretic mobility is 
known by means of the Henry’s equation [24]:  
ܷா ൌ ଶఌ௭௙ሺ௄௔ሻଷఎ       (Eq 2.10) 
where z is the zeta potential, UE is the electrophoretic mobility, ε is the dielectric 
constant, η is the viscosity, f (ka) is the Henry´s function, whose extended form is [24]: 
݂ሺ݇ܽሻ ൌ 1 ൅ 116 ሺ݇ܽሻ
ଶ െ 548 ሺ݇ܽሻ
ଷ െ 18 ሺ݇ܽሻ
ସ 
   ൈ ቂ ଵଵଶ ሺ1 െ ݇ܽሻ െ ቀ1 െ
ଵ
ଵଶ ሺ݇ܽሻଶቁ ݁௞௔ܧଵሺ݇ܽሻቃ  (Eq 2.11) 
where E1(ka) is the exponential integral of order one, k is the reciprocal of the thickness 
of the electrical double layer also commonly referred to as the “Debye length”, and a is 
the particle radius.  
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Zeta potential determinations based on electrophoretic measurements are 
performed usually in aqueous medium with a moderate electrolyte concentration. For 
these conditions, a Henry’s function value of 1.5 is used, known as the Smoluchowski 
approximation [24]. Therefore, the determination of zeta potential from UE is 
straightforward for systems that fit the Smoluchowski model: particles larger than 200 
nm dispersed in electrolyte with a concentration of ca. 10-3 M [23]. For small particles 
in a medium with a low dielectric constant, f(ka) assumes the value of 1.0, which also 
enables an easy calculation of the potential [24]. This is known as the Hückel 
approximation. Measurements in non-aqueous medium commonly use the Hückel 
approximation [23]. 
Zeta potential is measured using a combination of two measurement techniques: 
Electrophoresis and Laser Doppler Velocimetry, sometimes called Laser Doppler 
Electrophoresis. Velocity of particles is measured in a classical microelectrophoresis 
system consisting of a cell with electrodes at either end to which a potential is applied 
(Figure 2.9). Particle moves towards the electrode of opposite charge, their velocity is 
measured and expressed in unit field strength as their mobility. 
 
Figure 2.9: Capillary folded cell used for zeta potential measurements. 
 
In laser Doppler velocimetry a laser (Figure 2.10-1) is used to illuminate the 
particles within the sample. The light source is split to provide an incident and reference 
beam. The reference beam is “modulated” to provide the Doppler effect necessary. The 
laser beam passes through the centre of the sample cell (Figure 2.10-2), and the 
scattering at an angle of 17° is detected. When an electric field is applied to the cell, any 
particle moving through the measurement volume will cause the intensity of light 
detected to fluctuate with a frequency proportional to the particle speed. A (Figure 2.10-
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3) detector sends this information to a digital signal processor (Figure 2.10-4). This 
information is then passed to a computer (Figure 2.10-5) where the equipment software 
produces a frequency spectrum form which the electrophoretic mobility and hence the 
zeta potential is calculated. The intensity of the scattered light within the cell must be 
within a specific range to be successfully measured by the detector. If too much light is 
detected then the detector will become overloaded. To overcome this, an “attenuator” 
(Figure 2.10-6) is used to reduce the intensity of the laser and hence the intensity of the 
scattering. To correct for any differences in the cell wall thickness and dispersant 
refraction, compensation optics (Figure 2.10-7) are installed within the scattering beam 
path to maintain alignment of the scattering beams. 
 
Figure 2.10: Setup of a zeta potential measurement system. 
 
2.2.3 Electron microscopy 
Microscopy is an important tool for the characterization of nanomaterials 
structure. For example, this set of imaging techniques may be used to examine the 
detailed shape, size and distribution of a wide range of nanoscopic objects. There are 
different available classes of microscopic techniques, such as the traditional optical 
microscopy, or more powerful ones such as scanning electron microscopy (SEM), 
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transmission electron microscopy (TEM), and scanning probe microscopy (SPM), 
amongst others. 
 
2.2.3.1 Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) involves the transmission of an 
electron beam through a sample in a high-vacuum environment. The images and their 
associated contrasts arise from regional differences in electron densities in such sample. 
TEM has a resolution of ca. 1 to 100 nm and can provide very detailed structural 
information of polymeric materials. The TEM specimens need to be very thin in order 
to enable the transmission of electron beams through the sample.  
A transmission electron microscope (Figure 2.11a) is constituted by an electron 
source (electron gun) which emits electrons travelling through the vacuum created into 
the microscope column. A condenser lens focus the electron beam on the sample, and 
several objective lenses are used to form the diffraction pattern at the back focal plane 
and the sample image at the image plane; there are also some intermediate lenses to 
magnify the image or the diffraction screen. To obtain an improved contrasted image, 
an objective diaphragm is inserted in the back focal plane to select the transmitted 
beam. At the bottom of the microscope, the non-scattered electrons reach a fluorescent 
screen, which provides a contrasted image of the specimen, with a darkness distribution 
corresponding to its different electron densities. 
 
Figure 2.11: Schematic diagram of electron microscopes: a) TEM; b) SEM. 
 
In order to solve the material´s structure on the mesoscopic scale at even high 
resolutions comparable to interatomic distances, high-resolution transmission electron 
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microscopes (HRTEM) emerge as a powerful tool. HRTEM uses the transmitted and 
scattered electron beams directed to a sample to create a diffraction image, in contrast to 
conventional TEM that only uses the transmitted beams. The high resolution image 
recorded can be interpretable directly in terms of projections of individual atomic 
positions. In this way, defects and other inhomogeneities present in a material specimen 
can be accurately determined. A great advantage of the HRTEM microscope is the 
capability to observe both electron microscope images and diffraction patterns for 
determined selected area electron diffractions from a sample [25-27]. The selected area 
electron diffraction in an electron microscope is formed by setting an aperture in the 
imaging plane of the objective lens. Only rays passing through this aperture contribute 
to the diffraction pattern at the far field. For a perfect lens without aberrations, the 
diffracted rays come from an area that is defined by the back-projected image of the 
selected aperture. The aperture image is typically a factor of 20 times smaller because of 
the objective lens magnification.  The smallest area that can be selected in SAED is 
limited by the objective aberration. [28]. 
 
2.2.3.2 Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) is another valuable electron microscopy 
technique for the examination and analysis of the microstructural characteristics of solid 
objects, with a resolution of ca. 5 nm. SEM can also be used to obtain compositional 
information of nanomaterials by coupling an electron diffraction X-ray scattering 
detector. SEM enables the observation of heterogeneous organic and inorganic materials 
on the mesoscopic scale [29]. In a typical SEM experiment, an electron beam is focused 
to obtain a very fine spot size that is rastered over the surface, and an appropriate 
detector collects the electrons emitted from each point. In this way, an image having a 
great field depth and a remarkable three-dimensional appearance is built up line by line. 
The specimen is usually coated with a conducting film prior to examination to enhance 
electron conductivity and, thus, improving image contrast. 
A scanning electron microscope (Figure 2.11b) consists of an electron gun at the 
top of the column, which creates a divergent electron beam. In the column, which is 
under vacuum, a series of magnetic apertures focuses the electron beam, and an 
electrostatic field drives the electrons through a small spot called crossover and 
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accelerates them through the column until the sample chamber, where the electron beam 
interacts with the sample. The signals resulting from the beam-sample interaction are 
monitored. Finally, SEM constructs a virtual image from the signal emitted from the 
sample by scanning the electron beam line by line through a rectangular (raster) pattern 
on the sample surface. The scan pattern defines the area represented in the image. At 
any time, the beam illuminates only a single point in the pattern. As the beam moves, 
the signals it generates vary in strength, reflecting structural/morphological differences 
in the sample. 
 
2.2.4 Optical spectroscopy 
The three most important types of optical spectroscopies are ultraviolet and 
visible (UV-Vis), fluorescence and infrared (IR) spectroscopy. They differ only in the 
selection of the incident light wavelength. Both UV-Vis and fluorescence describe the 
phenomenon of electron excitation; namely, a valance electron of a molecule is excited 
upon absorbing energy from the electromagnetic radiation and is, thereby, transferred 
from one energy level to other more energetic level. The spectra are electronic. In 
contrast, IR spectra describe the vibration of atoms (not electrons) around a chemical 
bond. 
  
2.2.4.1 UV-vis absorption spectroscopy 
An electron transition consists of the promotion of an electron from a molecular 
orbital in the ground state to an unoccupied orbital by absorption of a photon. The 
molecule is, then, said to be in an excited state. Let us recall first the various types of 
molecular orbitals. A ߪ orbital can be formed either from two s atomic orbitals, from 
one s and one p, or from two p atomic orbitals having a collinear symmetry axis. The 
bond formed in this way is called a ߪ bond. A ߨ orbital is formed from two p atomic 
orbitals overlapping laterally. The resulting bond is called a ߨ bond. For example, in 
ethylene (CH2=CH2) the two carbon atoms are linked by one ߪ and one ߨ bond. 
Absorption of appropriate energy can promote, for example, one of the ߨ electrons to an 
anti-bonding orbital denoted by ߨכ. The transition is, then, called ߨ ՜ ߨכ. 
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A molecule may also possess non-bonding electrons located on heteroatoms 
such oxygen or nitrogen. The corresponding molecular orbitals are called ݊ orbitals. 
Promotion of a non-bonding electron to an anti-bonding orbital is possible, and the 
associated transition is denoted by ݊ ՜ ߨכ. Hence, molecules containing a non-bonding 
electron, such as oxygen, nitrogen, sulphur, or halogens, often exhibit absorption in the 
UV region. To illustrate these energy levels, Figure 2.12 shows the molecule 
formaldehyde as an example with all their possible transitions. In particular, the ݊ ՜ ߨכ 
transition deserves further attention: Upon excitation, an electron is removed from the 
oxygen atom and goes into the ߨכ orbital localized half-partially on both the carbon 
atom and the oxygen atom. The ݊ ՜ ߨכ excited state, thus, has a charge transfer 
character, as shown by the increase observed in the dipole moment regarding the ground 
state dipole moment of C=O [30, 31]. 
In summary, the electronic transitions observed in UV-Vis spectroscopy are 
݊ ՜ ߨכ, ߨ ՜ ߨכ, ݊ ՜ ߪכ, ߨ ՜ ߪכ, ߪ ՜ ߨכ, and ߪ ՜ ߪכ. The energy of these electronic 
transitions is, generally, in the following order: ݊ ՜ ߨכ <  ߨ ՜ ߨכ < ݊ ՜ ߪכ <ߨ ՜ ߪכ< 
ߪ ՜ ߨכ < ߪ ՜ ߪכ. Of the six transitions outlined, only the two lowest energetic ones 
(݊ ՜ ߨכ and ߨ ՜ ߨכ) are achieved by energies available in the 200 to 800 nm. The last 
four types of electronic transitions required higher energy inputs, below 200 nm, 
corresponding to the far ultraviolet region of the electromagnetic spectrum. For 
instance, most ߪ ՜ ߪכ transitions for individual bonds take place below 200 nm and a 
compound containing only ߪ bonds is transparent (near zero absorption) in the near-
UV-Vis region. For example, methane (which has only C-H bonds) the transition 
ߪ ՜ ߪכ takes place at 125 nm. 
In absorption and fluorescence spectroscopy, two important types of orbitals are 
considered: the Highest Occupied Molecular Orbitals (HOMO) and the Lowest 
Unoccupied Molecular Orbitals (LUMO). Both of these refer to the ground state of the 
molecule. For instance, in formaldehyde, the HOMO is the ݊ orbital and the LUMO is 
the ߨכ orbital.  
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Figure 2.12: Energy levels of molecular orbitals in formaldehyde and possible electronic 
transitions. 
 
When one of the two electrons of opposite spins (belonging to a molecular 
orbital of a molecule in the ground state) is promoted to a molecular orbital of higher 
energy, its spin is, in principle, unchanged so the total spin quantum number (ܵ ൌ ∑ ݏ௜ 
with ݏ௜ ൌ ൅ ଵଶ or ݏ௜ ൌ െ
ଵ
ଶ) is zero. Because of the multiplicities of both the ground and 
excited states (ܯ ൌ 2ܵ ൅ 1) are equal to 1, both are called singlet states (usually 
denoted ܵ଴ for the ground state, and ܵଵ, ܵଶ,... for the excited states (Figure 2.13). The 
corresponding transition is called a singlet-singlet transition. A molecule in a singlet 
excited state may undergo conversion into a state where the promoted electron has 
changed its spin; therefore, there are two electrons with parallel spins, and the total spin 
quantum number is 1 and the multiplicity is 3. Such state is called a triplet state because 
it corresponds to three states of equal energy. According to Hund’s rule, the triplet state 
has lower energy than the singlet state of the same configuration [32]. 
 
Figure 2.13: Distinction between singlet and triplet states. 
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An instrument for measuring the absorption of UV and visible radiation is built 
of one or more light sources, a wavelength selector, a sample container, radiation 
transducers, a signal processors and readout devices. Figure 2.14 shows a scheme of a 
single-beam instrument for absorption measurements. Single beam instruments vary 
widely in their complexity and performance characteristics. The simplest ones consist of 
a tungsten bulb as the source, a set glass filter for wavelength selection, a test tube for 
sample holders, a photovoltaic cell as the transducer, and an analogmeter as the readout 
device. Other sophisticated instruments have interchangeable tungsten and deuterium 
lamp sources, use a rectangular silica cell, and are equipped with a high-resolution 
grating monochromator with variable slit. Photomultiplier tubes are used as transducers, 
and the output is often digitalized, processed and stored in a computer so that it can be 
printer or plotted in several forms [33].  
 
 
 
Figure 2.14: General scheme of a single-beam instrument for UV-Vis absorption measure-
ments. 
 
2.2.4.2 Fluorescence spectroscopy 
Once a molecule is excited by the absorption of a photon, this can return its 
ground state through either fluorescence emission, internal energy conversion (i.e. direct 
return to the ground state without fluorescence emission for example, by heat radiation), 
intersystem crossing (possibly followed by phosphorescence emission), intramolecular 
charge transfer and/or conformational change. All these processes can be visualized in 
the Perrin-Jablonski diagram (Figure 2.15). The singlet electronic states are denoted as 
S0 (fundamental electronic state), S1, S2, ... and the triplet states as, T1, T2, ..., with 
different vibrational levels associated with each electronic state. It is important to note 
that energy absorption is very fast (≈1015 s) with respect to all other processes (so that 
there is no concomitant displacement of the nuclei according to the Franck-Codon 
principle) [30, 32]. The vertical arrows corresponding to the energy absorption process 
start from the 0 vibrational energy level, S0, since most of molecules are in this state at 
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room temperature. Absorption of a photon, hence, can bring a molecule to one of the 
vibrational levels of S1, S2. 
Emission of photons accompanying the S1 → S0 relaxation is called 
fluorescence. It should be emphasized that, apart from a few exception, fluorescence 
emission occurs from S1 and, therefore, its characteristics (except polarization) do not 
depend on the excitation wavelength (of course only one species exists in the ground 
state). The transition between the ground state and the excited stated (0-transition) is 
usually the same for absorption and fluorescence. However, the fluorescence spectrum 
is located at higher wavelengths than the absorption one because of the energy loss in 
the excited state due to vibrational relaxation (Figure 2.16). According to the Stokes 
rule the fluorescence emission wavelength should be always higher than that of 
absorption. However, in most cases the absorption spectrum partly overlaps the 
fluorescence spectrum, i.e. a fraction of light is emitted at shorter wavelengths than the 
absorbed light. Such an observation seems to be, at first, in contradiction with the 
energy conservation principle. However, such energy defect is compensated by the fact 
that a small fraction of molecules is in a higher vibrational level in the ground state as 
well as in the excited state at room temperature [32]. 
 
 
 
Figure 2.15: Perrin-Jablonski diagram and illustration of the relative positions of absorption, 
fluorescence and phosphorescence processes. 
 
In general, differences between the vibrational levels are similar in the ground 
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and excited states, so that the fluorescence spectrum often resembles the first absorption 
band. The gap, expressed in wavenumber, between the maximum of the first absorption 
band and the maximum of fluorescence is called the Stokes shift. It should be noted that 
photon emission is as fast as photon absorption. However, excited molecules remain in 
the S1 state for a certain time (a few tens of picoseconds to a few hundreds of 
nanoseconds, depending on the type of molecule and its surrounding medium) before 
emitting a photon or undergoing other relaxation processes. Thus, after excitation of a 
population of molecules by a very short light pulse, the fluorescence intensity decreases 
exponentially with a characteristic time, reflecting the average lifetime of the molecules 
in the S1 excited state.  
 
Figure 2.16: Illustration of the vibrational bands in the absorption and fluorescence spectra. 
 
As a consequence of the strong influence of the local environment or 
surrounding medium on fluorescence emission, fluorescent molecules are currently used 
for physicochemical, biochemical and biological investigation. For example, 
fluorescence spectroscopy can be employed as a highly sensitive method for protein 
analysis. Intrinsic protein fluorescence deriving from the naturally fluorescent amino 
acid tryptophan (and to a lesser extent from tyrosine and phenylalanine) can provide 
information on the protein conformational structure and it changes.  
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Figure 2.17: Schematic representation of a spectrofluorometer. 
 
 
Fluorescence Resonance Energy Transfer (FRET) is a process that occurs 
whenever the emission spectrum of a fluorophore, called the donor, overlaps with the 
absorption spectrum of another molecule, called the acceptor. In this process, an energy 
transfer from the donor to the acceptor occurs. The extent of energy transfer is 
determined by the distance between the donor and the acceptor, and the extent of 
spectral overlap. The spectral overlap is described in terms of the Förster distance (the 
distance at which FRET is 50% efficient) which is comparable in size to biological 
macromolecules (3-6 nm) [34]. Some examples of the vast number of applications of 
FRET include the development of biosensors [35], the monitoring of the release of 
molecules from drug delivery nanosystem [36], and real time monitoring of DNA [37] 
and RNA [38] intracellular processes.  
 
Figure 2.17 shows the components of a conventional spectrofluorometer. The 
light source is commonly a high-pressure xenon arc lamp, which offers the advantage of 
a continuous emission from 250 nm to the infrared. A monochromator is used to select 
the excitation wavelength. Fluorescence is collected at right angles with respect to the 
incident beam and detected through a monochromator by a photomultiplier. Automatic 
scanning of wavelengths is achieved by motorized monochromators, which are 
controlled by the electronic devices and the computer, in which the data are stored [30, 
32]. The optical module contains various parts: a sample holder, shutters, polarizers if 
necessary, and a beam splitter consisting of a quartz plate reflecting a few per cent of 
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the exciting light towards a quantum counter or a photodiode. A quantum counter 
usually consists of a triangular cuvette, containing a concentrated solution of a dye 
whose fluorescence quantum yield is independent of the excitation wavelength. 
 
2.2.4.3 Infrared spectroscopy 
 
Molecules consist of atoms which have a certain mass and are connected by 
elastic bonds. As a result, they can perform periodic motions, i.e. they have vibrational 
degrees of freedom. All motions of the atoms in a molecule relative one each other are a 
superposition of the so-called normal frequencies. These are described by a normal 
coordinate. For polyatomic molecules, the number of characteristic frequencies is 
3ܰ െ 6 for non-linear molecules and 3ܰ െ 5 for linear molecules, where N is the 
number of atoms in the molecule, which define their vibrational spectra. These spectra 
depend on atoms mass, their geometrical arrangement, and the strength of their 
chemical bonds. Molecular aggregates such as crystals or complexes behave like 
“super-molecules” in which the vibrations of the individual components are coupled. As 
a first approximation the normal vibrations are considered not coupled, i.e. they do not 
interact. However, the bonds elasticity does not strictly follow Hooke’s law. Therefore, 
overtone and combinations of normal vibrations may appear [30, 39]. 
Infrared (and RAMAN) spectrometers are the most important tools for observing 
vibrational spectra. Depending on the nature of the vibration, which is determined by 
the symmetry of the molecule, vibration may be active or forbidden in the infrared (or 
RAMAN) spectrum. 
From basic theory, it is easy to understand that a molecule can take up an 
amount of energy, ݄ߥ, to reach a vibrationally excited state only when the frequency of 
the incident radiation on a molecule is the same as the vibrational frequency of the 
latter. This phenomenon involves either a change of the molecule’s dipole moment or a 
change in its polarizability. If the former phenomenon takes place, we will observe an 
IR band; if the second one occurs, we will observe a RAMAN band. The absorption 
wavelength range of IR spectroscopy is from 2.5 to 1000 μm, which corresponds to the 
energy ݄ߥ ൌ ݄ܿ ෤߭ with ෤߭ = 4000-10 cm-1, with ܿ the light velocity.  
According to classical mechanics, the vibrating atoms groups in a molecule can 
be modelled as balls joined by springs (the molecular bonds). To take the simplest 
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example, let us consider two balls joined by one spring representing a diatomic  
molecule. In this approximation, two atoms and the connecting bond are treated as a 
simple harmonic oscillator composed of 2 masses (atoms or balls). These two balls can 
vibrate with a characteristic frequency that depends on the mass of the balls and on the 
spring force (spring force can be approximated by Hooke’s law). Matematically, the 
equation ߥ ൌ ሺ1 ሺ2ߨሻ⁄ ሻඥߢ ߤ⁄ , describes the characteristic oscillation frequency ߥ and 
how it depends on mass ߤ and spring constant force ߢ. According to this equation, 
stiffer spring constant (stronger bonds) result in a higher frequency, whereas heavier 
atoms result in lower frequencies. This simple system possess only a single 
characteristic frequency. The balls can only vibrate with this characteristic frequency or 
an integer multiple of this frequency. A more complex molecule can still be modelled 
quite accuarately as balls of different massess joined by springs of different tensions 
(representing different atoms with different bonds). Figure 2.18 shows a diagram 
representing the vibration of a diatomic molecule or one vibrational degree of freedom 
of a polyatomic molecule, which is excited by a transition from energy level ߭ ൌ 0 to 
߭ ൌ 1 [30, 39, 40]. 
 
 
 
Figure 2.18: Observation of the excitation of a vibrational state in the electronic ground state by 
infrared absorption. 
 
In the classical harmonic oscillator, ܧ ൌ ଵଶ ߢݔଶ ൌ ݄ߥ, where x is the 
displacement of the spring. Thus, the energy or frequency is dependent on how far one 
stretches or compresses the spring. If this simple model were true, a molecule could 
absorb energy of any wavelength. However, vibrational motion is quantized and, 
therefore, the molecules can only exist in finite energy states. In the case of harmonic 
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potentials, these states are equidistant, i.e. ܧ௜ ൌ ݄ߥሺ݊௜ ൅ 1 2⁄ ሻ, ݊௜ ൌ 0, 1, 2, … where the 
energy levels are numbered as ni. At ni = 0, the potential energy has its lowest value, 
which is not the potential minimum energy [39, 40]. According to the selection rules, 
only transitions to the next energy level are allowed; therefore, molecules will absorb an 
amount of energy equal to ݄ߥ. This rule is not inflexible and, occasionally, transitions of 
2݄ߥ, 3݄ߥ, or higher are observed. These correspond to bands called overtones in an IR 
spectrum. They are of lower intensity than the fundamental vibration bands. 
 
As mentioned above, infrared spectra cover the near infrared(0.75-3 μm), middle 
infrared (3-30 μm) and far infrared (30-300 μm) range. In this region, most molecules 
show absorption or emission bands arising from symmetry-allowed interaction with the 
radiatio. The energy of the absorbed and emitted light is equivalent to the energy 
difference between the lowest vibrational states of the electronic ground state of a 
molecule. 
 
Three types of instruments for IR absortion measurements are commonly 
available: dispersive spectrophotometers with a grid monochormator, Fourier thansform 
spectrometers employing an interferometer, and non-dispersive photometers using a 
filter or absorbing gas (typically used for analysis of atmospheric gases at specific 
wavelengths). 
 
Until 1980s, the most widely used instruments for IR measurements were 
dispersive spectrometers. Nowadays, this type of instruments has been displaced by 
Fourier transform (FT) spectrometers because of their speed, reability, enhanced signal-
to-noise ratio. Infrared spectrometers (Figure 2.19) usually combine a radiation source, 
collimator, fixed mirror, moving mirror, a sample holder, a device for spectral 
dispersion or selection of radiation (beam splitter), and a radition detector, all connected 
to appropiate recording and evaluation facilities. An ideal spectrometer records 
completely resolved spectra with a maximum signal-to-noise ratio. It requires a 
minimum amount of sample which is measured nondestructively in a minimum time, 
and it provides facilities for storing and evaluating the spectra. FTIR spectrometers can 
be single-beam or double-beam instruments. A typical procedure for determining 
transmittance or absorbance with this type of instrument is to first obtain a reference 
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interferogram by scanning a reference (usually air) twenty or thirty times coadding the 
data, and storing the results in the computer. A sample is inserted in the radiation path 
and the process repeated. The ratio of the sample to reference spectral data is, then, 
computed to obtain the transmittance at various frequencies. 
 
Infrared spectroscopy (IR) has long been used to determine molecular structures and to 
identify unknown compounds. IR data have been used to obtain information about the 
chemical composition, configuration, and crystallinity of polymeric and biological 
materials [30].  
 
 
 
Figure 2.19: Scheme of a FTIR instrument. 
 
2.2.4.4 Inductively coupled-plasma emission spectroscopy 
Inductively coupled plasma-atomic emission spectroscopy (ICP-AES) is a 
widespread technique for elemental analysis of a sample [41]. Most of the substances in 
gas state decompose in atoms when heated to a sufficiently high temperature. Unlike 
optical spectra of condensed matter, spectra of atoms in gas state consist of very narrow 
lines which originate from state transitions of each atom. Each element has its own 
characteristic spectrum, and spectral lines of different elements in one sample are barely 
superposed, which makes this technique very precise and sensitive [42]. In Figure 2.20, 
a scheme of an ICP-AES instrument is shown. A plasma source is used to make specific 
elements to emit light, after which a spectrometer separates this light in their 
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characteristic wavelengths. This technique is especially suited for direct analysis of 
liquid samples. The sample solution is transformed into an aerosol by a nebuliser. Small 
droplets (1-10 μm) are transferred by argon plasma. When the aerosol droplets enter the 
hot area of plasma, they are converted into salt particles. These salt particles are split 
into individual molecules that will subsequently fall apart to atoms and ions. In the 
plasma, even more energy is transferred to the atoms and ions, promoting the excitation 
of their electrons. When these excited atoms and ions back to a lower excitation state or 
to their ground state they will emit electromagnetic radiation in the ultra-violet/visible 
range of the spectrum. The classical approach for ICP-AES measurement is to collect 
and measure the emitted radiation radially, i.e. the optical axis is orthogonal to the 
central channel of the ICP. The limit of detection is in de order of ca. ng/ml. 
 
 
 
 
Figure 2.20: Scheme of an ICP-AES instrument. 
 
2.2.5 Superconducting quantum interference device (SQUID) 
A SQUID magnetometer is a sensitive device for measuring magnetic fields. 
SQUID magnetometers are used to characterize materials when the highest detection 
sensitivity over a broad temperatures range and application of magnetic fields up to 
several Tesla is needed. The main application of this instrument is the study of magnetic 
properties of materials by measuring the induced or remnant magnetic moment, usually 
as a function of applied magnetic field and temperature (Figure 2.21). A SQUID 
magnetometer combines several superconducting components, including the proper 
SQUID device, a superconducting magnet, detection coils, a flux transformer, and 
superconducting shields (Figure 2.22). To make a measurement, a sample is first 
attached to a sample rod. The sample is then scanned through the centre of a first-order 
or second-order superconducting gradiometer. The gradiometers form a closed flux 
transformer that is coupled to a SQUID. The shape and magnitude of the response curve 
can be then analyzed using a computer to obtain a corresponding magnetic moment 
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[43]. In particular, we use SQUID to measure the magnetic properties of magnetic 
nanoparticles (superparamagnetic materials, see section 5.2) and hybrids.  
 
 
Figure 2.21: Hysteresis loops (magnetization vs. applied magnetic field) characteristic of 
ferromagnetic and superparamagnetic NPs. For comparison, para- and diamagnetic behavior are 
also shown. The Figure indicates the remanence, Mr, and coercive field, Hc, values. 
 
Figure 2.22: Scheme of a SQUID magnetometer. 
 
2.2.6 Magnetic resonance imaging (MRI) 
One of the most valuable and widely used imaging methods in medical 
diagnostic is the Magnetic Resonance Image (MRI). Though the diagnostic potential of 
conventional MRI is immense and a variety of different contrast modes are well 
established, further improvements of the method have been pursued in past years by 
application of magnetic nanoparticles for contrast enhancement based on functional site 
specificity. 
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In MRI, the nuclear magnetic moment of protons is used as a sensitive probe of 
the chemical neighbourhood of protons in different tissues and organs of human body. 
Nuclear moments are aligned by means of an external magnetic bias field (commonly in 
the range of 0.2-3 T) and the precession of the spins is excited by transverse RF pulses 
at a proton resonance frequency of about 42.58 MHz T-1. After applying the pulse 
sequence, the induced magnetization decays and the longitudinal (T1) and transverse 
(T2) relaxation times of the precessing nuclear magnetic moments show tissue-specific 
differences that are used to generate the required image contrast. Imaging is performed 
by controlling external field gradients so that the resonance condition is fulfilled only in 
a restricted local region and, then, by scanning the resonant volume the image is built. 
Magnetic response signals are detected by pick-up coils. In this way, the tissue-specific 
differences of the relaxation time T1 and/or T2 may be used for construction of the T1- 
and T2.weighted images showing optimal contrast of special tissue features. In practice, 
for optimization of tissue contrast a variety of different pulse sequences (e.g., the widely 
applied spin-echo methods) may be used [44, 45]. 
Generally, a magnetic resonance scanner (Figure 2.23) is essentially defined by 
three hardware groups and their parameters: a) the main magnet with its homogeneity 
over imaging volume; b) the magnetic field gradient system with its linearity over the 
imaging volume; and c) the radiofrequency (RF) system with its RF signal homogeneity 
and signal sensitivity over the imaging volume. Whole-body MRI imposes very special 
demands on these system components [46, 47]: 
The main magnet. Magnetic resonance imaging requires a very strong magnetic 
field that has precisely the same magnitude and direction everywhere in the region we 
want to image. One of the key properties used to describe the quality of a MRI system is 
the uniformity, or homogeneity, of the applied magnetic field. For example, high-
quality MRI systems made for clinical use in hospitals will have magnetic fields that 
vary less than 5 parts per million (ppm) over a 40 cm diameter spherical volume in the 
region desired for imaging. 
The magnetic field gradient. As mentioned earlier, a key property of the static 
magnetic field of a MRI system is its homogeneity, but anything we place inside the 
magnetic field tends to change the magnetic field slightly. To make the magnetic field 
as uniform as possible and to compensate for changes caused by different objects in the 
field, we shim the field. Shimming is typically handled by placing small amounts of 
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two distinct sets of excitation and fluorescence wavelengths. A band of shorter 
excitation wavelengths from the illuminator and filters is directed to the specimen, 
while a band of longer fluorescence wavelengths emitted from the specimen forms an 
image of the specimen in the image plane [50].  
 
2.2.7.1 Fluorochromes 
To perform fluorescence microscopy effectively, it is necessary to select the 
proper fluorochrome, filters, and illuminator for a given application, and evaluate the 
quality of fluorescence signals. Fluorescence microscopy allows visualization of 
specific molecules that fluoresce in the presence of excitatory light. Thus, the amount, 
intracellular location, and movement of macromolecules, small metabolites, and ions 
can be studied using this technique. Typically, non-fluorescent molecules are tagged 
with a fluorochrome in order to make them visible. Fluorochromes, also known as 
fluorescent dyes or fluorescent molecules, are molecules capable of fluorescing. 
Examples of these are DAPI and the Hoechst dyes used to directly label nuclear DNA, 
or rhodamine-labeled phalloidin used to indirectly label cytoplasmic actin filaments 
[50]. If a fluorochrome is conjugated to a large macromolecule (through a chemical 
reaction or by simple adsorption), the tagged macromolecule is said to contain a 
fluorophore, the chemical moiety capable of producing fluorescence. Fluorochromes 
exhibit distinct excitation and emission spectra that depend on their atomic structure and 
electron resonance properties. Fluorescent dyes usually contain several unconjugated 
double bonds. Fluorochrome-labeled antibodies can be used to label fixed, 
permeabilizer cells in a method known as immunofluorescence microscopy. These 
techniques are commonly used to visualize the distribution of certain proteins in a cell 
or to make visible specific organelles, filaments, and biochemically distinct membrane 
regions [50].  
 
2.2.7.2 Important parameters of fluorochromes  
Two important parameters of fluorochromes are the Stokes shift, which is the 
difference between the excitation wavelength and emission wavelength, fluorochromes 
with large stoke shifts are advantageous for fluorescence microscopy as they permit to 
isolate the emission light by interference filters; the second parameter is the Quantum 
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efficiency of fluorescence emission, which is the fraction of absorbed photon quanta 
reemitted by a fluorochrome as fluorescence photons. Quenching is a phenomenon that 
reduces the quantum efficiency of a fluorochrome without altering the emission spectra. 
This phenomenon occurs by interaction with other molecules including other 
fluorochrome molecules. Fluorochromes are desired to be water soluble, chemically 
stable and resistant to photobleaching. Photobleaching is the loss of fluorescence due to 
photon-induced chemical damage and covalent modification.  
 
2.2.7.3 Fluorescence microscope 
A fluorescence microscope consists of the following parts (Figure 2.24): 
Light source: it must be a bright light source, such as a mercury or xenon arc lamp, 
because only a narrow band of wavelengths and, in consequence, a small portion of the 
illuminator output is used to excite the fluorochromes in the specimen. 
Epi-illuminator:  the epi-illuminator consists of the lamp and its collector lens plus a 
connector tube fitted with a field stop diaphragm, a relay lens, and slots for additional 
filters. It is attached to the lamp at one end and is mounted at the other end to the 
microscope in the vicinity of the fluorescence filter cube. The lamp housing should 
contain a focusable collector lens to fill the back aperture of the objective as required 
for Koehler illumination. On most research microscopes the epi-illuminator is a built-in 
component of the microscope setup. Apart from proper adjustment and focus of the 
lamp, little other manipulation of the illumination pathway is required, for example, the 
field stop diaphragm is centered and is opened to provide optimal framing of the 
specimen. Epi-illumination is much more efficient than transmitted mode (or diascopic) 
illumination because there is much less background in the fluorescence image. 
Filters: Filters used to isolate bands of wavelengths in fluorescence microscopy include 
colored glass filters, thin film interference filters, or a combination of them. The filters 
include long- or short-pass edge filters and narrow or broad bandpass filters. The filters 
must be selected in accordance with the absorption and emission of the fluorochromes 
to be observed. An appropriate selection of the filters sets can improve considerably the 
quality of the images obtained by fluorescence microscopy. 
Dichroic mirror:  The dichroic mirror or beam splitter is a special long-pass filter 
coated with multiple layers of dielectric materials similar to those contained in thin film 
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interference filters, but specially designed for reflection and transmission at certain 
boundary wavelengths. The mirror is mounted at a 45° angle with respect to the optic 
axis within a filter cube and faces the light source. At this angle, the dichroic mirror 
reflects short excitation wavelengths at a 90° angle along the optic axis to the specimen, 
but transmits long fluorescence wavelengths that are collected by the objective and 
directed to the image plane. The transition from near total reflection to maximal 
transmission can be remarkably sharp, occurring over 20–30 nm, allowing the mirrors to 
act as precise discriminators of excitation and fluorescence wavelengths. The 
specifications for a dichroic mirror assume a 45° angle between the axis of the incident 
beam and the plane surface of the mirror. Dichroic mirrors should be handled with 
extreme care, because the exposed dielectric layers can be scratched and damaged 
during handling and cleaning. 
 
Figure 2.24: Scheme of the fluorescence microscope optics. 
 
Objective lenses:  Proper selection of an objective lens is important, especially for 
imaging dim fluorescent specimens. High-numerical aperture (H-NA), oil immersion 
plan-fluorite lenses and planapochromatic objective lenses are ideal, because at NA = 
1.3 or 1.4 their light-gathering ability is especially high. These lenses give excellent 
color correction, so different fluorescent wavelengths are brought to the same focus in 
the focal plane. They are also transparent to UV light, a requirement for examining UV-
excitable dyes such as DAPI, Hoechst…. In addition, they contain low-fluorescence 
glass, a feature that minimizes background fluorescence and gives high contrast. Since 
image brightness (photon flux per unit area and time) is proportional to NA4/M2, where 
NA is the numerical aperture and M is the magnification at 60X, 1.4 NA 
planapochromatic objective is among the brightest objectives and is very well suited for 
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fluorescence imaging. The spatial resolution d for two noncoherent fluorescent point 
objects is the same as in bright-field microscopy with incoherent light, and is given as d 
= 0.61λ/NA, where λ is the mean wavelength of fluorescent light transmitted by the 
barrier filter. 
 
2.2.8 Confoncal laser scanning microscopy (CLSM)  
CLSM produces optical sections by scanning the specimen point-by-point with a 
laser beam focused in the specimen, using a spatial filter (usually a pinhole or a slit) to 
remove unwanted fluorescence from above and below the focal plane of interest. The 
term “optical section” refers to the instrument’s ability to produce sharper images of 
fluorescently labeled tissues than those produced using a standard epifluorescence 
microscope and, in most cases, without resorting to physical sectioning of the tissue. 
Optical paths of the various commercially available CLSMs are designed so that when 
the laser beam is focused in the specimen, it is confocal with the point of light focused 
at the pinhole in front of the photodetector. Thus, only information from the focal plane 
of interest reaches the photodetector. The power of this approach lies in its ability to 
image structures at discrete levels within an intact biological specimen with a theoretical 
lateral resolution of 0.14 μm and a vertical resolution of 0.23 μm with a lens of 1.4 NA 
[50]. 
 
2.2.8.1 Confocal laser scanning microscope 
The confocal microscope is an integrated microscope system consisting of a 
fluorescence microscope, multiple laser light sources, a confocal box or scans head with 
optical and electronic equipment, a computer and monitor for display, and software for 
acquiring, processing, and analyzing images. The scan head generates the photon 
signals required to reconstruct the confocal image and contains the following devices: 
inputs from one or more external laser light sources, fluorescence filter sets, a 
galvanometer-based rater scanning mechanism, one or more variable pinhole apertures 
for generating the confocal image, and  photomultiplier tube (PMT) detectors for 
different fluorescent wavelengths (Figure 2.25). 
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• Time sequences of three dimensionally images with multiple colors, which can 
be displayed as three-dimensional color movies in real time or in time-lapse 
mode.  
An additional advantage is the possibility to use confocal microscopy in reflection 
mode, in which a laser beam scans the three-dimensional surface of a reflective object. 
Fluorescence filter sets are not used for this mode of imaging; rather the focused spot of 
the laser is reflected off the surface. Reflections from features lying in the confocal 
plane pass through the confocal pinhole aperture, wheras light from reflections above 
and below of the focal plane is largely excluded.  
 
2.2.9 X-ray diffraction 
 
X-ray diffraction (XRD) is a versatile, powerful and non destructive technique 
that reveals detailed information about the chemical crystallographic structure of natural 
and manufactured materials. Diffraction effects are observed when an electromagnetic 
radiation impinges on periodic structures with geometrical variations on the length scale 
of the radiation wavelength. The inter-atomic distances in crystal and molecules is 
around to 0.15 – 0.5 nm, which correspond in the electromagnetic spectrum with the 
wavelength of X-rays, having photon energies between 3 and 8 keV [51]. 
 
There are three different types of interactions between X-rays and matter. First, 
the photoionization, where electrons may be liberated from their bound atomic states 
during the process, and which falls into the group of inelastic processes. In addition, 
other inelastic scattering process that incoming X-ray beams may undergo upon 
interaction with matter is the energy transfer to an electron but, in this case, without a 
release of the electron from the atom (phenomenon known as Compton scattering). 
Finally, X-rays may be elastically scattered by electrons, process known as Thomson 
scattering. In this process, the electron oscillates at the frequency of the incoming beam 
so the wavelength of the scattered radiation is conserved. 
There are many theories and equations to correlate the diffraction pattern and the 
material structure. The Bragg law is a simple way to describe the diffraction of X-rays 
by a crystal. In Figure 2.28a, the incident X-rays reach the crystal planes with an 
incident angle θ and are diffracted at an angle θ. The diffraction peak is observed when 
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the Bragg condition is satisfied [31, 51]: 
 
݊ߣ ൌ 2݀ sin ߠ     (Eq 2.12) 
 
where λ is the wavelength of the incident X-rays, d is the distance between each 
adjacent crystal plane (d-spacing), θ is the Bragg angle at which a diffraction peak is 
observed, and n (1, 2, ...) is an integer number, called the reflection order; this means 
that the Bragg condition can be satisfied by various X–ray wavelengths. The Bragg law 
gives a simple relationship between the diffraction pattern and the crystal structure, and 
many X-ray diffraction applications can be easily explained by this law. 
 
 
 
Figure 2.28: (a) Incident and reflected X-rays form an angle θ which is symmetric to the crystal 
normal plane; (b) The diffraction peak is observed at a Bragg angle θ [31]. 
 
In X-ray diffraction using a single wavelength, the Bragg equation is typically 
expressed with n = 1 for the first order of diffraction because higher order reflections 
can be considered as resulting from different lattice planes. For instance, the second-
order reflection from (hkl) planes is equivalent to the first-order reflection from (2h, 2k, 
2l) planes. The diffraction peak is displayed as diffracted intensities at a range of 2θ 
angles. For perfect crystals, the peak is a delta function, the dark straight vertical line 
shown in Figure 2.28b [31]. 
a) b) 
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Figure 2.29: Diffraction patterns from crystalline solids, liquids, amorphous solids, and 
monoatomic gases as well as their mixtures [31]. 
 
A typical diffraction peak is a broadened peak displayed by the curved line in 
Figure 2.28b. The peak broadening can be due to many effects, including imperfect 
crystal conditions, such strain, mosaic structures, and finite sizes; ambient conditions, 
such as atomic thermal vibrations; and instrumental conditions, such as X-ray beam 
size, beam divergence, beam spectrum distribution, and detector resolution. The curved 
line gives a peak profile, which is the diffracted intensity distribution of the Bragg 
angle. The highest point on the curve gives the maximum intensity of the peak, Imax. 
The width of the peak is typically measured by its full width at half maximum 
(FWHM). The total diffracted energy can be measured by the area under the peak, 
which is referred to as integrated intensity. The integrated intensity is a more consistent 
value for measuring the diffracted intensity of a reflection since it is less affected by all 
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peak broadening factors [31, 51]. 
The Bragg diffraction condition is based on the existence of a long periodicity of 
crystalline materials. As mentioned above, X-rays diffraction can provide information 
on the atomic arrangement in material with long-range order, short-range order, or no 
order at all, like gases, liquid, and amorphous solids, and a material may have one or to 
be a mixture of the former atomic arrangement types. Figure 2.29 gives a schematic 
comparison of the diffraction patterns for crystalline solids, liquids, amorphous solids, 
and monatomic gases as well as their mixtures. The diffraction patterns shown in this 
Figure are displayed as diffracted intensity versus 2ߠ assuming that the diffracted 
intensity is a unique function of the diffraction angle. The diffraction pattern from 
crystals has many sharp peaks corresponding to various crystal planes based on the 
Bragg law. The peaks at low 2ߠ angles are from crystal planes of large d-spacing and, 
vice versa, at high 2ߠ angles. To satisfy the Bragg condition at all crystal planes, the 
crystal diffraction pattern is actually generated from polycrystalline materials or powder 
materials. Therefore, the diffraction pattern is also called powder diffraction pattern. A 
similar diffraction pattern can be collected with a single crystal if this has been rotated 
at various angles during data collection so that the Bragg law can be satisfied when the 
crystal is at the right orientation. 
 
Both amorphous solid and liquid materials do not have the long-range order of 
crystals, but their atomic distances have a narrow distribution because of atoms are 
tightly packed. In this case, the intensity of the scattered X-rays forms one or two 
maxima with a very broad distribution in the 2ߠ range. The intensity vs. 2ߠ distribution, 
thus, reflects the distribution of the atomic distances. In the case of a gas there is no 
order at all, i.e. the atoms are distributed randomly in space. The scattering curve is 
featureless except that the scattered intensity drops continuously with the increase of 
2ߠ. On the other hand, the diffraction pattern from a material containing both 
amorphous and crystalline features has a broad background from the amorphous phase 
and sharp peaks from the crystalline phase. For example, many polymer materials have 
an amorphous matrix with crystallized regions. The diffraction pattern may contain air-
scattering background in addition to sharp diffraction peaks. The air-scattering can be 
generated from the incident beam or diffraction beam. If the air-scattering is not 
removed by the diffractometer, the diffraction pattern contains a high background at low 
2ߠ angle and the background gradually decreases with increasing 2ߠ angle [51]. 
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On the other hand, X-ray diffraction phenomena can also be explained in 
reciprocal space by the reciprocal lattice and the Ewald sphere. Reciprocal lattice is a 
transformation of the crystal lattice in real space to reciprocal space. The shape and size 
of a unit cell in real space can be defined by three vectors, a, b, and c, all starting from 
any single lattice point. The unit cell of the corresponding reciprocal lattice is, then, 
given by three vectors a*, b*, and c* (also referred to as reciprocal lattice axes), and: 
 
ࢇכ ൌ ଵ௏ ሺ࢈ ൈ ࢉሻ,  
࢈כ ൌ ଵ௏ ሺࢉ ൈ ࢇሻ,                                      (Eq 2.13) 
ࢉכ ൌ ଵ௏ ሺࢇ ൈ ࢈ሻ  
 
where V is the volume of the crystal unit cell in the real space and  
 
ܸ ൌ ࢇ · ࢈ ൈ ࢉ                                                         (Eq 2.14) 
 
Since each reciprocal lattice axis is the vector product of two lattice axes in real space, 
these are perpendicular to the plane defined by the two lattice axes. The original lattice 
axes and reciprocal lattice axes maintain the following relations: 
 
ࢇ · ࢈ ൌ ࢈ · ࢈ ൌ ࢉ · ࢉ ൌ ૚                                              (Eq 2.15) 
 
and 
 
࢈ · ࢇכ ൌ ࢉ · ࢇכ ൌ ࢇ · ࢈כ ൌ ࢉ · ࢈כ ൌ ࢈ · ࢉכ ൌ ࢇ · ࢉכ ൌ 0                     (Eq 2.16) 
 
Figure 2.30 illustrate the relationship between the original lattice in real space 
and the reciprocal lattice. The unit cell of the original lattice is drawn in dotted lines. 
The three reciprocal lattice axes define a unit cell of the reciprocal lattice (solid lines). 
The origin of the reciprocal lattice axes, denoted by O, is the origin of the reciprocal 
lattice. The repeat translation of the reciprocal lattice unit cell in three dimensions forms 
the complete reciprocal lattice. Except the origin, each lattice point is denoted by a set 
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of three integers (hkl), which are the number of translations of the three reciprocal 
lattice axes, respectively, to reach the lattice point. In other words, the vector drawn 
from the origin of the lattice point (hkl) is given by: 
 
H௛௞௟ ൌ ݄܉כ ൅ ݄܊כ ൅ ݈܋כ    (Eq 2.17) 
 
and the direction of the vector H௛௞௟ is normal to the lattice planes (hkl) in real space. 
The magnitude of the vector H௛௞௟ is given by the d-spacing of the (hkl) planes: 
 
|H௛௞௟| ൌ 1 ݀௛௞௟⁄      (Eq 2.18) 
 
 
Figure 2.30: Relationship between the original lattice in real space and the reciprocal lattice 
[52]. 
 
 Therefore, each point (hkl) in the reciprocal lattice represents a set of lattice 
planes (hkl) in the real space lattice. The position of the point in the reciprocal lattice 
defines the orientation and d-spacing of the lattice planes in the real space lattice. The 
farther away a reciprocal lattice point is from the origin, the smaller is the d-spacing of 
the corresponding lattice planes. For example, the reciprocal lattice point (111) 
represent the (111) lattice planes in the real apace lattice, and the lattice vector is given 
by Hଵଵଵ ൌ ܉כ ൅ ܊כ ൅ ܋כ and ݀ଵଵଵ ൌ 1 |ܪଵଵଵ| ൌ 1 ܉כ ൅ ܊כ ൅ ܋כ⁄⁄ . 
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Figure 2.31: The Ewald sphere and Bragg condition in reciprocal space. 
 
On the other hand, the relationship between the Bragg condition and the 
reciprocal lattice can be explained visually by the Ewald sphere, also referred as 
reflection sphere. Ewald came up with a geometrical construction to help the 
visualization of which Bragg planes are in the correct orientation to diffract. In Figure 
2.31, the diffracting crystal is located in the centre of the Ewald sphere, C. The radius of 
the Ewald sphere is defined as 1 ߣ⁄ . The incident beam can be visualized as the vector 
from I to C, and the diffracted beam is the vector from C to P. Both the incident and 
diffracted beams form an angle θ from a set of crystal planes (hkl). The d-spacing of the 
crystal planes is dhkl In the Ewald sphere; both incident beam vector ݏ଴ ߣ⁄  and diffracted 
beam vector ݏ ߣ⁄  start at the poin C and end at the point O and P, respectively. The 
vector from O to P is the reciprocal lattice vector H௛௞௟ and is perpendicular to the 
crystal planes. The three vectors have the following relationship: 
 
௦ି௦బ
ఒ ൌ ܪ௛௞௟ ൌ ݄܉כ ൅ ݄܊כ ൅ ݈܋כ                                    (Eq 2.19) 
 
and their magnitude can be expressed based on the Bragg law as: 
 
௦ି௦బ
ఒ ൌ
ଶ ୱ୧୬ ఏ
ఒ ൌ |ܪ௛௞௟| ൌ
ଵ
ௗ೓ೖ೗                                 (Eq 2.20)  
 
The point O is the origin of the reciprocal lattice, and the point P is the 
reciprocal point (hkl). The Bragg condition is satisfied only when the reciprocal lattice 
point falls on the Ewald sphere. For a single crystal, the chance to have a reciprocal 
lattice point on the Ewald sphere is very small if the crystal orientation is fixed. 
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Multiplying both ends of equation 2.48 by the three lattice axes in real space, 
respectively, the Laue equations are obtained: 
 
ࢇ · ሺݏ െ ݏ଴ሻ ൌ ݄ߣ 
࢈ · ሺݏ െ ݏ଴ሻ ൌ ݇ߣ                                          (Eq 2.21) 
ࢉ · ሺݏ െ ݏ଴ሻ ൌ ݄ߣ 
 
The Laue equations establish that a periodic three-dimensional lattice produces 
diffraction maxima at specific angles depending on the incident beam direction and the 
wavelength. The Laue equations are suitable to describe the diffraction geometry of a 
single crystal. The Bragg law is more conveniently used for powder diffraction. Both 
the Bragg law and Laue equations define the diffraction condition in different formats. 
 
On the other hand, the distance between the origin of the reciprocal lattice O and 
the lattice point P is reciprocal to the d-spacing. The largest possible magnitude of the 
reciprocal lattice vector is given by 2 ߣ⁄ . This means that the smallest d-spacing 
satisfying the Bragg condition is ߣ 2⁄ . In powder X-ray diffraction, the random 
orientation of all crystallites can take all possible orientations assuming an infinite 
number of crystallites. The trace of the reciprocal lattice points from all crystallites can 
be considered as a series of spherical surfaces with origin O as the centre point. 
Therefore, the condition to satisfy the Bragg law is only if the d-spacing is greater than 
half of the wavelength. In other words, the Bragg condition can be satisfied if a 
reciprocal lattice point falls in a sphere of 2ߣ from the origin O. This sphere is called the 
limiting sphere for powder diffraction. 
 
X-ray diffraction systems have a variety of configurations and component options to 
fulfil requirements of different samples and applications. As shown in Figure 2.32, a 
typical XRD system normally consist of five basic components: 
• The X-ray source produces X-rays with the required radiation energy, focal spot 
size, and intensity; 
• The X-ray optics establish the primary X-ray beam to the required wavelength, 
beam focus size, beam profile, and divergence; 
• The Goniometer and sample stage establish and tune the geometric relation 
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between primary beam, sample, and detector; 
• The sample alignment and monitor assist users about sample positioning into the 
instrument and monitors the sample state and position; 
• The area detector intercepts and records the scattering X-rays from a sample, 
and it saves and displays the diffraction pattern into a frame. 
Each of the former basic components may have several options suitable for various 
application and functions. The whole system is controlled by a computer equipped with 
a software for instrument control, data acquisition, and data analysis. In addition to the 
five basic components, there are some other accessories, such as a low and high-
temperature stages, helium or vacuum beam path for SAXS, beam stop, and alignment 
and calibration fixtures. 
 
 
Figure 2.32. Scheme of a X-ray diffractometer. 
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CHAPTER III - NIR-Light-Active Hybrid Polymeric 
Nanoparticles for Simultaneous Cancer Monitoring 
and Multimodal Therapy 
 
3.1 Summary 
In this chapter, we report the synthesis of a multifunctional biocompatible 
nanotheranostic nanoplatform consisting of a biodegradable PLGA matrix co-loaded with 
superparamagnetic iron oxide nanoparticles (SPIONs) and the anticancer drug doxorubicin 
(DOXO), and additionally surface-functionalized with indocyanine green (ICG), a NIR 
fluorescent dye. A detailed study of the different parameters involved in the synthetic process 
was done in order to achieve the optimal physicochemical properties of the nanoplatforms in 
terms of size, zeta potential, SPIONs/DOXO co-loadings and release profiles. Chemo- and 
photothermal therapeutic efficacy as well as magnetic resonance and optical fluorescence 
imaging performance were tested in vitro on a tumoral cervical HeLa cell line. Magnetic 
guided targeting of the present nanoplatforms was also proven with this cell line. The in vivo 
biodistribution of the nanoplatforms in a mice model was assessed. An effective 
nanoplatform accumulation in the tumor and, unexpectedly, in the brain area was observed, 
whilst lower presence of particles was noted in the rethiculo endotelyal system.  The present 
obsevrations suggest the NPs ability to possibly overcome the blood brain barrier. These 
results open up new possibilities to use our multifunctional nanoplatforms to treat brain-
located tumors and diseases. 
 
3.2 Introduction 
The advances provided by nanotechnology have offered new opportunities to 
develop novel nanocarriers able to improve the pharmacokinetics and the local 
bioavailability of a variety of drugs as well as providing additional functionalities 
including imaging, diagnosis or targeting with the final objective of obtaining true 
multifunctional nanomedical platforms through exploiting clever combinations of 
nanostructured materials in a single nanodevice [1-4]. These multifunctional 
nanoplatforms open new windows to overcome the different and still unresolved 
impediments in clinical practice and, in particular, in cancer therapeutics such as the 
substantial toxicity to normal tissues of drug doses required to completely eliminate 
the tumors, creating undesirable side effects; the poor effectiveness of drug treatments 
against multi-drug resistant cancer cells; the impossibility of early detection of very 
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small tumors or blood circulating malignant cells; or the spatial-temporal separation 
of diagnosis and therapeutic clinical phases, amongst others [2, 3].  
To construct multifunctional nanoplatforms, biodegradable polymeric 
nanoparticles (NPs) are an interesting approach provided that they are frequently used 
to improve the therapeutic impact of different types of drugs and bioactive molecules 
by enhancing their solubilization, their interaction with the biological environment, 
their absorption into a selected tissue, their bioavailability, their retention time and 
their intracellular penetration [5, 6], while simultaneously reducing the patient 
expenses and the risks of toxicity.  
To this end, poly-D,L-lactide-co-glycolide (PLGA) copolymer is one of the 
most successfully used biodegradable polymers for the development of nano- and 
micro-particle-based drug delivery systems and scaffolds for tissue engineering [7, 8] 
provided that it undergoes hydrolysis in the body to produce biodegradable and 
biocompatible metabolite monomers, lactic acid and glycolic acid, and with the 
additional advantage of being commercially available in a wide range of molecular 
weights and compositions. Because of the two former monomers are endogenous and 
easily metabolized by the body via the Krebs cycle, a minimal systemic toxicity is 
associated with the use of PLGA for drug delivery and biomaterial applications [9].  
For these reasons, PLGA nanoparticles (PLGA NPs) have been used for the 
encapsulation of a wide range of active compounds, ranging from hydrophilic and 
hydrophobic drugs, vaccines, proteins, or nucleic acids, amongst others, [10] 
exhibiting a high stability and loading capacity, and offering various feasible routes of 
administration. These characteristics have led to its approval by the US FDA and 
European Medicines Agency (EMA) to be used in several drug delivery systems in 
humans. PLGA NPs were also selected in some previous prospective studies to 
construct new multifunctional systems allowing simultaneous diagnosis and therapy 
(e.g. nanotheranostics devices). For example, the anticancer drug doxorubicin 
(DOXO) was bound to magnetic NPs that were embedded in a PLGA matrix by 
means of hydrophobic interactions. DOXO was sustainably released without 
inhibition due to the presence of the magnetic particles, which additionally provided 
the ability of magnetically-guided targeting through the application of an external 
magnetic field, as tested in mice, rats and humans [11, 12]. In a similar approach, 
Yang et al. [13] also co-loaded DOXO and superparamagnetic iron oxide NPs 
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(SPIONs NPs) inside PLGA NPs surface-functionalized by a monoclonal antibody 
(Herceptin, HER) to serve as an active targeting moiety on SK-BR3 cells, which 
overexpress the human epidermal growth factor receptor-2 (HER2). More recently, 
Kim et al. [14] also synthesized DOXO/SPION or DOXO-quantum dots (QDs) co-
loaded PLGA NPs stabilized with a polylysine-PEG-folate polymer to provide the 
nanoplatform with simultaneous chemotherapeutic, imaging (magnetic resonance, 
MRI, or fluorescence optical, FOI, imaging) and active targeting capabilities against 
KB cells, which overexpress folate receptors on their membrane. Also, SPIONs 
embedded in PLGA NPs were designed as a dual drug delivery and imaging system 
able to encapsulate both hydrophilic (carboplatin) and hydrophobic drugs (paclitaxel 
and rapamycin). Both in vitro and in vivo MR imaging showed that these NPs possess 
a better image resolution than commercial contrast agents [15, 16]. On the other hand, 
DOXO-loaded Au half-shelled-metallized PLGA NPs were obtained to achieve a 
synergistic tumor cytotoxicity by the simultaneous combination of chemo- and photo-
thermal therapies by exploiting the near-infrared (NIR) plasmonic properties of the 
metal layer. This nanoconstruct was additionally surface-functionalized with a 
monoclonal antibody (Herceptin) to dually ensure specific cell targeting and 
additional therapeutic activity as tested both in vitro and in vivo [17-19].   
Here, we report on a magnetically-targeted multifunctional nanoplatform able 
to be used for simultaneously perform magnetic resonance and optical imaging, and to 
enable, at the same, chemo- photothermal therapeutic activities with the advantage of 
avoiding additional chemical synthetic steps as the in situ growth process of a metal 
layer as done in previous works [17-19]. The present nanoplatform is composed of 
four different components. Firstly, PLGA NPs were used as a core matrix for co-
loading of DOXO as a chemotherapeutic agent, and hydrophobic SPIONs employed 
for both magnetically-guided targeting and as a T2-MRI contrast agent. Finally, 
indocyanine green (ICG), a tricarbocyanine dye with absorbing properties exclusively 
in the NIR electromagnetic spectrum, and currently used as a diagnostic compound 
for blood volume determination, ophthalmic angiography, cardiac output and hepatic 
function [20, 21], was complexed to the chitosan-functionalized surface of the PLGA 
NPs to provide the system with the capabilities of optical imaging and photo-thermal 
therapy under NIR light irradiation of suitable wavelength and power. Since these 
nanoplatforms are NIR-resonant, the simultaneous effect of targeted NIR-induced 
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hyperthermia and chemotherapy results in larger cell toxicities in a HeLa cervical 
cancer cell line at low drug concentrations, elucidating a synergistic effect. 
Furthermore, magnetic targeting additionally enhanced the therapeutic efficacy of the 
nanoplatforms. The cancerous cells were also imaged through MRI and confocal 
microscopy. Finally, preliminary in vivo studies using a mice-model highlighted the 
high accumulation of the nanoplatforms in the tumor area and, to much lesser extent, 
in the reticuloendothelium system (RES), as detected by fluorescence optical imaging. 
Strikingly, a relatively unexpected concentration of multifunctional nanoplatforms 
was also observed in the brain, which can open up the possibility of using these types 
of nanomaterials as specific theranostic nanodevices for diagnosis and treatment of 
brain diseases. 
 
3.3 Materials and methods 
 
3.3.1 Materials 
Poly(D,L-lactide-co-glycolide) (PLGA) of different molecular weights (7-17 
kDa; 24-38 kDa; 38-54 kDa and 40-75 kDa with 50:50 lactide–glycolide ratio; 4-14 
kDa and 66-107 kDa with 75:25 lactide–glycolide ratio), poly-vinyl alcohol (PVA) 
with 88% hydrolyzation degree, Pluronic F127, hydrogen tetrachloroaurate (III) 
trihydrate (HAuCl4), ascorbic acid, trisodium citrate dihydrate, sodium borohydride 
(NaBH4, 99%), FeCl2, FeCl3 and ICG were purchased from Sigma–Aldrich (St. 
Louis, MO, USA). Low molecular weight chitosan (LMW-chitosan, MW = 111 kDa) 
was purchased from Fluka (St. Louis, MO, USA). Oleic acid with 90% purity was 
purchased from Alfa Aesar (Karlshrue, Germany). DOXO HCl and fetal bovine 
serum (FBS) were purchased from Fisher Scientific (Pittsburgh, PA, USA). 
ProLong® Gold antifade reagent with DAPI and Dulbecco’s modified eagle medium, 
fetal bovine serum (FBS), L-glutamine, penicillin/streptomycin, sodium pyruvate, and 
MEM non-essential amino acids (NEAA) were purchased from Invitrogen (Carlsbad, 
USA). Dialysis membrane tubing (molecular weight cutoff ∼3500) was purchased 
from Spectrum Laboratories, Inc. (Rancho Dominguez, California). All other 
chemicals and solvents were of reagent grade (purchased from Sigma–Aldrich). HeLa 
Chapter III: NIR-Light-Active Polymeryc Hybrid Nanoparticles for Simultaneous Cancer Monitoring 
and Multitherapy. 
139 
 
cervical cancer cells were from Cell Biolabs (San Diego, CA, USA). All glassware 
was washed with aqua regia and HF 5% (v/v) and extensively rinsed with water. 
Milli-Q grade water were used in all preparations. 
 
3.3.2 Synthesis of SPIONs 
Oleic acid-stabilized SPIONs were synthesized by a coprecipitation method. 
Briefly, aqueous solutions of 0.1 M FeCl3 (30 mL) and FeCl2 (15 mL) prepared with 
N2 purged-water were mixed; then, 3 mL of 5 M ammonia solution were added in 
small aliquots of 0.6 mL while stirring. A black precipitate was formed indicating the 
formation of SPIONs. After 20 min of stirring under N2 atmosphere, 56.4 mg of oleic 
acid were added to the SPIONs and the temperature was raised to 80 °C and kept for 
30 min while stirring to evaporate the ammonia. The magnetic NPs were washed 
twice by centrifugation at 9000 rpm for 20 minutes to eliminate excess of oleic acid, 
the supernatant was discarded and the precipitate was lyophilized and stored at 4 °C 
[22, 23]. 
 
3.3.3 DXSP-PLGA-ICG NPs preparation 
PLGA NPs containing SPIONs and DOXO (DXSP-PLGA NPs) were 
prepared using a conventional nanoprecipitation method with modifications. In a 
typical preparation, PLGA (25 mg) was dissolved in a sealed vial containing acetone 
(4 mL) together with suitable amounts of DOXO (previously converted to its 
hydrophobic base form by addition of triethylamine as reported in literature) [24] and 
SPIONs dispersed in acetone by sonication with a probe type sonicator (20 kHz, 
Bandelin Sonopuls, Bandelin GmbH, Berlin, Germany) at 20 W for 10 min in an ice 
bath. Then, this organic solution was added dropwise with a syringe pump (0.166 
mL/min) to an aqueous solution (50 mL) containing Pluronic F127 (typically 1 wt. % 
if not otherwise stated) while stirring at 10 °C. After sonication at 100 W for 10 min 
in an ice bath to homogenize the resulting dispersion, the organic solvent was 
completely evaporated under mechanical stirring overnight, the dispersion 
subsequently centrifuged twice at 9000 rpm for 30 min and 20 ºC. Subsequently, the 
supernatant was removed and the final precipitate was resuspended in 5 mL of water.  
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ICG was complexed to the DXSP-PLGA NPs by electrostatic interactions with 
positively charged low molecular weight -chitosan (LMW-chitosan) displayed on the 
surface of the DXSP-PLGA NPs. First, 5 mL of DXSP-PLGA NPs suspension were 
mixed with 0.25 mL of 1 wt. % LMW-chitosan previously dissolved in 1% (v/v) 
acetic acid. After stirring for 4 h, DXSP-PLGA NPs were centrifuged twice at 9000 
rpm for 30 min to eliminate free and loosely adsorbed chitosan. Then, the DXSP-
PLGA NPs were mixed with 5 mg of ICG previously dissolved in 5 mL water and 
stirred 4 h at ambient temperature. Then, the sample was washed by centrifugation 
three times at 9000 rpm for 30 min at 20 ºC to eliminate excess of ICG, whose 
concentration in the supernatant was spectrophotometrically measured ir order to have 
an initial estimation of the ampunt of complexed dye. Subsequently, the supernatant 
was discharged and the pellet of DXSP-PLGA NPs with electrostatically bound ICG 
(DXSP-PLGA-ICG NPs) was redispersed in 5 mL of water, lyophilized and stored at 
4 ºC. 
 
3.3.4 Characterization of the NPs 
NP sizes were obtained  by dynamic light scattering (DLS) at 25 °C by means 
of an ALV-5000F (ALV-GmbH, Germany) instrument with vertically polarized 
incident light (λ = 488 nm) supplied by a diode-pumped Nd:YAG solid-state laser 
(Coherent Inc., CA, USA) operated at 2 W, and combined with an ALV SP-86 digital 
correlator (sampling time 25 ns to 100 ms). Experiment duration was in the range 5-
10 min, and each experiment was repeated at least three times. The correlation 
functions from DLS runs were analyzed by the CONTIN method to obtain the 
intensity distributions of decay rates (Γ), from which the apparent diffusion 
coefficients (Dapp = Γ /q2, q = (4πns/λ)sin(θ/2)) were derived (being ns the refractive 
index of solvent and θ the scattering angle). Values of the apparent hydrodynamic 
radius (rh,app) were calculated from the Stokes-Einstein equation 
 
    rh,app = kT/(6πηDapp)    (Eq 3.1) 
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where k is the Boltzmann constant and η is the viscosity of water at temperature T. 
Sizes and morphologies of the NPs were also acquired by transmission and scanning 
electron microscopy (TEM and SEM, respectively) by means of a Phillips CM-12 and 
a Carl Zeiss Libra 200 Fm Omega (TEM), and a FESEM Ultra Plus electronic 
microscopes operating at 120 and 20 kV, respectively. Samples were prepared for 
analysis by evaporating a drop of the NP dispersion on a carbon-coated cooper grid 
without staining (TEM) or on a silicon wafer (SEM). NPs zeta potential was 
measured by triplicate with a Zetasizer Nano ZS (Malvern, UK), using disposable 
folded capillary cells. UV-Vis and fluorescence spectroscopy spectra of the particles 
were performed in a Cary 100 Bio and Cary Eclipse spectrophotometers (Agilent 
Technologies, Santa Clara, CA, USA), respectively. Each sample  was measured three 
times, to ensure reproducibility, and averaged to produce a single spectrum. X-ray 
diffraction (XRD) experiments were carried out with a rotating anode X-ray generator 
(Siemens D5005, Germany). Twin Göbel mirrors were used to produce a well-
collimated beam of CuKa radiation (λ = 1.5418 Å). X-ray diffraction patterns were 
recorded with an imaging plate detector (AXS F.Nr. J2–394). 
The concentration of NPs was determined by viscometry. Dynamic viscosities 
of deionized water and polymeric NPs were measured with a capillary/rolling ball 
automated microviscometer (AMVn Microviscometer, Anton Paar, Austria). A 
rolling-ball viscometer consists of a computer-controlled stepper motor that rotates a 
capillary containing a ball immersed in the test fluid. The resistance to the 
gravitational pull on the ball is due to the fluid density and viscosity. The viscosity is 
determined by timing the ball rolling down a slope with a defined angle. Based on the 
rolling-ball principle the dynamic viscosity is defined by: 
 
ߟ ൌ ܭଵሺߠሻሺߩ஻ െ ߩௌሻݐ     (Eq 3.2) 
 
where ܭଵሺߠሻ is the cell calibration constant depending on the angle  ߠ, ݐ is the rolling 
ball time, and ߩ஻ and ߩௌ are the densities of the ball and sample, respectively.  
The concentration of NPs was calculated from the solvent’s and the sample’s 
specific viscosities (Eq 3.3) (measured in triplicate) and the hydrodynamic radius of 
the NPs using the Einstein’s viscosity relationship for spheres (Eq 3.4): 
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ఎ
ఎబ
(Eq 3.3)
ߟ௦௣ = 2.5 ቀ
௡మ
௏
ቁ ௘ܸ (Eq 3.4)
where Ș is the sample’s dynamic viscosity, Ș0 is the solvent viscosity, 
௡మ
௏
is the 
number of equivalent spheres per volume unit, ܸ݁ = ସ
ଷ
ߨܴ௘ଶ is the volume of an 
equivalent sphere, and Re is the hydrodynamic radius of an equivalent sphere. The 
UV-vis absorption (turbidity) of different dilutions of NPs was measured and plotted 
versus the calculated concentrations to prepare a calibration curve, thus, NP 
concentrations could be calculated from UV-vis measurements.
Figure 3.1: Diagram of the capillary/rolling ball measurement principle.
3.3.5 SPIONs, DOXO and ICG entrapment efficiency and 
loading/conjugation capacity
Content of SPIONs in DXSP-PLGA NPs was assessed by means of an 
inductively coupled plasma-mass spectroscopy (ICP-MS) equipment Varian 820-MS
(Agilent Technologies). DXSP-PLGA NPs were dissolved in 500 µL of concentrated 
HNO3 (68%) and the solution volume was raised to 5 mL with a 20% HNO3
To exactly quantify the extent of DOXO loading and ICG conjugation, DXSP-
PLGA-ICG NPs were weighted and dissolved in dimethylsulfoxide (DMSO). ICG 
solution 
for total Fe quantification. 
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and DOXO fluorescence calibration curves were prepared prior to measurements to 
verify spectral characteristics, linearity range, and possible overlap between the 
spectra of the two compounds. Samples were placed in quartz-0.5 mL cuvettes, and 
measurements were performed immediately after preparation. DMSO was used as a 
blank for background correction. The excitation wavelengths were 760 nm for ICG 
and 490 nm for DOXO, respectively, and spectral emission readings were recorded in 
1-nm intervals from 510 nm to 700 nm for DOXO and from 790 to 900 nm for ICG. 
All measurements and sample handling were done in reduced lighting conditions, and 
the instrument operating conditions were kept constant. The concentrations of ICG 
and DOXO were determined from the corresponding blank-subtracted reading at the 
peak emission wavelength, by using the previously obtained calibration curves of ICG 
and DOXO in DMSO. Drug loaded/conjugated, D.L., and entrapment efficiency, 
E.E., in the DXSP-PLGA-ICG NPs were calculated as follows: 
 
ܦ. ܮ. % ൌ ௪௘௜௚௛௧ ௢௙ ஽ை௑ை,ௌ௉ூைே௦ ௢௥ ூ஼ீ ௜௡ ே௉௦௪௘௜௚௛௧ ௢௙ ே௉௦ ൈ 100  (Eq 3.5) 
ܧ. ܧ. % ൌ ௪௘௜௚௛௧ ௢௙ ஽ை௑ை,ௌ௉ூைே௦ ௢௥ ூ஼ீ ௜௡ ே௉௦௪௘௜௚௛௧ ௢௙ ஽ை௑ை,ௌ௉ூைே௦ ௢௥ ூ஼ீ ௜௡௜௧௜௔௟௟௬ ௟௢௔ௗ௘ௗ ൈ 100 (Eq 3.6) 
 
3.3.6 In vitro release kinetics 
200 mg of DXSP-PLGA and PLGA/ICG NPs were resuspended either in 50 
mL of phosphate-buffered saline (PBS), pH 7.4 or sodium citrate-citric acid buffer, 
pH 5.5, complemented  with 10 % (v/v) of fetal bovine serum (FBS). For both ICG 
and DOXO, the total drug amount in the NPs was kept below 10% of the drug 
solubility limit in PBS in order to ensure sink conditions. The solubility limit of ICG 
in PBS is approximately 35 mg/mL, and for DOXO base below 1 mg/mL [25]. The 
suspension was divided into aliquots of 5 mL in tubes with a magnetic stirrer which 
were placed in a temperature controlled bath at 37 ºC and stirring speed of 100 rpm. 
The tubes were collected at regular time intervals and were centrifuged at 9000 rpm 
for 20 min, followed by lyophilization of the pellet for 36 h. Remaining drug (ICG 
and DOXO) in the polymeric NPs after release was measured by dissolving the 
nanoparticle pellet in DMSO for 24 h to release into solution. The percentage of ICG 
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and DOXO released from the NPs at a certain time interval was calculated by the 
following equation: 
 
% ICG or DOXO released = 100 − (% ICG or DOX remaining) (Eq 3.7) 
 
3.3.7 Laser irradiation experiments 
Temperature increment tests were performed with a continuous wave fiber-
coupled diode laser source of 808 nm wavelength (50W, Oclaro Inc, San Jose, CA, 
USA). The laser was powered by a Newport 5700-80 regulated laser diode driver 
(Newport Corporation, Irvine, CA, USA). A 5 m-long, 200-μm-core optical fiber was 
used to transfer laser power from the laser unit to the target solution, and equipped 
with a lens telescope mounting accessory at the output, which allowed the tuning of 
the laser spot size in the range 1-10 mm. The output power was independently 
calibrated using an optical power meter (Newport 1916-C), and the laser spot size was 
previously measured with a laser beam profiler (Newport LBP-1-USB) placed at the 
same distance from the lens telescope output as the NP sample holder (8 cm). For 
measuring the temperature change mediated by the present hybrid NPs, 2 mL of 
hybrid DXSP-PLGA-ICG NPs were placed in a quartz cuvette and irradiated for 
determined time intervals and/or at different power intensities. The sample 
temperature was measured with a type J thermocouple linked to a digital thermometer 
inserted into the solution. Bare PLGA NPs in water were used as a control. 
 
3.3.8 Magnetic resonance imaging and magnetic susceptibility 
Transverse relaxation times were measured at 9.4 T (400 MHz) with 440 mT 
m-1 gradients and 25 ºC with a Bruker Biospin USR94/20 instrument (Ettlingen, 
Germany). MRI phantoms were constructed in 1.6 % (w/v) agarose solutions (Sigma–
Aldrich) following a previously established experimental protocol [26].  Firstly, a 
1.6% (w/v) agarose solution was heated and stirred at 80 ºC until complete dissolution 
of the solid agarose. Then, while the system was fluid, an array of seven centrifuge 
tubes (1.5 mL) were placed within the agarose, which was slowly cool down to room 
temperature. After solidification, the tubes were removed and an agarose mold with 
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seven holes was obtained. For cell imaging, HeLa cells (2·106 cells) were seeded in 75 
cm2 flasks and cultured for 24 h at standard conditions (5% CO2 at 37 ºC) in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% (v/v) FBS, 2 
mM L-glutamine, 1% penicillin/streptomycin, 1 mM sodium pyruvate, and 0.1 mM 
MEM Non-Essential Amino Acids (NEAA). Then, the medium was replaced with 
fresh one containing DXSP-PLGA-ICG NPs (4 ) and incubated for 6 h; then, the 
medium with NPs was removed and cells were washed with PBS and incubated for 
additional 18 h. Afterwards, cells were tripzinized and resuspended in 100 µL of PBS. 
In each hole of the phantom a mixture of cells labeled with DXSP-PLGA-ICG NPs 
and 2% (w/v) agarose was set. After a resting period, 1.6% (w/v) agarose was added 
to the mold to seal the phantom holes. Imaging of the phantoms was performed 
acquiring a 3D-gradient echo image (T2-weighting) with the following parameters: 
field of view, 80×80×40 mm; matrix size: 512×512×256 points giving a spatial 
resolution of 156×156×156 μm; echo time TE = 7.89 ms and repetition time TR = 
100 ms; flip angle 20 degree and 2 averages.  
On the other hand, magnetic susceptibility measurements were carried out 
with a SQUID magnetometer (Quantum Design MPMS5, San Diego, CA, USA) at 5 
and 300 K. 
 
3.3.9 Cellular uptake 
DXSP-PLGA-ICG NPs cellular uptake was followed by confocal microscopy 
by seeding HeLa cells on poly-L-lysine coated glass coverslips (12 ×12 mm) placed 
inside 6-well plates (3 mL, 5·104 cells/well) and grown for 24 h at standard culture 
conditions, as reported in the former section. Then, the DXSP-PLGA-ICG NPs at the 
desired concentration were added to cells (200 μL, ∼ 5.0·108 particles/mL) and the 
incubation protocol was conducted as previously described. In some wells, a magnet 
of 0.5 T was placed below each individual well in order to study the possible effect of 
the applied magnetic field on partciles internalization. After 2 h of incubation the NP-
containing cells were washed three times with PBS and, then, fixed with 
paraformaldehyde 4% (w/v) for 10 min, washed and stained with BODIPY Phalloidin 
(Invitrogen) in 0.2% (w/v) Triton X-100 (permeabilizer). The cells were washed again 
with PBS pH 7.4, mounted on glass slides and stained with ProLong Gold antifade 
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DAPI (Invitrogen) and cured for 24 h at -20 °C. Samples were visualized at 63X 
using a confocal spectral microscope Leica TCS-SP2 (LEICA Microsystems 
Heidelberg GmbH, Mannheim, Germany; green channel for DOXO, λexc. 488 nm, and 
red channel for BODIPY Phalloidin, λexc. 633 nm); blue channel for DAPI, λexc. 355 
nm,. A similar protocol was also performed to observe the internalization of the NPs 
following the fluorescence of ICG (λexc. = 785 nm) without BODIPY Phalloidin to 
avoid overlapping of emissions.  
 
3.3.10 In vitro cytotoxicity 
Cytotoxicity induced by the nanoplatforms was determined by crystal violet 
staining as the inhibition of cellular growth. To this end, HeLa cells with an optical 
confluence of 80–90% were seeded into 96-well plates (100 µL, 1.5×104 cells/well) 
and grown for 24 h at standard culture conditions (5% CO2 at 37 ºC) in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10% (v/v) FBS, 2 mM L-
glutamine, 1% penicillin/streptomycin, 1 mM sodium pyruvate, and 0.1 mM MEM 
Non-Essential Amino Acids (NEAA). Afterwards, DXSP-PLGA-ICG NPs and 
corresponding controls (free DOXO, DOXO-loaded PLGA NPs and SP-PLGA-ICG 
NPs) were injected in the wells (100 μL) and incubated for 24 h and 48 h in the 
presence and absence of an apllied external field provided by a magnet (= 0.5 T) 
placed at the bottom of the wells. After incubation, the culture medium was discarded 
and the cells were washed with 10 mM PBS, pH 7.4, several times. The cells were 
shaken at room temperature (300 rpm, 15min) in the presence of 10 µL of a 
glutaraldehyde solution (11% (w/v) in water). The solution was discarded and cells 
were washed 3-4 times with milli-Q water. The cells were then shaken at room 
temperature (300 rpm, 15 min) in the presence of 100 μL of a crystal violet solution 
(0.1% (w/v) in 200 mM orthophosphoric acid, 200 mM formic acid, and 200 mM 2-
N-morpholino-ethanesulfonic acid (MES), pH 6). The solution was discarded, and the 
cells were again washed 3-4 times with milli-Q water. Once washed, the cells were 
left for incubation at room temperature overnight for drying. Once dried, the cells 
were shaken at room temperature (300 rpm, 15 min) in the presence of 100 µL of 
acetic acid (10% (v/v) in water). Immediately after, the absorbance of the resulting 
solution was measured with a Microplate Reader (FLUOstar Optima, BMG Labtech 
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GmbH, Germany) operating at 595 nm. All experiments were triplicate carried out. 
The growth inhibition was quantified as: 
 
% Inhibition ൌ 100 െ ଵ଴଴כOATA               (Eq 3.8) 
 
where OA and TA stand for the absorbance of studied samples and negative controls 
(cells in the absence of NPs), respectively. 
 
3.3.11 In vivo biodistribution 
To assess the in vivo performance of the nanoparticles 3·106 cells from MDA-
MB-231 adenocarcinome breast cell line [27] were injected in the dorsal flank of 
immunodeficient BALB/c nude mice. One week upon injection, cell implantation was 
checked by registering the fluorescent and bioluminescent activity of the cells. We 
next injected 10 mg/kg of either DXSP-PLGA-ICG NPs or free ICG in the tail vein 
and registered the in vivo fluorescent activity (λexc = 710 nm/λem = 840 nm) with a 
IVIS Spectrum imaging system (Caliper LifeSciences, Perkin-Elmer, USA) at 2, 4, 6, 
24, 48 and 96 h upon NPs administration. 
 
3.4 Results and discussion 
 
3.4.1 Effect of synthesis variables on NPs characteristics 
Factors such as particle size and surface properties could influence the 
circulation times, biodistribution, the interactions of NPs with cells and tissues and 
the ability to cross physiological drug barriers [28]. Hence, to design our 
nanoplatform we first establish the optimal physico-chemical properties of the PLGA 
core matrix. At this respect, the main aims are to control the PLGA NP size, their 
surface properties and the cargo release rate in order to achieve site-specific action of 
the active compound at the therapeutically optimal rate and dose regime, which are 
influenced by different parameters involved in the NP synthetic procedure (i.e. 
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molecular weight and concentration of PLGA chains, nature and concentration of the 
stabilizing agent, volumes of the oil and aqueous phases, and concentrations of cargo 
molecules, amongst others). Then, the influence of several of these parameters on the 
structural and physico-chemical properties of the bare PLGA NPs was firstly 
analyzed. 
 
3.4.1.1 Effect of PLGA molecular weight and concentration 
The effect of polymer molecular weight on the size and zeta potential of the 
resulting PLGA NPs was rather small, the NP diameters being largely determined by 
the primary size of the formed emulsion droplets (Table 3.1). On the other hand, an 
increase in PLGA concentration causes a significant increase in NPs diameters from 
146 ± 4 nm at 10 mg/mL PLGA to 191 ± 5 nm at 100 mg/mL (Figure 3.2a) [29, 30]. 
Increasing the PLGA concentration enhances the viscous resistance of the emulsion 
mixture thereby absorbing the agitation energy which, in turn, leads to the reduction 
in shear stress and to droplets with larger size and, hence, to larger NPs. Also, a 
significant decrease in NP zeta potential values was noted from -23.5 ±0.9 mV at 10 
mg/mL to −34.5 ±1.7 mV at 100 mg/mL, respectively. This decrease is consistent 
with the presence of more charged carboxylic groups of PLGA chains in the NPs, 
which ensures their colloidal stabilization. 
Table 3.1: Sizes, polydispersity indexes (PDI) and zeta potential values of PLGA NPs 
obtained with several PLGA polymers of different molecular weights and composition at a 
polymer concentration of 10 mg/ml. 
PL-GA 
Proportion 
Mw  
(kDa) 
rh 
(nm) 
PDI Zeta Potential  
(mV) 
50-50 7-17 82 ± 3 0.060 -28.3 ± 2.3 
50-50 24-38 75 ± 4 0.045 -29.9 ± 1.4 
50-50 38-54 81 ± 3 0.038 -31.5 ± 0.9 
50-50 40-75 83 ± 2 0.061 -33.8 ± 1.9 
75-25 4-15 75 ± 4 0.027 -22.0 ± 0.6 
75-25 66-107 77 ± 4 0.021 -18.4 ± 1.1 
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3.4.1.2 Effect of organic and aqueous phases volumes 
The effect of both organic and aqueous phase volumes (at constant polymer 
and stabilizer concentrations of 10 and 25 mg/mL, respectively) on the characteristics 
of the resulting NPs is shown in Fig. 3.2b-c. 
  
  
    
Figure 3.2: a) Effect of PLGA mass on the size () and zeta potential ({) of PLGA NPs. 
Effect of b) organic phase (acetone) and c) aqueous phase volumes on the size () and 
surface charge ({)  of PLGA NPs. In b) Vaqueous phase = 50 mL, and in c) Vacetone = 2.5 mL. d) 
Effect of F127 stabilizer concentration on the size () and surface charge ({) of PLGA NPs 
(Vaqueous phase = 50 mL, Vacetone = 2.5 mL). e) Effect of DOXO () and SPIONs ({) loaded 
concentration on the size of the resulting DXSP-PLGA NPs.  
a) b) 
c) d) 
e) 
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 An increase in both aqueous and organic phase volumes involved a reduction 
in both NP size and zeta potential. For the organic phase volume, the reduction in 
both size and zeta potential occurs up to a critical value (40 mL) provided the optimal 
diffusion of the PLGA polymer chains under such conditions, which favors the 
formation of smaller nanodroplets. Above such threshold value, the NP size started to 
increase from 90 ± 3 to 123 ± 6 nm due to the formation of reverse emulsion droplets 
of larger sizes. 
 
3.4.1.3 Effect of type and concentration of stabilizer concentration  
The increase in F127 stabilizer concentration slightly changed the average NP 
sizes from ca. 150 ± 9 to 162 ± 11 nm between 2.5 and 25 mg/mL of added F127; at 
larger F127 concentrations NP sizes increased up to ca. 190 ± 15 nm (Figure 3.2d). 
This effect can be ascribed to the enhancement of the aqueous solution viscosity, 
which results in a reduction of the net shear stress and the corresponding increase in 
particle size [31]. However, other researchers have reported the opposite effect [30-
33] originated from the orientation of more stabilizer molecules in the interfacial area 
which decreases the interfacial tension and, hence, favours the formation of smaller 
droplets [34]. It seems clear that the observed effect must be a balanced of both 
opposite effects.  
On the other hand, while increasing F127 concentration the zeta potential first 
slightly increases (from −33.8 ±1.8 mV at 2.5 mg/mL to −30.0 ±1.7 mV at 25 
mg/mL) and, then, it steeply rises up to -23.5 ±1.2 mV at 50 mg/mL F127. This 
decrease in the net electric charge arises from the successive number of F127 layers 
on the PLGA NPs which progressively shield the carboxyl groups of PLGA chains 
(bare PLGA NPs have a zeta potential of ca. -45.0 ± 2.8 mV) [35, 36]. The type of 
stabilizer also had some influence on the physico-chemical properties of the resulting 
NPs. Under standard preparation conditions, F127-stabilized PLGA NPs display 
lower sizes than PVA-stabilized ones (Table 3.2). Such size reduction could stem 
from the amphiphilicity of the Pluronic copolymer, whose hydrophobic blocks might 
penetrate the core-shell NP interface and interact with the PLGA chains given rise to 
more compact NPs. As a consequence, the hydrophilic blocks would shield the 
carboxylic groups of PLGA chains to a lesser extent, as observed from the smaller 
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(more negative) zeta potential values found for F127-stabilized NPs. In addition, the 
purification process of the stabilizer excess also influenced the final size and charge 
of the resulting NPs (Table 3.2).  
 
3.4.1.4 Effect of initially loaded DOXO and SPIONs 
The particle size and zeta potential of PLGA NPs loaded with SPIONs and the 
chemotherapeutic drug DOXO (DXSP-PLGA NPs) was found to be smaller than that 
of bare polymeric NPs, and dependent on the molecular weight of the PLGA polymer 
(Table 3.3). The size NP reduction upon cargo incorporation can stem from a 
compactation of the PLGA core through the enhancement of hydrophobic interactions 
between PLGA chains, drug molecules and oleic acid chains anchored on the SPIONs 
surfaces [37]. This enhanced hydrophobic interactions inside the polymeric matrix 
might involve a PLGA chain reconfiguration while exposing additional hydrophilic 
charged carboxylic groups to the aqueous medium, giving rise to lower (more 
negative) zeta potential values [38]. 
 
Table 3.2: Effect of stabilizer type and purification process on the size and shape of DXSP-
PLGA NPs at a stabilizer concentration of 10 mg/mL. 
Stabilizer Centrifugation 
cycle 
rh 
(nm) 
Zeta Potential  
(mV) 
F127 1 106 ± 6 -19.1 ± 1.2 
F127 2 95 ± 5 -22.7 ± 1.5 
PVA 1 114 ± 7 -8.8 ± 1.0 
PVA 2 105 ± 6 -9.8 ± 0.7 
 
On the other hand, the capability of the nanocarriers to entrap sufficient active 
drug concentration to exert their therapeutic activity is crucial for their clinical 
application. In this regard, as both the initial DOXO and SPIONs concentrations 
increase the entrapped amount of the respective cargos first rised and, then, reached a 
quasi-plateau region (Fig. 3.3). This behavior is favored by an enhanced cargo 
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miscibility inside the polymeric core promoting, at first, a larger incorporation in the 
organic phase. 
 
Table 3.3: Sizes, polidispersities (PDI) and zeta potential values of DXSP-PLGA NPs 
obtained with several 50:50 PLGA polymers of different molecular weight and composition 
loaded with 10 wt.% DOXO and 2 wt.% Fe3O4 NPs at a polymer concentration of 10 mg/mL. 
Mw 
(kDa) 
rh 
(nm) 
PDI Zeta Potential  
(mV) 
7-17 55.2 ± 0.7 0.030 -45.3 ± 3.2 
24-38 60.7 ± 0.7 0.028 -47.6 ± 2.9 
38-54 62.1 ± 1.0 0.030 -40.0 ± 2.1 
40-75 77.0 ± 1.4 0.062 -33.9 ± 1.9 
 
However, the increase in loading capacity (LC) is not proportional to the 
increase of initial drug content during formulation, thus, the entrapment efficiencies 
(EE) decreased. The maximum entrapped DOXO and SPIONs concentrations were 
found to be approximately of ca. 18 wt.% and ca. 9.5 wt.%, respectively. We have 
also noted an important increase in both LC and EE when co-loading both DOXO and 
SPIONs inside the PLGA matrix. For example, a drug EE of 95% and a LC of 8.9% 
was reached in the presence of 1.5 wt.% of oleic acid-stabilized SPIONs (as measured 
by ICP-MS), compared with a 39% EE and 3.2% LC when the SPIONs were not 
loaded inside the PLGA NPs. Provided that the drug content in NPs is affected by 
drug-polymer interactions and DOXO miscibility inside the polymeric matrix [39], it 
seems that the establishment of enhanced hydrophobic interactions between the 
different components inside the NPs would give rise to a synergistic effect which 
favours the enhanced solubilization ability of the present hybrid nanovehicle, as 
commented previously. 
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Figure 3.3: Loading capacity () and encapsulation efficiency ({) of PLGA NPs at different 
a) DOXO and b) SPIONs concentrations. In a), SPIONs concentration is kept constant at 5 
wt.% whilst in b) DOXO concentration is fixed at 10 wt.%. 
 
3.4.2 Standarization of DXSP-PLGA NPs 
Based on previous results and looking for small particle sizes to enable a 
parenteral administration route of the NPs, avoidance of recognition by macrophages, 
elevated zeta potentials to ensure colloidal stability and high payloads when required, 
we standarized the preparation of DXSP-PLGA NPs. In this way, standardized NPs 
were usually prepared by taking 25 mg of PLGA, 2 and 10 wt. % initial SPIONs and 
DOXO concentrations, respectively, and dissolved in 5 mL of acetone. The organic 
phase was added dropwise in a 50 mL F127 solution (1 wt. %) under stirring. After a 
brief sonication step to homogenize the resulting dispersion, the organic solvent was 
left to evaporate under stirring, and the particles recovered and washed through 
several centrifugation cycles. Afterwards, by exploiting their negative surface charge 
the resulting particles were covered through electrostatic layer-by-layer attraction 
with a LMW-chitosan to reverse the net electrical charge of the particles (+15.2 ± 0.9 
mV). Finally, ICG was complexed to the surface of the DXSP-PLGA NPs by 
electrostatic interactions too. 
 
3.4.3 DXSP-PLGA-ICG NPs characterization 
Oleic acid-stabilized SPIONs with a mean diameter of ca. 10 nm were 
obtained by a co-precipitation method (Figure 3.4a). The X-ray diffraction pattern of 
a) b) 
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the as-synthesized SPIONs clearly indicated that they are formed exclusively by 
magnetite (Fe3O4) (Figure 3.4b).  
 
 
Figure 3.4: a) TEM image of oleic acid-stabilized Fe3O4 NPs; b) Powder X-ray diffractogram 
(XRD) of as-synthesised oleci acid stabilized Fe3O4 NPs. Green lines indicate the position of 
the characteristic peaks in the diffractogram whereas brown vertical lines denote the 
characteristic peaks of magnetite X-ray diffraction pattern. 
 
The SPIONs appeared to uniformly assemble and distribute throughout the 
PLGA matrix (Figure 3.5a). This is believed to result from i) hydrophobic interactions 
between the oleic acid chains stabilizing the SPIONs, the drug molecules, and the 
PLGA chains; ii) hydrogen bonding between functional groups of the surfactant and 
polymeric chains, and/or iii) to existing dipole-dipole interactions between the 
entrapped SPIONs. The size of DXSP-PLGA NPs was estimated ca. 122 ± 11 nm by 
DLS with a surface electric charge of -35.3 ± 4.8 mV, which seems to be suitable for 
NPs passive tumor targeting through the enhanced permeability and retention effect 
(EPR) [40]. The successful incorporation of DOXO inside the hybrid NPs was 
corroborated by the appearance of absorption and fluorescence emission peaks at ca. 
480 and 591 nm, respectively, consistent with the spectra of free DOXO (Figures 3.5b 
a) 
b) 
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After coating the PLGA NP surface with LMW-chitosan, the estimated size of 
the hybrid NPs was ca. 135 ± 15 nm (114 ± 10 nm by TEM, Figure 3.5d), with a 
spherical shape and a zeta potential of ca. +15.2 ± 0.9 mV. The observed differences 
in size between DLS and TEM arise from the drying process and subsequent 
shrinkage polymeric chains underwent during TEM sample preparation. A negligible 
size variation was observed upon ICG complexation to give DXSP-PLGA-ICG 
hybrid NPs, which possessed a net zeta potential of -29.1 ± 2.5 mV pointing to the 
successful complexation of ICG molecules onto the NP surfaces. This was 
additionally corroborated by the appearance of a fluorescence emission peak for the 
hybrid NPs at ca. 820 nm, typical of ICG molecules (Figure 3.5c). 
DXSP-PLGA-ICG NPs remained stable upon extensive incubation under 
serum containing medium of physiological pH as observed from the negligible 
changes in NP size which points to the capability of the F127 stealth layer to avoid 
protein binding and subsequent NP aggregation, in agreement with literature data    
[42]. By contrast, under acidic conditions the larger hydrolytic degradation rate of 
PLGA chains involved a slightly decrease in NP stability at the end of the incubation 
period as denoted by the decreases in NP sizes (Figure 3.5e). Additionally, we 
observed that the strong complexation of ICG to the nanoplatform surface protect 
ICG from degradation provided that after 7 days of incubation the fluorescence 
intensity of complexed ICG on the hybrid NPs remained nearly ca. 58 %, while the 
intensity of free ICG decreased up to 6 % of its initial intensity (Figure 3.5f) [43]. 
 
3.4.4 NIR-induced hyperthermia 
Dyes that absorb energy in the near infrared region (NIR) will release heat 
following to exposure to the appropriate light wavelength, and this heat can contribute 
to malignant cell killing. Exposure of aqueous suspensions of DXSP-PLGA-ICG NPs 
to continuous NIR illumination at a laser power of 2.5 W/cm2 for 5 min results in an 
elevation of solution mean temperature able to produce cytotoxic cell hyperthermia. 
No important temperature changes were observed when bare PLGA NPs were 
exposed to NIR light (Figure 3.6a). In contrast, aqueous dispersions of DXSP-PLGA-
ICG NPs containing 1, 4 and 8 μM of ICG achieved temperature elevations of 4ºC, 
8ºC and 14ºC, respectively. Due to photo- and thermal degradation, there existed a 
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slow temperature decline after 8 min of laser irradiation. Hence, at concentrations 
above 4 μM ICG hybrid NPs can be easily heated up above 45 ºC, which is sufficient 
to induce irreversible damage to tumor cells but not normal cells, probably as a 
consequence of protein denaturation and poor DNA synthesis and repair due to the 
comparatively lower oxygen level and pH in cancerous cells [44]. These results 
suggest that these nanoplatforms could act as efficient NIR-light absorbers for 
photothermal tumor therapy.  
In addition, DXSP-PLGA-ICG NP dispersions achieved a more efficient laser-
dependent temperature response than free ICG at similar concentrations [45]. The 
possible reasons for this behavior may arise from a higher condensed concentration of 
ICG molecules on the NP surfaces than free ICG, which results in a higher energy 
efficiency and lower heat dissipation after laser irradiation [46].  
 
Fig. 3.6: a) Temperature increments as a function of time under NIR light irradition (2.5 W 
cm-2, 5 min at 808 nm) for aqueous solutions of () bare PLGA NPs; () 8 μM free ICG, 
and DXSP-PLGA-ICG NPs containing ({) 1, (S) 4 (T) and 8 μM conjugated-ICG. b) TEM 
image of DXSP-PLGA-ICG NPs after irradiation (2.5 W cm-2, 5 min at 808 nm). 
 
The morphology of the hybrid NPs after irradiation was, at least, partially 
conserved as observed by TEM images, where the nanoplatform morphology is still 
clearly observed (Figure 3.6b). Nevertheless, as a consequence of heating, drug 
molecules (see below) and some SPIONs were released; also, an enhaced SPIONs 
concentration near the PLGA matrix surface can be observed, probably as a result of 
partial melting of the polymeric core. 
 
a) b) 
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3.4.5 In vitro magnetic-resonance imaging 
SPIONs have received great attention as T2-contrast agents due to their 
capability to shorten spin-spin relaxation times which gives rise to decreases in the 
MRI signal intensity [47]. The specific weighted transverse-relaxivity (r2) values can 
be greatly increased by clustering SPIONs in reservoirs, resulting in higher saturation 
magnetizations than individual particles owing to the interaction between the 
assembled nanocrystals [48,49]. In this line, the present nanoplatforms displayed 
robust magnetic properties. The magnetization as a function of the applied magnetic 
field at 5 and 300 K is shown in Figure 3.7a-b. At 5 K, the thermal energy is not 
sufficient to induce magnetic moment randomization, thus, the nanoconstructs show 
typical ferromagnetic hysteresis loops with a remanence of 17.5 emu g-1 and a 
coercivity of 254 ± 9 Oe. However, at 300 K the thermal energy is enough to 
randomize the magnetic moments leading to a decrease of the magnetization and to no 
remanence or coercivity, thereby, the hybrid NPs possess superparamagnetic 
behavior. The saturation magnetization μsat of the nanoplatforms at 300 K was 60.7 
emu g-1, which is higher than values reported for other Au-Fe3O4 or Au-γ-Fe2O3 [48, 
49].  Also, the μsat of the nanoplatforms was observed to be lower than that of 
classical singly dispersed SPIONs possibly due to i) the diamagnetic mass of the 
polymer contributing to the total mass of the nanoplatforms, and ii) the presence of 
canted or noncollinear surface [50, 51].  
To evaluate the potential T2 enhancing capability of the present hybrid NPs, 
DXSP-PLGA-ICG NPs with various iron concentrations were investigated by T2-
weighted MR imaging at 9.4 T and 400 MHz. The Fe concentrations in the NPs were 
determined by ICP-MS. Fig. 3.7c shows the T2-weighted MR images of the hybrid 
NPs in aqueous media at different Fe concentrations ranging from 0.01 to 0.17 mM. 
The signal intensity of the MR images decreased as the Fe concentration increased, as 
expected for T2 contrast agents due to the shortening of spin-spin relaxation time of 
water, as commented previously. The specific relaxivity, r2, a measure of the change 
in spin-spin relaxation rate (T2-1) per Fe unit concentration, was determined to be 255 
mM Fe− 1s− 1 for DXSP-PLGA-ICG NPs. The relatively high r2 value could be due to 
the large external magnetic field (9.4 T) applied to the nanoplatforms, as well as their 
superior magnetic properties due to the enhanced magnetic interactions between 
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clustered SPIONs inside the polymeric matrix. It is worth noting that the obtained r2 
value was higher than that of commercially T2 MRI contrats agents based on 
functionalized Fe3O4 NPs such as Feridex/Endorem (r2 = 160 mM Fe− 1s− 1), Resovist 
(r2 = 151 mM Fe− 1s− 1) and Sinerem (r2 = 160 mM Fe− 1s− 1) [54,55] and rather similar 
as that of other polymeric nanoplatforms embedding clustered SPIONs [13, 14, 52]. 
 
 
 
Figure 3.7: Magnetization as a function of applied magnetic field of DXSP-PLGA-ICG NPs 
at a) 5 K b) 300 K. c) Spin-spin relaxivity (r2) of the hybrid NPs. 
 
3.4.6 Release kinetics  
DOXO release kinetics could be fine-tuned by simply changing the molecular 
weight of the PLGA core. The burst phase and, consequently, the amount of DOXO 
released at short incubation times may largely be increased by decreasing the 
molecular weight of the PLGA chains used to form the core of the polymeric NPs 
(Figure 3.8a). This behavior is related to the combination of several effects such as 
the decrease in the viscosity and compactation of the polymeric core, and a 
weakening of the hydrophobic interactions between PLGA chains and DOXO 
c) 
a) b) 
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molecules as the PLGA molecular weight decreases, which favors an enhanced 
mobility of drug molecules inside the PLGA core and a larger partition of DOXO 
molecules from the organic phase into the aqueous one. Hence, we decided to use 
PLGA NPs composed of a relatively large molecular weigth PLGA polymer (38-
54000 Da) to reduce drug leakage during the burst phase. For this type of PLGA NPs, 
it has been shown that the cargo release typically occurs via a combination of 
diffusion and erosion [53] through hydrolysis of the ester bonds in the polymer 
backbone. Also, the PLGA copolymer configuring the reservoir for DOXO drug 
molecules shows a glass-transition temperature (Tg) of ca. 45 ºC, which reduces the 
drug leakage during circulation and release when needed, that is, in the vicinity of 
tumors where acidic hydrolysis of the polymeric matrix can be enhanced [54]. 
In vitro cumulative DOXO release profiles at both neutral and acidic 
conditions in the presence of 10% (v/v) FBS showed a burst followed by a much 
slower diffusion-inititated release pattern due to the concentration gradient (Figure 
3.8b). At pH 7.4, ca. 17% DOXO was released from NPs during the first 5 h of 
incubation and, then, a more sustained release was observed, with ca. 38% released at 
48 h. The DOXO release could be enhanced upon irradiation of the hybrid NPs with 
NIR light (2.5 W cm-2 for 5 min), achieving 21 and 54% after 5 and 48 h of 
incubation, respectively; this result confirmed that drug release from the present 
hybrid NPs can be controllable by NIR-laser irradiation. This enhancement can be a 
consequence of the larger diffusion of the drug through the polymeric matrix upon 
temperature elevation.  
On the other hand, under acidic pH 5.5 DXSP-PLGA-ICG NPs released ca. 
37% of the initially loaded DOXO during the first 5 h and ca. 58 % after 48 h of 
incubation, respectively. The faster release under acidic conditions is originated from 
the reprotonation of the amine group of DOXO, which involves an increase in its 
hydrophilicity and a decrease in the affinity for the hydrophobic chains. This, in turn, 
favors its escape from the NP core by an out-diffusion process through the core-shell 
structure whose diffusion rate depends on factors such as copolymer crystallinity, 
viscosity, and drug association state [55]. Also, the larger hydrolitic degradation rate 
of PLGA NPs at acidic pH might contribute to the faster release kinetics of DOXO 
observed under these conditions. The incomplete cumulative release of DOXO results 
from the combination of the relatively short time duration of the release study and an 
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enhancement of polymer–drug interactions, which make the NP matrix more rigid 
difficulting the drug release [56, 57]. 
It is plausible that polymeric NPs are passively targeted to the tumor tissue 
through the EPR effect with minimised DOXO release along circulation in the 
bloodstream. After accumulation in the vicinity of the tumor cells, DOXO could be 
selectively released from the DXSP-PLGA-ICG NPs in the acidic solid tumor 
microenvironment for passive cellular uptake [58]. More importantly, intact DXSP-
PLGA-ICG NPs might be also taken up by tumor cells through nonspecific 
endocytosis and located preferentially at the acidic endosome compartments, in which 
the decreasing pH values might induce a faster DOXO release and a subsequent 
diffusion in the cytosol. This cellular uptake mechanism could bypass, to certain 
extent, the multidrug resistance (MDR) effect, which is often observed when free 
DOXO penetrates in the cell by passive diffusion.  
 
 
Figure 3.8: a) In vitro release kinetics of DOXO from DXSP-PLGA-ICG NPs of different 
copolymer molecular weight in aqueous serum-containing (10% (v/v) FBS) medium at pH 
7.4. ({) 40-75; () 38-54; (S) 24-38 and () 7-17 kDa. b) In vitro release kinetics of 
DOXO from DXSP-PLGA NPs (PLGA Mw = 38-54000) in aqueous serum-containing (10% 
FBS) medium of pH 7.4 in the absence () and presence ({) of irradiation (2.5 W cm-2, 5 
min at 808 nm), and  of pH (S) 5.5. c) In vitro release kinetics of ICG from DXSP-PLGA-
ICG  NPs. 
a) 
c) 
b) 
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On the other hand, in the time course of the release experiments a low amount 
of ICG was noted to be released at either of the tested conditions, which points to the 
strength of the electrostatic interactions between the sulfonate and amine groups of 
the dye and LMW-chitosan chains adsorbed on the NP surface, respectively (Fig. 
3.8c), as observed in related systems [59]. Meanwhile, a negligible release of SPIONs 
was observed under similar solution conditions. 
 
3.4.7 In vitro cellular uptake 
The uptake and cellular distribution of DXSP-PLGA-ICG NPs were analysed 
by confocal microscopy. After 2 h of cell incubation in the presence of DXSP-PLGA-
ICG NPs gave rise to a granular fluorescence pattern mainly in the cytoplasm, in 
contrast to the continuous fluorescence pattern observed in cell nuclei upon 
administration of free DOXO [60, 61]. This observation might be originated, on one 
hand, from a relatively low amount of DOXO released from the hybrid NPs (as can be 
deduced from release studies, see Figure 3.8) and, on the other, from a different 
internalization pathway of the hybrid NPs if compared to free chemo-drug, in 
particular, through an endocytosis-mediated mechanism (Figure 3.9a-b). In this way, 
the DXSP-PLGA-ICG NPs would be initially located within the endosome vesicles 
and would release DOXO in the cytosol in a sustained manner due to the endosome 
acidic environment and the size limitation which prevents the NPs from traversing the 
nuclear pore complex and eventually impeding the drug to enter the cell nuclei 
afterwards.  
The uptake of the hybrid NPs could be also easily followed by using the 
fluorescence emission of the complexed ICG dye in the nanoplatforms. The cell 
cytoplasm appears coloured due to the dye emission fluorescence signal, in this case 
in green due to the choice in the colour palette of the microscope. It is worth 
mentioning that a complete colocalization of both DOXO and ICG fluorescence 
signals is not uniformely present around cell nuclei. At this respect, it is necessary to 
bear in mind that DOXO fluorescence is largely enhanced when DOXO is released 
fropm the polymeric matix as a consequence of its self-quenching effect when inside 
the NPs [41]. In addition, some ICG molecules can be also released to the cytoplasm 
from the NPs and mainly bonded to intracellular proteins (glutathione S-transferase), 
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ICG NPs for 24 and 48 h, and a crystal violet cell cytotoxicity assay was performed 
provided that DOXO can cause interferences with formazan crystals when using the 
standard MTT cell proliferation assay. 
The concentration of free DOXO and DOXO loaded in the NPs was ca. 2.5 
μM, and of ICG loaded in the NPs 4.0 μM, respectively. SP-PLGA NPs and SP-
PLGA-ICG NPs exhibited negligible toxicity in HeLa cells in the absence of NIR 
irradiation. DXSP-PLGA NPs and DXSP-PLGA-ICG NPs displayed relatively 
similar cytotoxicities than free DOXO, being the former slightly more cytotoxic in the 
absence of irradiation after 48 h of incubation (Figure 3.11a). Intracellular NP-
released DOXO concentration could be enhanced by circumventing the multidrug 
resistance (MDR) effect which can appear when administering as a free drug, 
hampering the drug action by pumping out drug molecules from cytosol to 
extracellular area [63]; also, an enhanced internalization of the hybrid NPs into cells 
through inespecific endocytosis migth be expected, while free DOXO is transported 
into cells by a passive diffusion mechanism [64]. In contrast, the DOXO 
concentration inside cells can be reduced by the sustained release of the drug from the 
NPs, which is more important at short incubation times. All of these opposite events 
then would led to a similar DOXO concentration in cells and close cytotoxicity of free 
DOXO, DXSP-PLGA and DXSP-PLGA-ICG NPs.  
Cell cytotoxicity was significantly enhanced when NIR light of 2.5 W/cm2 
was irradiated for 5 min on HeLa cells treated with DXSP-PLGA-ICG NPs (60  and 
74% after 24 and 48 h of incubation, respectively) compared with those cells bearing 
DXSP-PLGA or SP-PLGA-ICG NPs under similar illumination conditions (20 and 
40% at 24 h of incubation, and 48 and 33% at 48 h, respectively, see Figure 3.11b). 
Therefore, it seems that the simultaneous combination of NIR hyperthermia ability 
provided by ICG and the chemotherapeutic action of DOXO can result in an enhanced 
cytotoxic effect. Apart for the inherent cytotoxicity provided by hyperthermia process 
(as denoted by the higher cytotoxicity found for SP-PLGA-ICG NPs in the presence 
of irradiation than in the absence), the observed larger cytotoxicity might be also 
caused by an altered kinetics, permeability and uptake of the chemotherapeutic agent 
during the heating process [65]. In this regard, the photothermal effect of ICG might 
help to partially melt the core of the PLGA polymeric matrix, releasing a larger 
amount of DOXO from DXSP-PLGA-ICG NPs (as observed in drug release 
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experiments, see Figure 3.8) for achieving an additional cytotoxic activity against the 
cancerous cell line. On the other hand, the cytotoxicity of DXSP-PLGA-ICG NPs was 
observed to be additionally enhanced (up to ca. 76 and 88% after 24 and 48 h of 
incubation) when an external magnetic field was applied to the cell culture, probably 
allowing concentration and NP attraction near the cells and, thereby, increasing the 
internalization of NPs and the localized release of DOXO inside cells inside cells and 
an enhanced photothermal response, as previously mentioned [66, 67].  
 
Figure 3.11: HeLa cell viabilities of free DOXO (black column), SP-PLGA NPs (stripped 
column), DXSP-PLGA NPs (light gray column), SP-PLGA-ICG NPs (squared column), 
DXSP-PLGA-ICG NPs (gray column) and DXSP-PLGA-ICG NPs in the presence of applied 
external magnetic field (sparse white column) a) in the absence and b) presence of continuous 
NIR light (808 nm) of 2.5 W cm-2 for 5 min. Data shown as mean ± SD (n=3). 
 
3.4.9 Optical imaging in vivo and biodistribution 
 By exploiting the fluorescence imaging ability of the present hybrid NPs, we 
performed a first brief analysis of the in vivo biodistribution after intravenous 
injection (at the tail vein) of the present hybrid NPs in a tumor-bearing mice model 
through NIR fluorescence optical imaging utilizing the intrinsic and sensitive laser 
fluorescence of ICG. Accumulation of DXSP-PLGA-ICG NPs in the tumor region 
took place in a very short time interval (2 h) through the EPR effect. Surprisingly, a 
relatively important fluorescence intensity around the tumor area is still retained after 
96 h post-injection (Figure 3.12); in contrast, a much lower fluorescence from free 
ICG administered as a control is observed due to its known blood instability and 
extremely short in vivo half-life (ca. 150-180 s)[68]. In fact, only traces of free ICG 
fluorescence were already detected after 48 h post-injection (image not shown). 
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Hence, it is clearly shown that the DXSP-PLGA-ICG NPs suitably stabilized ICG 
molecules avoiding their rapid photo-degradation and aqueous instability, and 
favoring a prolonged retention in the tumor through the EPR effect.  
 
Figure 3.12: Time-lapse in vivo NIR images of MDA-MB-231 breast adenocarcinoma tumor-
bearing mouse after intravenous tail injection of DXSP-PLGA-ICG NPs. The squared region 
denotes the tumor localization. 
 
3-D image reconstruction of the fluorescence images also allowed to 
determine that the hybrid NPs are mainly eliminated through the reticulendothelial 
system (RES); in particular, NPs are observed to accumulated mainly in the spleen 
and, to lesser extent, in the liver (Fig. 3.13), with no traces in lungs at 6 h post-
injection. At longer circulation times (96 h), the NP accumulation greatly reduces 
until completely disappear. From the fluorescence images, it can be also observed 
along the time interval analyzed some fluorescence in the bladder region. This might 
indicate that ICG can be partially dettached from the NPs by screening of electrostatic 
interactions between the dye and the polymeric NP surface; furthermore, it is also 
possible that some little fragments from the biodegraded NPs might be also excreted 
via renal clearance after polymer degradation in plasma and subsequent ICG released.  
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Alzheimer´s or Parkinson´s neurodegenerative diseases, or cerebrovascular accidents 
as strokes.   
 
3.5 Conclusions 
 In summary, the present results reveal that the possible combination of 
chemotherapy, magnetic targeting, and photothermal therapy through polymeric 
hybrid NPs is expected to significantly increase the likelihood  and selectivity of cell 
killing and, potentially, to overcome resistance to chemotherapeutic agents making 
these particles a promising approach not only for cancer therapy but also for other 
neurodegenerative diseases such as Alzheimer´s or Parkinson´s diseases thanks to 
their ability to overcome the blood brain barrier. PLGA hybrid NPs might be guided 
to the tumor area by an applied magnetic field as observed in vitro, and the 
subsequent combination of NIR laser irradiation and chemotherapy at the tumor site 
would enhance their therapeutic effectiveness. The permeability of tumor vessels and 
the sensitivity of tumor cells toward chemotherapeutics should be greatly enhanced by 
hyperthemia, holding the promise of improving drug efficacy. Photothermal ICG-
mediated therapy might facilitate triggered and instant drug release from the hybrid 
NPs, which is critical for achieving a high effective drug concentration in the tumor 
site. Moreover, one of the major advantages of NIR laser light as a source for 
localized hyperthermia is that light exposure is non-invasive and can be applied 
extracorporally compared with other types of hyperthermia like radiofrequency or 
microwave ablation. In addition, the magnetic and luminescent properties of the 
present hybrid NPs achieved through the simultaneous incoporation of Fe3O4 NPs and 
the fluorescent ICG dye in their nanostructure also allows, at the same time, their use 
as multimodal imaging diagnostic nanoplatforms able to follow their therapeutic 
response in vivo, configuring a good example of fully biocompatible and 
biodegradable theranostic nanodevices. 
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CHAPTER IV - Simple Control of Surface 
Topography of Gold Nanoshells by a Surfactant-less 
Seeded-Growth Method 
 
4.1 Summary 
In this chapter, we report the synthesis of branched gold nanoshells (BGNS) through 
a seeded-growth surfactant-less method. This was achieved by decorating PLGA NPs with Au 
seeds (NP-seed), using chitosan as an electrostatic self-assembling agent. Branched shells 
with different degrees of anisotropy and optical response were obtained by modulating the 
ratios of HAuCl4/K2CO3 growth solution, ascorbic acid (AA) and NP-seed precursor. Chitosan 
and AA were crucial in determining the BGNS size and structure, acting both as co-reductants 
and structure directing growth agents. Preliminary cytotoxicity experiments points to the 
biocompatibility of the obtained BGNS, allowing their potential use in biomedical 
applications. In particular, these nanostructures with “hybrid” compositions which combine 
the features of gold nanoshells and nanostars then can hold important potential applications 
as multifunctional nanoteranostic devices.  
 
4.2 Introduction 
The obtention of metal nanoparticles (NPs) through highly efficient and 
controlled synthetic methodologies has been a very active area of research during the 
past two decades due to their unique size- and shape- dependent properties [1-6]. In 
particular, gold (Au) NPs exhibit remarkable optical properties due to their localised 
surface plasmon resonance (LSPR) absorption with peak positions which are largely 
dependent on the NP size, shape, composition and the dielectric constant of the 
medium [7]. Also, the strong electromagnetic field generated by LSPR excitation can 
drastically enhance the fluorescence and Raman signals of nearby molecules [8-11]. 
Hence, all these extraordinary properties have increased the potential applications of 
these nanoscaled materials in different fields such as in catalysis [12, 13], photonics 
[14-16], sensing [17-20] or nanomedicine [21-24], amongst others. 
Au NPs have been produced to different shapes, such as spheres [25-27], rods 
[28-30], prisms [31], cubes [32], plates [33], nanoshells [34], hollow [35, 36] and 
branched [6, 37, 38] NPs. Non-spherical NPs and nanoshells can exhibit, for example, 
important shifts of their LSPR bands to the red and near-infrared region (NIR) of the 
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electromagnetic spectrum. Thanks to their great energy absorption capabilities they 
can generate considerable heat under red and NIR irradiation becoming excellent 
photothermal agents; moreover,  they possess unique catalytic and Surface Enhanced 
Raman Spectroscopy (SERS) properties in comparison to spherical NPs due to the 
their larger surface area, more availability of reactive metal sites, and the anisotropic 
distribution of the electromagnetic field near their surface, respectively. In addition to 
the former properties, the hollow architecture of Au nanoshells also enables the 
encapsulation of different cargo molecules to provide additional functionalities, which 
opens up their special utility in the fields of diagnosis and therapy [39-42].  
On the other hand, both theoretical calculations and experimental data indicate 
that a large electromagnetic field enhancement exists at the tips of branched particles, 
leading to stronger SERS [9, 43] and photothermal activities relative to non-branched 
ones provided that the large specific surface areas of the former facilitate a higher 
photohermal transduction efficiencies and an easier penetration of the electric field in 
comparison to smoother nanostructures [44, 45].  
Hence, the combination of a branched surface structure and cargo loading 
capability in a single nanostructure can open the door to develop a new class of 
exciting multifunctional nanomaterials for sensing and biomedical applications. In 
this regard, Halas et al. have synthesized nanoshells with a roughned surface by 
treating presynthesized nanoshells with an aqueous solution containing 
cetyltrimethylammonium bromide (CTAB), HAuCl4 and ascorbic acid (AA) followed 
by chemical etching of the pre-synthesized nanoshells [46, 47]. However, this 
methodology did not give rise to highly surface anisotropic structures, and the far-
field scattering properties of the roughened nanoshells were close to those of the 
smoothed ones except for small differences in the angular light scattering 
distributions; in addition, the used post-synthesis chemical etching approach is not 
ideal because it can lead to particle destabilization and does not allow control of the 
surface topography. To solve this issue, very recently Park et al. developed a high 
yield synthetic method to radially arrange gold spikes on the surface of polymeric 
NPs, so called “spiky nanoshells” [48, 49]. The synthetic procedure is based on the 
CTAB-assisted seed-growth method [29, 30] on negatively charged polymer 
templates in the presence of silver (Ag) ions. This metholodolgy leads to Au 
nanospikes organized at a radial positioned determined by the size of the polymer 
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template. The presence of CTAB and/or metal halide salts, in particular NaBr, play a 
key role in the formation and regulation of the spiky shell morphology [50]. However,  
this process has still several drawbacks as the use of toxic cationic surfactants 
(CTAB) during the particle synthesis (which can be a severe problem for intended 
biomedical applications if their complete elimination is not completelly achieved), or 
as being composed of several reduction steps, i.e. the reduction of deposited Ag ions 
on the surface of the polymeric template by NaBH4 followed by the CTAB-assisted 
growth of branches/spikes on the Ag seeds by reduction of an Au growth solution by 
AA exploiting the preferential binding of bromide ions from CTAB to selective facets 
of Au NPs [51].  
Here, we report an alternative methodology to synthesize branched gold 
nanoshells (BGNS) in high yield based on a simpler seed-reduction method. In this 
approach, pre-formed citrate-stabilized Au seeds were attached on the surface of 
chitosan-Pluronic F127 stabilized poly(lactic-co-gycolic) acid (PLGA) NPs and 
subsequently anisotropically grown by the addition of a growth solution exclusively 
formed by Au salt, potassium carbonate (K2CO3) and AA. By altering the feeding 
ratio of different raw components, the structure of the anisotropic metal nanoshells 
can be tuned and, thus, their associated optical properties. Finally, the biocompatibilty 
of the as-obtained nanoshells was tested in vitro to decipher future use in biological 
applications as biomedical nanoplatforms. 
 
4.3 Materials and methods 
Poly(D,L-lactic-co-glycolic) (PLGA) of 40-75 kDa with 50:50 lactide–
glycolide ratio, Pluronic F127, hydrogen tetrachloroaureate (III) trihydrate 
(HAuCl3·3H2O), low molecular weight chitosan (LMW-chitosan, MW = 111 kDa), 
potassium carbonate anhydrous, sodium borohydride, sodium citrate tribasic, 
resazurin (7-Hydroxy-3H-phenoxazin-3-one 10-oxide) and ascorbic acid were 
purchased from Sigma–Aldrich (St. Louis, MO, USA). ProLong® Gold antifade 
reagent with DAPI, Dulbecco’s modified eagle medium, fetal bovine serum (FBS), L-
glutamine, penicillin/streptomycin, sodium pyruvate, and MEM non-essential amino 
acids (NEAA) were purchased from Invitrogen (Carlsbad, USA). Dialysis membrane 
tubing (molecular weight cutoff ∼3500) was purchased from Spectrum Laboratories, 
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Inc. (Rancho Dominguez, California). Thiol-PEG (HS-PEG, molecular weight 5000 
Da was from Polymer Source (Ontario, Canada). All other chemicals and solvents 
were of reagent grade (purchased from Sigma–Aldrich). Milli-Q water was used for 
all aqueous solutions. All glassware was washed with aqua regia and HF 5% (v/v) and 
extensively rinsed with water. 
 
4.3.1 Preparation of PLGA NPs 
PLGA NPs were synthesized by a modified nanoprecipitation method (see 
Chapter 3). Briefly, a 10 % (w/v) solution of PLGA in acetone was added dropwise at 
a flow ratio of 0.166 mL/min to 50 mL of a cooled (10° C, 1 % (w/v) aqueous 
solution of F127 copolymer (PEO98-PPO67-PEO98) under moderate magnetic stirring 
(250 rpm). Then, the resulting emulsion was homogenized with a sonicating tip (100 
W, 20 kHz) for 10 minutes in an ice cold bath. The emulsion was magnetically stirred 
4 h and then centrifuged in 10 mL tubes at 9000 rpm for 30 min at 18 °C. The 
resulting pellets were dispersed in 5 mL of water, stirred 4 h, centrifuged and 
dispersed again under the same conditions. The final PLGA NP dispersion was 
translucent and homogenous with hydrodynamic size and zeta potential of 110 ± 20 
nm and -39 ± 7 mV, respectively.  
 
4.3.2 Synthesis of Au seed NPs 
Citrate-capped gold seeds were prepared based on a method previously 
reported by Jana et al. [29]. Briefly, 10 mL of 2.56·10-4 M tri-sodium citrate were 
mixed with 0.125 mL of 0.010 M HAuCl3·3H2O. Next, 0.3 mL of 0.1 M ice cold 
NaBH4 solution was added and the solution mixed. The solution turned orange-pink 
immediately, indicating particle formation. The seed dispersion was aged overnight to 
allow for decomposition of unreacted NaBH4. The average particle size obtained from 
TEM was 4 ± 2 nm. 
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4.3.3 Preparation of NP-seed precursor 
PLGA NPs have a negative surface charge (ca. – 40 mV in the present case) 
due to the carboxyl groups of the PLGA core; therefore, we used chitosan, a natural 
biocompatible polycation, to invert the surface charge of NPs to positive to allow the 
subsequent attachment of negatively charged Au seeds. Briefly, 25 mL of PLGA NPs 
were mixed with 1.25 mL of 1 % (w/v) chitosan (in 1% (v/v) acetic acid) and stirred 
for 4 h at room temperature, followed by centrifugation at 9000 rpm for 30 min at 18 
°C and subsequent dispersion in 25 mL of water. Then, 5 mL of Au seeds were added 
and stirred for 4 h, followed by centrifugation at 7000 rpm for 20 min at 18 °C. The 
supernatant was discarded and the pellets were dispersed in 25 mL of water. The NP-
seed dispersion was sonicated (20 W, 20 kHz) 5 s to avoid any kind of particle 
aggregation. Control samples without chitosan as seed-attaching element were 
prepared by mixing 4 mL of PLGA NPs with 21 µM of cisteamine, 21 μM of EDC 
and 21 µM of sulfo-NHS. This mixture was reacted 4 h followed by centrifugation at 
9000 rpm for 30 min and 18 °C and subsequent dispersion in 2 mL of water. 0.1 mL 
of citrate-capped seeds were added. Incubation and washing steps were the same as 
those of NP-chitosan-seeds samples.  
 
4.3.4 Preparation of Au growth solution.  
Au growth solution was prepared by dissolving 0.05 g of K2CO3 in 98 mL of 
water. After 30 min of stabilization, 2 mL of 0.025 M HAuCl4·3H2O was added and 
the solution aged for 24 h. The solution had a pH = 9.87 right before the synthesis. At 
this pH the predominant species of Au are [AuClx(OH)4-x]- (x = 0 - 4) , with 
predominance of [Au(OH)4]- [52]. The final concentration of Au+3 in the growth 
solution was 0.6 mM.  
 
4.3.5 Branched Gold Nanoshell growth (BGNS) 
To obtain homogeneous BGNS sizes, NP-seed precursor was filtered with 1.2 
µm filters (Merck Millipore, MA, USA) to eliminate large aggregates formed during 
centrifugation. In a typical synthesis, 1 mL of NP-seed precursor was mixed with 2.5 
mL of the Au growth solution under moderate stirring (400 rpm). After 1 min, 50 µL 
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of fresh 0.5 M AA (pH = 1.95) was added. After a few seconds the mixture changed 
from colorless to blue indicating the formation of branched nanoshells. After 
completion of the reduction reaction, and in order to ensure water stability for long 
time, thiolated polyethylene glycol was linked to the surface of the nanoshells. 
Briefly, BGNS (optical density ~1), K2CO3 (20 mM) and SH-PEG-OCH3 (0.5 mM) 
were mixed in a volume ratio of 2:1:2. The conjugation was carried out at 4 °C for 4 h 
under moderate stirring. Pegylated BGNs were centrifuged at 3500 rpm for 15 min at 
20 °C to eliminate free SH-PEG-OCH3, and subsequently dispersed in water. 
 
4.3.6 Particle Characterization 
Dynamic light scattering measurements were performed at 25 °C by means of 
an ALV-5000F (ALV-GmbH, Germany) instrument with λ = 488 nm wavelength, 
scattering angle to incident beam was θ = 90 ° and sampling time 120 s. Zeta potential 
measurements were performed at 25 °C in a Zetasizer Nano ZS (Malvern Instruments, 
UK) using folded capillary disposable cells and measured by triplicate. UV-Vis 
spectroscopy measurements were performed in a CARY 100 Bio UV-Visible (Agilent 
Technologies, Santa Clara, USA) spectrophotometer. UV-vis spectra of BGNS were 
recorded 30 min after the growth reaction without dilution. UV-vis kinetic 
experiments were recorded with a sampling time of 5 s at 25 °C. Transmission 
electron microscopy (TEM) images of PLGA NPs and BGNs were obtained with a 
Philips CM-12 (Philips, Netherlands) microscope operating at 120 kV. HR-TEM 
images and selected area electron diffraction (SAED) patterns were obtained with a 
transmission electron microscope (Carl-Zeiss Libra 200 FE-EFTEM, Germany) 
operating at 200 kV. Scanning electron microscopy (SEM) images were obtained with 
a FESEM Ultra Plus (Zeiss, Germany) microscope operating at 20 kV. X-ray 
diffraction (XRD) experiments were carried out with a rotating anode X-ray generator 
(Siemens D5005, Germany). Twin Göbel mirrors were used to produce a well-
collimated beam of CuKa radiation (λ = 1.5418 Å). X-ray diffraction patterns were 
recorded with an imaging plate detector (AXS F.Nr. J2–394). 
The concentration of BGNS was determined by viscometry, as previously 
described. Briefly, dynamic viscosities of deionized water and BGNS were measured 
with a capillary/rolling ball automated microviscometer (AMVn Microviscometer, 
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Anton Paar, Austria). The viscosity is determined by timing the ball rolling down a 
slope with a defined angle. Based on the rolling-ball principle, the dynamic viscosity 
is defined by: 
 
ߟ ൌ ܭଵሺߠሻሺߩ஻ െ ߩௌሻݐ     (Eq 4.1) 
 
where ܭଵሺߠሻ is the cell calibration constant depending on the angle  ߠ, ݐ is the rolling 
ball time, and ߩ஻ and ߩௌ are the densities of the ball and sample, respectively.  
The concentration of BGNS was calculated from the solvent’s and the 
sample’s specific viscosities (Eq 4.2) (measured in triplicate) and the hydrodynamic 
radius of the BGNS using the Einstein’s viscosity relationship for spheres (Eq 4.3): 
 
ߟ௦௣ ൌ 1 െ ఎఎబ     (Eq 4.2) 
 ߟ௦௣ ൌ 2.5 ቀ௡మ௏ ቁ ௘ܸ          (Eq 4.3) 
 
where η is the sample’s dynamic viscosity, η0 is the solvent viscosity, 
௡మ
௏  is the number 
of equivalent spheres per volume unit (the concentration of PGNHs),  ܸ݁ ൌ ସଷ ߨܴ௘ଶ  is 
the volume of an equivalent sphere, and Re is the hydrodynamic radius of an 
equivalent sphere. The UV-vis absorption of different dilutions of BGNHS was 
measured and plotted versus the calculated concentrations to prepare a calibration 
curve, thus, concentrations of BGNS samples could be calculated from UV-vis 
measurements. Our results were compared with concentrations calculated by using the 
theoretical extinction coefficient of nanoshells of the same size [53]. The difference 
found was less than one order of magnitude, which could stand for the different 
topography; nevertheless, our results are in agreement with other values reported [21, 
54-56].  
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4.3.7 Cell nanoparticle uptake  
BGNS uptake was followed by confocal microscopy by seeding HeLa cells on 
poly-L-lysine coated glass coverslips (12×12 mm2) placed inside 6-well plates (3 mL, 
1.5·105 cells/well) and grown for 24 h at standard culture conditions, that is, 5% CO2 
at 37 ºC) in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% 
(v/v) FBS, 2 mM L-glutamine, 1% penicillin/streptomycin, 1 mM sodium pyruvate, 
and 0.1 mM MEM Non-Essential Amino Acids (NEAA). Then, 400 μL of NP 
solution (1·109 NPs/mL) in PBS were added to cells. After 6 h of incubation the NP-
containing cells were washed three times with PBS pH 7.4 and, then, fixed with 
paraformaldehyde 4% (w/v) for 10 min, washed with PBS. Samples were visualized 
with an oil immersion 63X objective (NA 1.4) using a DMI6000B Leica microscope 
(Leica Microsystems, Germany) in differential interference contrast (DIC) and 
fluorescence modes.  
Uptake of BGNS by HeLa cells was also investigated by TEM. HeLa cells 
were seeded in 6-well plates (3 mL, 1.5·105 cells/well) and grown for 24 h at standard 
culture conditions. Then, 400 μL (1·109 NPs/mL) were added to cells. After 6 h of 
incubation the NP-containing cells were washed three times with PBS, trypsinized 
and centrifuged at 1500 rpm for 4 min. Cell pellets were fixed with 500 µL of 2.5 % 
(v/v) glutaraldehyde. The pellet was then included in agar, post-fixed with osmium 
tetraoxide in 0.1 M cacodylate buffer (1% (w/v)), and finally pelletized with Eponate 
(Ted Pella Inc, Redding, CA, USA). Ultra-thin cuts were obtained with an 
ultramicrotome (UltraCut S, Leica, Germany) and were analyzed by TEM (JEOL 
JEM 1011, Japan). 
 
4.3.8 Resazurin cell cytotoxicity assay 
HeLa cells were seeded in a 96-well-plate at 15000 cells/well (3 wells/sample) 
in 100 µL growth medium (Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% Fetal Bovine Serum (FBS), 2 mM L-glutamine, 1% 
penicillin/streptomycin, 1 mM sodium pyruvate, and 0.1 mM MEM Non-Essential 
Amino Acids (NEAA). After 24 h, cells were incubated 6 h with 50 μL of BGNS at 
different concentrations and some cells were left without BGNS as a control (blank). 
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Then, cells were washed with PBS and a solution out of 10% (v/v) of Resazurin 
(Sigma-Aldrich) and 90% of growth medium was added to each well (100 µL/well) 
and incubated for 3 h. Fluorescence spectra were recorded with a microplate 
fluorescence spectrometer (FluoroLog-3, Horiba, Japan). Spectra were recorded by 
exciting at 560 nm and recording fluorescence emission in the range 572-650 nm. The 
background signal (640-650 nm) was subtracted to the average maximal fluorescence 
of each sample. Values were normalized and plotted against concentration in 
logarithmic scale. 
 
4.4 Results and discussion 
The current synthesis of BGNS involved the preparation of Au seed-decorated 
PLGA NPs (NP-seed) and subsequent branched nanoshell growth by using a growth 
solution exclusively containing HAuCl4, K2CO3 and AA; in this way, avoidance of 
using CTAB eliminates the inherent disadvantages of its use in the synthetic process 
such as difficulty of clearance and potential toxicity in biomedical applications [48, 
49]. In particular, the solely reaction of HAuCl4 and AA has been previously used to 
grow dendritic patches onto polystyrene nanospheres by exploiting the conformal 
surface growth of Au onto the polymeric NP surface regulated by AA surface 
adsorption [57], or to obtain flower-like gold NPs by using chitosan as stabilising 
agent [58]. Nevertheless, to the best of our knowledge this is the first work in which 
the present synthetic approach is used to obtain branched gold nanoshells. A relative 
similar approach was recently used to grow silver-polymer composites by using 
PLGA NPs to electrostatically attach silver ions which are subsequently 
photorreduced; capping agents such as polyvinyl alcohol (PVA) or sodium citrate are 
added prior the addition of the strong reductant agent (AA) to complete the reduction 
reaction [59]. However, in contrast to the methodology developed here, in the former 
approach the addition of the capping agents is key to attain the star-like structure; in 
its absence, only spheroidal-like particles are obtained. 
As with most anisotropic particles, the present growth of the gold branched 
shell on top of chitosan/F127-functionalised PLGA NPs is a seed-mediated process. 
In a typical synthesis (see Figure 4.1), Au seeds with a diameter of ca. 4 nm were 
prepared by fast reduction with sodium borohydride in the presence of sodium citrate 
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potential, E0 = 1.002 V) but not isolated AuI to Au0 (E0 = -1.5 V) [61], hence, leading 
to a preferential reduction of Au salt on the seed surfaces. This should directly 
contribute to the formation of branches on the seed-decorated PLGA NPs used as 
nanotemplates presumably because of the slow and directional diffusion of gold 
precursors to the NP-attached seeds which, in the present case, is not regulated by the 
presence of halide ions, as reported in previous works [50].  
Here, chitosan also plays an important role in the synthetic process: On one 
hand, chitosan chains contribute as a reducing agent in the redox reaction of HAuCl4 
[62, 63]. However, in the presence of chitosan solely, one day is needed at least to 
produce a partial roughened gold coverage around the polymeric NPs with an 
absorbance peak centered at ca. 570 nm, which is typical of aggregated Au NPs 
(Figure 4.3). The full metal coverage of the polymer core is not achieved indicating 
that chitosan does not act as a strong reducing agent. On the other hand, the 
electrostatic interactions between chitosan´s amine groups and primary Au seeds, and 
the scrolling and protrusion capacity of vicinal chitosan chains can triggered for 
agglomeration of primary seeds, which can serve as secondary nuclei for further 
growth of larger crystals which configure the nanoshell spikes, that is, the chitosan 
chains can act as a structure-directing agent supporting the growth of anisotropic gold 
shells [58, 64, 65]. TEM and HR-TEM images confirm this point (Figure 4.3b-c), 
where some agglomerates of small particles can be observed. The HR-TEM image 
exhibited regions of varying contrast starkly different from the uniformly dark 
particles of spherical Au nanocrystals. Also, the flat nature of these nanocrystals can 
be deduced by the presence of Moiré patterns arising from the presence of two 
superimposed, different crystal lattices [66]. 
TEM images (Figure 4.4) revealed that synthesized BGNs were covered with 
branches in high yield, and the final product was free of small particles and other 
nanostructures. The branches formed were stable and hardly changed after several 
months of storage at room temperature under common laboratory conditions. 
Resulting branched Au nanoshells prepared by this process possess the advantages of 
being quickly and easily obtained, enabling the control of their morphology without 
using non-toxic materials.  
It is well known that the plasmon peak position of smooth shells can be 
readily controlled by changing the ratio between the core diameter and shell 
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thickness, and that the increased core/shell ratio results in strong red shifts of the 
nanoshell plasmon band [67]. However, very large cores are often not desirable as 
they significantly increase the overall particle diameter, and the preparation of very 
thin uniform shells can be synthetically challenging. Hence, coupling a shell with 
branches one can readily tune the plasmon band over a wide wavelength range 
without significantly changing the nanoshell size (or the amount of gold). Trying to 
decipher the mechanism/s involved in their formation, we here considered the 
systematic variation of different factors involved in the synthesis of these spiky gold 
nanoshells in order to test their influence on the reaction kinetics and on the size, 
shape and optical properties of the resulting particles. 
 
 
Figure 4.3: a) UV-vis absorption spectrum of NP-seed in the presence of Au growth solution 
and in the absence of AA after 1 day of reaction. Although chitosan by itself acts as reductant, 
its activity is not sufficient to generate fully-developed BGNS. b) TEM image of a NP-seed 
after 1 day under the aforementioned conditions (Scale bar is 50 nm). c) HR-TEM image 
showing the agglomeration of small flat crystals (as observed from the presence of Moiré 
patterns, see arrow) as precursors of branches. 
 
a) b) 
c) 
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4.4.1 Effect of ascorbic acid 
Experimentally, the influence of AA concentration on the structure and 
properties of BGNS was studied by altering the amount of supplied AA. As already 
well known, the reduction of the auric ion by AA is stoichiometric at a molar ratio of 
ascorbic acid to gold (AA:Au3+) of 1.5 [68]. All present experiments were performed 
at an AA:Au3+ ratio above 1.97 so it is clear that the branched morphology results 
from an excess of AA. As shown in Figure 4.4, the increase of ascorbate ions from 5 
to 75 μL of a 0.5 M solution led to a rapid change in solution color from colorless to 
blue-greenish in few seconds, indicating the main role of AA as a reducing agent.  
 
  
Figure 4.4: a) TEM images of BGNS showed the great anisotropy of these structures with 
spikes protruding from the core (AA solution = 5 μL, Au growth solution = 2.5 mL, and NP-
seeds solution = 0.5 mL). b) SEM image showing a high yield production of BGNS and 
negligible undesired by-products. Scale bar is 200 nm in a) and 500 nm in b). 
 
In fact, the widespread heterogeneous nucleation may result from the fact that 
both the gold precursor, [Au(OH)xCl4-x]-, and AA could be expected to adsorb onto 
the seed-decorated core polymeric particles, further raising the probability of 
nucleation on the surface of NPs. In particular, AA could bind to the chitosan chains 
favoring the surface reduction of Au ions in the closest vicinity of gold seeds 
electrostatically-attached along the biopolymer chains, which would facilitate the 
anisotropic shell morphology. The changes in solution color correspond to variations 
in the position of the wide plasmon absorption band of Au nanoshells spreading over 
a) b) 
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ca. 500-1000 nm, as well as in the NP size and shape. The plasmon absorption peak 
first red shifted from ca. 680 nm to more than 1000 nm upon addition of 5 to 20 μL of 
AA solution, typical for the size increase of nanoshells and the emergence and growth 
of multiple spikes onto their surfaces (Figure 4.5). TEM images showed that the 
products of such reactions exhibited branched structures, with the number and length 
of branches increasing as the AA concentration does within this concentration range 
(Figure 4.6a-b). The appearance of a plasmon band at 700-1000 nm is not only 
coincidental with the appearance of the spikes but its intensity gradually enhances 
with the increase in the nanoshell size and count of branches.   
 
Figure 4.5:  Effect of AA concentration on UV-vis absorption spectra of BGNs. Volumes of 
Au growth solution and NP-seed were kept constant at 2.5 mL and 0.5 mL, respectively. 
 
In contrast, upon addition of larger volumes of AA solution (20 to 75 μL) a 
progressive slight blue-shift of the plasmon peak is observed as a consequence of the 
progressive formation of more spheroidal and less roughened nanoshells through the 
apparent growth of the nanoshell core and the reduction in the number and protrusion 
of spikes (Figure 4.6c-d), with the whole nanoshell diameters slightly decreasing from 
210 to 190 nm as previously observed in the formation of pure gold star-shaped NPs 
in aqueous solution [58, 69]. Nevertheless, the apparent protrusion of these gold 
structures demonstrates that these are unlikely to have formed in the bulk and 
subsequently attached to the core-PLGA nanospheres by heterocoagulation but they 
have been, in fact, heterogeneously nucleated and grown in all accessible dimensions 
(laterally as well as towards the bulk solvent). 
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Figure 4.6: TEM images showing the effect of AA on NP size and structure. Added AA 
volumes were: a) 5 µL; b) 20 µL; c) 50 µL; and d) 75 µL. Au growth solution and NP-seed 
volumes were kept constant at 2.5 mL and 0.5 mL, respectively. e) Size distribution of BGNS 
observed in a). f) Size distribution of BGNS observed in d). Scale is 200 nm in a) and c), and 
500 nm in b) and d).  
 
Hence, the obvious variation of nanoshell size and morphology by controlling 
the AA concentration clearly involved that the supply of Au0 in the reaction system 
was a key for generating branched nanoshells. In this regard, it is necessary to bear in 
mind that the nature of gold reduction strongly depends on the dissociation degree of 
the AA molecule. As indicated in Figure 4.7, the pH of the reduction reactions carried 
out in this work varied between 2.98 (for 75 μL AA) and 7.15 (for 5 μL AA). With 
a) b) 
c) d) 
e) f) 
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dissociation constants pKa,1 = 4.17 and pKa,2 = 11.58, it is therefore expected that 
mainly the non-dissociated (H2Asc) and singly deprotonated (HAsc-) forms of AA 
participate in the gold reduction reaction. As has been previously noted, the reducing 
strength of ascorbic acid increases with pH, i.e. with the prevalence of the HAsc- form 
[70]. 
 
Figure 4.7: pH of the reaction mixtures with different initial volumes of AA. Initial pH of Au 
growth solution and AA were 9.87 and 1.95, respectively. 
 
It can be deduced that even at low AA concentrations the transformation of 
AuI to Au0 is sufficiently fast, as observed with the naked eye and when measured the 
reaction kinetics by spectrophotometry (see below), to induce the branched coverage 
of the nanoshell surfaces, being the HASc- form of AA the main reductant species. 
This anisotropic coverage may be partially assisted: i) on one hand, by the 
concentration-dependent facet selectivity of Au0 onto the seed surfaces which should 
allow the preferential growth along certain crystalline faces of the initial nuclei 
(polycrystalline citrate-Au seeds), in particular, along existent twin boundaries, in a 
kinetically controlled process as ocurred for pod and star-shaped single NPs [65, 67, 
68] (Figure 4.8a); ii) on the other, by the presence of chitosan chains acting as 
nucleation centers and structure directing agents. In fact, when chitosan is absent in 
the reaction solution (for example, when substituted by cysteamine molecules 
covalently attached to PLGA carboxyl groups with EDC/sulfo-NHS) only slightly 
roughened nanoshell surfaces were obtained (Figure 4.8b).  
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which represented the reactivity of gold ions. This led us to investigate the influence 
of other experimental variables that could improve the Au0/seed ratio, which also 
allowed for tailoring the properties of the present BGNs. 
 
4.4.2 Influence of NP-seed precursor 
 The influence of NP-seed concentration on the properties of as-prepared 
BGNS was also studied. As the amount of NP-seed increased from 0.1 to 3 mL, with 
the amount of AA and Au growth solution fixed at 50 μL and 2.5 mL respectively, a 
progressive red shift of the wide plasmon absorption band maximum from 672 nm to 
> 1000 nm was observed (Figure 4.9).  
 
Figure 4.9:  Effect of NP-seed concentration on the UV-vis absorption spectra of BGNS. 
Volumes of Au growth solution and AA were kept constant at 2.5 mL and 50 µL, 
respectively. As the number of NP-seed increases, the plasmon band maximum red-shifts. 
 
Under TEM, complete nanoshell gold coverage is observed with increases in 
the size, number and length of the branches (Figure 4.10). Obviously, the addition of 
more seed-decorated polymeric NPs led to lower Au0/seed ratios providing less Au0 
to supply the growth on each NP. A lower Au0/NP seed ratio facilitated then a 
branched growth rather than an isotropic one, which also relied on the AA 
concentration as commented previously.  
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Figure 4.10: TEM images of BGNS showing the effect of added NP-seeds. Added volumes 
were: a) 0.5 mL; b) 1 mL; c) 2 mL; d) 3 mL. Au growth solution and AA volumes were kept 
constant at 2.5 mL and 50 µL, respectively. e) Size distribution of BGNS observed in a). f) 
Size distribution of BGNS observed in d). Scale bars are 100 nm in a-b) and 200 nm in c-d). 
  
A control experiment indicated that at a relatively low added AA 
concentration (for example, after the addition of 10 μL of 0.25 M AA solution) the as-
prepared nanoshells were even more branched in spite of NP sizes became larger with 
the increase of NP-seed particles (Figure 4.11). As mentioned previously, despite a 
relatively fast reduction of AuI to Au0 was achievable even at low AA concentrations, 
which led to a high reactivity of gold ions in contrast with observations made, for 
example, when using hydroquinone as reductant (for which the opposite effect was 
a) b) 
c) d) 
e) f) 
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found during the obtention of urchin-like Au NPs [72]), the lower avavilability of 
metal ions seems to favour the deposition of Au on more energetically favorable 
directions, resulting in the anisotropic growth of the agglomerated nanocrystals 
around the chitosan chains. If the excess concentration of Au0 was high enough in the 
reaction system, the deposition rate of Au0 on higher energy facets would be faster 
than on lower ones resulting in branched nanoshells.  
 
Figure 4.11: BGNS obtained after using 10 μL of 0.25 M AA with a more branched 
structure. Scale bar is 200 nm. 
 
4.4.3 Influence of Au growth solution 
 Another factor that changes the plasmonic properties and structure of the 
BGNS was the variation of HAuCl4 growth solution concentration relative to the 
amount of NP-seed precursor.  
 
 
Figure 4.12: Effect of Au+3 growth solution volume on UV-vis absorption spectra of BGNS. 
Volumes of AA and NP-seed were kept constant at 50 µL and 1 mL, respectively.  
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 Figure 4.13: TEM images showing the effect of Au growth solution concentration. Added 
volumes of Au growth solution were: a) 0.01 mL; b) 0.1 mL; c) 1.25 mL; d) 2.5 mL. AA and 
NP-seed volumes were kept constant at 50 µL and 1 mL, respectively. e) Size distribution of 
BGNS observed in b). f) Size distribution of BGNS observed in d). Scale bars are 200 nm. 
 
4.4.4 Reaction kinetics 
The formation of branched-shell NPs was facilitated by a large gold reactivity 
under certain conditions which was deduced as a kinetics-favored process, as 
previously mentioned, since branching occurs regardless of the growth solution/NP-
seed ratio. We failed to catch in most of the conditions the whole extension of the 
time-dependent kinetics of branched-shell growth provided that they are almost 
instantaneously formed after the addition of AA. However, when possible, the spectra 
a) b) 
c) d) 
e) f) 
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measured in situ during the shell growth denote, on one hand, gradual red-shifts of the 
plasmon bands into the NIR region and, on the other, increases in light absorbance 
with reaction time until reaching a plateau value due to the progressive increase in 
shell thickness and in the number and length of spikes (Figure 4.14). In particular, as 
the added AA concentration increases up to 20 μL, the plasmon band additionally red-
shifts during the metal shell growth, and the reaction kinetics became faster. Above 
20 μL, the reduction reaction takes place instantaneously but a red-shift of the 
plasmon band with time can be also noted; however, the absolute final position of the 
maximum blue-shifts regarding lower added AA concentrations due to the observed 
changes in structure of the resulting nanoshells, as mentioned previously in subsection 
4.4.1. 
For example, we could observe that upon injection of 5 μL of a 0.50 M AA 
solution the absorbance reached its maximum within ca. 120 s (Figure 4.14, row 1) 
and the plasmon peak is red-shifted ca. 100 nm from the first time point measured (at 
5 s). However, TEM images obtained at a very short stage of the metal growth 
process under the former reaction conditions exceptionally allowed to observe that the 
formation of branches onto the electrostatically attached seeds might already occurred 
at the earliest stages of the gold nanolayer formation, that is, when this is not fully 
developed (Figure 4.15a-b) in contrast to previous observations by Wei et al. [73] and 
Park et al.  [49], where a very fast isotropic growth of gold islands takes place first 
followed by anisotropic growth of sharp branches at low gold concentrations onto 
these islands. As the reaction carried on, the polymeric NPs were fully covered with a 
branched gold shell which became thicker and more branched with time after 
completion of the reduction reaction due to the progressive depletion of the gold ions 
which deposite on more energetically preferred directions (Figure 4.15c-d) [72]. This 
fact would be additionally facilitated through the role played by chitosan as 
agglomerating agent of crystal seeds in their vicinity to give intermediate particles 
crystal plane defects which would act as additional nucleation growth centers for 
branch formation [58, 74]. 
 
Chapter IV: Simple Control o
 
Figure 4.14: a) Time evol
volumes of AA. Au growth
respectively. b) Time evolu
evolution of absorbance inten
 
It is worth mention
of ca. 30 nm is observed
which kept constant durin
the nanoshell morphology
(Figure 4.15e-f). These r
mechanism of the anisotro
formation of the branched
f Surface Topography of Gold Nanoshells by a Surfa
199 
ution of UV-vis absorption spectra upon addi
 solution and NP-seed were kept constant at 
tion of the plasmon peak wavelength position
sity at λmax.  
ing that a slight blue shift of the plasmon a
 when maintaining the growth duration fro
g prolonged growth (Figure 4.16). Within t
 was slightly tuned from spiky to smoother g
esults would be consistent with a kinetic-f
pic gold nanoshells [75, 76]. Namely, the k
 shells should be thermodynamically unstabl
ctant-less Seeded-
Growth Method 
 
tion of different 
1 mL each one, 
 (λmax). c) Time 
bsorption band 
m 3 to 8 min, 
his time period 
old nanoshells 
avored growth 
inetics-favored 
e and tended to 
Chapter IV: Simple Control of Surface Topography of Gold Nanoshells by a Surfactant-less Seeded-
Growth Method 
 
200 
 
transform to isotropic shells [77]. Consequently, it seems that after ca. 8 min, a 
thermodynamic equilibrium of the NP surfaces structure was built up through the 
reorganization of their sizes of surface atoms which, in turn, suppressed the additional 
transformation of the NP morphology and, thereby, the blue shift of absorption 
spectra.  
  
 
 
Figure 4.15: TEM images of BGNS growth. Reactants volumes were 2.5 mL of Au growth 
solution, 0.5 mL of NP-seed and 30 μL of AA, respectively. Aliquots (10 µL) of the reaction 
mixture were taken at: a) 0, b) 5 s, c) 60 s, d) 120 s, e) 180 s and f) 8 min. Scale bars are 50 
nm in a), b) and e), and 100 nm in c), d) and f).  
a) b) 
c) d) 
e) f) 
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Figure 4.16: UV-vis absorption spectra of BGNs after 3 and 8 minutes of reaction. A slight 
blue shift of the plasmon peak is observed indicating that the structure undergoes a reshaping 
into a more thermodynamically stable geometry with a lower anisotropy degree. Reactants 
volumes were 2.5 mL of Au growth solution, 0.5 mL of NP-seed and 30 μL of AA, 
respectively. 
 
The existence of highly active facets was confirmed by powder XRD and 
HRTEM observation of spiky nanoshells (Figure 4.17). XRD indicated that the lattice 
parameters of the spiky nanoshells fitted well to the face-centered-cubic structure of 
bulk gold crystal, showing reflections in the 2θ range of 25-70º indexable to the 
(111), (200) and (220) reflections of fcc Au (JCPDS, file nº 4-0784) [74] (Figure 
4.17a). SAED patters also confirmed that these branched nanoshells were crystalline 
and randomly oriented, confirming the diffraction peaks obtained by XRD (Figure 
4.17b). The appearance of these peaks meant that the spiky nanoshells were 
polycrystalline (in particular, formed by a polycrystalline core with a number of 
single crystal spikes branching out from the surface). Besides, the nanoshells 
possessed the strongest (111) diffraction peak indicating that the branched growth of 
these hybrid particles might be thought the deposition of Au0 mainly on (111) lattice 
planes. This consideration was further proved by HRTEM (Figure 4.17c). Under 
HRTEM, interplanar distances in elongated single branches were found to be 0.236 
nm corresponding to (111) lattice planes, whereas in some branches formed by 
several agglomerated crystals an interplanar spacing of 0.203 nm was also found, 
corresponding to (200) lattice planes. This result is reasonable since despite the XRD 
and SAED patterns show predominace of (111) lattice planes, peaks belonging to 
(200) and (220) crystal planes with sufficient intensity are also present. For the 
analyzed branches, the growth direction was vertical to the (111) plane, indicating 
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Interestingly, the time interval in between the two injection steps also influenced the 
plasmon absorption band and size of the nanoshells attributed to the different face 
activity of gold seeds and particles during the different growth time intervals (Figure 
4.17d), as observed in previous works [72].  
 
 
  
Figure 4.18: UV-vis spectra of BGNS: a) after one-off addition of 50 μL of AA (spectra were 
measured after 5 s, 5, 10, 15, 20 and 25 min); b) after stepwise addition of 10 µL each 5 min; 
c) after stepwise addition of 10 µL each 1 min. d) Comparison of the spectra obtained after a 
single 50 μL addition and 5 addition of 10 μL aliquots of AA added each 5 min. e) TEM 
images of BGNs obtained after multiple additions of 10 μL aliquots of AA and f) after a 
single addition of 50 μL. Scale bar is 200 nm in e) and f).  
 
a) b) 
c) d) 
e) f) 
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 Similarly, it was also found that the use of seeds stored within 1 day after 
preparation resulted in more branched nanoshells than that over 1 day provided that 
the former possessed active facets with higher surface energy, facilitating the 
deposition of Au0 along these facets and therefore, the branched growth of the shells. 
 
4.4.5 Cell cytotoxicity assay 
Here, we preliminary tested the potential biocompatibility of the as-obtained 
BGNS by using the resazurin cell viability assay in order to establish if the 
synthesized BGNS could be used in biomedical applications. Resazurin is a blue dye, 
itself weakly fluorescent until it is irreversibly reduced to the pink colored and highly 
red fluorescent resorufin. Resazurin is effectively reduced in mitochondria in the 
presence of diaphorase as the enzyme, and NADPH or NADH the reductant that 
converts resazurin to resorufin. Then, this conversion makes useful this test to analyze 
cell viability by assaying  the cell mitochondrial metabolic activity. 
 Cell viability of pegylated BGNS was assayed in a HeLa cervical cell line in a 
wide range of particle concentrations (ca. 2·108-2·1011 NP/mL). As observed in Figure 
4.19a the cell viability was above 90% in the whole concentration range except at the 
largest concentration, for which it decreases to ca. 83%. These data denote a priori an 
excellent biocompatibility of this kind of particles although additional experiments 
would be required to fully confirm this point.  
On the other hand, to reject possible false positives and to confirm the 
effective incorporation of the NPs inside the cells, optical and transmission electron 
microscopies were performed. In this way, BGNS seem to be internalized by the cells, 
and are present to large extents in the cell cytoplasm but not in nuclei, as observed 
from differential interference contrast (DIC) optical microscopy images (Figure 
4.19b). TEM images also confirmed the internalization of the present type of particles 
inside the cell cytoplasm (in particular, inside intracellular vacuoles, see Figure 4.19c-
d), probably occurring via a non-specific endocytosis pathway.  
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reactivity of gold ions by reduction of AuI to Au0 on the seed surfaces onto preferred 
facet via a kinetics-favored process. This process is additionally assisted by the 
presence of the chitosan chains which enable the formation of nanocrystal 
agglomerates, which can serve as secondary nuleation centers, and can directed the 
crystal growth through preferred orientations. A excessive amount of AA promotes an 
instant reduction of the particles, decreasing their anisotropy by the isotropic 
deposition of the gold ions and the adsorption of excess AA on the surface of 
nanoshells. Meaningfully, the as-prepared BGNS were stable in aqueous solution for 
several months, and were found to be internalised by cells in the cytoplasm and fully 
biocompatible, as deduced from a cell viability test. The hollow and branched 
architecture of BGNS is also advantageous because it adds another control 
characteristic (i.e. core size) to tune the plasmon band position to the near infrared 
region of the electromagnetic spectrum, and allowing their potential use as 
photothermal agents and/or surface enhanced Raman scattering (SERS) probes. In 
addition, other functional materials and molecules can be incorporated into the core to 
fabricate multifunctional materials. In this way, these branched hollow NPs hold 
potential applicability as multifunctional nanoteranostic agents due to their optical 
properties and core-carrying capacity. 
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CHAPTER V - Polymeric-Gold Nanohybrids for 
Combined Imaging and Cancer Therapy 
 
5.1 Summary 
In this chapter, we report the use of folic acid (FA)-functionalized, doxorubicin 
(DOXO, a potent anticancer drug)/SPION-loaded poly(lactic-co-glycolic acid)-Au porous shell 
nanoparticles for simultaneous targeted delivery of localized hyperthermia in combination 
with magnetic resonance imaging in human cervical cancer (HeLa) cells. These polymeric-
gold nanohybrids (PGNHs) were produced by a seeded-growth method using chitosan as an 
electrostatic “glue” to attach Au seeds to DOXO/SPION-PLGA NPs. In order to determine their 
potential as theranostic nanoplatforms, we have analyzed their physicochemical properties, 
cellular uptake and photothermal and chemotherapeutic efficiencies in vitro. In addition, the 
present nanoplatforms showed a NIR-light triggered release of cargo molecules under 
illumination. The capacity to induce localised cell death in a well-focused region was also 
demonstrated. The functionalization of our PGNHs with the targeting ligand folic acid 
improved their internalization efficiency and specificity. Furthermore, we have proved in vitro 
the possibility to guide our PGNHs to cancer cells by an external magnetic field, which 
additionally increased the cellular uptake and therapeutic efficiency.  
 
5.2 Introduction 
 The outstanding physicochemical properties of nanomaterials and their clever 
combinations are allowing the development of multifunctional nanoplatform-based 
integration strategies for multimodal imaging [1-4], simultaneous real-time diagnosis 
and therapy (theranostics) [4-11] and multimodal therapy [12-16], which holds 
promise to be in the near future an alternative to current, conventional diagnosis and 
therapeutics for cancer, and are potentially offering new approaches for earlier 
detection and/or minimally invasive treatments [17, 18]. One advantage of these new 
approaches is multidiagnostic and/or multitherapeutic functions can be easily 
incorporated into the same nanoscale complex, with the potential to simultaneously 
combine these features in clinical applications.  
  This kind of biomedical nanosystems opens new windows to potentially 
overcome some of the different substantial impediments still unresolved in cancer 
therapeutics, such as for example the substantial toxicity to normal tissues of drug 
doses required to completely eliminate tumors, the poor effectiveness of drug 
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treatments against multi-drug resistant cancer cells, the impossibility of early 
detection of very small tumors or blood circulating malignant cells, or the temporal 
separation of diagnostics and therapeutic clinical phases [3-6].  
Hence, the simultaneous combination of several different therapies in a single 
nanoplatform to enhance malignant cell cytotoxicity with targeted drug delivery and 
diagnostic imaging capabilities appears as a very attractive choice to solve, at least 
partially, these issues. In this regard, one treatment combined with chemotherapy 
which has shown promising results is thermo-chemotherapy [19-21]. Thermo-
chemotherapy is the simultaneous application of a chemotherapeutic agent and 
hyperthermia (the therapeutic procedure used to raise the temperature above 42-43 ºC 
°C of a body area affected by maligniciency [22]). Despite the demonstrated enhanced 
cytotoxicity of some chemotherapeutic agents due to macroscopic temperature 
increases at low drug doses [21, 23-29], temperature increments can affect cell 
structure and/or function, such as membranes, cytoskeleton or the synthesis of 
macromolecules and DNA repair;  therefore, refined temperature control (both and 
temporally) is required [22] in order to avoid undesirable side effects often caused due 
to non-targeted heating by conventional means (hot water baths, microwave or 
ultrasound [30-33]).  
Recently, near-infrared (NIR) resonant nanomaterials such as gold (Au) 
nanoshells [7, 8, 34-37], Au nanocages [38], Au nanorods [39-43], and single-walled 
carbon nanotubes [44-47] have shown a great ability to absorb NIR light and convert 
it into cytotoxic local heat able to be used for tumor-selective treatments. Hence, if 
heat and drugs could be simultaneously delivered by nanoplatform at the tumor area, 
the therapeutic efficacy would be expected to be significantly improved with minimal 
side effects [42]. To additionally minimize administrated doses and maximize 
therapeutic efficacy, molecules such as antibodies, peptides or small ligands can be 
also attached to the surface of the former nanomaterials to provide improved targeted 
delivery through the recognition of overexpressed specific receptors on the surface of 
malignant cells [48, 49], although different in vivo studies have pointed to such 
surface modifcations only moderately enhance tumor/cell specificity, and passive 
tumour targeting dominates [50].  
Finally, to provide the nanomaterial with diagnostic capabilities, the use of 
loaded/attached superparamagnetic iron oxide nanoparticles (SPIONs) in/to 
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nanoplatforms would allow their use as imaging T2 contrast agents in magnetic 
resonance imaging (MRI) to obtain highly resolved 3D images of living organisms 
[51]. Through SPIONs manipulation by an external magnetic field, magnetically 
targeted drug delivery nanosytems for regulating drug release would be also expected 
[52]. 
Here, we report the use of folic acid (FA)-functionalized, doxorubicin 
(DOXO, a potent anticancer drug)/SPION-loaded poly(lactic-co-glycolic acid)-Au 
porous shell nanoparticles for simultaneous targeted specific delivery of localized 
cytotoxic heat and chemotherapy combined with MRI diagnosis in human cervical 
cancer (HeLa) cells. Previously, Halas et al. [35, 53] developed Au nanoshells with a 
silica core, in which SPIONs and the fluorescent dye indocyanine green (ICG) were 
encapsulated in a silica layer surrounding the metal shell for MRI and fluorescence 
imaging. The therapeutic response of the nanoconstruct was achieved through the 
NIR photothermal properties of the Au shell, and targeted delivery of the platform 
was pursued through the surface attachment of a human epidermal growth factor 
receptor 2 (HER2) antibody to target HER2 overexpressing cancer cells. A related 
system was developed by Hyeon et al. [54] but, in this case, SPIONs were directly 
embedded in the Au shell. This group also co-loaded SPIONs (or quantum dots, QDs) 
with DOXO inside PLGA NPs functionalized with FA ligands for simultaneous MRI 
(or fluorescence imaging) and targeted controlled delivery [55]. Dai et al. obtained 
Au nanoshell micelles composed of a cholesteryl succinyl silane core loaded with 
DOXO and SPIONs to achieve the simultaneous combination of MRI, magnetic 
targeted drug delivery, light triggered drug release, and photothermal therapy [56]. 
Yoo et al. [57-60] and Haam et al. [61] developed bare or antibody-functionalized 
DOXO-loaded PLGA-Au half and full nanoshells, respectively, to analyze the 
targeted and non-targeted simultaneous cytotoxic combination provided by NIR-
induced hyperthermia and released drug on skin (A431), breast (SK-BR-3 and MCF7) 
and cervical (HeLa) cancer cells, and for rheumatoid arthritis treatment.  
In this work, we present a polymeric-gold nanohybrid (PGNH) in which 
DOXO molecules and SPIONs are co-loaded to different extents inside the core of 
biocompatible and biodegradable PLGA NPs, and a complete porous gold layer is 
grown onto the surface of the polymeric NPs to provide NIR-light responsiveness to 
the PGNHs. FA attached to the surface of the Au layer allows PGNHs to be 
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specifically delivered in vitro to folic acid receptors overexpressed on the membrane 
surface of a HeLa cancer cell line to allow their internalization by receptor-mediated 
endocytosis, increasing cell accumulation [62, 63]. This is further enhanced when an 
external magnetic field is applied to the cultured cells by means of a magnetic-guiding 
effect [52]. Also, the presence of SPIONs allows increasing levels of magnetic 
contrast of cancerous cells by MRI. Since these nanoplatforms are NIR-resonant, the 
simultaneous effect of targeted NIR-induced hyperthermia and chemotherapy results 
in larger cell toxicities at lower drug concentrations. In comparison with the pairwise 
combinations, a synergistic effect is observed. Thus, the importance of our report lies 
in the simultaneous successful combination of chemotherapy with hyperthermia, 
magnetic and ligand assisted-targeted delivery and high-resolution imaging fulfilled 
in a single hybrid nanoconstruct. 
 
5.3 Materials and methods 
 
5.3.1Materials 
Poly(D,L-lactide-co-glycolide) (PLGA) of 38-54 kDa with 50:50 lactide–
glycolide ratio, Pluronic F127, FeCl2, FeCl3, HAuCl3·3H2O, folic acid, N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), low molecular 
weight chitosan (LMW-chitosan, MW = 111 kDa), ascorbic acid, trisodium citrate 
dihydrate, sodium borohydride (NaBH4, 99%), FeCl2, FeCl3, crystal violet solution, 
and Nile Red (NR) were purchased from Sigma–Aldrich (St. Louis, MO, USA). N-
hydroxysulfosuccinimide (sulfo-NHS) was purchased from ProteoChem (Cheyenne, 
USA). Calcein AM, propidium iodide, BODIPY® Phalloidin and ProLong® Gold 
antifade reagent with DAPI were purchased from Invitrogen (Carlsbad, USA). Oleic 
acid with 90% purity was purchased from Alfa Aesar (Karlshrue, Germany). 
DOXO·HCl and Dulbecco’s Modified Eagle Medium, fetal bovine serum (FBS), L-
glutamine, penicillin/streptomycin, sodium pyruvate, and MEM non-essential amino 
acids (NEAA) were purchased from Fisher Scientific (Pittsburgh, USA). SH-PEG5000-
NH2 and SH-PEG5000-OCH3 were purchased from Laysan Bio, Inc. (Arab, USA). 
Dialysis membrane tubing (molecular weight cutoffs ∼100-500 and ∼3500 Da) was 
purchased from Spectrum Laboratories, Inc. (Rancho Dominguez, CA, USA). All 
Chapter V: Polymeric-Gold Nanohybrids for Combined Imaging and Cancer Therapy 
219 
 
other chemicals and solvents were of reagent grade (purchased from Sigma–Aldrich). 
All glassware was washed with aqua regia and HF 5% (v/v) and extensively rinsed 
with water. Milli-Q water was used for preparation of aqueous solutions. 
 
5.3.2 Synthesis of SPIONs 
Oleic acid-stabilized Fe3O4 SPIONs were synthesized by a coprecipitation 
method [64, 65]. Briefly, aqueous solutions of 0.1 M of FeCl3 (30 mL) and FeCl2 (15 
mL) prepared with N2 purged-water were mixed; then, 3 mL of 5 M ammonia 
solution were added in small aliquots of 0.6 mL while stirring. A black precipitate 
was formed indicating the formation of SPIONs. After 20 min of stirring under N2 
atmosphere, 56.4 mg of oleic acid were added to the SPIONs and the temperature was 
raised to 80 °C and kept for 30 min while stirring to evaporate the ammonia. The 
magnetic NPs were washed twice by centrifugation at 9000 rpm for 20 min to 
eliminate excess of oleic acid, the supernatant was discarded and the precipitate was 
lyophilized and stored at 4 °C. 
 
5.3.3 Preparation of DOXO/SPION-PLGA NPs  
PLGA NPs containing SPIONs/DOXO or SPIONs/NR were prepared using a 
conventional emulsion-evaporation method with modifications. In a typical 
preparation, PLGA (25 mg) was dissolved in a sealed vial containing 2 mL of 
methylene chloride (MC), 2.5 mg of DOXO (previously converted to its hydrophobic 
base form by addition of triethylamine, as reported in literature [66] (or 2.5 mg of 
Nile Red, NR, when corresponding), and 2 mg of SPIONs dispersed in MC by 
sonication with a probe type sonicator (20 kHz, Bandelin Sonopuls, Bandelin GmbH, 
Berlin, Germany) at 20 W for 10 min in an ice bath.  DOXO (NR) concentration was 
measured by UV-vis spectroscopy with a calibration curve (Figure 5.1a-b) Then, this 
organic solution was added in a single step to a Pluronic F127 aqueous solution (50 
mL, 1% (w/v)) and was immediately sonicated at 100 W for 15 min in an ice bath. 
The organic solvent was completely evaporated under mechanical stirring overnight, 
the dispersion was subsequently centrifuged twice at 9000 rpm for 30 min and 20 ºC, 
the supernatant removed, and the final precipitate was resdispersed in 5 mL of water.   
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5.3.5 Preparation of DXSP-PGNHs 
Au citrated-capped nanoseeds were complexed to DOXO/SPION-PLGA NPs 
by means of electrostatic interactions between the positively charged chitosan on the 
surface of the NPs and negatively charged citrate-Au seeds. First, 5 mL of PLGA NPs 
suspension were mixed with 0.25 mL of 1 wt. % low molecular weight-chitosan 
previously dissolved in 1% (v/v) acetic acid. After stirring for 4 h, NPs were 
centrifuged twice at 9000 rpm for 30 min to eliminate free and loosely adsorbed 
chitosan. Then, the positively charged NPs were mixed with 1 mL of Au nanoseed 
solution and stirred 4 h at ambient temperature. The sample was centrifuged at 7000 
rpm for 15 min and 20 °C. The supernatant was discharged and the precipitate was 
redispersed in 5 mL of water. To grow the gold nanoshells, 1 mL of the Au nanoseed 
decorated DOXO/SPION-PLGA NPs was mixed with 20 mL of an Au growth 
solution (0.05 wt.% K2CO3 and 0.02 wt.% HAuCl3·3H2O stored for 24 h prior use) 
and stirred 1 min; subsequently, 50 µL of ascorbic acid (0.5 M) were added. 
Immediately after the sample changed from clear to blue color, indicating the porous 
shell formation to give DOXO/SPION-PLGA NPs with a porous shell layer (DXSP-
PGNHs). DXSP-PGNHs were left standing overnight for Ostwald rippening. Then, 
they were washed three times by centrifugation at 3500 rpm for 15 min and 20 °C, 
and finally redispersed by vortexing in water. High yields of DXSP-PGNHs were 
obtained with negligible generation of by-products such as small Au NPs. Despite 
sedimentation due to the high density of gold layer and SPIONs cargo, DXSP-PGNHs 
presented no large agglomeration in water, buffers or cell growth medium containing 
FBS, as observed by visual inspection and optical microscopy.  
 
5.3.6 Characterization of DOXO/SPION-PLGA and DXSP-PGNHs 
NPs 
NP sizes were obtained  by dynamic light scattering (DLS) at 25 °C by means 
of an ALV-5000F (ALV-GmbH, Germany) instrument with vertically polarized 
incident light (λ = 488 nm) supplied by a diode-pumped Nd:YAG solid-state laser 
(Coherent Inc., CA, USA) operated at 2 W, and combined with an ALV SP-86 digital 
correlator (sampling time 25 ns to 100 ms). NP sizes and morphologies were also 
acquired by transmission and scanning electron microscopy (TEM and SEM, 
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respectively) by means of a Phillips CM-12 and a Carl Zeiss Libra 200 Fm Omega, 
and a FESEM ultra Plus electronic microscopes operating at 120 and 20 kV, 
respectively. Samples were prepared for analysis by evaporating a drop of the hybrid 
NP dispersion on a carbon-coated copper grid without staining (TEM) or on a silicon 
wafer (SEM). ζ-potentials were measured with a Zetasizer Nano ZS (Malvern, UK) 
using dispossable folded capillary cells. Samples were measured in triplicate in PBS 
(pH 7) at 25 °C. Optical characterization of the nanoconjugates was carried out by 
UV-vis-NIR and fluorescence spectroscopies with a Cary Bio 100 spectrophotometer 
and a Cary Eclipse spectrfluorometer, respectively (Agilent Technologies, USA). The 
concentration of PGNHs was determined by viscometry and UV-vis spectroscopy as 
reported previously in Chapters 3 and 4.  
For DOXO loading capacity (LC) and encapsulation efficiency (EE) 
quantification, 1 mL of the DOXO/SPION-PLGA NP dispersion was lyophilized for 
24 h, weighted and dissolved in 2 mL of dimethyl sulfoxide. The amount of DOXO 
was measured by UV-vis and/or fluorescence spectroscopy with a previously 
prepared calibration curve (Figure 5.1c-d). The LC and EE of the SPIONs were 
assessed by ICP-MS in a Varian 820-MS equipment (Agilent Technologies, USA). 
Drug loaded, D.L., and entrapment efficiency, E.E., in the DXSP- NPs were 
calculated as follows: 
 
ܦ. ܮ. % ൌ ௪௘௜௚௛௧ ௢௙ ஽ை௑ை,ௌ௉ூைே௦ ௢௥ ூ஼ீ ௜௡ ே௉௦௪௘௜௚௛௧ ௢௙ ே௉௦ ൈ 100  (Eq 5.1) 
ܧ. ܧ. % ൌ ௪௘௜௚௛௧ ௢௙ ஽ை௑ை,ௌ௉ூைே௦ ௢௥ ூ஼ீ ௜௡ ே௉௦௪௘௜௚௛௧ ௢௙ ஽ை௑ை,ௌ௉ூைே௦ ௢௥ ூ஼ீ ௜௡௜௧௜௔௟௟௬ ௟௢௔ௗ௘ௗ ൈ 100  (Eq 5.2) 
 
5.3.7 Conjugation of FA to DXSP-PGNHS NPs 
5 mL of 11.33 mM FA solution in 130 mM NaHCO3 buffer (pH 7.0) where 
mixed with 5 mL of 34 mM of N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC) and 5 mL of 34 mM of N-hydroxisulfosuccinimide (sulfo-
NHS), both dissolved in NaHCO3 buffer. This mixture was reacted for 20 min at 
ambient temperature and protected from light [68]. Excess reagents were eliminated 
by extensive dialysis (membrane MWCO 0.1-0.5 kDa). The activated FA was mixed 
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with a 2.25 mM solution of SH-PEG5000-NH2 dissolved in the same buffer 
([FA]:[PEG] = 5). This was reacted 4 h at ambient temperature in the dark. After 
reaction, the SH-PEG5000-FA conjugate was dialyzed 24 h with a 3500 MWCO 
cellulose membrane against water to eliminate unreacted FA-NHS and by-products.  
DXSP-PGNHs and BNK-PGNHs were pegylated with SH-PEG5000-FA in a 
straightforward process. Briefly, 2 mL of PGNHs were mixed with 1 mL of 20 mM 
K2CO3 and 1 mL of SH-PEG5000-FA (or SH-PEG5000-OCH3) and stirred 4 h in an ice 
bath. PGNHs were centrifuged at 3500 rpm for 10 min at 20ºC and washed three 
times to eliminate excess of SH-PEG5000-FA.  In order to determine the number of FA 
molecules attached to PGNHs, a control sample with water instead of PGNHs was 
subjected to the same procedure. A calibration curve of SH-PEG500-FA was prepared 
(Figure 5.2a-b). Samples with 0, 5, 10, 15 and 25 µL of SH-PEG5000-FA stock 
solution (0.56 mM) were prepared and left to a final volume of 500 µL with K2CO3 
and water in the same proportions (1:3). A control sample (2 mL of deionized water, 1 
mL of K2CO3 (20 mM) and 1 mL of SH-PEG5000-FA) was made exactly the same as 
the PGNH-PEG5000-FA one. Supernatants after pegylation of PGNHs and of control 
sample (supernatant was used to avoid error from possible aggregate formation and 
sedimentation) were extracted very carefully with a micropipette and used to calculate 
the concentration of SH-PEG5000-FA attached to PGNHs using a calibration curve 
(Figure 5.2c). The concentration of non-attached SH-PEG5000-FA was subtracted to 
the concentration of the processed control sample and this value was assumed to be 
the concentration of SH-PEG5000-FA attached to PGNHs.   
 
5.3.8 Laser induced temperature increase with NIR-continuous wave 
illumination (NIR-CW) 
Temperature increment tests were performed with a continuous wave fiber-
coupled diode laser source of 808 nm wavelength (50W, Oclaro Inc, San Jose, CA, 
USA). The laser was powered by a Newport 5700-80 regulated laser diode driver 
(Newport Corporation, Irvine, CA, USA). A 200-μm-core optical fiber was used to 
transfer laser power from the laser unit to the target solution, and equipped with a lens 
telescope mounting accessory at the output, which allowed for tuning of the laser spot 
size in the range 1-10 mm. The output power was independently calibrated using an 
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microscope was coupled with an 830 nm IR laser diode via fiber optics and a beam-
coupling device (Rapp-Opto DL-830 CW laser, 130 mW maximum output) and fixed 
spot illumination coupling. The maximum light power reaching the sample image 
plane on top of the used 63X/1.4 oil immersion Plan-Apochromat objective was 
measured to be ~30 mW (continuous output). The light energy was dispersed on a 
circular spot of ca. 6 μm2. A tunable power supply output power of the laser could be 
varied smoothly from 0 to 30 mW effective light power on the sample plane. HeLa 
cells (1·105 per dish) were seeded and cultured for 24 h in 35 mm Ibidi® µ-grid 500 
dishes at standard culture conditions. Then, cells were washed with PBS and the 
medium was replaced with fresh medium containing NR-PGNHs (1·109 NPs/mL) and 
incubated for 6 h. Subsequently, NP-containing cells were washed three times with 
PBS, and the medium containing NR-PGNHs was replaced with fresh medium and 
incubated for additional 18 h. The dishes were placed on the microscope stage within 
a controlled temperature and 5 % CO2 atmosphere chamber. After localization and 
focusing, cells containing NR-PGNHs were illuminated for 1 s with a power of 0.3 
mW/µm2 or 0.6 mW/µm2 (= 3.6 mW / 6 µm2) (NIR-SPI) which correspond to laser 
fluences of 3·104 and 6·104 J/cm2 and total deposited energies of 1.8 and 3.6 mJ, 
respectively. These laser intensities cause negligible damage to cells as it was 
demonstrated previously [69]. Confocal microscopy images of NR-PGNHs-
containing cells were acquired with a LSM 510 META confocal microscope from 
Zeiss (Germany) before and after illumination with the laser-microscope in order to 
observe the laser-triggered release of cargo from NR-PGNHs. NR was excited with a 
488 nm argon laser and light emission was acquired with a LP 590 nm filter. 
 
5.3.10 Effect of NIR light on DXSP-PGNHs shape (with NIR-SPI) 
In order to investigate the effect of laser illumination on the morphology of the 
NPs, 1 mL of SiO2 beads (5 µm) with positive surface charge was mixed with 1 mL 
of negatively charged DXSP-PGNHs for 15 min and centrifuged at 1500 rpm for 10 
minutes to discard non-attached NPs. A drop of the SiO2/DXSP-PGNHs assembly 
was cast on a carbon-coated copper grid and left drying. TEM images of the 
assemblies placed in the center of the copper grid (easily detectable due to the large 
size of the SiO2/DXSP-PGNHs) were acquired and, then, the grid was placed on a 
microscope glass slide and illuminated with the laser-microscope tandem at the same 
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powers previously used in release experiments. TEM images of the same SiO2/DXSP-
PGNHs assemblies previously analyzed were acquired after laser illumination. In this 
way, we were able to observe the effect of laser illumination on DXSP-PGNHs 
morphology.  
 
5.3.11 NIR-laser triggered release of DOXO (with NIR-CI) 
Release kinetics of DOXO from DOXO/SPION-PLGA NPs and from DXSP-
PGNHs was assessed in vitro at 37 °C in PBS buffer (pH 7.2). Briefly, 5 mL of 
DOXO/SPION-PLGA NPs or DXSP-PGNHs with known DOXO concentrations 
were placed in centrifuge tubes. Samples were maintained in a 37 °C bath with 
constant stirring. The samples were irradiated repeatedly over a period of 5 min, 
followed by 1 h intervals with the laser turned off. Each hour, 500 µL of sample were 
taken and centrifuged at 3500 rpm (DXSP-PGNHs) or at 5000 rpm (DOXO/SPION-
PLGA NPs) for 10 min at 20 °C. The supernatant was carefully extracted and its 
fluorescence at 594 nm was measured in a Cary Eclipse spectrophotometer (Agilent 
Technologies, Spain) for quantification of released DOXO with a calibration curve 
(Figure 5.1e-f). After centrifugation and supernatant extraction, the settled 
DOXO/SPION-PLGA NPs and DXSP-PGNHs were resuspended with fresh buffer 
and returned to the original sample. 
 
5.3.12 Cellular uptake by confocal microscopy 
DXSP-PGNHs uptake was followed by confocal microscopy by seeding HeLa 
cells on poly-L-lysine coated glass coverslips (12×12 mm2) placed inside 6-well 
plates (3 mL, 5·104 cells/well) and grown for 24 h at standard culture conditions (5% 
CO2 at 37 ºC in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 
10% (v/v) FBS, 2 mM L-glutamine, 1% penicillin/streptomycin, 1 mM sodium 
pyruvate, and 0.1 mM MEM Non-Essential Amino Acids (NEAA)). Then, 200 μL 
(1·109 NPs/mL) were added to cells. After 6 h of incubation the NP-containing cells 
were washed three times with PBS pH 7.4 and, then, fixed with paraformaldehyde 4% 
(w/v) for 10 min, washed with PBS, permeabilized with 0.2% (w/v) Triton X-100, 
and stained with BODIPY® Phalloidin (Invitrogen). The cells were washed again 
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with PBS, mounted on glass slides stained with ProLong® Gold antifade DAPI 
(Invitrogen) and cured for 24 h at -20 °C. Samples were visualized with 20X and 63X 
objectives using a confocal spectral microscope Leica TCS-SP2 (Leica Microsystems 
GmbH, Heidelberg Mannheim, Germany), whereby the blue channel corresponds to 
DAPI (λex 355 nm), the red channel to BODIPY® Phalloidin (λex 633 nm), and the 
green channel to DOXO/SPION-PLGA-Au PS NPs as captured in reflection mode. 
 
5.3.13 Cellular uptake by TEM 
Uptake of DXSP-PGNHs by HeLa cells was also investigated by TEM. HeLa 
cells were seeded in 6-well plates (3 mL, 5·104 cells/well) and grown for 24 h at 
standard culture conditions. Then, 200 μL (1·109 NPs/mL) were added to cells. After 
6 h of incubation the NP-containing cells were washed three times with PBS, 
trypsinized and centrifuged at 1500 rpm for 4 min. Cell pellets were fixed with 500 
µL of 2.5 wt.% glutaraldehyde. The pellet were then included in an agar pellet, post-
fixed with osmium tetraoxide in 0.1 M cacodylate buffer (1% (w/v)), and finally 
pelletized with Eponate (Ted Pella Inc, Redding, CA, USA). Ultra-thin cuts were 
obtained with an ultramicrotome (UltraCut S, Leica Microsystems GmbH) and were 
analyzed with TEM (JEOL JEM 1011, Japan). 
 
5.3.14 Cellular uptake by magnetic resonance imaging and magnetic 
susceptibility 
Transverse relaxation times were measured at 9.4 T (400 MHz) with 440 mT 
m-1 gradients and 25 ºC with a Bruker Biospin USR94/20 instrument (Ettlingen, 
Germany). MRI phantoms were constructed in 1.6% (w/v) agarose solutions (Sigma–
Aldrich) following a previously published experimental protocol [70].  Firstly, a 1.6% 
(w/v) agarose solution was heated and stirred at 80 ºC until complete dissolution of 
the solid agarose. Then, while the system was fluid, an arrangement of seven 
centrifuge tubes (1.5 mL) were placed within the agarose and allowed to cool to room 
temperature. After solidification, the tubes were removed and an agarose mold with 
seven holes was obtained. For cell imaging, HeLa cells (2·106 cells) were seeded in 75 
cm2 flasks and cultured for 24 h at standard condition. Then, the medium was 
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replaced with fresh one containing a suitable amount of PGNHs (with or without FA) 
(1·109 NPs/mL) and incubated for 6 h. Then, the medium with the NPs was removed 
and the cells were washed with PBS and incubated for 18 h. Cells were tripzinized 
and resuspended in 100 µL of PBS. In each hole of the phantom a mixture of cells 
labeled with NPs and agarose 2% (w/v) was placed. After a resting period, 1.6% (w/v) 
agarose was added to the mold to seal the phantom holes. Imaging of the phantoms 
was performed acquiring a 3D-Gradient echo image (T2-weighting) with the 
following parameters: field of view: 80×80×40 mm, matrix size: 512×512×256 points 
giving a spatial resolution of 156×156×156 μm, echo time TE = 7.89 ms and 
repetition time TR = 100 ms, flip angle 20º and 2 averages. Magnetic susceptibility 
measurements were carried out with a SQUID magnetometer (Quantum Design 
MPMS5, San Diego, CA) at 5 K and 300 K. 
 
5.3.15 Chemo-photothermal cytotoxicity (with NIR-CI) 
The chemo-photothermal cytotoxic effect of non-functionalized, FA-
functionalized and magnetically guided FA-functionalized PGNHs was qualitatively 
assessed on HeLa cells. Cells (3 mL, 5·104 cells/well) were seeded in 6-well plates 
and grown for 24 h at standard culture conditions. Then, 200 μL (1·109 NPs/mL) were 
added to cells. After 6 h of incubation the NP-containing cells were washed three 
times with PBS pH 7.4 and illuminated with a laser (808 nm) at 2.5 W/cm2 for 5 min. 
Cells were incubated for further 18 h. Right before analysis with a confocal 
microscope (Leica Microsystems GmbH) cells were washed three times with PBS to 
eliminate any residue of serum esterase that could cause interference [69]. Then, 3 mL 
of PBS with 1 wt.% of calcein AM (λex = 495 nm, λem = 515 nm) and 1 wt.% of 
propidium iodide (λex = 495 nm, λem = 515 nm) were added and incubated for 10 min.  
 
5.3.16 In vitro cell growth cytotoxicity 
Cytotoxicity induced by DXSP-PGNHs was determined by crystal violet 
staining [71, 72] as the inhibition of cellular growth. To this end, HeLa cells with an 
optical confluence of 80–90% were seeded into 96-well plates (100 µL, 1.5·104 
cells/well) and grown for 24 h at standard culture conditions. Afterwards, the DXSP-
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PGNHs and control samples were injected in the wells (100 μL) and incubated for 24 
h and 48 h. After incubation, the culture medium was discarded and the cells were 
washed with 10 mM PBS, pH 7.4 several times. The cells were shaken at room 
temperature (300 rpm, 15 min) in the presence of 10 µL of a glutaraldehyde solution 
(11% (w/v) in water). The solution was discarded and cells were washed 3-4 times 
with milli-Q water. The cells were then shaken at room temperature (300 rpm, 15 
min) in the presence of 100 μL of a crystal violet solution (0.1% (w/v) in 200 mM 
orthophosphoric acid, 200 mM formic acid, and 200 mM 2-N-morpholino-
ethanesulfonic acid (MES), pH 6). The solution was discarded, and the cells were 
again washed 3-4 times with milli-Q water. Once washed, the cells were left for 
incubation at room temperature overnight for drying. Once dried, the cells were 
shaken at room temperature (300 rpm, 15 min) in the presence of 100 µL of acetic 
acid (10% (v/v) in water). Immediately after, the absorbance of the resulting solution 
was measured with a Microplate Reader (FLUOstar Optima, BMG Labtech GmbH, 
Germany) operating at 595 nm. All experiments were triplicate carried out. The 
growth inhibition was quantified as: 
 
% Inhibition ൌ 100 െ ଵ଴଴כOATA      (Eq 5.3) 
 
where OA and TA stand for the absorbance of studied samples and negative controls 
(cells in the absence of PGNHs), respectively. 
 
5.4 Results and discussion 
 
5.4.1 Preparation and characterization of the multifunctional 
nanoplatforms 
 Core-shell nanomaterials composed of iron oxide coated with a layer of a 
different inorganic material such as gold are very interesting since the resulting 
nanostructures can combine the magnetic and optical properties of the constituent 
elements while reducing the toxicity of the iron oxide, which opens the door to these 
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[64], with an average inorganic core diameter of 9.8 ± 0.9 nm as measured by TEM 
(Figure 5.4a). It is worth mentioning that the size of the resulting PGNHs is largely 
determined by the size of the primary PLGA NPs. In this way, the molecular weight 
of the PLGA polymer as well as other external factors in the NP preparation 
procedure (polymer and stabilizer concentration, temperature, cargos concentration, 
ultrasonic power and duration, etc.) can be tuned to reach the desired final PGNHs 
size [74-77]. 
 
Figure 5.4: a) TEM image of oleic acid-stabilized Fe3O4 NPs; b) Powder X-ray diffractogram 
of as-synthesised oleci acid stabilized Fe3O4 NPs. Green lines indicate the position of the 
characteristic peaks in the diffractogram whereas orange vertical lines denote the 
characteristic peaks of magnetite X-ray diffraction at (from left to right) (111), (220), (311), 
(400), (422), (511), and (440) planes. 
 
A mixed dispersion of SPIONs, DOXO (or NR when corresponding), and 
PLGA in methylene chloride, as detailed in the Experimental Section, was poured 
into an aqueous solution of block copolymer F127, EO97PO69EO97 (where EO and PO 
are an oxyethlyene and an oxypropylene unit, respectively, and the subscripts denote 
a) 
b)
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the block lengths), used as an emulsifier and stabilizer, and the resulting solution 
underwent strong sonication. After solvent evaporation DOXO/SPION-PLGA NPs 
displayed a mean hydrodynamic diameter of ca. 122 ± 11 nm as measured by 
dynamic light scattering (DLS) (Figure 5.5a), which was consistent with TEM and 
field emission electron microscopy (FEI-SEM) data (Figure 5.5e-f).  
 
Figure 5.5: Size distribution of DOXO/SPION-PLGA NPs as obtained by a) DLS and b) 
TEM. c) TEM and d) FEI-SEM images of PLGA NPs. e) and f) TEM images of 
DOXO/SPION-PLGA NPs. In e) we can observe embedded SPIONs in a PLGA NP as 
homogenously distributed dark spots. DOXO/SPION-PLGA NPs were slightly heterogenous, 
which could account for the broad UV-vis absorption peaks of PGNHs. 
 
 
a) b) 
c) d) 
e) f) 
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Differences in sizes between these techniques arise from the dehydration 
underwent by the samples under the preparation procedure for TEM and SEM 
measurements [78]. TEM images of DOXO/SPION-PLGA NPs indicated that many 
SPIONs were successfully embedded into the matrix of each PLGA NP. The 
successful incorporation of DOXO inside the PLGA NPs was corroborated by the 
appearance of absorption and emission peaks at 490 and 591 nm, respectively, 
consistent with spectra of free DOXO (Figure 5.6).  
 
Figure 5.6: UV-vis absorption and fluorescence spectra of free DOXO (1 and 3) and DOXO-
PLGA NPs (2 and 4).  
 
The number density of SPIONs and DOXO could be easily tuned by varying 
the amount of SPIONs in the initial reaction mixture and the DOXO/PLGA molar 
ratio. In particular, when the mass ratio of DOXO to PLGA was 10 wt.%, the 
maximum drug encapsulation efficiency (EE) was ca. 95% and the loading capacity 
(LC) was 8.9 wt.% in the presence of 5 wt.% SPIONs (as measured by inductively 
coupled plasma mass spectrometry, ICP-MS) compared to 73% EE and 3.2 wt.% LC 
in their absence, which suggests a possible synergistic effect through additional 
hydrophobic interactions between DOXO molecules, oleic acid (OA) surfactant on 
the SPIONs surfaces and PLGA chains [56].  
To grow the porous Au layer, low molecular weight chitosan chains were 
firstly adsorbed onto the surface of the negatively charged PLGA NPs derived from 
the terminal carboxyl groups of the PLGA chain (ζ-potential of ca. -35.3 ± 4.8 mV) 
[79] by electrostatic interactions. The ζ-potential of the PLGA NPs was increased 
from -35.3 ± 3.2 to +60.4 ± 3.9 mV by increasing the amounts of the coated chitosan 
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(Figure 5.7), confirming the successful coating of chitosan on the surface of the 
PLGA NPs. The hydrodynamic diameter changes from ca. 140 ± 14 to ca. 180 ± 17 
nm after biopolymer coating, also denoting the absence of any severe agglomeration 
due to the electrostatic repulsions between the positively charged particles and the 
steric stabilization provided by the polyethylene oxide chains surrounding the PLGA 
NPs.  
 
Figure 5.7: ζ-potential (■) and hydrodynamic diameter (○) of DOXO/SPION-PLGA NPs in 
deionized water after surface coating with increasing amounts of chitosan. After coating with 
the polycation, citrate-capped Au seeds were attached by electrostatic interactions, which 
subsequently acted as nucleation centers for Au shell growth. 
 
Subsequently, negatively charged Au seeds with a diameter of about 2-3 nm 
were adsorbed onto the surface of the chitosan-coated PLGA NPs via electrostatic 
interactions. A ζ-potential of ca. -11.4 ± 2.1 mV indicated the successful deposition of 
Au seeds onto the surface of polymeric NPs (Figure 5.8a). Finally, the attached Au 
nanoseeds were used to nucleate the growth of a porous gold nanoshell by reduction 
of HAuCl4 to bulk Au metal (Figure 5.8b-c). For PGNHs stabilization, a 
heterobifunctional polyethyleneglycol chain, SH-PEG5000-OCH3 or SH-PEG5000-NH2 
when corresponding, was used by exploiting the strong bond formation between 
sulfhydryls groups and metal gold surfaces (final ζ-potential of ca. -4.8 ± 2.1 mV). 
PGNHs settled due to the high density of the Au shell and the SPION-loaded PLGA 
core; nevertheless, after vortexing no agglomerates in solution were observed by 
visual inspection and DLS for at least two weeks after pegylation when stored in PBS 
at 4 ºC.  
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Figure 5.8: a) TEM image of Au nanoseeds decorating DOXO/SPION-PLGA NPs; b) TEM 
and c) SEM images of DXSP-PGNHs NPs. 
 
To achieve targeted delivery of the nanoconstruct and enhance cellular 
acummulation inside cancerous cervical HeLa cells, FA was conjugated to the amino 
groups of PEG chains (Figure 5.9) to bind the FA-overexpressed receptors on cell 
membrane surfaces. The number of SH-PEG5000-FA molecules conjugated to PGNHs 
was calculated to be 1.78· 106 molecules/PGNH. 
UV-vis spectra of DXSP-PGNHs at different stages of preparation are shown 
in Figure 5.10. The extinction spectrum of the blank PLGA NPs exhibited no obvious 
peak in the range from 400 nm to 800 nm (Figure 5.10a, plot 1) as a result of light 
scattering of the nanoparticles [80]. The peak at ca. 480 nm (Figure 5.10a, plot 2) was 
attributed to the absorbance of DOXO corroborating its successful loading into the 
PLGA NPs. After Au-seed adsorption, a plasmon resonance peak at ca. 535 nm for 
Au nanoparticles clustered at the surface of the PLGA NPs was present (Figure 5.10a, 
plot 3), and the metal seeds were observed as densely distributed dark spots by TEM 
(Figure 5.8a). 
 
a) b) 
c) 
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The structure of the metallic nanoshell could be also changed from a relatively 
smooth surface to a spiky structure depending on the synthetic conditions, the latter 
resembling the classical structure of a virus capside (Figure 5.10c inset). The Au 
nanoshell also seemed to be dense, multicrystalline and porous, which conveniently 
enables DOXO release through the gold pores (Figure 5.10d-e), and as additionally 
corroborated by electron diffraction X-ray (EDX) analysis (Figure 5.12). In this 
regard, EDX of PGNHs displayed Au and C peaks, the latter stemming from carbon 
atoms from the PLGA core; in addition, SEM maps for each element distribution 
coincide, which gives an additional confirmation that the Au shell is porous. 
 
 
Figure 5.10: a) UV-vis absorption spectra of DXSP-PGNHs at different stages of their 
growth process. b) TEM images of PGNHs with a flat and c) a spiky surface mimicking a 
virus capside. d) SEM image of PGNHs showing their rough surface topology. e) High 
magnification TEM images showing the multicrystalline and porous structure of the Au shell.  
 
a) b) 
c) d) e) 
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Figure 5.13: Hydrodynamic diameter of DXSP-PGNH-FA with different shell thickness, 
obtained by varying the VNP-seed/Vascorbic acid ratio and keeping VAu growth solution constant at 20 
mL. 
 
5.4.2 Temperature Elevation Induced by NIR Laser Irradiation 
 The absorbance between 750 nm and 900 nm (Figure 5.10a) suggests that 
these hybrid nanoplatforms can be suitable for NIR light-triggered release of drugs 
and photothermal therapy [81] at relatively low laser output energies due to their 
enhanced absorption provided by their relatively large extinction cross-sections [82]. 
Exposure of aqueous suspensions of PGNHs to NIR-continuous wave illumination 
(NIR-CW setup at 808 nm) resulted in a rapid elevation of solution temperatures, 
which is an important feature for selective treatment of solid tumors. To investigate 
the hyperthermic potential of PGNHs, firstly the heat generated by NIR-CW at a laser 
power of 2.5 W/cm2 over time (total illumination time = 10 min; total energy 
delivered = 188.6 J) on PGNHs solutions of different concentrations was measured.  
No obvious temperature change was observed when deionized water was exposed to 
NIR light (Figure 5.14a). By contrast, aqueous dispersions of PGNHs at 
concentrations 1·108-1·1010 NP/mL achieved temperature elevations of ca. 6, 8ºC, 
11ºC, 13ºC, and 16ºC, respectively. Hence, at concentrations above 5·108 NP/mL, 
samples can be easily heated up above 43ºC, which is sufficient to kill tumor cells 
[83]. When changing the laser irradiation at a fixed NP concentration of 5·108 NP/mL, 
powers above 2.5 W/cm2 overcome the required temperature threshold for thermal 
ablation of cancer cells (Figure 5.14b) with temperature elevations of up to 40 ºC, 
which can cause cargo release and cellular death (see below).  
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Figure 5.16: TEM images of DXSP-PGNHs supported on silica spheres of 5 μm size: a, c) 
before, and b, d) after NIR-SPI with a laser power of 0.3 and 0.6 mW/μm2, respectively. In b), 
the spikes are smoothed but their shape is kept. d) At larger laser powers a re-shaping from a 
spiky morphology to a smoother sphere takes place. Also, e) detachment of some portions of 
the DXSP-PGNHs surface and f) complete nanoplatform rupture was observed.  
 
The morphology of PGNHs upon NIR-SPI was studied by TEM. For this, 
DXSP-PGNHS were electrostatically attached to positively charged 5 µm SiO2 beads. 
TEM images of DXSP-PGNH/SiO2 assemblies were acquired before and after 
illumination with NIR light under NIR-SPI conditions. Figure 5.16 shows images of 
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the nanoplatforms irradiated under different intensities. The structure of the PGNHs 
was observed to be kept up to power intensities of ca. 0.3 mW/μm2 (Figure 5.16b). 
Above such threshold, fusion of the Au layer with subsequent loss of spikes (when 
present) and nanoplatform rupture was observed when illuminated at 0.6 mW/μm2 
(Figure 5.16d-f), which is consistent with observations of single-cell in vitro NR 
release experiments. 
 These data corroborated that the photostability of the present nanostructures 
was not maintained under pulsed laser irradiation. Pulsed lasers can melt and reshape 
gold nanostructures to nanospheres even in picosenconds [88, 89]. This irreversible 
transformation of shape will dramatically deteriorate the heat producing ability [88]. 
Hence, in view of the present observations, we decided to use continuous wave (CW) 
illumination to perform the analysis of the drug light-triggered release in vitro.  Also, 
CW irradiation was used to carry out the in vitro cytotoxicity tests of the DXSP-
PGNH nanoplatforms, in this case, with the caution of maintaining the total energy 
light input per cell similar to that used in the pulsed laser-cargo release irradiation 
experiments (4.2 mJ/cell) (section 5.4.3). 
  
5.4.4 Triggered Release of DOXO by NIR Light 
 The PLGA copolymer which configures the reservoir for DOXO drug 
molecules showed a glass-transition temperature (Tg) of ca. 45 ºC [90], which reduces 
the drug leakage during circulation and releases the drug when needed, that is, in the 
vicinity of tumor. However, the incorporation of the Au layer allows an additional 
light-triggered drug release mechanism by applying NIR laser irradiation, that is, the 
heat generated by DXSP-PGNHs under illumination is sufficiently higher to 
overcome the PLGA Tg inducing an enhanced release of the chemotherapeutic drug, 
as depicted by cell irradiation experiments (see Figure 5.15).  
Figure 5.17a shows the characteristics of the DOXO release from bare 
DOXO/SPION PLGA NPs and DXSP-PGNHs solutions (PBS buffer pH 7.4 with 
10% (v/v) FBS) in the absence and presence of NIR-CW irradiation. Samples were 
irradiated repeatedly over a period of 5 min, followed by 1 h intervals with the laser 
turned off. We observed that the release profile of the DXSP-PGNHs follows a 
similar trend as that of DOXO/SPION PLGA NPs, that is, an initial burst release 
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the total mass of the nanoplatforms. Additionally, the presence of canted or 
noncollinear surface spins, which has been observed in ferromagnetic materials with 
substituted diamagnetic neighboring cations, may also contribute to a decrease in Msat 
since saturation of these spins usually requires higher magnetic fields [35]. 
SPIONs have received great attention as T2 contrast agents due to their 
capability to shorten the spin-spin relaxation times, which results in a decrease in the 
MRI signal intensity and enables to differentiate between normal and abnormal 
tissues [92]. In addition, the specific weighted transverse-relaxivity (r2) values can be 
greatly increased by clustering SPIONs in reservoirs, which leads to higher saturation 
magnetizations than that of individual ones owing to the interactions between the 
assembled nanocrystals [93-95].  
In order to evaluate the T2 contrast capabilities of the present hybrid 
nanoplatforms, DXSP-PGNHs with various Fe concentrations (as determined by ICP-
MS) were investigated by T2-weighted MRI at 9.4 T and 400 MHz. The signal 
intensity of the MR images decreased as the iron concentration increased, as expected 
for T2 contrast agents due to the shortening of the spin-spin relaxation time of water, 
as commented previously [96]. The specific relaxivity, r2, a measure of the change in 
spin-spin relaxation rate (T2-1) per unit Fe concentration, was determined to be 207 
mM Fe− 1 s− 1 for our DXSP-PGNH (Figure 5.19c). This high r2 value could be due to 
the large external magnetic field (9.4 T) applied to the nanoplatforms as well as their 
superior magnetic properties due to the enhanced magnetic interactions between 
clustered SPIONs inside the polymeric matrix of the nanoplatforms. It is worth 
mentioning that at high magnetic field strengths, the two contrast agents approved by 
the US Food and Drug Administration (FDA), AMI-25 and Resovist, have 
considerably lower r2 values (160 and 151 mM Fe− 1s− 1, respectively) than the 
nanoplatforms here synthesized. Meanwhile, other types of hybrid particles 
embedding clustered SPIONs such as magnetic Au nanoshells, polymeric NPs or 
hybrid fibers have been reported with relaxivities comparable to our DXSP-PGNHs 
[35, 55, 97-101]. Hence, these data suggest that the present DXSP-PGNHs may be 
used in imaging diagnosis, in which the distribution of the particles depicted by MRI 
may be used to assist planning of chemo- and photothermal therapy and to predict the 
treatment outcome. 
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microscopy images of HeLa cells incubated with non-functionalized DXSP-PGNHs 
and functionalized DXSP-PGNHs-FA showed that the cellular uptake of the latter 
was enhanced compared to naked ones as denoted by the increased scattered light 
from the particles inside the cells [102-104] (denoted in green in Figure 5.20b-e by 
changing the color palette in the merged images shown).  
After 4 h of incubation with HeLa cells, only a relative small amount of non-
functionalized nanoplatforms appeared to be inside the cells (Figures 5.20b-c); in 
contrast, FA-functionalized nanoplatforms are more numerous inside the cells (larger 
number of green spots, Figure 5.20c-d) and appeared to be specifically bound to the 
cell membrane and within vesicular compartments inside cells (Figure 5.21). This 
demonstrated that the functionalized DXSP-PGNHs-FA are more easily internalized 
by cells than the non-functionalized ones, presumably through a receptor-mediated 
endocytosis process [105]. On the other hand, particle cell uptake was additionally 
enhanced upon application of an external magnetic field to cells by placing a magnet 
below the culture wells, as observed by fluorescence images (Figures 5.20f-g). This 
demonstrated that the simultaneous use of folate and magnetic field exhibited a 
synergistic effect on nanoplatform targeting to HeLa cells. The particles would 
remain in endosomal/lysosomal compartments and would not enter nuclei, as denoted 
by z-axis cross-sectional confocal microscopy and TEM images (Figure 5.20h and 
Figure 5.21).  
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Because our nanohybrids are multifunctional, we were able to evaluate the 
enhanced uptake due to the present hybrid NPs by TEM and MRI imaging. The cells 
labelled with the nanoplatforms clearly appear as hypointense spots in T2-MR images 
of HeLa cells after being inoculated with DXSP-PGNHs and resuspended in 1.6% 
(w/v) agarose solution acquired with the 9.4 T MR scanner. Cells incubated with 
DXSP-PGNHs-FA (Figures 5.21d-e) were substantially darker than those incubated 
with non-functionalized DXSP-PGNHs (Figures 5.21b-c).  
 
 
Figure 5.21: T2-weighted MR image of HeLa cells. a) Control sample with unlabelled 1·106 
cells; b, d) 1·105 and c, e) 1·106  cells labelled with DXSP-PGNHs and DXSP-PGNHs-FA, 
respectively. f) TEM image showing nanoplatform´s cellular uptake. In g), the encapsulation 
of nanoplatforms inside endocytosic vesicles is observed. h) DXSP-PGNHs entering the cells 
by endocytosis and subsequent formation of vesicles. i) DXSP-PGNHs inside and outside a 
broken vesicle upon light irradiation. 
f) 
g) h) 
i) 
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On the other hand, TEM images (Figures 5.21f-h) showed that DXSP-PGNH-
FA NPs were endocytosed and the nanoplatforms seemed to be accumulated within 
vesicles (see arrows). However, some NPs were found free in the cytoplasm, which 
suggested that NPs may escape from vesicles (Figure 5.21i).  
 
5.4.7 Chemo-photothermal cytotoxicity of nanoplatforms 
In order to obtain a qualitative demonstration of the specificity and the 
enhanced localized cell cytotoxicity of our nanohybrids, a cell viability assay in the 
presence and absence of irradiation was performed by staining viable cells with 
calcein acetoxymethyl ester (calcein AM) and dead cells with propidium iodide (PI) 
in order to verify the chemo-photothermal effect of DXSP-PGNHs-FA.  
Figure 5.22 shows a fluorescence microscope image of HeLa cells incubated 
with DXSP-PGNHs-FA for 24 h. The estimated amount of DOXO contained inside 
these nanoplatforms was ca. 1.3 μM. In the absence of NIR irradiation, cells (Figure 
5.22a-b) showed a vivid green color over the entire area analyzed, suggesting that the 
nanohybrids alone did not induce cell death because of the low DOXO dose and the 
slow drug release. By contrast, after NIR-CW exposure (2.5 W cm− 2 for 10 min), a 
well-marked red-fluorescent region was present, indicating that the cells exposed to 
NIR-CW were dead (Figure 5.22c), whereas those not exposed were mostly alive 
(green cells in the inset of Figure 5.22c). For comparison, cells containing BNK-
PGNH-FA without loaded DOXO were also illuminated under the same conditions to 
elucidate whether the cell death was induced only through NIR-induced hyperthermia 
or by the combined effects of DOXO chemotoxicity and NIR-CW. As shown in 
Figure 5.22d, many of the cells still appeared alive; therefore, it is possible to 
conclude that the combined chemo- and phototherapy was more cytotoxic under the 
present conditions than chemo- or photo-treatments alone. The origin of such effect 
can be originated from the combination of an enhanced DOXO toxicity upon 
temperature elevation under NIR irradiation [21], the larger sensitivity to heat of cells 
exposed to DOXO and/or to intracellular protein denaturation which inhibits normal 
cellular growth and proliferation and possible induced some cell membrane damages 
[106]. 
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through the pores of the metal layer in spite of this was not very significant since the 
amount of DOXO released should be low to inhibit tumor cell proliferation to large 
extents in the time scale of the experiment. In addition, some toxicity could be also 
caused by leakage of small amounts of non-encapsulated DOXO released during the 
FA functionalization process and washing steps and DOXO diffusion from some NPs 
with incomplete Au shells, which might be present in solution. All this is further 
supported when compared cytotoxicities of HeLa cells incubated with different 
concentrations of free DOXO, which resulted in lower viabilities compared with 
DXSP-PGNHs containing the same amount of drug.  
Also, a slight enhanced free DOXO cytotoxicity was observed under NIR 
irradiation (2.5 W/cm2 for 5 min). Moreover, when exposing the cells to NIR laser 
illumination CVs in the presence of BNK-PGNHs and DXSP-PGNHs decreases up to 
67 and 39%, respectively. These larger cell mortalities appeared when the solution 
temperature raised above 43 ºC upon irradiation, at which tumor cells are damaged 
probably by denaturation of intracellular proteins, as mentioned previously [106]. 
Notably, DXSP-PGNHs exhibited an additional cytotoxic effect ((CVBNK-PGNHs – 
CVDXSP-PGNHs)/ CV BNK-PGNHs) of 42% compared to BNK-PGNHs due to the remote 
release of DOXO, which was more important as the amount of DOXO increased in 
solution. The mechanism is speculated to be caused by the altered kinetics, 
permeability and uptake of the chemotherapeutic agent during the heating process 
[42]. The photothermal effect of the Au nanolayer can partially melt the core of the 
polymeric matrix, releasing a larger amount of DOXO from DXSP-PGNHs.  
On the other hand, the presence of the targeting ligand, folic acid, which 
favored an enhanced particle accumulation inside the cells as shown above, led to a 
further decreased in the cell viability up to 31% after 24 h (Figure 5.23b). The 
targeting efficacy of FA was further corroborated by adding an excess of FA to cells 
prior the addition of DXSP-PGNH-FA NPs. In this case, cell viability was similar to 
that observed for non functionalized DXSP-PGNH NPs. 
 On the other hand, cell cytotoxicity was additionally increased to larger 
extents when a magnetic field is applied to the cell culture for magnetic guiding of the 
particles, achieving a mortality of 82%. The targeting-induced tumoricidal effect was 
calculated to be 20% (CV DXSP-PGNHs – CV DXSP-PGNHs-FA)/ CV BNK-PGNHs), and 
increased to 54% when magnetic targeting is also applied.  
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After 24 h of further incubation (48 h in total), the CVs with each 
nanostructure were also examined to reveal additional systemic cytotoxicity. Cell 
viability of HeLa cells treated with the functionalized nanoplatforms was additionally 
decreased due to the combined inhibitory effects of targeted hyperthermia and the 
sustained DOXO release (Figure 5.23b). In the case of DXSP-PGNHs-FA, the CV 
was 20%, and this nanoplatform exhibited an enhanced cytotoxic effect of 23% if 
compared to the non-functionalized ones. An additional enhancement of cell toxicity 
was observed when an external magnetic field was applied (93% cell toxicity). In this 
case, the targeting-induced tumoricidal effect was calculated to be 73%  (CV DXSP-
PGNHs – CV DXSP-PGNHs-FA+magnetic field)/ CV BNK-PGNHs). These results demonstrated the 
improved cellular uptake by the combined effect of FA and magnetic targeting, and 
the synergistic chemotherapeutic and Au-shell driven hyperthermic efficacies of 
DXSP-PGNHs-FA.  
 
Figure 5.23: a) Cell growth inhibition of HeLa cells after incubation for 24 h in the presence 
of free DOXO in the absence (black columns) and presence (stripped columns) of NIR 
irradiation, 2.5 Wcm-2 for 5 min at 808 nm; BNK-PGNHs in the absence (light grey columns) 
and presence of NIR irradiation (squared columns); and DXSP-PGNHs in the absence (dark 
grey columns) and presence of NIR irradiation (dashed columns). Different free DOXO and 
equivalent DOXO loaded concentrations (13, 1.3 and 0.13 μM) inside the nanoplatforms were 
tested (when corresponding). b) Cell growth inhibition of HeLa cells after incubation for 24 
and 48 h in the presence of BNK-PGNHs (black columns) and DXSP-PGNHs (stripped 
columns) in the absence of NIR irradiation; BNK-PGNHs (light grey columns), DXSP-
PGNHs (squared columns), DXSP-PGNHs-FA (dark grey columns), DXSP-PGNHs-FA 
pretreated with free FA (dense quared columns), and DXSP-PGNHs-FA + applied magnetic 
field (dashed columns) in the presence of NIR-CI (2.5 Wcm-2 for 5 min). Equivalent DOXO 
concentration in DXSP-PGNHs and DXSP-PGNHs-FA was 1.3 µM.  
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5.5 Conclusions 
We have synthesized polymeric core-coated Au nanoshells as a 
multifunctional platform to combine MR imaging, magnetic- and folic-acid targeted 
drug delivery, NIR light-triggered drug release, and photothermal therapy 
simultaneously into one system.  The resulting nanoplatforms displayed enhanced T2 -
weighted MRI properties and surface plasmon absorbance in the NIR region, thus, 
exhibiting a NIR-induced temperature elevation and a NIR light-triggered and 
stepwise release behavior of doxorubicin.  
The present nanoplatforms could be guided to the tumor area by the 
combination of ligand-induced and magnetic-assisted targeting, which enhanced their 
targeting effectiveness as observed in vitro by microscopies. In this regard, cell 
viability tests revealed that the combination of chemotherapy, magnetic and ligand-
induced targeting, and NIR photothermal therapy through the use of DXSP-PGNH-
FA increased the likelihood of cell killing significantly showing a synergistic effect, 
which potentially might help to overcome resistance to chemotherapeutic agents, 
making it a promising approach for cancer therapy. In this regard, the permeability of 
tumor vessels and the sensitivity of tumor cells toward chemotherapeutics should be 
greatly enhanced by hyperthemia, holding the promise of improving drug efficacy. In 
addition, photothermal therapy may facilitate triggered and enhanced drug release 
from the multifunctional nanoparticles, which is critical for achieving a high effective 
drug concentration in the tumor. Future studies employing more sophisticated 
nanoplatforms should perfectly allow both spatially and temporally improved 
hyperthermia, opto-magnetic-resonance imaging contrast agents for in vivo 
monitoring of tissue pharmacokinetics and cell tracking, and to enable a perfect and 
on-demand control of drug release dynamics for completely efficient chemotherapy. 
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CHAPTER VI - Fluorescent Drug-loaded PLGA-based 
Branched Gold Nanoshells for Localized Multimodal 
Therapy and Imaging of Tumoral Cells  
 
6.1 Summary 
 In this chapter, we report the synthesis of PLGA/DOXO-core Au-branched shell 
nanostructures (BGNSHs) functionalized with a human serum albumin/indocyanine green/folic 
acid complex (HSA-ICG-FA) to configure a multifunctional nanotheranostic platform. First, 
branched gold nanoshells (BGNSHs) were obtained through a seeded-growth surfactant-less 
method. These BGNSHs were loaded during the synthetic process with the chemotherapeutic 
drug doxorubicin, a DNA intercalating agent and topoisomerase II inhibitior.  In parallel, the 
fluorescent near-infrared (NIR) dye isocyanine green (ICG) was conjugated to the proein human 
serum albumin (HSA) by electrostatic and hydrophobic interactions. Subsequently, folic acid 
was covalently attached to the HSA-ICG complex. In this eay, we created a protein complex 
with targeting specificity and fluorescent imaging capability. The resulting HSA-ICG-FA complex 
was adsorbed to the gold nanostructures surface (BGNSH-HSA-ICG-FA) in a straightforward 
incubation process thanks to the high affinity of HSA to gold surface. In this manner, BGNSH-
HSA-ICG-FA platforms were featured with multifunctional abilities: the possibility of 
fluorescence imaging for diagnosis and therapy monitoring by exploiting the inherent 
fluorescence of the dye, and a multimodal therapy approach consisting of the simultaneous 
combination of chemotherapy, provided by the loaded drug, and the  potential of 
photodynamic and photothermal therapies (provided by the dye and the gold nanolayer of the 
metallic hybrid structure, respectively) upon NIR light irradiation of suitable wavelength. The 
combination of this trimodal approach was observed to exert a synergistic effect on the 
cytotoxicity of tumora cells Furthermore, FA was proved to enhance the internalization of 
nanoplatform. The ability of the nanoplatforms as fluorescence imaging contrast was tested by 
preliminary analyzing their biodistribution in vivo in a tumor-bearing mice model. 
 
6.2 Introduction 
One of the areas of nanotechnology that has captured great interest by scientific 
community worldwide is the development of nanoengineered multifunctional systems 
which may be potentially used in a clinical strategy that simultaneously combine a 
(multi)diagnostic test and single or combined therapies based on the test results, the so-
called nanotheranostic devices [1-7]. Nanoengineering of materials for this purpose 
involves the design, fabrication and testing of nanosystems that must combine several 
features such as biocompatibility, stealthness, long-circulating blood times, drug 
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transport and its triggerable release, imaging capabilities, and/or targeatibility, amongst 
others [8-12]. Improvement and suitable conjunction of all these characteristics would 
allow the early diagnosis of cancer and other diseases, the significant reduction of the 
therapeutic drug doses and subsequent reduction of adverse side effects, or the 
simultaneous combination of several therapeutic treatments with a real-time 
monitorization of their effectiveness [1, 3, 9, 10].  
Amongst all the different diagnostic imaging techniques, fluorescence imaging 
offers a unique approach for visualizing morphological details in tissue with subcellular 
resolution, and becomes a powerful non-invasive tool for visualizing the full range of 
bio-species from living cells to animals. Most of the conventional fluorescence probes 
for bioimaging are based on single-photon excitation, emitting low energy fluorescence 
when excited by high energy light. These probes have some limitations: (i) DNA 
damage and cell death due to long-term exposure to high energy excitation; (ii) low 
signal-to-noise ratio caused by significant auto-fluorescence from the biological tissues; 
(iii) and low penetration depth in the biological tissues.  Compared with visible light 
excitation, near-infrared (NIR) light excitation of NIR contrast agents for in vivo 
imaging provides several advantages such as deep penetration, weak autofluorescence, 
reduced photobleaching and low phototoxicity [13, 14].  In addition, these NIR probes 
can be simultaneously used under exposition to NIR light as phototherapeutic agents, 
acting as efficient photosensitizers transforming endogeneous oxygen to singlet oxygen 
(1O2) to kill cancer cells, the so-called photodynamic therapy (PDT) [15-17]. Because of 
this therapy is based on direct light administration to tumors/tissues, PDT treatment has 
remarkably improved tumor selectivity and reported side effects as compared to 
conventional chemo- and radio-therapies [18, 19]. However, PDT efficacy in tumors is 
largely limited by different factors such as the inadequeate selectivity and poor water 
solubility of most photosensitizers [18, 20-23], the self-destruction of photosensitizers 
upon light irradiation [24], and the depletion of tissue oxygen and disruption of tumor 
blood flow, which causes severe local hypoxia and cease the production of 1O2 [25, 26], 
hindering the therapeutic efficacy of PDT and restricting its potential application in 
clinics [27]. 
On the other hand, novel plasmonic photothermal effects of gold nanostructures 
such as gold nanorods and nanostars [28-32], nanoshells [33-35], carbon nanotubes [36-
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39] or graphene oxide [40-42] activated by NIR light illumination are being actively 
studied for their tumoricidal efficacies. Nevertheless, while these nanomaterials can 
certainly increase the local temperature around cancerous regions upon exposition to 
NIR light, it is not entirely evident that the photothermal effect is sufficient to achieve 
the desired level of cancer-cell cytotoxicity with a wide range [43, 44]. Thus, for patient 
compliance, the development of nanosystems for largely enhancing the tumorocidal 
efficacy by combination of different therapeutic approaches is vital and can allow to 
overcome current limitations of single available therapies and lead to synergisitc 
cytotoxic effects [45-48].  
Hence, with the aim to simultaneously combine chemotherapy, photo- and 
thermotherapies with fluorescence imaging capability for diagnosis under NIR light 
illumination we here developed a multifunctional nanoplatform consisting of a 
poly(lactic-co-glycolic acid) biodegradable matrix loaded with the anticancer drug 
doxorubicin (DOXO). The polymeric PLGA nanoparticle (NP) was covered with a 
porous gold shell, which provides the nanoplatform the ability of NIR light absorption 
and subsequent efficient energy transduction in the form of localised heat due to NIR 
resonance of the metal shell, and also accelerates drug released from the nanoplatform 
[49].  
The nanoshell surface was functionalized with human serum albumin (HSA) for 
stealthness, to which the fluorescent dye indocyanine green (ICG) was non-covalently 
conjugated to provide the nanoplatform with fluorescence imaging and singlet oxygen 
production capabilities. ICG is a tricarbocyanine dye with absorbing properties 
exclusively in the NIR electromagnetic spectrum, and currently used as a diagnostic 
agent for blood volume determination, ophtalmic angiography, cardiac output and 
hepatic function [50, 51]. In addition, folic acid was also covalently conjugated to the 
protein surface to provide the nanoplatofrm with specific targeability. In this way, heat, 
singlet oxygen species and drug could be simultaneosuly delivery to the selected tumor 
region. We demonstrated that the present nanoplatforms showed synergistic therapeutic 
effects in vitro by combination of chemo-, photo- and thermo-therapies, and can 
simultaneously act as effective contrast agents for in vivo optical imaging by exploiting 
the fluorescence enhancement of the dye upon positioned near the metal surface while 
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tuning the plasmon resonance of the nanoshell to the emission wavelength of the 
fluorophore [52]. 
 
 
6.3 Materials and Methods  
 
6.3.1 Materials 
 Human serum albumin (HSA), indocyanine green (ICG), doxorubicin (DOXO), 
folic acid (FA), poly(D,L-lactide-co-glycolide) (PLGA) of 7-17 kDa with 50:50 lactide–
glycolide ratio, Pluronic F127, hydrogen tetrachloroaureate (III) trihydrate 
(HAuCl3·3H2O), N-(3-dimethylamniopropyl)-3-ethylcarbodiimide hydrochloride 
(EDC), sulfo-N-hydroxysuccinimide (Sulfo-NHS), 1,3-diphenylisobenzofuran (DPIBF), 
low molecular weight chitosan (LMW-chitosan, MW = 111 kDa), potassium carbonate 
anhydrous, sodium borohydride, sodium azide, sodium citrate tribasic and ascorbic acid 
were purchased from Sigma–Aldrich (St. Louis, MO, USA). ProLong® Gold antifade 
reagent with DAPI was purchased from Invitrogen (Carlsbad, USA).  DOXO HCl, fetal 
bovine serum (FBS), Dulbecco’s modified eagle medium (DMEM), fetal bovine serum 
(FBS), L-glutamine, penicillin/streptomycin, sodium pyruvate, and MEM non-essential 
amino acids (NEAA) were purchased from Fisher Scientific (Pittsburgh, PA, USA). 
Dialysis membrane tubing (molecular weight cutoff ∼3500) was purchased from 
Spectrum Laboratories, Inc. (Rancho Dominguez, CA, USA). All other chemicals and 
solvents were of reagent grade (purchased from Sigma–Aldrich). Milli-Q water was 
used for all aqueous solutions. All glassware was washed with aqua regia and HF 5% 
(v/v) and extensively rinsed with water. All the chemicals were of analytical grade and 
used without further purification. 
 
6.3.2 Synthesis of BGNSHs 
PLGA-core gold-shell nanoconstructs (BGNSHs) were synthesized following a 
seeded-growth protocol based on previously protocols but with modifications [53]. 
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First, PLGA NPs were synthesized by a nanoprecipitation process, using acetone as the 
organic solvent and F127 as a stabilizer agent. Briefly, in a typical preparation 25 mg of 
PLGA were dissolved in 2.5 mL of acetone. When corresponding, a suitable amount of 
DOXO (previously converted to its hydrophobic base form by addition of triethylamine, 
as reported in literature [54])  was added. This organic solution was added dropwise at 
0.166 mL/min to 50 mL of F127 1% (w/v) in water at a 10 °C and moderate stirring at 
250 rpm. The emulsion was homogenized with a sonicating tip at 100 W in an ice bath 
for 15 min. Acetone, non-encapsulated DOXO, and excess stabilizer were eliminated by 
stirring for 4 h and subsequent centrifugation twice at 9000 rpm for 30 min. DOXO 
concentration in the supernatant was measured by UV-vis spectroscopy by using a 
previously obtained-drug calibration curve. The final pellet was dispersed in 25 mL of 
water by vortexing for 30 s and filtered through 0.45 μm filters (Merck Millipore, 
USA). PLGA NPs had a hydrodynamic diameter and zeta potential of 100 ± 20 nm and 
-39 ± 8 mV, respectively.  
In order to grow the gold nanolayer around the PLGA dielectric NP core, 5 mL 
of PLGA NPs were incubated for 4 h with 0.25 mL of chitosan. Chitosan, a 
biocompatible polycation, was adsorbed on the negative surface of PLGA NPs by 
electrostatic attraction, inverting the NPs surface charge to +4 mV. Excess of chitosan 
was eliminated by centrifugation twice at 9000 rpm for 15 min and 20 °C. Then, 
positively charged PLGA NPs were incubated for 4 h with 5 mL of citrate-capped Au 
seeds prepared following a methodology previously reported by Jana et al. [55]. Non-
attached gold seeds were eliminated by centrifugation twice at 7000 rpm for 15 min at 
20 °C. Subsequently, an Au growth solution was prepared by dissolving 0.05 g 
potassium carbonate and 2 mL of 0.025 M HAuCl4·3H2O, and aged 24 h prior use. The 
growth of the Au shell was achieved by mixing 1 mL of PLGA NPs-seed precursor with 
20 mL of the Au growth solution and subsequent reduction with 25 µL of 0.5 M 
ascorbic acid. PGNHs were immediately formed, as noticed by the blue coloration of 
the mixture solution. BGNSHs were left stand overnight and washed twice by 
centrifugation at 3500 rpm for 15 min and 20 °C 
 
6.3.3 HSA-ICG complex 
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Indocyanine green (ICG) was non-covalently conjugated to human serum 
albumin (HSA) by mixing both reactants under ambient conditions. 10 mL of 5 µM 
HSA and 10 mL of 30 µM ICG both in 50 mM MES buffer at pH 6 were mixed and 
shaken for 4 h at ambient temperature. Then, in order to remove unbound ICG, the 
mixture was dialyzed 24 h against MES buffer with a cellulose dialysis membrane with 
MWCO of 3500 Da. Absorbance peaks of the protein-dye complex (λmax = 780 nm) and 
bare protein (λmax = 280 nm) were monitored to account for free-dye removal. The 
concentration of bound ICG was determined after subtraction of the ICG concentration 
in the supernantant to that initially added. The HSA-ICG complex was stored at 4 °C 
and protected from light before use.  
 
6.3.4 Folic acid activation and conjugation to HSA-ICG complexes 
Folic acid (FA) was reacted with EDC and sulfo-NHS to generate an active 
species, FA*, and covalently attached to the HSA-ICG complex. First, 1mL of 1 mM 
folic acid in MES 50 mM (pH 6) where mixed with 0.6 mg of N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC)  and 0.6 mg of N-
hydroxisulfosuccinimide (sulfo-NHS). This mixture was reacted for 20 min at ambient 
temperature and protected from light. FA* was reacted with HSA-ICG in order to form 
a covalent bond between the activated FA* and amine groups of HSA. 50 µL of FA* 
and 10 mL of HSA-ICG (molar ratio 5:1) were mixed for 4 h at ambient temperature. 
The product was dialyzed 24 h against MES buffer with a cellulose membrane (MWCO 
3500 Da) to eliminate unreacted FA* and remaining reaction by-products.  The number 
of FA molecules conjugated to HSA was calculated with an UV-vis calibration curve of 
FA (Figure 6.1a-b). This curve was prepared by making dilutions of a stock solution of 
FA, and measuring their absorbance spectra. Absorbance at 280 nm was plotted against 
concentration and fitted to a linear curve.  
Then, 50 μL of 5 μM FA* was mixed with 10 mL of 5 μM HSA-ICG in a 5:1 
molar ratio. The initial concentration of FA* in the reacting mixture was 0.02487 mM. 
After 4 h of reaction and 24 h of dialysis to remove unreacted compounds, HSA-ICG 
complexes displayed two new peaks at ca. 275 and 360 nm which correspond to FA 
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(Figure 6.2) confirming the formation of HSA-ICG-FA complex. The concentration of 
FA in the complexes was found to be 3 molecules of FA per HSA-ICG complex entity.  
 
 
Figure 6.1: a) UV-vis spectra and calibration curve of FA, and b) linear fit of absorbance at 280 
vs FA concentration. 
 
 
Figure 6.2: a) UV-vis spectra of HSA-ICG complexes before and b) after reaction with FA*.  
 
6.3.5 Adsorption of HSA-ICG-FA on BGNSHs  
2 mL of BGNSHs with an optical density of 1 at 800 nm were mixed with 0.500 
mL of HSA-ICG-FA complex for 48 h under stirring in the dark. Afterwards, BGNSH-
HSA-ICG-FA nanoconjugates were centrifuged three times for 15 min at 3500 rpm and 
20 °C in order to eliminate non-adsorbed complexes and resuspended in PBS (pH 7.4) 
buffer solution. The absorbance of the supernatant was closely monitored to account for 
unbound HSA-ICG-FA concentration in the supernatant in order to calculate the amount 
a) b) 
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of ICG molecules on the nanoshells (∼5.5 ± 0.4 μM). Finally, to further stabilize the 
protein coating, to 1 mL BGNSH-HSA-ICG-FA nanoconjugates in PBS (pH 7.4), N-(3-
dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (5 mg, 25 mmol) and N-
sulfo-hydroxysulfosuccinimide (5 mg, 25 mmol) were added. The reaction was carried 
out for 2 h at room temperature. Cross-linked BGNSH-HSA-ICG-FA complexes were 
purified with desalting zeba spin columns (Fisher Scientific, USA). 
 
6.3.6 Nanoplatform characterization 
NP sizes were obtained  by dynamic light scattering (DLS) at 25 °C by means of 
an ALV-5000F (ALV-GmbH, Germany) instrument with vertically polarized incident 
light (λ = 488 nm) supplied by a diode-pumped Nd:YAG solid-state laser (Coherent 
Inc., CA, USA) operated at 2 W, and combined with an ALV SP-86 digital correlator 
(sampling time 25 ns to 100 ms). NP sizes and morphologies were also acquired by 
transmission and scanning electron microscopy (TEM and SEM, respectively) by means 
of a Phillips CM-12 and a Carl Zeiss Libra 200 Fm Omega (for TEM), and FESEM 
ultra Plus electronic microscopes (for SEM) operating at 120 and 20 kV, respectively. 
Elecron difracttion X-ray spectroscopy (EDX) was also performed using the same 
instrument as for SEM imaging. Samples were prepared for analysis by evaporating a 
drop of the hybrid NP dispersion on a carbon-coated copper grid without staining 
(TEM) or on a silicon wafer (SEM). ζ-potentials were measured with a Zetasizer Nano 
ZS (Malvern, UK) using dispossable folded capillary cells. Samples were measured in 
triplicate in PBS (pH 7.4) at 25 °C. The gold concentration in solution was determined 
by inductively coupling plasma-mass spectrometry (ICP-MS) in a Varian 820-MS 
equipment (Agilent Technologies, USA). The corresponding concentration of BGNSH-
HSA-ICG-FA particles was calculated by assuming a sphere model of 100 nm diameter. 
UV-Vis spectra were measured in a Cary Bio 100 UV-Vis spectrophotometer (Agilent 
Technologies, USA).  Fluorescence spectra were monitored in a Cary Eclipse 
spectrophotometer (Agilent Technologies, USA).  
 
6.3.7 NIR-laser induced temperature increase  
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Temperature increment tests were performed with a continuous wave fiber-
coupled diode laser source of 808 nm wavelength (50W, Oclaro Inc, San Jose, CA, 
USA). The laser was powered by a Newport 5700-80 regulated laser diode driver 
(Newport Corporation, Irvine, CA, USA). A 200-μm-core optical fiber was used to 
transfer laser power from the laser unit to the target solution, and equipped with a lens 
telescope mounting accessory at the output, which allowed for tuning of the laser spot 
size in the range 1-10 mm. The output power was independently calibrated using an 
optical power meter (Newport 1916-C) and laser spot size was previously measured 
with a laser beam profiler (Newport LBP-1-USB), which was placed at the same 
distance (8 cm) between the lens telescope output and the quartz cuvette (or the 96-well 
plate). For measuring the temperature change mediated by the present BGNSH-HSA-
ICG-FA, 2 mL of BGNSH-HSA-ICG-FA conjugates, PBS buffer containing 10% (v/v) 
FBS, BGNSHS and free ICG samples were placed in a quartz cuvette and irradiated for 
10 min at 2 W cm-2. The temperature of samples was measured with a type J 
thermocouple linked to a digital thermometer inserted into the solution. 
 
6.3.8 NIR-laser triggered release of DOXO  
Release kinetics of DOXO from BGNSH-HSA-ICG-FA was assessed in vitro at 
37 °C in PBS buffer (pH 7.4) containing 10% (v/v) fetal bovine serum. Briefly, 5 mL of 
DOXO-loaded BGNSH-HSA-ICG-FA with known DOXO concentration (3 μM) were 
placed in centrifuge tubes (in triplicate). Samples were maintained in a 37 °C bath with 
constant stirring. The samples were irradiated over a period of 10 min. Each hour, 500 
µL of sample were taken and centrifuged at 3500 rpm for 10 min at 20 °C. The 
supernatant was carefully extracted and its fluorescence at 594 nm was measured in a 
Cary Eclipse spectrophotometer (Agilent Technologies, Spain) for quantification of 
released DOXO with a calibration curve. After centrifugation and supernatant 
extraction, the settled DOXO-loaded BGNSH-HSA-ICG-FA were resuspended in 500 
µL with fresh buffer and returned to the original sample. 
 
6.3.9 In vitro singlet oxygen generation 
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The generation of singlet oxygen in vitro was performed by following the decay 
of the absorbance peak at 420 nm of 1,3-diphenylisobenzofurane (DPIBF), which is a 
specific singlet oxygen trap [56]. Briefly, 2 mL of sample (deionized water, free ICG, 
BGNSH-HSA, or BGNSH-HSA-ICG-FA conjugates) were placed in a quartz cuvette, 
and 100 μL of 1 mM DPIBF in ethanol were added. Concentration of free ICG and ICG 
bound to BGNSH-HSA-ICG-FA was 5 μM. The UV-vis spectrum of samples before 
illumination was recorded and taken as the initial (100%) absorbance value. The sample 
was magnetically stirred and illuminated with NIR-light (808 nm) for 10 min; then, the 
UV-vis spectra recorded and the process was repeated twice. The total illumination time 
was 15 min. The singlet oxygen generation was qualitatively determined at three 
different laser powers densities: 2, 4 and 6 W/cm2.  
 
6.3.10 Tumor cells 
MDA-MB-231 adenocarcinoma breast and HeLa cervical cancer cells from Cell 
Biolabs (San Diego, CA, USA) were used for in vitro studies. Cells were grown at 
standard culture conditions (5% CO2 at 37 ºC) in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% Fetal Bovine Serum (FBS), 2 mM L-glutamine, 1% 
penicillin/streptomycin, 1 mM sodium pyruvate, and 0.1 mM MEM Non-Essential 
Amino Acids (NEAA).  
 
6.3.11 Cellular uptake by fluorescence microscopy  
Cellular uptake of BGNSH-HSA-ICG-FA was followed by confocal 
fluorescence microscopy by seeding MDA-MB-231 and HeLa cells on poly-L-lysine 
coated glass coverslips (12 ×12 mm) placed inside 6-well plates (1.5·105 cells/well with 
3 mL of DMEM), and grown for 24 h at standard culture conditions. Then, the 
conjugates were added to cells (200 μL in PBS pH 7.4, 1·1010 particles/mL). After 6 h 
of incubation, the NP-containing cells were washed three times with PBS, fixed with 
paraformaldehyde 4% (w/v) for 10 min, washed with PBS pH 7.4, treated with Triton 
X-100 (permeabilizer) for 10 min, and finally washed again with PBS pH 7.4. Then, 
coverslips were mounted on glass slides, stained with DAPI (Invitrogen) and cured for 
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24 h at -20 °C. Samples were visualized at 63X using a confocal fluorescence 
microscope (Leica DMI6000B, Leica Microsystems, Germany) using blue channel for 
DAPI, λexc. 350 nm, red channel for ICG (λexc. 760 nm), and transmitted light in 
differential interference contrast (DIC) mode. 
 
 
6.3.12 In vitro cell cytotoxicity 
Cytotoxicity of nanoplatforms was tested in vitro by the CCK-8 cytotoxicity 
assay. Breast MDA-MB-231 and cervical HeLa cancer cells with an optical confluence 
of 80–90% were seeded into 96-well plates (100 µL, 1.5·104 cells/well) and grown for 
24 h at standard culture conditions in 100 µL growth medium. After 24 h of incubation 
at 37 °C and 5% CO2, 50 μL of free DOXO (3 μM), free ICG (5 μM), BGNSH-HSA-
FA, BGNSH-HSA-ICG (5 μM ICG), BGNSH-HSA-ICG-FA (5 μM ICG), DOXO-
loaded BGNSH-HSA-FA (3 μM DOXO), and DOXO-loaded BGNSH-HSA-ICG-FA (3 
μM DOXO, 5 μM ICG) were added to the wells. Some wells were left without particles 
as a negative control (blank) adding additional 50 μL of PBS. After 6 h of incubation, 
the culture medium was discarded, the cells washed with 10 mM PBS, pH 7.4 several 
times, new culture medium (100 μL) added (previously aerated for 2 min) and incubated 
for 1 h. A set of cells were illuminated with 808 nm laser at 2 W/cm2 for 5 min and then 
incubated 15 min. This process was repeated twice more. Then, cells were left incubated 
for additional  followed by incubation for 17 h. Another set of cells was left without 
illumination in order to determine the intrinsic cytotoxicity of the nanoplatforms. After 
24 h total incubation, 10 μL of CCK-8 reagent was added to each well, and after 2 h the 
absorption at 450 nm of cell samples was measured with an UV-vis microplate 
absorbance reader (Bio Rad model 689, USA). Cell viability was calculated as: 
 
%ܥܸ ൌ  ஺௕௦ೞೌ೘೛೗೐஺௕௦್೗ೌ೙ೖ ݔ100                                               (Eq 6.1) 
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chains to bind negatively charged citrated-Au seeds. Finally, the PLGA NP-seed precursor was 
used as substrate to grow branched Au nanoshells, which resemble virus structures. 
 
Trasmission and scanning electron microscopies confirmed the morphology of 
the hybrid gold nanoshells (BGNSHs), which resemble a virus capside (Figure 6.4a-b) 
with a size of ca. 85 ± 15 nm. The ultraviolet-visible/NIR absorption spectrum of 
BGNSHs exhibited a pronounced surface plasmon absorption in the NIR region (λ ≈ 
770 nm, Figure 6.4c) consistent with a reticular Au shell formed around the dielectric 
polymeric core of the nanoplatform. In the absence of the metal shell, the DOXO-
loaded PLGA NPs exhibited absorption maxima at λ ≈ 490 nm, in agreement with the 
absorbance peak of free DOXO. Electron diffraction X-ray spectroscopy (EDX) showed 
traces of C and O elements from the polymeric inner components and Au corresponding 
to the metal shell, which was a first evidence of the porous nature of the metal shell, as 
observed previously in Chapter 4 and 5. This was additionally confirmed while 
examining high-resolution TEM (HR-TEM) images, where the existence of voids or 
pores on the metal layer could be observed (Figure 6.4d).  
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protein complex at ca. 780 nm (in the absence of BGNSHS), typical of the dye (Figure 
6.5b), and at 278 and 385 nm (Figure 6.5c), corresponding to FA. Changes in zeta 
potential of the protein from -5.6 ± 2.3 to -27.6 ± 4.6 mV were observed at different 
stages of the conjugation process (Table 6.1). 
 
Figure 6.5: UV-vis spectra of free ICG, free FA, HSA-ICG and HSA-ICG-FA complexes after 
24 h of dialysis. b) Change in ICG absorbance of HSA-ICG complexes before and after FA 
conjugation. c) UV-vis spectra of HSA-ICG-FA complexes showing the FA peaks before and 
after 24 h of dialysis.  
 
 
 
Table 6.1: Zeta potential of HSA complexes in MES 50 M (pH 6) 
Sample Zeta Potential 
(mV) 
HSA -5.6 ± 0.4
HSA-ICG -1.0± 0.9 
a) b) 
c) 
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HSA-ICG-FA -27.6 ± 1.7 
 
Incubation of the protein complexes with the hybrid gold nanoshells led to the 
formation of BGNSH-HSA-ICG-FA nanoplatforms. Moreover, the succesfull 
conjugation of the HSA-ICG-FA complex to the BGNSHs was confirmed, on one hand, 
by a slight red-shift and broadening of the LSPR band of the metal nanoshell due to the 
higher refractive index of HSA than pure buffer (Figure 6.6a) [61, 62] and the peak 
absorbance positions of bounded ICG and, on the other, by the increase and blue-shift of 
the fluorescence peak of ICG upon protein complex adsorption onto the nanoplatform 
surface (Figure 6.6b).  
The sizes of BGNSH-HSA-ICG-FA nanoplatforms were determined by dynamic 
light scattering (DLS) approximately to be ∼ 135 ± 25 nm with and an effective zeta 
potential of -16.3 ±  1.7 mV (Table 6.2). The 30 nm increase in size regarding bare 
BGNSHs is consistent with the formation of a protein multilayer onto the gold surfaces, 
in agreement with previous reports [63]. We then determined the gold concentration of 
BGNSH-HSA-ICG (or BGNSH-HSA-ICG-FA) by inductively coupled plasma-mass 
spectroscopy (ICP-MS). Combined analysis by ICP-MS and UV-vis spectroscopy 
showed that about 450 ICG molecules were anchored per BGNSHS.  
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Figure 6.6: a) UV-vis spectra of bare BGNSHS and BGNSH-HSA-ICG-FA in PBS with 10% 
(v/v) FBS. b) Fluorescence spectra of free ICG (5 μM) and BGNSH-HSA-ICG-FA (with 5 μM 
of conjugated ICG). c) UV-vis spectra of BGNSH-HSA-ICG-FA in PBS with 10% (v/v) FBS 
right after incubation and after 96 h of storage at room temperature. 
 
Table 6.2: Hydrodynamic radius and zeta potential of BGNSHs in PBS 10mM (pH 7.4) 
Sample  rh 
(nm) 
Zeta Potential  
(mV) 
Bare BGNSHs  55.2 ± 4.9 -24.6 ± 1.8 
BGNSH-HSA 67.1 ± 8.9 -20.9 ± 2.4 
BGNSH-HSA-ICG 68.1 ± 14.6 -16.6 ± 1.2 
BGNSH-HSA-ICG-
FA 
68.3 ± 12.3 -16.3 ± 1.7 
 
a) 
c) 
b) 
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The BGNSH-HSA-ICG-FA platforms exhibited excellent dispersivity and 
stability in bare PBS and PBS containing 10% (v/v) FBS (Figure 6.6c), with no 
aggregates observed visually or by optical microscopy. Hence, the nanoplatform 
structure should enable for a simultaneous effective DOXO release through the porous 
Au layer and photodynamic- and photothermal-induced tumoricidal effect using NIR 
light because of minimal absorption by water and hemoglobin at this wavelength range.  
To explore the photophysical and photochemical properties of BGNSH-HSA-
ICG nanoplatforms, we first compared the fluorescence intensity of BGNSH-HSA-ICG 
and free ICG. We observed that the fluorescence of ICG was enhanced once it was 
adsorbed onto the metal shell surface as a part of the protein complex due to a metal 
enhanced fluorescence effect (Figure 6.6b). In this regard, it has been previously shown 
that ICG fluorescence enhancement takes place upon dye adsorption onto a metal 
surface at separation distances between the metal surface and the adsorbed dye between 
7 and 50 nm [52]. This evidence suggested the existence of a multilayer protein 
structure on the BGNSHs surface which efficiently separated the dye molecules from 
the metal surface, avoiding their fluorescence quenching by the strong BGNSHs surface 
plasmonic effect.    
To evaluate the potential hyperthermic potential of the nanoplatforms, the 
temperature increase generated by NIR laser irradiation (808 nm and 2 W cm-2 for 10 
min) was measured (Figure 6.7a). The temperature of BGNSH-HSA-ICG solutions 
increased by ca. 19.5 ºC after 5 min of irradiation compared to ca. 15, 6 and 1 ºC of 
BGNSH-HSA, free ICG and buffer solutions, respectively. We also noted that the 
temperature rose rapidly within 3-4 min of irradiation, lying to a quasiplateau region 
afterwards. These results demonstrated the latent capability of the present 
nanoplatforms for hyperthermia or ablation of cancer cells, which was additionally 
enhanced thanks to the proper selection of the shell material and thickness (the HSA 
layer doped with ICG) with strong absorption in the NIR region [64]. Also, the heat 
generated by the nanoplatforms under NIR irradiation was sufficient to overcome the 
glass transition temperature of PLGA (45 ºC) to induce a sudden drug release of DOXO 
from nanoplatforms followed by a slower diffusion release phase. The amount of drug 
released was steeply increased (Figure 6.7b), coincident with NIR laser irradiation, 
which is certainly useful for increasing the tumoricidal effect of the nanoplatforms.  
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Figure 6.7: a) Temperature increases as a function of time under NIR light irradiation (808 nm 
at 2 W cm-2 ) of (T) PBS buffer solution with 10% (v/v) FBS, (z) BGNSHs, (S) free ICG and 
() BGNSH-HSA-ICG-FA, respectively. b) Release profile of DOXO from BGNSH-HSA-
ICG-FA nanoplatforms in the (z) absence and () presence of NIR irradiation (10 min).  
 
The possibility of using the BGNSH-HSA-ICG-FA nanoplatforms as potential 
PDT agents was tested by measuring their 1O2 generation capability under laser 
irradiation at 808 nm. Given that photodegradation may greatly restrict the efficiency of 
the nanoplatforms as potential PDT and PPT agents, we investigated the photostability 
of free ICG, BGNSH-HSA and BGNSH-HSA-ICG-FA nanoconstructs. First, the 
stability of the ICG fluorescence signal in the nanoplatform was greatly enhanced if 
compared with that of free ICG at similar concentration (5 μM) in the absence of 
irradiation, that is, whilst free ICG fluorescence decreases up to 50% in two days and 
7% in one week, complexed ICG to the nanoplatform maintained ∼ 55% of its original 
fluorescence after almost one month under storage (Figure 6.8a). On the other hand, 
fluorescence spectra after different time periods of laser irradiation showed that the 
fluorescence peak of ICG at ca. 810 nm decreased immediately after irradiation and 
almost dissapeared after 15 min under NIR light of 4 W/cm2 and 6 W/cm2 power 
density, while it barely changed after 30 min of persistent irradiation at 2 W/cm2 (Figure 
6.8b). It is worth noting that both LSPR of BGNSHs at 770 nm and the morphology of 
the nanoplatforms (Figure 6.8c) did not change under the latter irradiation conditions. 
These facts evidenced that BGNSHs were very stable upon continuous wave (CW) laser 
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irradiation at the selected NIR irradiation power, while complexed ICG molecules 
undergo certain photobleaching regardless anchoring on BGNSHs. 
 
 
Figure 6.8: a) Fluorescence stability of () free ICG and ({) ICG complexed to BGNSH-
HSA-ICG-FA nanoplatforms. Lines are to guide the eye. b) Photostability of BGNSH-HSA-
ICG-FA nanoplatforms after continuous illumination with NIR-light. c) TEM image of one 
BGNSH-HSA-ICG-FA after 30 min of irradiation at 2 W/cm2. Scale bar is 100 nm. 
 
The generation of 1O2 was determined quantitatively by following the 
absorbance intensity decay at 420 nm of 1,3-diphenylisobenzofurane (DPIBF), which is 
a specific singlet oxygen trap, as previously mentioned [56]. Based on the photostability 
results, we tested the 1O2 production after 30 min of illumination. 1O2 production was 
observed to increase up to 20 min oflaser irradiation and then, it reaches a quasi plateau 
region, which certainly indicates that a reduction in the singlet oxygen production took 
place (Figure 6.9). Also, the 1O2 production was enhanced as the irradiated energy input 
was larger. Interestingly, the 1O2 production of the BGNSH-HSA-ICG-FA 
nanoplatforms was slightly lower than that free ICG of similar concentration provided 
that the laser energy for the production of singlet oxygen was less in the former case 
a) b) 
c) 
Chapter VI: Fluorescent Drug-loaded PLGA-based Branched Gold Nanoshells for Localized 
Multimodality Therapy and Imaging of Tumoral Cells 
 
287 
 
than in the latter (that is, for BNSH-HSA-ICG-FA nanoplatforms laser energy is 
simultaneously absorbed by ICG and the metal shell to produce singlet oxygen and 
heat), in agreement with previous works [32, 41, 46]. By contrastm, the 1O2 generation 
ability of free ICG and BGNSH-HSA-ICG-FA nanoplatforms also obviously decreased 
after first 10 min of irradiation, which is consistent with the change in fluorescence 
intensity of ICG and HSA-ICG-FA complex (Figure 6.8b).  
 
 
 
 
Figure 6.9: Decay of absorbance of DPIBF after illuminating with 2 W cm-2 in pure water, 
BGNSH-HSA, BGNSH-HSA-ICG-FA and ICG. b) Decay of DPIBF absorbance at 420 nm 
discarding the contribution of photodegradation by laser and the contribution of 
thermodegradation induced by BGNSH-HSA at 2, 4 and 6 W cm-2. 
 
To determine the potential use of this kind of nanoplatforms as a potential 
fluorescence imaging contrast agent, in vitro and in vivo localization experiments of the 
nanoplatforms were performed. Confocal NIR images provided by ICG fluorescence 
b) 
a) 
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showed internalization of the nanoplatforms with an homogeneous distribution in the 
cytoplasm of MDA-MB-231 breast (Figure 6.10a-c) and HeLa cervical cancer cells 
(Figure 6.10d-f), probably ocurring via a receptor-mediated endocytosis pathway 
provided that both kind of cells overexpressed folate receptors on their surface [65, 66]. 
In vivo targeting visualization of the nanoplatforms was tested by preparing tumor-
bearing mice by implanting MDA-MB-231 cells into the subcutis of Balb/C nude mice. 
 When the tumor reached approximately 100 mm3 in size, intravenous 
administration of 10 mg/kg of BGNSH-HSA-ICG-FA into the mouse tail vein was 
performed. For comparison, HSA/ICG-loaded PLGA NPs with the same dye 
concentration were also administered as a control.  
 
 
 
Figure 6.10: a) Transmission, b) fluorescence and c) merged confocal NIR images of BGNSH-
HSA-ICG-FA nanoplatform internalization inside MDA-MB-231 cells. d) Transmission, e) 
fluorescence and f) merged images of fluorescence microscopy images of BGNSH-HSA-ICG-
FA nanoplatform internalization inside HeLa cells. In d-e) nuclei were stained with DAPI (blue 
channel, λexc = 355 nm) and ICG localization around nuclei was coloured in green (λexc = 712 
nm. 
 
a) b) 
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c) 
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Finally, we further evaluated in vitro the multidimensional therapeutic potential 
of the present BGNSH-HSA-ICG-FA nanoplatforms on systemic chemotherapy 
(DOXO), localized hyperthermia from the Au shell and photodynamic activity provided 
by ICG molecules in the absence and presence of NIR laser irradiation by cell-counting 
kit-8 cell proliferation assay (CCK-8). This test is based on the bioreduction of 2-(2-
methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, 
monosodium salt (WST-8), which produces a water-soluble formazan dye in the 
presence of an electron carrier, 1-methoxy phenazine methosulfato (PMS).  
Cell viabilities (CV) of HeLa and MDA-MB-231 cells treated with free DOXO, 
free ICG, BGNSH-HSA-FA, BGNSH-HSA-ICG, DOXO-loaded BGNSH-HSA-FA and 
DOXO-loaded BGNSH-HSA-ICG-FA in the absence and presence of laser illumination 
after 24 h are shown in Figure 6.13. The HSA-BGNSHs particles were completely non-
toxic as denoted their very low cytotoxocity. In addition, DOXO-loaded BGNSH-HSA, 
and DOXO-loaded BGNHS-HSAICG nanoplatforms also displayed low toxicities due 
to, on one hand, the slow diffusion of drug through the metal shell which cannot inhibit 
tumor-cell proliferation (if compared with the largest cytoxicity of free DOXO) and, on 
the other, due to the low citotoxicity of ICG as observed from the cytotoxicity values of 
the free dye.  
In comparison, NIR laser illumination (808 nm and 2 W cm-2 for 3 intervals of 5 
min, see experimental section for details) led to a noticeable increased in cell 
cytotoxicity. BGNHS-HSA-FA nanoplatforms decreased cell viability upon NIR 
irradiation as a consequence of the generation of the hyperthermic effect from the metal 
nanolayer, which led to protein denaturation and subsequent inhibition of normal 
cellular growth and proliferation [68] if compared to the non-irradiated sample. Also, it 
should be noted that BGNSH-HSA-ICG-FA nanoplatforms killed more cells than either 
free ICG or BGNSH-HSA-ICG after irradiation (Figure 6.13). Given that the 
cytotoxicity of BGNSH-HSA was negligible at low concentrations, this improved 
efficiency might be attributed to a possible enhanced cellular uptake of BGNSH- HSA-
ICG-FA and to a synergistic PDT/PTT effect. In order to confirm this point, we proceed 
to incubated BGNSH- HSA-ICG-FA with 100 mM sodium azide (NaN3) for 30 min 
before irradiation provided that NaN3 protect cells against PDT damage [32]. The 
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phototoxicity of BGNSH-HSA-ICG-FA with NaN3 turned to be similar to that of 
BGNSH-HSA-FA particles.  
Notably, for example, BGNSH-HSA-ICG-FA exhibited a synergistic cytotoxic 
effect in HeLa cells of 47.1% ((CVBGNSH-HSA+laser - CVBGNSH-HSA-ICG+laser)/ CVBGNSH-
HSA+laser) and 56.5% (CVfree ICG+laser - CVBGNSH-HSA-ICG+laser)/CV free ICG+laser) if compared 
with BGNSH-HSA nanoplatforms and free ICG, respectively. On the other hand, the 
chemotherapuetic effect of DOXO also led to an enhanced citotoxicity when loaded 
inside BGNSH-HSA-ICG-FA if compared to free DOXO and unloaded BGNSH- HSA-
ICG-FA particles as a consequence of the remote and sustained controlled release of the 
chemotherapeutic drug, which is favored by the partial meting of the polymeric core, for 
additional cytotoxic activity against the target cancer cell line. In this regard, DOXO-
loaded BGNSH-HSA-ICG-FA nanoplatforms exhibited an additional cytotoxic effect of 
74.0% ((CV BGNSH-HSA-ICG-FA+laser - CVDOXO-loaded BGNSH-HSA-ICG-FA+laser)/ BGNSH-HSA-ICG-
FA+laser) compared with unloaded BGNSH-HSA-ICG-FA nanoplatforms.  
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Figure 6.13: Cell viability of a) HeLa and b) MDA-MB-231cells after 24 h of incubation in the 
absence and presence of NIR light irradiation (2 W/cm2 at 808 nm in 3 intervals of 5 min each). 
Colors code: Yellow, free DOXO; Red, free ICG; Cyan, BGNSH-HSA-FA; Green, BGNSH-
HSA-ICG-FA; Violet, DOXO-loaded BGNSH-HSA-FA; Orange, DOXO-loaded BGNSH-
HSA-ICG-FA nanoplatforms. c) Cell viabilty of HeLa cells under irradiation in the presence of 
DOXO-loaded BGNSH-HSA-ICG-FA (orange), BGNSH-HSA-ICG-FA (pink), BGNSH-HSA-
ICG-FA + NaN3 (dark green), and BGNSH-HSA-ICG (dark blue). 
 
 
6.5 Conclusions 
In summary, we have successfully fabricated a potential smart theranostic 
nanoplatform composed of a chemotherapeutic agent (DOXO) and a polymer-based 
gold shell which additionally combines localized photothermal activity provided by the 
metal shell and generation of singlet oxygen species by an incorporated ICG 
photosensitizer under NIR light illumination. The gold nanolayer was functionalized 
with an HSA-ICG-FA complex to provide, on one hand, stealthness to the nanoplatform 
and, on the other, photodynamic therapy, fluorescence-based imaging and targetability 
abilities In addition, the thickness of the protein layer was suitable to provide an 
enhancement of the dye fluorescence by the plasmonic coupling of the metal nanolayer. 
In vitro confocal fluorescence imaging confirmed the successful cell internalization of 
the hybrid nanoplatforms whilst in vivo fluorescence imaging demonstrated that 
nanoplatforms are highly localized and retained in the tumor region for long time. The 
simultaneous combination of chemotherapy, hyperthermia and oxygen reactive species 
led to an enhanced in vitro cell cytotoxicity, as measured in two different cancer cell 
lines. Further studies are being developed to minimize light irradiation doses and 
nanoplatform concentrations by optimization of the synthetic protocols , to add new 
functionalities and to quantify the cytotoxic potential of the nanoplatforms in vivo. 
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CHAPTER VII - Targeted Combinatorial Therapy 
Using Gold Nanostars as Theranostic Platforms 
 
7.1 Summary 
 In this chapter, we present the development of multimodal therapy nanoplatoform 
based on gold nanostars (Au NS) as core particles. These NS are functionalized the 
chemotherapeutic drug doxorubicin (DOXO), which is conjugated to the NS surface by means 
of a cleavable heterofunctional crosslinker (sulfo-LC-SPDP) to allow its relase under the 
action of reducting enzymes. To ensure a specific delivery of the chemotherapeutic drug, the 
nanoplatoform is additionally functionalized with folic acid (FA) as targeting ligand and 
cellular uptake adjuvant. By synthetically modifying the plasmon band of Au NS to the near 
infrared (NIR) region of the electromagnetic spectrum, the present nanoplatform are able to   
simultaneously combinethe capability of phototothermal therapy (PTT),through the 
conversion of absorbed light energy into localised heat, and chemotherapy, enabling their 
monitoringby means of optical fluorescence imaging thanks to DOXO autofluorescence. The 
cellular uptake was observed to be enhanced when the targeting ligand are bound to the 
nanoplatform. In addition, the therapeutic efficiency of the nanoplatformtested in HeLa cells 
demonstrated the larger cytotoxicity efficiency of the combined therapies if compared to 
individual ones. 
 
7.2 Introduction 
 During last decades enormous efforts have been done to develop new effective 
methods for cancer therapy. Those relying on a single therapeutic treatment such as 
chemotherapy, radiotherapy, immunotherapy, gene therapy, thermotherapy or 
photodynamic therapy, although effective, still present different and important 
drawbacks such as inespecificity, very toxic side effects and/or development of  cell 
resistances amongst others, which compromise many times the recovery of patients[1-
4].In contrast to single treatments, the combination of several therapeutic approaches 
(the so-called multi-modality therapy) with different drugs and techniques may 
cooperatively supress cancer development with potential advantages (e.g., synergistic 
efffects and reversal of drug resistance) and reduced side effects[5-9]. 
Gold-based nanomaterials have attracted great interest in the field of cancer 
diagnosis and treatment because of their enhanced optical properties including strong 
light absorption and scattering in the visible and near-infrared (NIR) wavelength 
regions related to their localised surface plasmon resonance (LPSR)[10-12], 
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biocompatibility, colloidal and chemical stability and ability to be functionalised 
through reactive groups of the capping agents (e.g. amino or carboxyl groups) or 
through thiol-mediated binding to the gold surface [13-15]. In particular, gold 
nanostructures have been investigated as suitable platforms for combinatorial 
therapeutics, especially for the conjunction of chemo- and phototherapy by exploiting 
the ease of gold functionalization and the possibility of matching the wavelength of 
irradiating light with the LPSR of the nanostructure; in this case, coherent oscillations 
of electrons in the conduction band will induce photothermal conversion by 
converting the absorbed light to heat [16-18]. 
A variety of gold anisotropic nanoparticles (NPs) such as gold nanorods[19-
22], nanocages[23-25], hollow nanospheres[26, 27], nanoshells[28-31]or branched 
nanoparticles[32-35] typically exhibit LPSRs in the NIR region, the so-called “tissue 
therapeutic window” because of the lower optical attenuation from water and blood 
components in this spectral range (650-900 nm)[36] and their abilityto produce 
cytotoxic hyperthermia upon NIR laser irradiation when localised temperature is 
above 43 ºC, which kills malignant cells though apoptosis or necrosis[37].Also, these 
anisotropic NPs can be passively or actively concentrated in the tumor region due to 
an enhanced permemability and retention (EPR) effect or specific biotargeting, 
respectively, with long serum half-life circulation times[38-40]. 
Particularly, the use of branched AuNPs or gold nanostars (Au NS) with 
plasmon peaks tunable in the NIR range is of special interest thanks to their ease of 
synthesis for large scale production and size tunability, LPSR bands in the NIR 
window for deep bioimaging and great potential for NIR energy absorption due to 
high scattering cross-section ratios for efficient photothermal transduction, large 
surface-to-volume ratios useful for improving drug loading, and multiple sharp 
branches acting as “hot-spots” for Surface enhanced Raman spectroscopy (SERS)-
based (bio)sensing[41-44]. 
Hence, apart from their great interest in biomedical fields such as 
plasmonic[45, 46]and SERS biosensors[42, 47-50]and bioimaging[33, 43, 51-53],this 
kind of nanoparticles have found important applicationsduring last years as single 
therapeutic probes to fight agains tumors by explotation of their light absorbing and 
binding properties in photodynamic (PDT)[44, 54], photothermal (PTT)[32, 35, 54, 
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55]; therapies, and photocontrolled-drug release[56] while using incident NIR light 
for irradition.  
In contrast, to the best of our knowledge almost no works have exploited the 
potential role of Au NS as multitherapeutic nanoplatforms for multimodal treatment 
of tumors. In this regard, Wang et al.[57] constructed pegylated Au NS functionalized 
with the photosensitizer Ce6 for coordinated photodynamic/plasmonic photothermal 
therapies upon single continuous wave (CW) laser irradiation. Both in vitro and in 
vivoexperiments demonstrated that the difference in photostability between 
photosensitizers and the gold nanostructure can be used to modulate PDT and PTT by 
adjusting the irradiation time. It is necessary to mention that while preparing the 
present work, Chen et al. [59] also reported in vitro and in vivo studies ofa 
multimodal chemo- and photothermal therapeutic system based on Au NS covalently 
functionalized with the peptide cyclic RGD as a targeting moiety.  
In the present study, Au NS prepared by reducing Au3+ in N,N-
dimethylformamide (DMF)[58] followed by pegylation. The chemotherapeutic drug 
doxorubicin (DOXO, an intercalating DNA agent and  topoisomerase II inhibitor)[60] 
was grafted onto the surface of the polyethylene glycol (PEG)-functionalized Au NS 
through disulfide linkagesfor enzymatic-responsive controlled drug delivery, in 
contrast to the system developed by Chen et al.Folic acid, a targeting ligand which 
avidly binds to folate receptorsoverexpressed in different classes of tumors such as 
ovarian, breast, colon, renal or lung ones [61] was covalently linked to the surface of 
PEG-Au NS via carbodiimide chemistry to configure a multitherpautic nanconstruct 
integrating targeting, chemo- and photothermal therapies (folic acid-targeted Au NS, 
FA-DOXO/Au NS). The affinity of DOXO/Au NS and FA-DOXO/Au NS to a 
cervical cancer Hela cell line, which overexpresses folate receptors, was examined by 
fluorescence microscopy by using the inherent fluorescence of the drug. Furthermore, 
we also compared the chemo-photothermal therapeutic efficaciy of FA-DOXO/Au 
NS, DOXO/Au NS, FA/Au NS, Au NS and free DOXO in Hela cells under different 
concentrations and NIR light irradiation conditions, demonstrating the existence of a 
synergistic effect when applying the combinatorial treatments.  
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7.3 Materials and methods 
 
7.3.1 Materials 
 Hydrogen tetrachloroaurate (III) trihydrate (HAuCl4), N-(3-
dimethylamniopropyl)-3-ethylcarbodiimide hydrochloride (EDC), sulfo-N-
hydroxysuccinimide (Sulfo-NHS), trisodium citrate dihydrate, sodium borohydride 
(NaBH4, 99%), ascorbic acid, potassium carbonate (K2CO3), doxorubicin 
hydrochloride (DOXO HCl), folic acid (FA), glutathione (GSH), PBS and HEPES 
bufferswere purchased from Sigma Aldrich Co (St. Louis, Missouri, USA). 
Sulfosuccinimidyl 6-(3´-[2-pirydildithio]-propiamido) hexanoate (Sulfo-LC-SPDP), 
Traut´s and Ellman´s reagents were purchased from Pierce (Rockford, Illinois, USA). 
Dialysis membrane tubing (molecular weight cutoff ∼100-500 and ∼3500 Da) was 
purchased from Spectrum Laboratories, Inc. (Rancho Dominguez, CA, USA).Thiol-
PEG amine (HS-PEG-NH2, molecular weight 5000 Da) was from Polymer Source 
(Ontario, Canada). Poly(vinylpyrrolidone) (PVP K15, 10000 Da) and DMF were from 
Fluka (St. Louis, Missouri, USA).ProLong® Gold antifade reagent with DAPI, 
Dulbecco’s Modified Eagle Medium, crystal violet solution, fetal bovine serum 
(FBS), L-glutamine, penicillin/streptomycin, sodium pyruvate, and MEM Non-
Essential Amino Acids (NEAA) were purchased from Invitrogen (Carlsbad, USA). 
HeLa cervical cancer cells were from Cell Biolabs (San Diego, CA, USA). All other 
chemicals and solvents were of reagent grade (purchased from Sigma–Aldrich). Milli-
Q water was used for all aqueous solutions. All glassware was washed with aqua regia 
and HF 5% (v/v) and extensively rinsed with water. All the chemicals were of 
analytical grade and used without further purification. 
 
7.3.2 Synthesis of pegylated Au NS 
 Au NS were prepared by a seed-mediated method as previously described[58]. 
Typically, gold nanoparticles (Au NPs) of 15 nm were prepared by standard citrate 
reduction and used as seeds[62]. Briefly, 5 mL of 1 wt.% sodium citrate aqueous 
solution was added under continuous stirring to a boiling aqueous solution of HAuCl4 
(100 mL, 0.5 mM) and allowed to react for 15 min. Then, Au particles were 
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transferred into ethanol through PVP modification. Thus, 5 mL of a PVP aqueous 
solution containing a sufficient amount to provide approximately 60 molecules of 
PVP per nm2 of gold was added dropwise to the Au colloid and allowed to react 
overnight. Finally, the solution was centrifuged at 4000 rpmfor 90 min, the 
supernatant removed, and the particles redispersed in ethanol. 
 For obtention of Au NS, in a typical synthesis 82 μLofan aqueous solution of 
50mMHAuCl4 was mixed with 15 mL of10 mM PVP solution in DMF. After the 
complete disappearance of the Au3+CTTS absorption band at 325 nm, acertain 
amount of preformed-seed dispersion was added undercontinuous stirring and allowed 
to react until completion of thereaction (no further changes in the UV-vis-NIR 
spectra). Theratio of [HAuCl4] to [seed] was set to 90. Au NS solutions were 
centrifuged three times at 4500 rpm for 45 min, redispersed in water and stored. 
Au NS were pegylated by mixing 1 mL of Au NS aqueous solution (1.65 
mM), 2 mL of HS-PEG-NH2 (4 mM) and 2 mL of K2CO3 (10 mM) under continuous 
stirring overnight. For removing the unattached HS-PEG-NH2, the nanoparticle 
solution was centrifuged three times at 10500 rpm and redispersed at a concentration 
of 0.25 mM. 
 
7.3.3 Preparation of SH-DOXO-SS 
 Firstly, 50 μL of DOXO (3.4 mM), 50 μL of Traut´s (34 mM) and 5 μL 
EDTA in PBS (pH 7.4) were incubated for 1 h at room temperature. .The yield of the 
reaction (thiolated DOXO) was 80% as determined by Ellman´s reagent assay 
following manufacturer´s specifications. Afterwards, 14 μL of this solution were 
reacted with 1 mL of sulfo-LC-SPDP (4 mM) in HEPES buffer (pH 7.4) for 24 h. 
Excess reagents were eliminated by centrifugation using Zeba spin columns . 
 
7.3.4 Preparation of Au NS-PEG-SS-DOXO/FA nanoconjugates 
In a first step, folic acid was activated by placing 1 mL of a folic acid solution (2 mM) 
in HEPES buffer reacting with EDC (4 mM) and sulfo-NHS (4 mM) for 6 h. Excess 
reagents where eliminated by extensive dialysis. Subsequently, 1 mL of SH-DOXO-
SS, 1 mL of FA-EDC-Sulfo NHS and Au NS (0.25 mM) were mixed in HEPES 
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buffer overnight at room temperature. Excess DOXO and FA were removed by 
centrifugation (9000 rpm, 8 min) followed by dialysis when required. Nanoconjugates 
were redispersed in HEPES buffer. The conjugates were stored in Milli-Q water  at 
4°C. 
 
7.3.5 Nanoconjugates characterization and drug loading 
 The Au NS size and morphology were characterized using transmission 
electron microscopy (TEM). TEM was performed on a Carl Zeiss Libra 200 Fm 
Omega electronic microscopes operating at 120 kV. Samples were prepared for 
analysis by evaporating a drop of the nanoconjugate dispersion on a carbon-coated 
copper grid without staining. A histogram of the particle size distribution and 
theaverage particle diameter was obtained by measuring about 200particles in an 
arbitrarily chosen area in the photomicrograph. Au NS conjugate hydrodynamic sizes 
were also measured by dynamic light scattering (DLS) at 25 °C by means of an ALV-
5000F (ALV-GmbH, Germany) instrument with vertically polarized incident light (λ 
= 488 nm) supplied by a diode-pumped Nd:YAG solid-state laser (Coherent Inc., CA, 
USA) operated at 2 W, and combined with an ALV SP-86 digital correlator (sampling 
time 25 ns to 100 ms). ζ-potentials were measured with a Zetasizer Nano ZS 
(Malvern, UK) using dispossable folded capillary cells. Samples were measured in 
triplicate in PBS (pH 7) at 25 °C. Optical characterization of the nanoconjugates was 
carried out by UV-vis-NIR and fluorescence spectroscopies with a Cary Bio 100 
spectrophotometer and a Cary Eclipse spectrfluorometer, respectively (Agilent 
Technologies, USA). The gold concentration in solution was determined by 
inductively coupling plasma-mass spectrometry (ICP-MS) in a Varian 820-MS 
equipment (Agilent Technologies, USA).The number of Au NS was calculated 
assuming a sphere model of 90 nm in diameter. 
 
7.3.6 NIR-laser induced temperature increase  
Temperature increment tests as a function of time were used to determine the 
phothotermal activity of the hybrid nanoconjugates. These tests were performed with 
a continuous wave fiber-coupled diode laser source of 808 nm wavelength (50W, 
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Oclaro Inc, San Jose, CA, USA). The laser was powered by a Newport 5700-80 
regulated laser diode driver (Newport Corporation, Irvine, CA, USA). A 200-μm-core 
optical fiber was used to transfer laser power from the laser unit to the target solution, 
and equipped with a lens telescope mounting accessory at the output, which allowed 
for tuning of the laser spot size in the range 1-10 mm. The output power was 
independently calibrated using an optical power meter (Newport 1916-C) and laser 
spot size was previously measured with a laser beam profiler (Newport LBP-1-USB), 
which was placed at the same distance (8 cm) between the lens telescope output and 
the quartz cuvette (or the 96-well plate). For measuring the temperature change, 2 mL 
of Au NS-PEG nanoconjugatesin cell culture medium supplemented with 10% (v/v) 
FBS were placed in a quartz cuvette and irradiated for different times (0-10 min) at 
several laser power densities. The temperature of samples was measured with a type J 
thermocouple linked to a digital thermometer inserted into the solution. 
 
7.3.7 Drug loading efficiency and release kinetics of DOXO  
 To calculate the DOXO loading efficiency, Au NS-PEG-SS-DOXO-FA 
nanoconjugates were collected by centrifugation and the unconjugated DOXO in the 
supernatant was quantified by using a DOXO UV-vis calibration curve at 490 nm. To 
corroborate DOXO concentration in some cases, this was also determined by 
fluorescence spectroscopy. Au-PEG-SS-DOX wasfirst treated with dithiothreitol 
(DTT) for 4 h, and the freeDOXO-SH was separated by dialysis. The 
fluorescenceintensity of DOXO-SH was calibrated, and the concentration ofbound 
DOXO was determined from known concentration of freeDOXO-SH in gold solution 
obtained after dialysis treatment.The DOXO loading was calculated according to the 
formula: drug loading (DL) = (mass of drug conjugated with Au NS / total mass of 
drug conjugated and Au NS). 
 To investigate the in vitro DOXO release profile, PBS containing 10% 
(v/v)FBS with or without GSH (10 mM) were used to release DOXO fromAu NS-
PEG-SS-DOXO-FAby dialysis. Dislysate (2 mL) was withdrawn at different time 
intervals and an equal volume of PBS was added to the solution outside of the dialysis 
bag to maintain the net volume of the system. The absorbance peak (490 nm) of the 
solutions was detected, and the quantities of free drug were calculated by using a 
Chapter VII: Targeted Combinatorial Therapy Using Gold Nanostars as Theranostic Platforms 
 
308 
 
standard calibration curve. 
 
7.3.8 Cellular uptake by confocal microscopy 
HeLa cervical cancer cells from Cell Biolabs (San Diego, CA, USA) were 
used for in vitro studies. Nanoconjugates(Au NS-PEG-SS-DOXO and Au NS-PEG-
SS-DOXO-FA) uptake was followed by confocal microscopy by seeding HeLa cells 
on poly-L-lysine coated glass coverslips (12 × 12 mm) placed inside 6-well plates (3 
mL, 1.5·104 cells/well) and grown for 24 h at standard culture conditions (5% CO2 at 
37 ºC in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% (v/v) 
FBS, 2 mM L-glutamine, 1% penicillin/streptomycin, 1 mM sodium pyruvate, and 0.1 
mM MEM Non-Essential Amino Acids (NEAA)). Then, nanoconjugates at the 
desired concentration were added to cells (100 μL). After 2 h of incubation the Au 
NS-containing cells were washed three times with PBS, then, fixed with 
paraformaldehyde 4% (w/v) for 10 min, washed again with PBS pH 7.4, mounted on 
glass slides and stained with ProLong® Gold antifade DAPI to stained nuclei, and 
cured for 24 h at -20 °C. Confocal images of DOXO were made using the 
autofluorescnece of DOXO with a confocal spectral microscope Leica TCS-SP2 
(LEICA Microsystems Heidelberg GmbH, Mannheim, Germany; green channel for 
DOXO, λexc. 488 nm; blue channel for DAPI, λexc. 355 nm).Both bright-view 
differential interference contrastimages and confocalfluorescence images were 
obtained with a 40X (NA 1.2) and 63X (oilimmersion, NA 1.4) objectives. 
 
7.3.9 In vitro cytotoxicity 
To quantitatively evaluate the effect of the nanoconjugates on HeLa cells, 
cytotoxicity induced by the nanoconjugates was determined by the crystal violet 
assay. HeLa cells with an optical confluence of 80–90% were seeded into 96-well 
plates (100 µL, 1.5·104 cells/well) and grown for 24 h at standard culture conditions. 
The cells were treated with 100 μL of free DOXO, Au NS-PEG, Au NS-PEG-SS-
DOXO, Au NS-PEG-SS-DOXO-FA. FA receptors of HeLa cells in several wells 
were previously blocked with excess FA prior addition of Au NS-PEG-SS-DOXO-
FA. The dose of nanoconjugates was set according to the contained DOXO 
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concentrationin Au NS within a range of 0.2–5μM DOXO.After cells were incubated 
for 4h, the photothermal treatment was then performedusing a 808 nm laser. The 
beam diameter was 1.0 cmand the power density of the laser source was fixed at 
2.0W/cm2 . The cells were exposed under the 808 nmlaser for 10 min, and then 
incubated for another 18 h. Afterwards, the culture medium was discarded and the 
cells were washed with 10 mM PBS, pH 7.4 several times. The cells were shaken at 
room temperature (300 rpm, 15min) in the presence of 10 µL of a glutaraldehyde 
solution (11% (w/v) in water). The solution was discarded and cells were washed 3-4 
times with PBS. The cells were then shaken at room temperature (300 rpm, 15 min) in 
the presence of 100 μL of a crystal violet solution (0.1% w/v in 200 mM 
orthophosphoric acid, 200 mM formic acid, and 200 mM 2-N-morpholino-
ethanesulfonic acid (MES), pH 6). The solution was discarded, and the cells were 
again washed 3-4 times with milli-Q water. Once washed, the cells were left for 
incubation at room temperature overnight for drying. Once dried, the cells were 
shaken at room temperature (300 rpm, 15min) in the presence of 100 µL of acetic acid 
(10% w/w in water). Immediately after, the absorbance of the resulting solution was 
measured with a Microplate Reader (FLUOstar Optima, BMG Labtech GmbH, 
Germany) operating at 595 nm. All experiments were triplicate carried out. The 
growth inhibition was quantified as: 
 
% Inhibition ൌ 100 െ ଵ଴଴כ୓୅୘୅    (Eq. 7.1) 
 
where OA and TA stand for the absorbance of studied samples and negative controls 
(cells in the absence of NPs), respectively. 
 
7.4 Results and discussion 
 
7.4.1 Nanoconjugate characterization 
The reaction for the synthesis of Au NS-PEG-SS-DOXO-FA is illustrated in 
Scheme 1. Au NS were prepared by a seed-mediated procedure in DMF in the 
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presence of PVP as the capping agent. Then, Au NS were modified by covalently 
thiol Au-S bonding of HS-PEG-NH2onto Au NS surfaces. The biocompatible HS-
PEG-NH2 not only serves as a coating to reduce protein adsorption and nonspecific 
machrophage uptake, but also as a linking agent providing terminal functional groups 
for conjugation of ligands and biomolecules. Here, we followed a previously 
developed approach to incorporate a disulfide bond[63] onto the Au NS surfaces in 
order to achieve an enzyme-triggered release of a thiolated bounded chemotherapeutic 
drug (DOXO-SH) upon cell internalization of the hybrid nanoconjugate. To do this, a 
heterobifunctional cross-linker sulfo-LC-SPDP was used to obtain Au NS-PEG-SS 
conjugates. Then, a free sulfhydryl group was grafted to DOXO through modification 
of the drug witht Traut´s reagent to obtained DOXO-SH. The confirmation of DOXO 
thiolation was performed by an Ellman´s reagen assay, which confirmed a yield of ca. 
80%. Upon combination of the DOXO-SH with Au NS-PEG-SS, stable disulfide 
linkages were formed between the Au NS and the drug. Finally, to provide 
targeability to the nanoconjugates folic acidwas covalently attached to the remaining 
amine-PEG chains by carbodiimide chemistry. 
 TEM images illustrated the morphology of the functionalized Au NS before 
and after DOXO conjugation.The average diameter of the Au NS before and after 
drug conjugation was rather similar (ca. 92 ±20 nm) indicating they were well 
dispersed after DOXO conjugation (Figure 7.1a-b). Dynamic light scattering was used 
to measure the hydrodynamic size of Au NS and confirmed that PEG, DOXO and FA 
were conjugated sequentially in the manner illustrated in Figure 7.2. The 
hydrodynamic diameter of PVP-functionalized Au NS was 112 ± 23 nm. After 
immobilization of PEG, Au NS diameter was rather similar to that of PVP-stabilized 
Au NS (107 ± 21 ), and was further increased to 129 ± 28  by subsequent coating with 
DOXO and FA through linkage with the LC-sulfo-SPDP linker (Figure 7.1c). 
 The modification of Au NS by DOXO and FA was monitored by UV-vis 
absorption fluorescence and Fourier Tranform infrared (FT-IR) spectra (Figure 7.3). 
Consistent with previous reports [55, 58], Au NS-PEG showed an absorbance peak at 
ca. 808 nm which is 18 nm red-shifted compared to that of PVP-stabilised Au NS (∼ 
790 nm). Free DOXO and FA displayed chaarcteriatic peaks at ca. 490 and 360 nm, 
respectively [64]. 
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 Au NS-PEG-SS-DOXO-FA nanoconjugates still exhibited the characterisitc 
absorption peaks of DOXO and FA, respectively, with an additional 9 nm red-shift in 
the plasmon band of Au NS as a consequence of the increase in the refractive index 
around the metal NP surface and the absence of aggregation, in agreement with TEM 
and DLS[58]. Fluorescence spectra also confirmed the successful attachment of 
DOXO to the Au NS. The fluorescence peak of DOXO did not shift after conjugation 
with Au NS (Figure 7.3b). Also, quenching of DOXO fluorescence was not observed, 
and if exists, this was minimaldue to the limited extent of overlap between absorption 
spectrum of Au NS and emission spectrum of DOXO. In this regard, linkers with long 
chains could be anchored on the surfaces of Au NS, which may perturb the energy 
transfer by increasing the distance between Au NS and the attached molecule; in 
addition, quenching efficiency decreases with increasing nanoparticle diameter, which 
is favored the relatively large size of Au NS[65-67].The estimated DOXO loading 
rate was 3.1% (w/w) by quantifying the unconjugated DOXO in the supernatant by 
both UV-vis and fluorescence data.  
 
 
Figure 7.3: a) Normalized UV-Vis spectra of Au NS-PVP (⎯), Au NS-PEG (⎯), free DOXO (20 μM, 
⎯), free FA (⎯) and Au-NS-PEG-SS-DOXO-FA (⎯) in HEPES buffer (pH 7.4). Arrows denote the 
peaks corresponding to DOXO and FA in Au-NS-PEG-SS-DOXO-FA nanoconjugates. b) 
Fluorescence spectra of free DOXO initially added (20 μM, ⎯), free DOXO in the supernatant (⎯), 
and Au-NS-PEG-SS-DOXO-FA (⎯) in HEPES buffer (pH 7.4).  
 
 To further verify the presence of the disulfide linkage in Au NS-PEG-SS-
DOXO, DTT was added to a solution of these nanoconjugates provided that it cleaves 
and reduces disulfide linkages into free sulfhydryls[68]. We treated Au NS-PEG-SS-
DOXO with an excess amount of DTT (10 mM) for cleaving and detaching DOXO 
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from Au NS, and separated DOXO-SH through dialysis. The resulting Au NS 
solution exhibited a drastic decrease in DOXO fluorescence after 2h of incubation, 
which confirmed the previous formation of disulfide bonds on nanocinjugate´s 
surfaces (Figure 7.4a). 
 
 
Figure 7.4: a) Decrease in DOXO fluorescence before (⎯) and after (⎯) DTT addition (15 
mM) to Au NS-PEG-SS-DOXO-FA nanoconjugates dispersed in HEPES buffer (pH 7.4). b) 
Fluorescence spectra of Au NS-PEG-SS-DOXO-FA nanoconjugates dispersed in HEPES 
buffer (pH 7.4) immediately (⎯) and after 12 h (⎯) of incubation. c) In vitro DOXO release 
profile in HEPES buffer containing 10% (v/v) FBS (pH 7.4) in the absence (z) and presence 
() of glutathione (10 mM). 
 
 To investigate the stability of the nanoconjugates, UV-vis spectra of Au NS 
and Au NS-PEG-SS-DOXO-FA in cell culture medium with 10 % (v/v) fetal bovine 
serum immediately and after 12 h incubation were measured (Figure7.4b). Noshifts in 
the absorption spectra were detected and, in particular, in the plasmon peak of Au NS, 
which denoted the absence of particle aggregation upon incubation.  
On the other hand, we analyzes the in vitro release profiles of DOXOAu NS-
PEG-SS-DOXO nanoconjugates in the absence and presence of 10 mM glutathione 
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(GSH). In this way, we tried to simulate the reducing conditions inside cells provided 
that glutathione is a major endogenous antioxidant produced by the cells, participating 
directly in the neutralization of free radicals and reactive oxygen compounds, as well 
as maintaining exogenous antioxidants such as vitamins C and E in their reduced 
(active) forms[69]. It also reduces disulfide bonds formed within cytoplasmicproteins 
to cysteines by serving as an electron donor. 
As would be expected, DOXO release was much faster in PBS buffer 
containing 10 % (v/v) FBS and glutathione (10 mM) than in its absence. Almost 42% 
of DOXO was release from Au NS-PEG-SS-DOXO in the initial 4 h when incubated 
with glutathione, and an almost complet release was achieved at 24 h incubation. In 
contrast, only ca. 30% of drug was released in the solution without the peptide upon 
incubation for more than 24 h.  
On the other hand, Au NS have plasmon bands tunable in the NIRtissue 
optical window. These kind of nanoparticles are verystable, with a high potential to 
effectively transduceabsorbed laser light energy into heat[57]. Hence, the presence of 
the Au NS nanoconjugates in cell growth medium with 10% (v/v) FBS generated 
significant temperature increases upon NIR-light excitation which matches the 
plasmon resonance peak of the Au NS. The solution temperature increments 
depended on the energy input and/or the nanoconjugate concentration (Figure 7.5a-b). 
For example, Au NS-PEG nanoconjugates at the lowest concentration (1·108 NP/mL) 
attained a maximum temperature increase of 12.5 ºC under a NIR irradiation of 3 
W/cm2 for 10 min. A similar temperature increment is achieved at the largest Au NS 
concentration tested (1·1011 NP/mL) but using an input energy three times lower (1 
W/cm2)for only 7 min. 
It should be noted that the photostability of gold nanostructures is different 
under pulse laser and countinuous wave (CW)lasers. Femtosecond or nanosecond 
pulse lasers can melt andreshape gold nanostructures to nanospheres even in 
picoseconds[70-72]. This irreversible transformation of shape will 
dramaticallydeteriorate their heat producing ability[70, 73].On thecontrary, gold 
nanostructures are extremely stable under CWlaser in aqueous solutions or biological 
tissues[74]. To check this point, we recordedthe UV–vis spectra of Au NS(1·1010 
NP/mL) upon laser irradiation at 2 W/cm2 for 1 h and 6 h. As shown in Figure 
7.5c,only slight differencesare observed in the UV–vis spectra after 1 h of irradiation, 
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probably due to a lower surface rougheness of the Au NS as a consequence of less 
acute spikes due to localised melting of some apexes, as observed in TEM (Figure 
7.5d). However, when increasing the irradiation time for 6 h an evident broadening of 
the plasmon peak of the Au NS was present due to shape transformation and some 
aggregation of the nanoparticles. Therefore, it is preferable to use CW laser instead of 
pulse laser, so that the therapeutic efficiency of photothermal treatment can 
accumulate to the desired level by simply adjusting the irradiation time and power. 
 
 
Figure 7.5: a) Temperature increments of Au NS-PEG particles (1·1010 NP/mL) in HEPES 
buffer with 10% (v/v) FBS (pH 7.4) upon NIR laser illumination of different intensities (808 
nm). b) Temperature increments as a function of irradiation intensity of Au NS-PEG PBS 
solutuins (10% (v/v) FBS added) of different concentrations under NIR laser illumination 
(808 nm, 10 min). c) UV-vis spectra of Au NS in HEPES buffer (pH 7.4) before (⎯) and 
after 1 (⎯) and 8 h (⎯) of light irradiation at 808 nm and 2 W/cm2. d) TEM image of Au NS 
after 1 h of irradiation at 2 W/cm2. 
 
7.4.2 Cellular uptake of nanoconjugates 
 To visualize the cellular uptake of the nanoconjugates, the red fluorescence 
emitted by DOXO from Au NS-PEG-SS-DOXO and Au NS-PEG-SS-DOXO-FA was 
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captured by laser confocal microscopy after incubation with cervical HeLa tumor 
cells which overexpressed folate receptors in their membrane surfaces (Figure 7.6). 
The weak red fluorescence of DOXO from Au NS-PEG-SS-DOXO in HeLa cells 
indicated that a low amount of nanoconjugates entered inside cells, and they were 
exclusively confined inside the cell cytoplasm (Figure 7.6a). By contrast, Au NS-
PEG-SS-DOXO-FA uptakewas enhanced if compared to that of Au NS-PEG-SS-
DOXO. In addition, certain incorporation of the drug inside the cell nuclei (as 
corresponds for DOXO acting as a DNA intercalating agent) could also be observed 
for Au NS-PEG-SS-DOXO-FA, which further proved the enhanced cell uptake of the 
FA-functionalized nanoconjugatesin the time scale analyzed (Figure 7.6b). 
 
 
 
Figure 7.6: Transmission, fluorescence confocal and overlaid images of a) Au NS-PEG-
DOXO and b) Au NS-PEG-SS-DOXO-FA (1 μM DOXO) after 2 h of incubation. Nuclei 
were stained with DAPI (blue channel, λexc. = 365 nm); DOXO autofluorescence was 
registered by light excitation at λexc. = 485 nm. Scale bars 10 μm. 
 
 In this regard, Dam et al.[56] designed a nanostructure composed of nucleolin-
specific aptamer and Au NS which wereactively transported to the nucleus after 5 h 
incubation,and inducedmajor changes to the nuclear phenotype. In anotherstudy by 
Yuan et al.[54], TAT-peptide functionalizedAu NS were observed in the nuclear 
region bytwo-photon photoluminescence imaging. However,they did not find any true 
intranuclear TAT-NS exceptsome particles in the nuclear cleft. These 
resultssuggested that the red fluorescence observed from thenucleus in our study may 
be contributed by free DOXOreleased from Au NS-PEG-SS-DOXO-FA as a result of 
the disulfide bond breakage.On the other hand, 3D-reconstruction images of thin 
a) 
b) 
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were compared by using the crystal violet assay (Figure 7.8a).  
All samples showed dose-dependent anti-tumor activity. At thehighest dose 
level, the inhibition ratio of Au NS PEG-SS-DOXO-FA was above 90 % of total 
cells, whichwas much higher than that of Au NS-PEG (67 %), DOXO (58%) and Au 
NS-PEG-SS-DOXO (86 %) at the same dose level.With the increase in concentration 
ofAu NS-PEG-SS-DOXO-FA nanoconjugates, the cell viability distinctively 
decreasedafter incubation for 24 h. The cell mortality could be directly observed by 
optical microcopy. Under the combination of NIR irradiation and selective 
chemotherapy, cells completely lost their integrity and only aggregates of membrane 
components were seen (Figure 7.8b-c).  
 
 
Figure 7.8: a) Cell viability of HeLa cells after 24 h of incubation in the absence and presence of 
NIR light irradiation (2 W cm-2 for 10 min at 808 nm) at different DOXO concentrations assayed 
by the crystal violet method. Colors code: Black, free DOXO; Red, free DOXO+NIR light; Cyan, 
Au NS-PEG; Green, Au-NS-PEG+NIR light; Magenta, Au NS-PEG-SS-DOXO+NIR; Yellow, Au 
NS-PEG-SS-DOXO-FA+NIR light; Orange, Au NS-PEG-SS-DOXO-FA+NIR light after 
saturating FA cell receptor by addition of an excess amount of free FA. b) Optical microscopy 
images of NIR-irradiated HeLa cells (808 nm, 2 W/cm2 for 10 min) b) in the absence and c) 
presence of Au NS-PEG-SS-DOXO-FA (5 μM DOXO). 
b) c) 
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 As observed from experimental data, most cellscould take up certain amounts of Au NS-
PEG-SS-DOXO butthe resulting cytotoxicity was lowerthan that of Au NS PEG-SS-DOXO-FA. 
Thus, the FA molecular guideon the surface of Au NS recognizedfolate receptors and 
mediatedinternalization of the nanoconjugates in cells, as observed when previously adding free 
FA in excess to the sample cells, in agreement with results present in previous 
chapters.Subsequent endosomal transport and lysosomal degradationcould release the toxic 
DOXO from Au NS-PEG-SS-DOX-FA to induce apoptosis in cancer cells, which involed evident 
cellular morphological changes after the action of the nanoconjugates. Similarly, Nevellet 
al.[77]and Pandey et al [78]have demonstrated the improved photothermaleffect of combining FA-
conjugated gold nanorodswith NIR irradiation.The results herein demonstrated the selective anti-
tumor efficacy ofAu NS-PEG-SS-DOXO-FA combining chemotherapy andphotothermal therapy 
under NIR laser irradiation, that eclipsed that of DOXO, Au NS, or Au NS-PEG-SS-DOXO. 
 
7.5 Conclusions 
 In summary, we have successfully developedtumor targeted Au NS-PEG-SS-
DOXO nanoconjugates forcombinedphotothermal and chemo-therapy. Tumor-
targeting ability of Au NS nanoconjugateswas further enhanced when a targeting 
molecule, FA, was attached to the nanoconjugate surface, and tested on FA-
overexpressing cells such as HeLa by FA-mediated activetargeting. Au NS-PEG-SS-
DOXO-FA enabledthe active delivery of the chemotherapeutic drug near the nucleus, 
allowing its subsquent incorporation upon further incubation. Tumor cellsshowed 
significant morphological changes upon the action of NIR light irradiation and the 
chemotherapeutic drug. In comparisonwith conventional hyperthermia or 
chemotherapy,the enhanced tumor therapy efficacy was demonstrated in Au NS-PEG-
SS-DOXO-FAin vitro due to thecombination of the dual treatment. A synergistic 
effect between the chemotherapy and thermotherapy was confirmed by the 
therapeutic results of Au NS PEG-SS-DOXO-FA treated groups when compared with 
Au NS or free DOXO treated groups. Meanwhile, the nature of the targeting ligand 
could improve the cellular uptake of nanoconjugates, as demonstrated by 
experimental cytotoxicity data of Au NS-PEG-SS-DOXO, Au NS-PEG-SS-DOXO-
FA, nad those when previously blocking celll FA receptors with free FA before 
addition of NS-PEG-SS DOXO-FA nanoconjugates. The above facts provide insight 
into thedevelopment of new strategies to design drug-loadednanoconstructs with 
increased therapeutic efficacy and prompt further exploration of these 
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nanoconstructsfor combined therapy of other related diseases. To the best of our 
knowledge, this is an innovation,only one recent work recently appeared while 
preparing this manuscript combined the photothermal therapeutic effect of gold 
nanostars and the chemotherapeutic effect of DOX for tumor-targeted therapy[61]. In 
contrast to this work, our nanoconjugates enabled the enzymatic-triggerable release of 
the chemotherapeutic drug inside the cells by breaking the disulfide bond through 
which the drug is bound to the Au Ns surface. In this way, our construction 
thenprovides additionalselectivity to the chemotherapeutic activity of the 
nanoconjugates. 
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Conclusions 
 
The results obtained reveal that the possible combination of chemotherapy, 
magnetic targeting, and photothermal therapy through polymeric NPs is expected to 
increase the likelihood of cell killing significantly, to improve the selectivity greatly 
and, potentially, to overcome resistance to chemotherapeutic agents, making it a 
promising approach not only for cancer therapy but also for other diseases as 
Alzheimer´s or Parkinson´s thanks to the ability of the present NPs to overcome the 
BBB. PLGA hybrid NPs could be guided to the tumor area by a magnetic field, 
followed by the combination of NIR laser irradiation at the tumor site, which should 
enhance the targeting effectiveness. The permeability of tumor vessels and the 
sensitivity of the tumor cells toward chemotherapeutics should be greatly enhanced by 
hyperthemia, holding the promise of improving drug efficacy. Photothermal ICG-
mediated therapy may facilitate triggered and instant drug release from the NPs, which 
is critical for achieving a high effective drug concentration in the tumor. Moreover, one 
of the major advantages of NIR laser light as a source of hyperthermia is that the 
exposures are non-invasive and applied extracorporally, compared with other types of 
hyperthermia like radiofrequency or microwave ablation. In addition, the magnetic and 
luminescent properties of the hybrid NPs gained through the simultaneous incoporation 
of Fe3O4 NPs and the fluorescent ICG dye in their nanostructure also allows, at the same 
time, the use of these nanoplatforms as multimodal imaging diagnostic nanoconstructs 
able to follow their therapeutic response in vivo, configuring an example of fully 
biocompatible and biodegradable theranostic nanodevices. 
We have synthesized branched gold nanoshells (BGNS) with PLGA cores by 
means of a surfactant-less method, using an HAuCl4/K2CO3 growth solution and 
concentrated ascorbic acid as reductant. Size and structure (anisotropy) and, in 
consequence, the optical properties of nanostructures were tuned by modulating the 
synthetic conditions (feed ratios of Au growth solution, AA and NP-seed precursor). 
Both chitosan and AA played an important role as co-reductants and directing agents, 
resulting in the growth of highly branched structures resembling geometries found in 
nature, such as viruses, sea-urchins or bushes. Among the diverse experimental 
variables, the concentration of AA was dominant to enhance the reactivity of gold ions 
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by preferential reduction of AuI to Au0 on the seed surfaces onto preferred facet via a 
kinetics-favored process. A excessive amount of AA promotes an instant reduction of 
the particles, decreasing their anisotropy by the isotropic deposition of the gold ions and 
the adsorption of excess AA on the surface of nanoshells. Meaningfully, the as-prepared 
BGNS were stable in aqueous solution for several months, and were found to be 
internalised by cells in the cytoplasm and fully biocompatible, as deduced from a cell 
viability test. The hollow and branched architecture of BGNS is also advantageous 
because it adds another control characteristic (i.e. core size) to tune the plasmon band 
position to the near infrared region of the electromagnetic spectrum, and allowing their 
potential use as photothermal agents and/or surface enhanced Raman scattering (SERS) 
probes. In addition, other functional materials and molecules can be incorporated into 
the core to fabricate multifunctional materials. In this way, these branched hollow NPs 
hold potential applicability as multifunctional nanoteranostic agents due to their optical 
properties and core-carrying capacity. 
Likewise, we have synthesized polymeric core-Au coated nanoshells as a 
multifunctional platform to combine MR imaging, magnetic- and folic-acid targeted 
drug delivery, NIR light-triggered drug release, and photothermal therapy 
simultaneously into one system. The resulting nanoplatforms display enhanced T2 -
weighted MRI properties and surface plasmon absorbance in the NIR region, thus 
exhibiting an NIR-induced temperature elevation and an NIR light-triggered and 
stepwise release behavior of doxorubicin.  
Cell viability tests reveal that the combination of chemotherapy, magnetic, and 
ligand-induced targeting, and NIR photothermal therapy. DXSP-PLGA-PGNH-FA 
increased the likelihood of cell killing significantly and shoewd an improved cellular 
uptake driven by FA and magnetic targeting. Selectivity of DXSP-PGNHs-FA will be 
tested in further studies using a cell line without overexpressed FA receptors (FA-R) 
and co-cultures with FA-R non-overexpressing and overexpressing cellular lines. This 
potentially might help to overcome resistance to chemotherapeutic agents, making it a 
promising approach for future cancer therapy.  
The nanoplatforms could be guided to the tumor area by the combination of 
ligand-induced and magnetic-assisted targeting, followed by NIR laser irradiation at the 
tumor site. This would enhance their targeting effectiveness as observed in vitro tests , 
in which a synergistic effect in killing cancer cells was found by the combined 
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photothermal therapy and the magnetic-field and ligand-guided drug delivery.  
In this regard, the permeability of tumor vessels and the sensitivity of the tumor 
cells toward chemotherapeutics should be greatly enhanced by hyperthemia, holding the 
promise of improving drug efficacy. In addition, photothermal therapy may facilitate 
triggered and enhanced drug release from the multifunctional nanoparticles, which is 
critical for achieving a high effective drug concentration in the tumor.  
Future studies employing more sophisticated nanoplatforms should perfectly 
allow both spatially and temporally improved hyperthermia, opto-magnetic-resonance 
imaging contrast agents for in vivo monitoring of tissue pharmacokinetics and cell 
tracking, and enable a perfect and on-demand control of drug release dynamics for 
completely efficient chemotherapy. 
We have successfully fabricated a potential smart theranostic nanoplatform 
composed of a chemotherapeutic agent (DOXO) and a polymer-based gold shell which 
additionally combines localized photothermal activity provided by the metal shell and 
generation of singlet oxygen by the ICG photosensitizer under NIR light illumination. 
The gold nanolayer was functionalized with HSA-ICG-FA complex to provide, on one 
hand, stealthness to the nanoplatform and on the other hand photodynamic therapy and 
fluorescence based imaging capabilities and the targeting ligand (folic acid). In addition, 
the thickness of the protein layer was suitable to provide an enhancement of the dye 
fluorescence by the plasmonic coupling of the metal nanolayer. In vitro confocal 
fluorescence imaging confirmed the succesfull cell internalization of the hybrid 
nanoplatforms whilst in vivo fluorescence imaging demonstrated that the nanoplatforms 
are highly localized and retained in the tumor region for long time thanks. Certain 
accumulation of the nanoplatforms in the brain area is also observed, which might open 
up the utility of the present system to fight against diverse brain diseases. The 
simultaneous combination of chemotherapy hyperthermia and oxygen reactive species 
led to an enhanced in vitro cell cytotoxicity of the nanoplatforms, as measured in two 
different cancer cell lines. Further studies are being developed to minimize light 
irradiation doses and nanoplatform concentrations by optimization of the synthetic 
protocols while adding new functionalities and to quantify the cytotoxic potential of the 
nanoplatforms in vivo. 
 Finally, we have successfully developed tumor targeted gold nanostars functionalized 
with DOXO (Au NS-PEG-SS-DOXO) nanoconjugates for combined photothermal and chemo-
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therapy.  Tumor-targeting ability of Au NS nanoconjugates was further enhanced when a 
targeting molecule, FA, was attached to the nanoconjugate surface, and tested on FA-
overexpressing cells such as HeLa by FA-mediated active targeting. Au NS-PEG-SS-DOXO-
FA enabled the active delivery of the chemotherapeutic drug near the nucleus, allowing its 
subsquent incorporation upon further incubation.  
 Tumor cells showed significant morphological changes upon the action of NIR light 
irradiation and the chemotherapeutic drug. In comparison with conventional hyperthermia or 
chemotherapy, the enhanced tumor therapy efficacy was demonstrated in Au NS-PEG-SS-
DOXO-FA in vitro due to the combination of the dual treatment.  
 A synergistic effect between the chemotherapy and thermotherapy was confirmed by 
the therapeutic results of Au NS PEG-SS-DOXO-FA treated groups when compared with Au 
NS or free DOXO treated groups. Meanwhile, the nature of the targeting ligand could improve 
the cellular uptake of nanoconjugates, as demonstrated by experimental cytotoxicity data of Au 
NS-PEG-SS-DOXO, Au NS-PEG-SS-DOXO-FA, nad those when previously blocking celll FA 
receptors with free FA before addition of NS-PEG-SS DOXO-FA nanoconjugates. The above 
facts provide insight into the development of new strategies to design drug-loaded 
nanoconstructs with increased therapeutic efficacy and prompt further exploration of these 
nanoconstructs for combined therapy of other related diseases. To the best of our knowledge, 
this is an innovation, only one recent work recently appeared while preparing this manuscript 
combined the photothermal therapeutic effect of gold nanostars and the chemotherapeutic effect 
of DOX for tumor-targeted therapy [61]. In contrast to this work, our nanoconjugates enabled 
the enzymatic-triggerable release of the chemotherapeutic drug inside the cells by breaking the 
disulfide bond through which the drug is bound to the Au Ns surface. In this way, our 
construction then provides additional selectivity to the chemotherapeutic activity of the 
nanoconjugates. 
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